JPH0680686A - Acidic functional group-bearing lipid derivative and fine carrier particle coated therewith - Google Patents

Acidic functional group-bearing lipid derivative and fine carrier particle coated therewith

Info

Publication number
JPH0680686A
JPH0680686A JP25909092A JP25909092A JPH0680686A JP H0680686 A JPH0680686 A JP H0680686A JP 25909092 A JP25909092 A JP 25909092A JP 25909092 A JP25909092 A JP 25909092A JP H0680686 A JPH0680686 A JP H0680686A
Authority
JP
Japan
Prior art keywords
compound
added
mixture
reduced pressure
under reduced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP25909092A
Other languages
Japanese (ja)
Other versions
JP2710900B2 (en
Inventor
Yasuri Morikawa
安理 森川
Kunio Azuma
邦雄 東
Katsutoshi Aono
勝利 青野
Atsushi Sasaki
淳 佐々木
Naoichi Murahashi
直一 村橋
Masahiro Sakagami
昌浩 阪上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
D D S KENKYUSHO KK
Original Assignee
D D S KENKYUSHO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by D D S KENKYUSHO KK filed Critical D D S KENKYUSHO KK
Priority to JP4259090A priority Critical patent/JP2710900B2/en
Publication of JPH0680686A publication Critical patent/JPH0680686A/en
Application granted granted Critical
Publication of JP2710900B2 publication Critical patent/JP2710900B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

PURPOSE:To provide fine carrier particles for drug delivery, to be hardly scavenged by the reticulo-endothelial tissue. CONSTITUTION:The objective lipid derivative with a compound having at least one acidic functional group added to one end of the polyethylene glycol chain >=3 in the polymerization degree of ethylene glycol and a compound having at least one >=5C alkyl and/or alkenyl group at the other end. The other objective fine carrier particles coated with this derivative.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、新規な酸性官能基を有
する脂質誘導体および該誘導体を使用した微粒子キャリ
ヤーに関する。更に詳しくは、酸性基を有する物質で被
覆した微粒子キャリヤーを製造するにあたっての該物質
として使用される酸性官能基を有する脂質誘導体および
該誘導体を使用して得られる微粒子キャリヤーに関す
る。
FIELD OF THE INVENTION The present invention relates to a lipid derivative having a novel acidic functional group and a fine particle carrier using the derivative. More specifically, it relates to a lipid derivative having an acidic functional group used as a substance for producing a fine particle carrier coated with a substance having an acidic group, and a fine particle carrier obtained by using the derivative.

【0002】[0002]

【従来技術および問題点】生体に投与された薬物を必要
な組織に必要な時に必要な量だけ送達し、有効な薬物治
療を行なうドラッグデリバリーシステムの一つの手段と
して、リポソームやリピッドマイクロスフェアーなどの
微粒子キャリヤーを利用することは一般にすでに公知で
ある。
2. Description of the Related Art Liposomes, lipid microspheres, etc. are used as one means of drug delivery system for delivering effective drug treatment by delivering a drug administered to a living body to a required tissue in a required amount at a required time. It is generally already known to utilize the fine particle carriers of

【0003】しかるに、リポソームは細網内皮系組織に
捕捉され易く、血液中に望ましい時間滞留しない。従っ
て、リポソームをいかに細網内皮系組織に捕捉され難く
するかがリポソームを使用する上での解決されるべき課
題として残されていた。
However, liposomes are easily trapped by reticuloendothelial tissues and do not stay in blood for a desired time. Therefore, how to make the liposome difficult to be captured by the reticuloendothelial system remains a problem to be solved in using the liposome.

【0004】[0004]

【課題を解決するための手段】上記の課題に対して、本
発明者は種々の検討を行い、その結果、酸性基を有する
部分と脂質部分との中間にポリエチレングリコール鎖を
導入して得られる新規物質の酸性官能基を有する脂質誘
導体によりリポソームを被覆すれば前記課題が解決する
ことを見い出し、本発明を完成した。
Means for Solving the Problems To solve the above problems, the present inventor has conducted various studies, and as a result, obtained by introducing a polyethylene glycol chain between the acidic group-containing portion and the lipid portion. The present invention has been completed by finding that the above problems can be solved by coating a liposome with a lipid derivative having an acidic functional group of a novel substance.

【0005】すなわち、本発明は、エチレングリコール
の重合度が3以上のポリエチレングリコール鎖の一端に
1個または複数個の酸性官能基を有する化合物が付加さ
れかつ他端に1個または複数個の炭素原子数5以上のア
ルキル基および/またはアルケニル基を有する化合物が
付加されてなる酸性官能基を有する脂質誘導体、及びこ
れによって被覆された微粒子キャリヤーに関する。
That is, according to the present invention, a compound having one or a plurality of acidic functional groups is added to one end of a polyethylene glycol chain having a degree of polymerization of ethylene glycol of 3 or more and one or a plurality of carbon atoms is added to the other end. The present invention relates to a lipid derivative having an acidic functional group to which a compound having an alkyl group and / or an alkenyl group having 5 or more atoms is added, and a fine particle carrier coated with the lipid derivative.

【0006】以下、本発明を詳細に説明する。The present invention will be described in detail below.

【0007】まず、本発明の酸性官能基を有する脂質誘
導体について説明する。
First, the lipid derivative having an acidic functional group of the present invention will be described.

【0008】本発明の酸性官能基を有する脂質誘導体
は、エチレングリコールの重合度が3以上のポリエチレ
ングリコール鎖の一端に1個または複数個の酸性官能基
を有する化合物が付加されかつ他端に1個または複数個
の炭素原子数5以上のアルキル基および/またはアルケ
ニル基を有する化合物が付加されてなるものであるが、
このポリエチレングリコール鎖のエチレングリコール重
合度は、微粒子キャリヤーの微粒子の表面から離れた形
で酸性官能基が存在するような構造をとらせるために、
3以上、好ましくは3〜10、より好ましくは3〜7であ
る。エチレングリコールの重合度が2以下であるとき
は、後出検査例1(重合度1のものとの比較例)に示す
ように、酸性官能基を有する脂質誘導体の水性溶媒に対
する溶解性が低くて使用できない。なお、エチレングリ
コールの重合度は、ポリエチレングリコールの末端水酸
基が他の官能基に置換されまたは脱離されているときに
も1個として算入する。
In the lipid derivative having an acidic functional group of the present invention, a compound having one or a plurality of acidic functional groups is added to one end of a polyethylene glycol chain having a degree of polymerization of ethylene glycol of 3 or more, and 1 is added to the other end. A compound having one or more alkyl groups and / or alkenyl groups having 5 or more carbon atoms is added,
The degree of ethylene glycol polymerization of this polyethylene glycol chain is such that an acidic functional group exists in a form separated from the surface of the fine particles of the fine particle carrier,
It is 3 or more, preferably 3 to 10, and more preferably 3 to 7. When the degree of polymerization of ethylene glycol is 2 or less, the solubility of the lipid derivative having an acidic functional group in an aqueous solvent is low as shown in Test Example 1 (Comparative Example with Polymerization Degree 1). I can not use it. The degree of polymerization of ethylene glycol is included as one even when the terminal hydroxyl group of polyethylene glycol is substituted or eliminated by another functional group.

【0009】酸性官能基としては、例えば、燐酸残基、
硫酸残基、カルボキシル基、スルフォニル基、スルフェ
ニル基、スルフィニル基、フォスフォノ基、フォスフォ
ニル基、フォスフィニル基、フォスフェニル基、ジヒド
ロヒドロキソフォスフォラス基、ヒドロジヒドロキソフ
ォスフォラス基、ヒドロヒドロキソフォスフォラス基お
よびジヒドロキソフォスフォラス基を挙げることができ
る。
Examples of the acidic functional group include a phosphoric acid residue,
Sulfate residue, carboxyl group, sulfonyl group, sulfenyl group, sulfinyl group, phosphono group, phosphonyl group, phosphinyl group, phosphenyl group, dihydrohydroxophosphorus group, hydrodihydroxophosphorus group, hydrohydroxophosphorus group and dihydro A xosophorus group can be mentioned.

【0010】これらの酸性官能基を1個または複数個有
する化合物としては、例えば、燐酸;硫酸;燐酸モノメ
チルエステルなどの燐酸残基を有する化合物;硫酸N−
(3−ヒドロキシプロピル)アミドなどの硫酸残基を有
する化合物;2−ヒドロキシエタンフォスフォン酸など
のフォスフォン酸誘導体;2−ヒドロキシエタンフォス
フェン酸などのフォスフェン酸誘導体;ヒドロキシメタ
ンスルフォン酸などのスルフォン酸誘導体;p−ヒドロ
キシメチルベンゼンスルフェン酸などのスルフェン酸誘
導体;3−ヒドロキシ−2−ブタンスルフィン酸などの
スルフィン酸誘導体;リンゴ酸−1−メチルエステル、
グルタミン酸などのカルボン酸;および酸性官能基を有
する糖を挙げることができる。
Examples of compounds having one or more of these acidic functional groups include phosphoric acid; sulfuric acid; compounds having phosphoric acid residues such as phosphoric acid monomethyl ester; sulfuric acid N--
A compound having a sulfuric acid residue such as (3-hydroxypropyl) amide; a phosphonic acid derivative such as 2-hydroxyethanephosphonic acid; a phosphenic acid derivative such as 2-hydroxyethanephosphonic acid; a sulfone such as hydroxymethanesulfonic acid. Acid derivatives; Sulfenic acid derivatives such as p-hydroxymethylbenzenesulfenic acid; Sulfinic acid derivatives such as 3-hydroxy-2-butanesulfinic acid; Malic acid-1-methyl ester,
Mention may be made of carboxylic acids such as glutamic acid; and sugars having acidic functional groups.

【0011】そして、酸性官能基を有する糖としては、
例えば、N−アセチルノイラミン酸;グルクロン酸、ガ
ラクツロン酸などのウロン酸;および次のような糖に前
述の酸性官能基が1個または複数個結合したものを挙げ
ることができる。ここに次のような糖としては、例え
ば、単糖類の、アラビノピラノース、キシロピラノー
ス、リキソピラノース、リボフラノースなどのアルドペ
ントース;グルコピラノース(グルコース)、ガラクト
ピラノース(ガラクトース)、マンノピラノース(マン
ノース)、フコピラノース(フコース)などのアルドヘ
キソース;2−アミノ−2−デオキシグルコピラノー
ス、2−アミノ−2−デオキシガラクトピラノ−スなど
のヘキソサミン;および2−アセトアミノ−2−デオキ
シグルコピラノース、2−アセトアミノ−2−デオキシ
ガラクトピラノースなどのヘキソサミン誘導体;ならび
に、オリゴ糖類である、ラクトース、キシロピオース、
マルトース、セロビオース、キトビオース、メリビオー
ス、エピセロビオース、ツラノース、スクロース、ラク
ツロース、ルチノースなどの二糖類;ラフィノース、ウ
ンベリフェロース、シアリルラクトース、6′−ガラク
トシルラクトースなどの三糖類;およびジフコシルラク
トース、ラクト−N−テトラオース、ラクト−N−ネオ
テトラオースなどの四糖類を挙げることができる。
And as the sugar having an acidic functional group,
Examples thereof include N-acetylneuraminic acid; uronic acids such as glucuronic acid and galacturonic acid; and those in which one or more of the above-mentioned acidic functional groups are bonded to the following sugars. Examples of the following sugars include, for example, monosaccharides such as arabinopyranose, xylopyranose, lyxopyranose, and ribofuranose; aldopentose; glucopyranose (glucose), galactopyranose (galactose), and mannopyranose ( Mannose), fucopyranose (fucose), and other aldohexoses; 2-amino-2-deoxyglucopyranose, 2-amino-2-deoxygalactopyranose, and other hexosamines; and 2-acetamino-2-deoxyglucopyranose, 2 -Hexosamine derivatives such as acetamino-2-deoxygalactopyranose; and oligosaccharides, lactose, xylopiose,
Disaccharides such as maltose, cellobiose, chitobiose, melibiose, epicellobiose, turanose, sucrose, lactulose and rutinose; trisaccharides such as raffinose, umbelliferose, sialyllactose and 6'-galactosyl lactose; and difucosyl lactose, lacto-N. And tetrasaccharides such as tetraose and lacto-N-neotetraose.

【0012】酸性官能基と糖との結合様式としては、例
えば、−OPO3 2 ,−OPO3Na2 ,−OPO
(OPh)2 などのように燐酸エステル、−OSO
3 H、−OSO3 Naなどのように硫酸エステル等エス
テル結合を介するもの;−O−(CH2 n −COO
H、−O−(CH2 n −OPO3 2 などのようにエ
ーテル結合を介するもの;および、例えば、下記のよう
に酸性官能基が糖の炭素原子に直接結合しているものを
挙げることができる。
[0012] The bonding mode of an acidic functional group and a sugar, for example, -OPO 3 H 2, -OPO 3 Na 2, -OPO
(OPh) 2 etc., phosphate ester, -OSO
3 H, be via acid ester an ester bond, such as -OSO 3 Na; -O- (CH 2 ) n -COO
Mentioned and, for example, those acidic functional group is bonded directly to a carbon atom of the sugar as follows; H, -O- (CH 2) shall through an ether bond, such as n -OPO 3 H 2 be able to.

【0013】[0013]

【化1】 更に、糖の炭素原子にメチレン基等の低級アルキル基を
介して酸性官能基が結合している場合もある。
[Chemical 1] Furthermore, an acidic functional group may be attached to the carbon atom of the sugar via a lower alkyl group such as a methylene group.

【0014】ポリエチレングリコールの一端に酸性官能
基を有する糖以外の化合物が付加されるときの結合様式
は、例えば、−OPO3 2 、−OPO3 Na2 などの
ような燐酸エステル、−OSO3 H、−OSO3 Naな
どのような硫酸エステル等エステル結合;−O−(CH
2 n −COOH、−O−(CH2 n −OPO
3 2 、−O−(CH2 n −CONH−などのような
エーテル結合;および、例えば、下記のように酸性官能
基がポリエチレングリコールの炭素原子に直接結合して
いるものを挙げることができる。
When a compound other than a sugar having an acidic functional group is added to one end of polyethylene glycol, the coupling mode is, for example, a phosphate ester such as -OPO 3 H 2 , -OPO 3 Na 2 or -OSO 3. H, sulfuric acid ester an ester bond, such as -OSO 3 Na; -O- (CH
2) n -COOH, -O- (CH 2) n -OPO
Ether linkages such as 3 H 2 , —O— (CH 2 ) n —CONH—, and, for example, those in which an acidic functional group is directly bonded to a carbon atom of polyethylene glycol as described below. it can.

【0015】[0015]

【化2】 ポリエチレングリコールに酸性官能基を有する糖が付加
されるときは、例えば、グリコシド結合が挙げられる。
酸性官能基を有する糖は、糖骨格のいずれの炭素原子に
おいてもポリエチレングリコールに付加されていてもよ
く、グリコシド結合を介して付加されている場合はアノ
マー中心の配位はαでもβでもよい。因みに、酸性官能
基を有する糖のポリエチレングリコールへの付加は、グ
リコシド結合が容易である。
[Chemical 2] When a sugar having an acidic functional group is added to polyethylene glycol, for example, a glycosidic bond can be mentioned.
The sugar having an acidic functional group may be added to polyethylene glycol at any carbon atom of the sugar skeleton, and when added via a glycosidic bond, the coordination of the anomeric center may be α or β. Incidentally, addition of sugar having an acidic functional group to polyethylene glycol facilitates glycosidic bond.

【0016】ポリエチレングリコール鎖の他端に付加さ
れている1個または複数個の炭素原子数5以上のアルキ
ル基および/またはアルケニル基を有する化合物におけ
るアルキル基およびアルケニル基の炭素原子数は、好ま
しくは10以上であるが、50より大きくなるとこれらの化
合物の合成反応の効率が低下する。また、アルキル基お
よびアルケニル基は、直鎖および分枝鎖のいずれでもよ
い。
The number of carbon atoms of the alkyl group and the alkenyl group in the compound having one or more alkyl groups and / or alkenyl groups having 5 or more carbon atoms attached to the other end of the polyethylene glycol chain is preferably It is 10 or more, but if it exceeds 50, the efficiency of the synthesis reaction of these compounds decreases. The alkyl group and alkenyl group may be linear or branched.

【0017】これらの化合物が1個または複数個のアル
キル基および/またはアルケニル基を有する態様として
は、第一に分枝鎖型アルキル基またはアルケニル基であ
る場合と、第二に分枝鎖型および/または直鎖型アルキ
ル基またはアルケニル基が次に例示するようにリンカー
を介して結合してる場合を挙げることができる。
As an embodiment in which these compounds have one or a plurality of alkyl groups and / or alkenyl groups, there are firstly a branched alkyl group or alkenyl group and secondly a branched chain type. And / or a linear alkyl group or an alkenyl group may be bonded via a linker as exemplified below.

【0018】[0018]

【化3】 ポリエチレングリコール(PEG)とアルキル基および
/またはアルケニル基を有する化合物との結合様式は、
例えば、PEG−OCO−n−C1633などのようなエ
ステル結合;PEG−O−n−C1837などのようなエ
ーテル結合;末端水酸基をアミノ基に変換したポリエチ
レングリコールのアミノ基に対してPEG−NHCO−
n−C1531、PEG−NHCO−CH−(n−C16
332 などのようなアミド結合;ウレタン結合;および
ウレア結合;更にはポリエチレングリコールの末端炭素
原子にアルキル基またはアルケニル基が直接結合してい
るものを挙げることができる。
[Chemical 3] The bonding mode of polyethylene glycol (PEG) and a compound having an alkyl group and / or an alkenyl group is
For example, an ester bond such as PEG-OCO-n-C 16 H 33 and the like; an ether bond such as PEG-O-n-C 18 H 37 and the like; to an amino group of polyethylene glycol in which a terminal hydroxyl group is converted to an amino group. On the other hand, PEG-NHCO-
n-C 15 H 31, PEG -NHCO-CH- (n-C 16 H
33 ) An amide bond such as 2 ; a urethane bond; and a urea bond; and further those having an alkyl group or an alkenyl group directly bonded to the terminal carbon atom of polyethylene glycol.

【0019】因みに、ポリエチレングリコールの末端−
OH基を−NH2 基に変えるには、例えば、次のように
するとよい。
Incidentally, the end of polyethylene glycol
In order to change the OH group to the —NH 2 group, for example, the following may be performed.

【0020】[0020]

【化4】 上述のように、本発明物質の酸性官能基を有する脂質誘
導体は新規物質であるが、一般的には、例えば、次のよ
うにして製造することができる。
[Chemical 4] As described above, the lipid derivative having an acidic functional group of the substance of the present invention is a novel substance, but it can be generally produced, for example, as follows.

【0021】すなわち、PEGの一端に酸性官能基を有
する糖などの酸性官能基を有する化合物または酸性官能
基自体を導入した後、他の一端を、前述の末端−OH基
を−NH2 に変える方法などで、アミノ基に変換し、次
いでこれをアシル化、ウレタン化またはウレア化するこ
とにより目的化合物の保護体を得ることができる。これ
を脱保護して目的化合物に誘導できる。
[0021] That is, after the introduction of the compound or an acidic functional group itself has an acidic functional group such as sugars, having an acidic functional group at one end of the PEG, the other end, changing the terminal -OH groups of the aforementioned -NH 2 A protected compound of the target compound can be obtained by converting it to an amino group by a method and then acylating, urethanizing or urea-converting the amino group. This can be deprotected to induce the desired compound.

【0022】また、アミノ基に変換することなく、エー
テル化またはエステル化を経て保護体とした後、脱保護
して目的化合物へ導く方法もある。
There is also a method in which a protected compound is obtained through etherification or esterification without conversion to an amino group and then deprotected to obtain the desired compound.

【0023】また、PEGの一端にアルキル基またはア
ルケニル基を導入した後、これに酸性官能基を有する糖
などの酸性官能基を有する化合物または酸性官能基自体
を導入した後、脱保護して目的化合物に誘導できる。
Further, after introducing an alkyl group or an alkenyl group into one end of PEG and then introducing a compound having an acidic functional group such as a sugar having an acidic functional group or the acidic functional group itself into the PEG, deprotection is carried out. Can be induced by compounds.

【0024】なお、酸性官能基を有する化合物は、酸性
官能基を有する糖を含めて、一般的な酸性官能基導入法
に基いて合成可能であり、また、酸性官能基のみを導入
する場合も一般的な方法に基いて行なうことができる。
The compound having an acidic functional group can be synthesized based on a general method for introducing an acidic functional group including a sugar having an acidic functional group, or when only an acidic functional group is introduced. It can be performed based on a general method.

【0025】次に、本発明の微粒子キャリヤーについて
説明する。
Next, the fine particle carrier of the present invention will be described.

【0026】本発明の微粒子キャリヤーは、上述した本
発明の物質である酸性官能基を有する脂質誘導体を配合
して得られる微粒子キャリヤーであって、該物質の特定
の性質を専ら利用する物である。
The fine particle carrier of the present invention is a fine particle carrier obtained by blending the above-mentioned substance of the present invention, which is a lipid derivative having an acidic functional group, and is a product which makes full use of specific properties of the substance. .

【0027】本発明の微粒子キャリヤーは、具体的に
は、リポソーム、リピッドマイクロスフェアー、ミセ
ル、エマルジョンを挙げることができる。これらキャリ
ヤーの調製はそれぞれ従来公知の方法に従って行えばよ
く、基本的には本発明の物質を両親媒性物質である他の
膜成分と共に溶媒に溶解または分散して混合する。
Specific examples of the fine particle carrier of the present invention include liposomes, lipid microspheres, micelles and emulsions. Each of these carriers may be prepared by a conventionally known method, and basically, the substance of the present invention is dissolved or dispersed in a solvent and mixed with other membrane components which are amphipathic substances.

【0028】例えば、リポソームの場合には、ホスファ
チジルコリン、スフィンゴミエリン、ホスファチジルエ
タノールアミン等の脂質やジアルキル型合成界面活性剤
等の膜成分物質と本発明の物質とを予め混合し、これを
公知の方法(Ann. Rev. Biophys. Bioeng., 9, 467(198
0))に従いリポソームの水分散液を調製する。かかるリ
ポソームは膜安定化剤としてコレステロール等のステロ
ール類、ジアルキルリン酸、ステアリルアミン等の荷電
物質およびトコフェロール等の酸化防止剤を含んでいて
もよい。
For example, in the case of liposomes, lipids such as phosphatidylcholine, sphingomyelin and phosphatidylethanolamine, and membrane component substances such as dialkyl-type synthetic surfactants and the substance of the present invention are mixed in advance, and the mixture is subjected to a known method. (Ann. Rev. Biophys. Bioeng., 9, 467 (198
An aqueous dispersion of liposomes is prepared according to 0)). Such liposomes may contain sterols such as cholesterol, charged substances such as dialkylphosphoric acid and stearylamine, and antioxidants such as tocopherol as a membrane stabilizer.

【0029】リピッドマイクロスフェアーの場合には、
ホスファチジルコリンと本発明の物質とを予め混合し、
これに大豆油を加えて公知のリピッドマイクロスフェア
ーの調製方法に従い処理することにより目的のリピッド
マイクロスフェアーを得ることができる。
In the case of lipid microspheres,
Premixing the phosphatidylcholine with the substance of the invention,
The desired lipid microspheres can be obtained by adding soybean oil to this and treating it according to a known method for preparing lipid microspheres.

【0030】ミセルの場合には、ポリオキシソルビタン
脂肪酸エステル、脂肪酸ナトリウムポリオキシエチレン
硬化ヒマシ油等の界面活性剤と本発明の物質とを予め混
合し、公知のミセルの調製方法に従い処理することによ
り目的のミセルを製造することができる。
In the case of micelles, a surfactant such as polyoxysorbitan fatty acid ester, fatty acid sodium polyoxyethylene hydrogenated castor oil and the substance of the present invention are mixed in advance and treated according to a known method for preparing micelles. The desired micelle can be manufactured.

【0031】エマルジョンの場合には、ポリオキシソル
ビタン脂肪酸エステル、脂肪酸ナトリウム、ポリオキシ
エチレン硬化ヒマシ油等の界面活性剤と本発明の物質と
を予め混合し、これに大豆油等の油脂を加えて公知のエ
マルジョンの調製方法に従い処理することにより目的の
エマルジョンを製造することができる。
In the case of an emulsion, a surfactant such as polyoxysorbitan fatty acid ester, sodium fatty acid, polyoxyethylene hydrogenated castor oil, etc. and the substance of the present invention are mixed in advance, and oils such as soybean oil are added thereto. The target emulsion can be produced by treating according to a known emulsion preparation method.

【0032】上記のようにして製造される微粒子キャリ
ヤーにおいて本発明の物質が全脂質膜成分に対して占め
る割合は約1/40モル比以上、好ましくは1/20モル比以上
とするのが望ましい。
The ratio of the substance of the present invention to the total lipid membrane components in the fine particle carrier produced as described above is preferably about 1/40 molar ratio or more, and more preferably 1/20 molar ratio or more. .

【0033】かくして、本発明の物質によって被覆され
た微粒子キャリヤーが得られるが、本発明の物質は、例
えば酸性基を有するが、水溶性スペーサー(本発明物質
ではPEG構造)を有しない脂質誘導体に較べて水溶性
が顕著に向上しているので(後出検査例1参照)、微粒
子キャリヤーの調製が極めて容易となるのである。
Thus, a fine particle carrier coated with the substance of the present invention is obtained. The substance of the present invention is, for example, a lipid derivative having an acidic group but no water-soluble spacer (PEG structure in the substance of the present invention). In comparison, the water solubility is remarkably improved (see Test Example 1 below), which makes it extremely easy to prepare the fine particle carrier.

【0034】かかる微粒子キャリヤーが保持しうる薬物
には特に制限はなく、水溶性薬物でも脂溶性薬物でもよ
く、例えばシトシンアラビノシド、ダウノルビシン及び
メトトレキセートに代表される制癌剤、ペニシリンGに
代表される抗生物質、インシュリン、インターフェロン
及び組織プラスミノーゲンアクチベータに代表される生
理活性物質などを挙げることができる。
There is no particular limitation on the drug which the fine particle carrier can hold, and it may be a water-soluble drug or a fat-soluble drug. For example, an anticancer drug represented by cytosine arabinoside, daunorubicin and methotrexate, and an antibiotic represented by penicillin G. Examples include substances, insulin, interferons, and physiologically active substances represented by tissue plasminogen activator.

【0035】[0035]

【実施例】以下、実施例及び検査例により本発明をさら
に説明する。
The present invention will be further described below with reference to examples and inspection examples.

【0036】実施例1 本実施例における反応を図1に示す。Example 1 The reaction in this example is shown in FIG.

【0037】(a) 化合物1−1と化合物1−2のグリコ
シル化反応 化合物1−1(1.05g)とアルコール(化合物1−2)
(3.38g)を塩化メチレン(100ml)に溶解し、BF3
Et2 O(1.59g)を加え、室温で7日間撹拌した。反
応液をクロロホルムで希釈し、水、5%NaHCO
3 水、水で順次洗浄、乾燥後溶媒を減圧下留去した。残
渣をピリジン(20ml)に溶解し、無水酢酸(15ml)を加
え、室温で2時間撹拌した。
(A) Glycosylation Reaction of Compound 1-1 and Compound 1-2 Compound 1-1 (1.05 g) and alcohol (Compound 1-2)
Dissolve (3.38 g) in methylene chloride (100 ml) and add BF 3 ·.
Et 2 O (1.59 g) was added, and the mixture was stirred at room temperature for 7 days. Dilute the reaction mixture with chloroform and add water, 5% NaHCO 3.
3 Washed successively with water and water, dried and the solvent was distilled off under reduced pressure. The residue was dissolved in pyridine (20 ml), acetic anhydride (15 ml) was added, and the mixture was stirred at room temperature for 2 hours.

【0038】反応液を酢酸エチルで希釈し、水、クエン
酸水、水、5%NaHCO3 水、水で順次洗浄、乾燥後
溶媒を減圧下留去した。残渣をシリカゲル(150 g)を
用いるカラムクロマトグラフィー(ヘキサン−酢酸エチ
ル 2:1)で精製した。再度、シリカゲル(150 g)
を用いるカラムクロマトグラフィー(クロロホルム)で
精製し、α−グリコシド(化合物1−3)(0.56g)と
β−グリコシド(化合物1−4)(0.83g)を得た。
The reaction solution was diluted with ethyl acetate, washed successively with water, citric acid water, water, 5% NaHCO 3 water and water, dried and the solvent was distilled off under reduced pressure. The residue was purified by column chromatography (hexane-ethyl acetate 2: 1) using silica gel (150 g). Again, silica gel (150 g)
Was purified by column chromatography (chloroform) to give α-glycoside (Compound 1-3) (0.56 g) and β-glycoside (Compound 1-4) (0.83 g).

【0039】(α−グリコシド)1 H−NMR(CDCl3 )δ:0.88(3H,t,J=
6.84Hz),1.20−1.34(30H,m),1.57(2H,
m),2.02(3H,s),2.03(3H,s),2.06(3
H,s),3.44(2H,m),3.58(2H,m),3.63
−3.74(9H,m),3.75(3H,s),3.82−3.86
(1H,m),4.45(1H,d,J=10.26Hz),4.8
8(1H,dd,J=3.67Hz,10.26 Hz),5.16
(1H,dd,J=9.52Hz,10.26 Hz),5.21(1
H,d,J=3.67Hz),5.55(1H,dd,J=9.52
Hz,10.26 Hz). (β−グリコシド) [α]D −16.4°(c 1.09,CHCl3 ).1 H−NMR(CDCl3 )δ:0.88(3H,t,J=
6.84Hz),1.20−1.34(30H,m),1.57(2H,
m),2.02(3H,s),2.02(3H,s),2.05(3
H,s),3.44(2H,m),3.58(2H,m),3.60
−3.69(8H,m),3.73−3.79(1H,m),3.75
(3H,s),3.39−3.98(1H,m),4.04(1H,
d,J=8.08Hz),4.66(1H,d,J=7.82H
z),5.01(1H,dd,J=7.82Hz,8.79Hz),
5.22(1H,dd,J=8.80Hz,9.28Hz),5.26
(1H,dd,J=8.79Hz,9.28Hz). (b) 化合物1−5の合成 化合物1−3(155mg )をメタノール(5ml)に溶解
し、28%NaOMe in MeOH(20μl)を加
え、室温で4時間攪拌した。反応液を減圧下濃縮し、残
渣をメタノール(5ml)に溶解し、 0.1N NaOH水
(2ml)を加え、室温で20時間攪拌した。
(Α-Glycoside) 1 H-NMR (CDCl 3 ) δ: 0.88 (3H, t, J =
6.84Hz), 1.20-1.34 (30H, m), 1.57 (2H,
m), 2.02 (3H, s), 2.03 (3H, s), 2.06 (3
H, s), 3.44 (2H, m), 3.58 (2H, m), 3.63
-3.74 (9H, m), 3.75 (3H, s), 3.82-3.86
(1H, m), 4.45 (1H, d, J = 10.26Hz), 4.8
8 (1H, dd, J = 3.67Hz, 10.26Hz), 5.16
(1H, dd, J = 9.52Hz, 10.26Hz), 5.21 (1
H, d, J = 3.67 Hz), 5.55 (1 H, dd, J = 9.52)
Hz, 10.26 Hz). (Β-glycoside) [α] D −16.4 ° (c 1.09, CHCl 3 ). 1 H-NMR (CDCl 3 ) δ: 0.88 (3H, t, J =
6.84Hz), 1.20-1.34 (30H, m), 1.57 (2H,
m), 2.02 (3H, s), 2.02 (3H, s), 2.05 (3
H, s), 3.44 (2H, m), 3.58 (2H, m), 3.60
-3.69 (8H, m), 3.73-3.79 (1H, m), 3.75
(3H, s), 3.39-3.98 (1H, m), 4.04 (1H,
d, J = 8.08Hz), 4.66 (1H, d, J = 7.82H)
z), 5.01 (1H, dd, J = 7.82Hz, 8.79Hz),
5.22 (1H, dd, J = 8.80Hz, 9.28Hz), 5.26
(1H, dd, J = 8.79Hz, 9.28Hz). (b) Synthesis of Compound 1-5 Compound 1-3 (155 mg) was dissolved in methanol (5 ml), 28% NaOMe in MeOH (20 μl) was added, and the mixture was stirred at room temperature for 4 hr. The reaction mixture was concentrated under reduced pressure, the residue was dissolved in methanol (5 ml), 0.1N NaOH aqueous solution (2 ml) was added, and the mixture was stirred at room temperature for 20 hr.

【0040】反応液を加熱後ローム・アンド・ハース社
製陽イオン交換樹脂「アンバーライトIRC−50」を加
え、不溶物を濾去後濾液を減圧下濃縮乾固し、残渣をエ
ーテルで洗浄し、目的化合物1−5(80mg)を無色粉末
として得た。
After heating the reaction solution, a cation exchange resin "Amberlite IRC-50" manufactured by Rohm and Haas was added, insoluble materials were filtered off, the filtrate was concentrated to dryness under reduced pressure, and the residue was washed with ether. The target compound 1-5 (80 mg) was obtained as a colorless powder.

【0041】[α]D +31.7°(c 0.99,MeO
H).1 H−NMR(CD3 OD)δ:0.90(3H,t,J=
6.59Hz),1.24−1.38(30H,m),1.57(2H,
m),3.40−3.45(2H,m),3.46−3.50(2H,
m),3.57−3.61(2H,m),3.62−3.73(10H,
m),3.86−3.90(1H,m),3.92(1H,d,J=
10.26 Hz). 実施例2 本実施例における反応も図1に示す。
[Α] D + 31.7 ° (c 0.99, MeO
H). 1 H-NMR (CD 3 OD) δ: 0.90 (3 H, t, J =
6.59Hz), 1.24-1.38 (30H, m), 1.57 (2H,
m), 3.40-3.45 (2H, m), 3.46-3.50 (2H,
m), 3.57-3.61 (2H, m), 3.62-3.73 (10H,
m), 3.86-3.90 (1H, m), 3.92 (1H, d, J =
10.26 Hz). Example 2 The reaction in this example is also shown in FIG.

【0042】(a) 化合物2−1の合成 化合物1−4(138mg )をメタノール(5ml)に溶解
し、28%NaOMe in MeOH(20μl)に加
え、室温で5時間攪拌した。反応液を減圧下圧縮し、残
渣をメタノール(5ml)に溶解し、 0.1N NaOH水
(3ml)に加え、室温で20時間攪拌した。
(A) Synthesis of Compound 2-1 Compound 1-4 (138 mg) was dissolved in methanol (5 ml), added to 28% NaOMe in MeOH (20 μl), and stirred at room temperature for 5 hours. The reaction solution was compressed under reduced pressure, the residue was dissolved in methanol (5 ml), added to 0.1 N NaOH aqueous solution (3 ml), and stirred at room temperature for 20 hours.

【0043】反応液を加熱後「アンバーライトIRC−
50」を加え、不溶物を濾去後濾液を減圧下濃縮乾固し、
残渣をエーテルで洗浄し、目的化合物2−1(87mg)を
無色粉末とした得た。
After heating the reaction solution, "Amberlite IRC-
50 "was added, the insoluble matter was filtered off, the filtrate was concentrated to dryness under reduced pressure,
The residue was washed with ether to obtain the target compound 2-1 (87 mg) as a colorless powder.

【0044】[α]D −22.8°(c 0.68,MeO
H).1 H−NMR(CD3 OD)δ:0.90(3H,t,J=
6.59Hz),1.24−1.36(30H,m),1.57(2H,
m),3.22−3.28(1H,m),3.40−3.45(2H,
m),3.45−3.50(2H,m),3.55−3.61(3H,
m),3.62−3.75(8H,m),3.76−3.82(1H,
m),4.06−4.11(1H,m),4.32(1H,d,J=
7.82Hz). 実施例3 本実施例における反応を図2に示す。
[Α] D −22.8 ° (c 0.68, MeO
H). 1 H-NMR (CD 3 OD) δ: 0.90 (3 H, t, J =
6.59Hz), 1.24-1.36 (30H, m), 1.57 (2H,
m), 3.22-3.28 (1H, m), 3.40-3.45 (2H,
m), 3.45-3.50 (2H, m), 3.55-3.61 (3H,
m), 3.62-3.75 (8H, m), 3.76-3.82 (1H,
m), 4.06-4.11 (1H, m), 4.32 (1H, d, J =
7.82Hz). Example 3 The reaction in this example is shown in FIG.

【0045】(a) 化合物1−1と化合物3−1のグリコ
シル化反応 化合物1−1(6.00g)とアルコール体(化合物3−
1)(8.04g)を塩化メチレン(180ml )に溶解し、B
3 ・Et2 O(9.05g)を加え、室温で5日間攪拌し
た。
(A) Glycosylation Reaction of Compound 1-1 and Compound 3-1 Compound 1-1 (6.00 g) and an alcohol compound (Compound 3-
1) (8.04g) is dissolved in methylene chloride (180ml),
F 3 · Et 2 O (9.05 g) was added, and the mixture was stirred at room temperature for 5 days.

【0046】反応液をクロロホルムで希釈し、水、5%
NaHCO3 水、水で順次洗浄、乾燥後溶媒を減圧下留
去した。残渣をシリカゲル( 200g)を用いるカラムク
ロマトグラフィー(クロロホルム)で2回精製し、α−
グリコシド(化合物3−2)(3.66g)とβ−グリコシ
ド(化合物3−3)(1.60g)を得た。
The reaction solution was diluted with chloroform and diluted with water, 5%.
It was washed successively with NaHCO 3 water and water, dried and the solvent was evaporated under reduced pressure. The residue was purified twice by column chromatography (chloroform) using silica gel (200 g) and α-
Glycoside (Compound 3-2) (3.66 g) and β-glycoside (Compound 3-3) (1.60 g) were obtained.

【0047】(α−グリコシド) [α]D ;+92.1°(c 0.91,CHCl3 ).1 H−NMR(CDCl3 )δ:2.02(3H,s),2.0
3(3H,s),2.06(3H,s),3.63−3.73(9
H,m),3.75(3H,s),3.77(2H,m),3.82
−3.87(1H,m),4.45(1H,d,J=10.02 H
z),4.88(1H,dd,J=3.67Hz,10.26 H
z),5.17(1H,dd,J=9.77Hz,10.02H
z),5.21(1H,d,J=3.67Hz),5.54(1H,
dd,J=9.77Hz,10.26 Hz). (b) 化合物3−4の合成 化合物3−2(3.70g)をDMF(40ml)に溶解し、ア
ジ化ナトリウム(0.74g)を加え、浴温60℃で20時間攪
拌した。
(Α-Glycoside) [α] D ; + 92.1 ° (c 0.91, CHCl 3 ). 1 H-NMR (CDCl 3 ) δ: 2.02 (3H, s), 2.0
3 (3H, s), 2.06 (3H, s), 3.63-3.73 (9
H, m), 3.75 (3H, s), 3.77 (2H, m), 3.82
-3.87 (1H, m), 4.45 (1H, d, J = 10.02 H
z), 4.88 (1H, dd, J = 3.67Hz, 10.26H
z), 5.17 (1H, dd, J = 9.77Hz, 10.02H
z), 5.21 (1H, d, J = 3.67Hz), 5.54 (1H,
dd, J = 9.77 Hz, 10.26 Hz). (b) Synthesis of compound 3-4 Compound 3-2 (3.70 g) was dissolved in DMF (40 ml), sodium azide (0.74 g) was added, and the mixture was stirred at a bath temperature of 60 ° C for 20 hours.

【0048】反応液混合物を酢酸エチルで希釈し、水
洗、乾燥後溶媒を減圧下留去した。残渣をシリカゲル
( 200g)を用いるカラムクロマトグラフィー(クロロ
ホルム)で精製し、目的化合物3−4(2.10g)を無色
油状物質として得た。
The reaction mixture was diluted with ethyl acetate, washed with water, dried and the solvent was distilled off under reduced pressure. The residue was purified by column chromatography (chloroform) using silica gel (200 g) to obtain the target compound 3-4 (2.10 g) as a colorless oily substance.

【0049】1H−NMR(CDCl3 )δ:2.02(3
H,s),2.03(3H,s),2.06(3H,s),3.40
(2H,t,J=5.13Hz),3.63−3.73(9H,
m),3.75(3H,s),3.82−3.87(1H,m),4.
45(1H,d,J=10.26 Hz),4.88(1H,dd,
J=3.66Hz, 10.26Hz),5.17(1H,dd,J=
9.77Hz,10.26 Hz),5.21(1H,d,J=3.66H
z),5.54(1H,dd,J=9.77Hz,10.26 H
z). (c) 化合物3−5の合成 化合物3−4(1.70g)とp−トルエンスルホン酸1水
和物(0.66g)をエタノール( 100ml)に溶解し、リン
ドラー触媒(3.00g)を加え、室温40psi で5時間接触
還元を行った。
1 H-NMR (CDCl 3 ) δ: 2.02 (3
H, s), 2.03 (3H, s), 2.06 (3H, s), 3.40
(2H, t, J = 5.13Hz), 3.63-3.73 (9H,
m), 3.75 (3H, s), 3.82-3.87 (1H, m), 4.
45 (1H, d, J = 10.26 Hz), 4.88 (1H, dd,
J = 3.66Hz, 10.26Hz), 5.17 (1H, dd, J =
9.77Hz, 10.26Hz), 5.21 (1H, d, J = 3.66H)
z), 5.54 (1H, dd, J = 9.77Hz, 10.26H
z). (c) Synthesis of compound 3-5 Compound 3-4 (1.70 g) and p-toluenesulfonic acid monohydrate (0.66 g) are dissolved in ethanol (100 ml), Lindlar catalyst (3.00 g) is added, and the mixture is allowed to stand at room temperature. Catalytic reduction was performed at 40 psi for 5 hours.

【0050】触媒を濾過後、濾液を減圧下濃縮し、目的
物化合物3−5(2.05g)を無色泡状物質として得た。
After filtering the catalyst, the filtrate was concentrated under reduced pressure to obtain the target compound 3-5 (2.05 g) as a colorless foamy substance.

【0051】(d) 化合物3−7の合成 アミン(化合物3−5)( 198mg)と活性エステル(化
合物3−6)( 110mg)を塩化メチレン(10ml)に溶解
し、トリエチルアミン(63mg)を加え、室温で3時間攪
拌した。
(D) Synthesis of compound 3-7 Amine (compound 3-5) (198 mg) and active ester (compound 3-6) (110 mg) were dissolved in methylene chloride (10 ml), and triethylamine (63 mg) was added. The mixture was stirred at room temperature for 3 hours.

【0052】反応液を酢酸エチルで希釈し、水、クエン
酸水、水で順次洗浄、乾燥後溶媒を減圧下留去した。残
渣をシリカゲル(20g)を用いるカラムクロマトグラフ
ィー(クロロホルム−酢酸エチル 1:1)で精製し、
目的化合物3−7( 135mg)を無色粉末として得た。
The reaction solution was diluted with ethyl acetate, washed successively with water, citric acid water and water, dried and the solvent was distilled off under reduced pressure. The residue was purified by column chromatography (chloroform-ethyl acetate 1: 1) using silica gel (20 g),
The target compound 3-7 (135 mg) was obtained as a colorless powder.

【0053】[α]D +68.3°(c 0.98,CHC
3 ).1 H−NMR(CDCl3 )δ:0.88(3H,t,J=
3.84Hz),1.22−1.34(24H,m),1.63(2H,
m),2.03(6H,s),2.06(3H,s),2.18(2
H,t,J=7.57Hz),3.46(2H,m),3.55(2
H,m),3.58−3.65(2H,m),3.67(2H,
m),3.70−3.76(1H,m),3.75(3H,s),3.
82−3.87(1H,m),4.45(1H,d,J=10.02 H
z),4.88(1H,dd,J=3.67Hz,10.26 H
z),5.17(1H,dd,J=9.53Hz,10.02 H
z),5.24(1H,d,J=3.67Hz),5.55(1H,
dd,J=9.53Hz,10.26 Hz),6.11(1H,br
s). (e) 化合物3−8合成 化合物3−7( 110mg)をメタノール(3ml)に溶解
し、28%NaOMe in MeOH(20μl)を加
え、室温で20時間攪拌した。反応液を減圧下濃縮し、残
渣をメタノール(3ml)に溶解し、 0.1N NaOH水
(2ml)を加え、室温で3時間攪拌した。
[Α] D + 68.3 ° (c 0.98, CHC
l 3 ). 1 H-NMR (CDCl 3 ) δ: 0.88 (3H, t, J =
3.84Hz), 1.22-1.34 (24H, m), 1.63 (2H,
m), 2.03 (6H, s), 2.06 (3H, s), 2.18 (2
H, t, J = 7.57Hz), 3.46 (2H, m), 3.55 (2
H, m), 3.58-3.65 (2H, m), 3.67 (2H,
m), 3.70-3.76 (1H, m), 3.75 (3H, s), 3.
82-3.87 (1H, m), 4.45 (1H, d, J = 10.02 H
z), 4.88 (1H, dd, J = 3.67Hz, 10.26H
z), 5.17 (1H, dd, J = 9.53Hz, 10.02H
z), 5.24 (1H, d, J = 3.67Hz), 5.55 (1H,
dd, J = 9.53 Hz, 10.26 Hz), 6.11 (1H, br
s). (e) Synthesis of Compound 3-8 Compound 3-7 (110 mg) was dissolved in methanol (3 ml), 28% NaOMe in MeOH (20 μl) was added, and the mixture was stirred at room temperature for 20 hr. The reaction mixture was concentrated under reduced pressure, the residue was dissolved in methanol (3 ml), 0.1N NaOH aqueous solution (2 ml) was added, and the mixture was stirred at room temperature for 3 hr.

【0054】反応液に「アンバーライトIRC−50」を
加え、不溶物を濾去後濾液を減圧下濃縮乾固し、残渣を
エーテルで洗浄し、目的化合物3−8(80mg)を無色粉
末として得た。
"Amberlite IRC-50" was added to the reaction solution, the insoluble matter was filtered off, the filtrate was concentrated to dryness under reduced pressure, and the residue was washed with ether to obtain the target compound 3-8 (80 mg) as a colorless powder. Obtained.

【0055】[α]D +35.4°(c 1.01,MeO
H).1 H−NMR(CD3 OD)δ:0.90(3H,t,J=
6.84Hz),1.24−1.36(24H,m),1.60(2H,
m),2.20(2H,t,J=7.33Hz),3.34−3.38
(2H,m),3.41−3.46(2H,m),3.54−3.56
(2H,m),3.60−3.64(2H,m),3.65−3.73
(6H,m),3.90(1H,m),3.97(1H,J=1
0.26 Hz). 実施例4 本実施例における反応も図2に示す。
[Α] D + 35.4 ° (c 1.01, MeO
H). 1 H-NMR (CD 3 OD) δ: 0.90 (3 H, t, J =
6.84Hz), 1.24-1.36 (24H, m), 1.60 (2H,
m), 2.20 (2H, t, J = 7.33Hz), 3.34-3.38
(2H, m), 3.41-3.46 (2H, m), 3.54-3.56
(2H, m), 3.60-3.64 (2H, m), 3.65-3.73
(6H, m), 3.90 (1H, m), 3.97 (1H, J = 1
0.26 Hz). Example 4 The reaction in this example is also shown in FIG.

【0056】(a) 化合物4−2の合成 カルボン酸(化合物4−1)( 204mg)、N−ヒドロキ
シスクシンイミド(HOSu)(46mg)およびN,N′
−ジシクロヘキシルカルボジイミド(DCC)(83mg)
の塩化メチレン(20ml)溶液を室温で20時間攪拌した。
反応液に塩化メチレン(5ml)に溶かしたアミン体(化
合物3−5)( 364mg)を加え、ついでトリエチルアミ
ン( 115mg)を加え室温で3時間攪拌した。
(A) Synthesis of Compound 4-2 Carboxylic acid (Compound 4-1) (204 mg), N-hydroxysuccinimide (HOSu) (46 mg) and N, N '.
-Dicyclohexylcarbodiimide (DCC) (83 mg)
A methylene chloride (20 ml) solution of was stirred at room temperature for 20 hours.
The amine compound (compound 3-5) (364 mg) dissolved in methylene chloride (5 ml) was added to the reaction solution, triethylamine (115 mg) was added, and the mixture was stirred at room temperature for 3 hours.

【0057】反応液をクロロホルムで希釈し、水、5%
NaHCO3 水、水、クエン酸水、水で順次洗浄、乾燥
後溶媒を減圧下留去した。残渣をシリカゲル(30g)を
用いるカラムクロマトグラフィー(ヘキサン−酢酸エチ
ル 1:1)で精製し、目的化合物4−2(65mg)を無
色粉末として得た。
The reaction solution was diluted with chloroform and diluted with water, 5%.
The organic layer was washed successively with NaHCO 3 water, water, citric acid water and water, dried and the solvent was distilled off under reduced pressure. The residue was purified by column chromatography using silica gel (30 g) (hexane-ethyl acetate 1: 1) to obtain the target compound 4-2 (65 mg) as a colorless powder.

【0058】[α]D +50.0°(c 0.83,CHC
3 ).1 H−NMR(CDCl3 )δ:0.88(6H,t,J=
6.59Hz),1.20−1.33(56H,m),1.34−1.43(2
H,m),1.53−1.63(2H,m),1.98−2.05(1
H,m),2.03(6H,s),2.06(3H,s),3.45
−3.50(2H,m2 ),3.25−3.57(2H,m),3.58
−3.64(4H,m),3.64−3.69(2H,m),3.70−
3.76(1H,m),3.75(3H,s),3.81−3.87(1
H,m),4.45(1H,d,J=10.26 Hz),4.88
(1H,dd,J=3.66Hz,10.26Hz),5.17(1
H,dd,J=9.28Hz,10.26 Hz),5.24(1H,
d,J=3.66Hz),5.55(1H,dd,J=9.28H
z,10.26 Hz),6.04(1H,m). (b) 化合物4−3の合成 化合物4−2( 540mg)をメタノール(3ml)に加え、
28%NaOMe inMeOH(20μl)を加え、室温
で24時間攪拌した。反応液を減圧下濃縮し、残渣にメタ
ノール(3ml)と0.1 N NaOH水(2ml)を加え、
室温で6時間攪拌した。
[Α] D + 50.0 ° (c 0.83, CHC
l 3 ). 1 H-NMR (CDCl 3 ) δ: 0.88 (6H, t, J =
6.59Hz), 1.20-1.33 (56H, m), 1.34-1.43 (2
H, m), 1.53-1.63 (2H, m), 1.98-2.05 (1
H, m), 2.03 (6H, s), 2.06 (3H, s), 3.45
-3.50 (2H, m 2 ), 3.25-3.57 (2H, m), 3.58
-3.64 (4H, m), 3.64-3.69 (2H, m), 3.70-
3.76 (1H, m), 3.75 (3H, s), 3.81-3.87 (1
H, m), 4.45 (1H, d, J = 10.26 Hz), 4.88
(1H, dd, J = 3.66Hz, 10.26Hz), 5.17 (1
H, dd, J = 9.28Hz, 10.26Hz), 5.24 (1H,
d, J = 3.66Hz), 5.55 (1H, dd, J = 9.28H
z, 10.26 Hz), 6.04 (1H, m). (b) Synthesis of Compound 4-3 Compound 4-2 (540 mg) was added to methanol (3 ml),
28% NaOMe in MeOH (20 μl) was added, and the mixture was stirred at room temperature for 24 hours. The reaction mixture was concentrated under reduced pressure, methanol (3 ml) and 0.1 N NaOH aqueous solution (2 ml) were added to the residue,
Stir at room temperature for 6 hours.

【0059】反応液を氷冷し、母液をデカンテーション
で除き、析出した目的化合物4−3(35mg)を無色粉末
として得た。
The reaction solution was ice-cooled and the mother liquor was removed by decantation to obtain the precipitated target compound 4-3 (35 mg) as a colorless powder.

【0060】[α]D +23.1°(c 0.46,MeO
H).1 H−NMR(CD3 OD)δ:0.90(6H,t,J=
6.84Hz),1.12−1.34(56H,m),1.34−1.45(2
H,m),1.50−1.58(2H,m),2.19(1H,
m),3.34−3.46(4H,m),3.52−3.56(2H,
m),3.60−3.64(2H,m),3.64−3.74(6H,
m),3.88−3.92(1H,m),3.93(1H,d,J=
10.26 Hz),4.86(1H,d,J=3.91Hz). 実施例5 本実施例における反応を図3に示す。
[Α] D + 23.1 ° (c 0.46, MeO
H). 1 H-NMR (CD 3 OD) δ: 0.90 (6 H, t, J =
6.84Hz), 1.12-1.34 (56H, m), 1.34-1.45 (2
H, m), 1.50-1.58 (2H, m), 2.19 (1H,
m), 3.34-3.46 (4H, m), 3.52-3.56 (2H,
m), 3.60-3.64 (2H, m), 3.64-3.74 (6H,
m), 3.88-3.92 (1H, m), 3.93 (1H, d, J =
10.26 Hz), 4.86 (1H, d, J = 3.91 Hz). Example 5 The reaction in this example is shown in FIG.

【0061】(a) 化合物5−1と化合物1−2のグリコ
シル化反応 減圧下 150℃で3時間乾燥した粉末「モレキュラーシー
ブ4A」(MS4A)( 600mg)と臭化亜鉛( 177mg)
およびアルコール体(化合物1−2)( 631mg)を塩化
メチレン(20ml)中室温で2時間攪拌した。一方、クロ
ル体(化合物5−1)( 400mg)と「MS4A」(1.00
g)を塩化メチレン(15ml)中室温で2時間攪拌後、上
記反応混合液に滴下した。室温で20時間攪拌後不溶物を
セライト濾過し、濾液を水、5%NaHCO3 水、水で
順次洗浄、乾燥後溶媒を減圧下留去した。
(A) Glycosylation Reaction of Compound 5-1 and Compound 1-2 Powder "Molecular Sieve 4A" (MS4A) (600 mg) and zinc bromide (177 mg) dried under reduced pressure at 150 ° C. for 3 hours.
The alcohol compound (Compound 1-2) (631 mg) was stirred in methylene chloride (20 ml) at room temperature for 2 hours. On the other hand, chloro form (Compound 5-1) (400 mg) and "MS4A" (1.00
g) was stirred in methylene chloride (15 ml) at room temperature for 2 hours and then added dropwise to the above reaction mixture. After stirring at room temperature for 20 hours, the insoluble material was filtered through Celite, the filtrate was washed successively with water, 5% NaHCO 3 water and water, dried and the solvent was evaporated under reduced pressure.

【0062】残渣をシリカゲル( 100g)を用いるカラ
ムクロマイトグラフィー(クロロホルム−メタノール 2
00:1)で精製し、β−グリコシド体(化合物5−3)
( 157mg)および.α−グリコシド体(化合物5−2)
( 262mg)をそれぞれ無色泡状物質として得た。
The residue was subjected to column chromitography (chloroform-methanol 2) using silica gel (100 g).
00: 1) and β-glycoside (compound 5-3)
(157 mg) and. α-Glycoside (Compound 5-2)
(262 mg) was obtained as a colorless foam.

【0063】(α−グリコシド) [α]D −13.0°(c 0.92,CHCl3 ).1 H−NMR(CDCl3 )δ:0.88(3H,t,J=
6.84Hz),1.20−1.34(30H,m),1.57(2H,
m),1.88(3H,s),1.98(1H,dd,J=12.4
6 Hz,12.70 Hz),2.03(3H,s),2.04(3
H,s),2.14(3H,s),2.15(3H,s),2.61
(1H,dd,J=4.64Hz,12.70 Hz),3.42−3.
48(3H,m),3.56−3.67(10H,m),3.80(3
H,s),3.90(1H,m),4.06(1H,ddd,J
=9.53Hz,9.77Hz,10.50 Hz),4.08(1H,d
d,J=1.96Hz,10.50 Hz),4.09(1H,dd,
J=5.62Hz,12.46 Hz),4.29(1H,dd,J=
2.69Hz,J=12.46 Hz),4.86(1H,ddd,J
=4.64Hz,J=9.77Hz,12.46 Hz),5.10(1
H,d,J=9.53Hz),5.32(1H,dd,J=1.96
Hz,8.55Hz),5.39(1H,ddd,J=2.96H
z,5.62Hz,8.55Hz). (β−グリコシド) [α]D +55.4°(c 0.89,CHCl3 ).1 H−NMR(CDCl3 )δ:0.88(3H,t,J=
6.59Hz),1.20−1.34(30H,m),1.52−1.59(2
H,m),1.86(1H,dd,J=11.72 Hz,12.70
Hz),1.87(3H,s),2.00(3H,s)2.03(3
H,s),2.05(3H,s),2.15(3H,s),2.44
(1H,dd,J=5.13Hz,12.70 Hz),3.43(2
H,m),3.49−3.53(1H,m),3.58(2H,
m),3.61−3.65(2H,m),3.65−3.76(5H,
m),3.79(3H,s),3.80−3.85(1H,m),3.
86−3.92(1H,m),4.12(1H,dd,J=8.55H
z,12.46 Hz),4.13(1H,ddd,J=10.26 H
z,10.50 Hz,J=10.75 Hz),4.62(1H,d
d,J=2.20Hz,10.50 Hz),4.89(1H,dd,
J=2.44Hz,12.46 Hz),5.22(1H,ddd,J
=5.13Hz,10.75 Hz,11.72 Hz),5.31(1H,
ddd,J=2.44Hz,J=3.42Hz,J=8.55H
z),5.39(1H,dd,J=2.20Hz,3.42Hz),
6.40(1H,d,J=10.26 Hz). (b) 化合物5−4の合成 化合物5−2( 190mg)をメタノール(5ml)に溶解
し、28%NaOMe in MeOH(20μl)を加
え、室温で15時間攪拌した。反応液を減圧下濃縮し、残
渣をメタノール(3ml)に溶解し、0.1 N NaOH水
(3ml)を加え、室温で20時間攪拌した。
(Α-Glycoside) [α] D -13.0 ° (c 0.92, CHCl 3 ). 1 H-NMR (CDCl 3 ) δ: 0.88 (3H, t, J =
6.84Hz), 1.20-1.34 (30H, m), 1.57 (2H,
m), 1.88 (3H, s), 1.98 (1H, dd, J = 12.4
6 Hz, 12.70 Hz), 2.03 (3H, s), 2.04 (3
H, s), 2.14 (3H, s), 2.15 (3H, s), 2.61
(1H, dd, J = 4.64Hz, 12.70Hz), 3.42-3.
48 (3H, m), 3.56-3.67 (10H, m), 3.80 (3
H, s), 3.90 (1H, m), 4.06 (1H, ddd, J
= 9.53Hz, 9.77Hz, 10.50Hz), 4.08 (1H, d
d, J = 1.96 Hz, 10.50 Hz), 4.09 (1H, dd,
J = 5.62Hz, 12.46Hz), 4.29 (1H, dd, J =
2.69 Hz, J = 12.46 Hz), 4.86 (1H, ddd, J
= 4.64Hz, J = 9.77Hz, 12.46Hz), 5.10 (1
H, d, J = 9.53Hz), 5.32 (1H, dd, J = 1.96)
Hz, 8.55Hz), 5.39 (1H, ddd, J = 2.96H
z, 5.62 Hz, 8.55 Hz). (Β-Glycoside) [α] D + 55.4 ° (c 0.89, CHCl 3 ). 1 H-NMR (CDCl 3 ) δ: 0.88 (3H, t, J =
6.59Hz), 1.20-1.34 (30H, m), 1.52-1.59 (2
H, m), 1.86 (1H, dd, J = 11.72 Hz, 12.70
Hz), 1.87 (3H, s), 2.00 (3H, s) 2.03 (3
H, s), 2.05 (3H, s), 2.15 (3H, s), 2.44
(1H, dd, J = 5.13Hz, 12.70Hz), 3.43 (2
H, m), 3.49-3.53 (1H, m), 3.58 (2H,
m), 3.61-3.65 (2H, m), 3.65-3.76 (5H,
m), 3.79 (3H, s), 3.80-3.85 (1H, m), 3.
86-3.92 (1H, m), 4.12 (1H, dd, J = 8.55H
z, 12.46 Hz), 4.13 (1H, ddd, J = 10.26 H
z, 10.50 Hz, J = 10.75 Hz), 4.62 (1H, d
d, J = 2.20 Hz, 10.50 Hz), 4.89 (1H, dd,
J = 2.44Hz, 12.46Hz), 5.22 (1H, ddd, J
= 5.13Hz, 10.75Hz, 11.72Hz), 5.31 (1H,
ddd, J = 2.44Hz, J = 3.42Hz, J = 8.55H
z), 5.39 (1H, dd, J = 2.20Hz, 3.42Hz),
6.40 (1H, d, J = 10.26 Hz). (b) Synthesis of Compound 5-4 Compound 5-2 (190 mg) was dissolved in methanol (5 ml), 28% NaOMe in MeOH (20 μl) was added, and the mixture was stirred at room temperature for 15 hr. The reaction mixture was concentrated under reduced pressure, the residue was dissolved in methanol (3 ml), 0.1 N NaOH aqueous solution (3 ml) was added, and the mixture was stirred at room temperature for 20 hr.

【0064】反応液に「アンバーライトIRC−50」を
加え、不溶物を濾去後濾液を減圧下濃縮乾固し、残渣を
エーテルで洗浄し、目的化合物5−4( 113mg)を無色
粉末として得た。
"Amberlite IRC-50" was added to the reaction solution, the insoluble matter was removed by filtration, the filtrate was concentrated to dryness under reduced pressure, and the residue was washed with ether to obtain the target compound 5-4 (113 mg) as a colorless powder. Obtained.

【0065】[α]D −0.3 °(c 1.08,MeO
H).1 H−NMR(CD3 OD)δ:0.90(3H,t,J=
6.84Hz),1.26−1.38(30H,m),1.58(2H,
m),1.60(1H,dd),2.01(3H,s),2.82
(1H,dd,J=4.46Hz,12.46 Hz),3.46−3.
51(3H,m),3.58−3.72(15H,m),3.81−3.88
(2H,m),3.90−3.95(1H,m). 実施例6 本実施例における反応を図4に示す。
[Α] D −0.3 ° (c 1.08, MeO
H). 1 H-NMR (CD 3 OD) δ: 0.90 (3 H, t, J =
6.84Hz), 1.26-1.38 (30H, m), 1.58 (2H,
m), 1.60 (1H, dd), 2.01 (3H, s), 2.82
(1H, dd, J = 4.46Hz, 12.46Hz), 3.46-3.
51 (3H, m), 3.58-3.72 (15H, m), 3.81-3.88
(2H, m), 3.90-3.95 (1H, m). Example 6 The reaction in this example is shown in FIG.

【0066】(a) 化合物6−1と化合物1−2のグリコ
シル化反応 化合物6−1( 293mg)とアルコール(化合物1−2)
( 664mg)を塩化メチレン(15ml)に溶解し、BF3
Et2 O( 312mg)を加え、室温で20時間攪拌した。
(A) Glycosylation reaction of compound 6-1 and compound 1-2 Compound 6-1 (293 mg) and alcohol (compound 1-2)
(664 mg) was dissolved in methylene chloride (15 ml), and BF 3 ·
Et 2 O (312 mg) was added, and the mixture was stirred at room temperature for 20 hours.

【0067】反応液をクロロホルムで希釈し、水、5%
NaHCO3 水、水で順次洗浄、乾燥後溶媒を減圧下留
去した。残渣をシリカゲル(60g)を用いるカラムクロ
マトグラフィー(クロロホルム−酢酸エチル 1:1)
で精製した。再度シリカゲル(60g)を用いるカラムク
ロマトグラフィー(クロロホルム−メタノール 200:
1)で精製し、β−グリコシド(化合物5−3)( 303
mg)とα−グリコシド(化合物5−2)(26mg)を得
た。
The reaction solution was diluted with chloroform and diluted with water, 5%.
It was washed successively with NaHCO 3 water and water, dried and the solvent was evaporated under reduced pressure. Column chromatography of the residue using silica gel (60 g) (chloroform-ethyl acetate 1: 1).
Purified in. Column chromatography again using silica gel (60 g) (chloroform-methanol 200:
1) and β-glycoside (compound 5-3) (303
mg) and α-glycoside (Compound 5-2) (26 mg) were obtained.

【0068】(b) 化合物6−2の合成 化合物5−3( 141mg)をメタノール(5ml)に溶解
し、28%NaOMe in MeOH(20μl)を加
え、室温で3時間攪拌した。反応液を減圧下濃縮し、残
渣をメタノール(3ml)に溶解し、0.1 N NaOH水
(4ml)を加え、室温で2日間攪拌した。
(B) Synthesis of Compound 6-2 Compound 5-3 (141 mg) was dissolved in methanol (5 ml), 28% NaOMe in MeOH (20 μl) was added, and the mixture was stirred at room temperature for 3 hours. The reaction mixture was concentrated under reduced pressure, the residue was dissolved in methanol (3 ml), 0.1 N NaOH aqueous solution (4 ml) was added, and the mixture was stirred at room temperature for 2 days.

【0069】反応液に「アンバーライトIRC−50」を
加え、不溶物を濾去後濾液を減圧下濃縮乾固し、残渣を
エーテルで洗浄し、目的化合物6−2(85mg)を無色粉
末として得た。
"Amberlite IRC-50" was added to the reaction solution, the insoluble material was filtered off, the filtrate was concentrated to dryness under reduced pressure, and the residue was washed with ether to obtain the target compound 6-2 (85 mg) as a colorless powder. Obtained.

【0070】[α]D −11.4°(c 0.76,MeO
H).1 H−NMR(CD3 OD)δ:0.90(3H,t,J=
6.84Hz),1.25−1.38(30H,m),1.58(2H,
m),1.66(1H,dd,J=11.48 Hz,12.95 H
z),2.00(3H,s),2.39(1H,dd,J=4.64
Hz,12.95 Hz),3.46−4.02(21H,m). 実施例7 本実施例における反応を図5に示す。
[Α] D -11.4 ° (c 0.76, MeO
H). 1 H-NMR (CD 3 OD) δ: 0.90 (3 H, t, J =
6.84Hz), 1.25-1.38 (30H, m), 1.58 (2H,
m), 1.66 (1 H, dd, J = 11.48 Hz, 12.95 H
z), 2.00 (3H, s), 2.39 (1H, dd, J = 4.64)
Hz, 12.95 Hz), 3.46-4.02 (21H, m). Example 7 The reaction in this example is shown in FIG.

【0071】(a) 化合物6−1と化合物3−1のグリコ
シル化反応 化合物6−1( 876mg)とアルコール(化合物3−1)
( 830mg)を塩化メチレン(50ml)に溶解し、BF3
Et2 O( 932mg)を加え、室温で21時間攪拌した。
(A) Glycosylation reaction of compound 6-1 and compound 3-1 Compound 6-1 (876 mg) and alcohol (compound 3-1)
(830 mg) was dissolved in methylene chloride (50 ml), and BF 3 ·
Et 2 O (932 mg) was added, and the mixture was stirred at room temperature for 21 hours.

【0072】反応液をクロロホルムで希釈し、水、5%
NaHCO3 水、水で順次洗浄、乾燥後溶媒を減圧下留
去した。残渣をシリカゲル( 150g)を用いるカラムク
ロマトグラフィー(クロロホルム−メタノール 200:1
→クロロホルム−メタノール100:1)で精製し、β−
グリコシド(化合物7−2)( 566mg)、ついでβ−グ
リコシド(化合物7−2)とα−グリコシド(化合物7
−1)の3:1の混合物( 208mg)を得た。
The reaction solution was diluted with chloroform and diluted with water, 5%.
It was washed successively with NaHCO 3 water and water, dried and the solvent was evaporated under reduced pressure. The residue was subjected to column chromatography using silica gel (150 g) (chloroform-methanol 200: 1).
→ Purify with chloroform-methanol 100: 1), β-
Glycoside (Compound 7-2) (566 mg), followed by β-glycoside (Compound 7-2) and α-glycoside (Compound 7)
A 3: 1 mixture of -1) (208 mg) was obtained.

【0073】(β−グリコシド) [α]D +4.6 °(c 1.75,CHCl3 ).1 H−NMR(CDCl3 )δ:1.89(1H,dd,J
=11.70 Hz,12.95Hz),1.89(3H,s),2.01
(3H,s),2.03(3H,s),2.06(3H,s),
2.15(3H,s),2.43(1H,dd,J=4.88Hz,
12.95 Hz),3.51−3.56(1H,m),3.62−3.85
(9H,m),3.80(3H,s),3.88−3.97(2H,
m),4.12(1H,dd,J=8.30Hz,12.46 H
z),4.13(1H,ddd,J=10.26 Hz,10.51 H
z,10.99 Hz),4.56(1H,dd,J=2.20Hz,
10.51 Hz),4.89(1H,dd,J=2.44Hz,12.4
6 Hz),5.25(1H,ddd,J=4.88Hz,10.99
Hz,11.70 Hz),5.28(1H,ddd,J=2.44H
z,3.42Hz,8.30Hz),5.40(1H,dd,J=2.
20Hz,3.42Hz),5.93(1H,d,J=10.26 H
z). (b) 化合物7−3の合成 化合物7−2( 675mg)をDMF(15ml)に溶解し、ア
ジ化ナリトウム( 137mg)を加え、浴温60℃で40時間攪
拌した。
(Β-Glycoside) [α] D + 4.6 ° (c 1.75, CHCl 3 ). 1 H-NMR (CDCl 3 ) δ: 1.89 (1 H, dd, J
= 11.70 Hz, 12.95 Hz), 1.89 (3 H, s), 2.01
(3H, s), 2.03 (3H, s), 2.06 (3H, s),
2.15 (3H, s), 2.43 (1H, dd, J = 4.88Hz,
12.95 Hz), 3.51-3.56 (1H, m), 3.62-3.85
(9H, m), 3.80 (3H, s), 3.88-3.97 (2H,
m), 4.12 (1H, dd, J = 8.30Hz, 12.46H
z), 4.13 (1H, ddd, J = 10.26 Hz, 10.51 H
z, 10.99 Hz), 4.56 (1H, dd, J = 2.20 Hz,
10.51 Hz), 4.89 (1H, dd, J = 2.44Hz, 12.4
6 Hz), 5.25 (1H, ddd, J = 4.88Hz, 10.99
Hz, 11.70 Hz), 5.28 (1H, ddd, J = 2.44H
z, 3.42Hz, 8.30Hz), 5.40 (1H, dd, J = 2.
20Hz, 3.42Hz), 5.93 (1H, d, J = 10.26H
z). (b) Synthesis of compound 7-3 Compound 7-2 (675 mg) was dissolved in DMF (15 ml), sodium azide (137 mg) was added, and the mixture was stirred at a bath temperature of 60 ° C for 40 hours.

【0074】反応混合物を酢酸エチルで希釈し、水洗、
乾燥後溶媒を減圧下留去した。残渣をシリカゲル(50
g)を用いるカラムクロマトグラフィー(クロロホルム
−メタノール 150:1)で精製し、目的化合物7−3
( 510mg)を無色油状物質として得た。
The reaction mixture was diluted with ethyl acetate, washed with water,
After drying, the solvent was distilled off under reduced pressure. The residue is treated with silica gel (50
The target compound 7-3 was purified by column chromatography (chloroform-methanol 150: 1) using g).
(510 mg) was obtained as a colorless oily substance.

【0075】[α]D +2.6 °(c 1.02,CHC
3 ).1 H−NMR(CDCl3 )δ:1.89(1H,dd,J
=11.70 Hz,12.94Hz),1.89(3H,s),2.01
(3H,s),2.03(3H,s),2.06(3H,s),
2.15(3H,s),2.44(1H,dd,J=4.89Hz,
12.94 Hz),3.43−3.50(2H,m),3.50−3.54
(1H,m),3.61−3.73(7H,m),3.75−3.90
(2H,m),3.80(3H,s),4.12(1H,dd,
J=8.55Hz,12.46 Hz),4.14(1H,ddd,J
=10.02 Hz,10.50 Hz,10.75 Hz),4.46(1
H,dd,J=2.20Hz,10.50 Hz),4.90(1H,
dd,J=2.44Hz,12.46 Hz),5.25(1H,dd
d,J=4.89Hz,10.75 Hz,11.70 Hz),5.27
(1H,ddd,J=2.44Hz,3.42Hz,8.55H
z),5.40(1H,dd,J=2.20Hz,3.42Hz),
5.94(1H,d,J=10.02 Hz). (c) 化合物7−4の合成 化合物7−3(510mg )とp−トルエンスルホン酸1水
和物(150mg )をメタノール(50ml)に溶解し、リンド
ラー触媒(1.50g)を加え、室温50psi で7時間接触還
元を行った。触媒を濾去後、濾液を減圧下で濃縮し、目
的化合物(590mg )を得た。
[Α] D + 2.6 ° (c 1.02, CHC
l 3 ). 1 H-NMR (CDCl 3 ) δ: 1.89 (1 H, dd, J
= 11.70 Hz, 12.94 Hz), 1.89 (3 H, s), 2.01
(3H, s), 2.03 (3H, s), 2.06 (3H, s),
2.15 (3H, s), 2.44 (1H, dd, J = 4.89Hz,
12.94 Hz), 3.43-3.50 (2H, m), 3.50-3.54
(1H, m), 3.61-3.73 (7H, m), 3.75-3.90
(2H, m), 3.80 (3H, s), 4.12 (1H, dd,
J = 8.55Hz, 12.46Hz), 4.14 (1H, ddd, J
= 10.02 Hz, 10.50 Hz, 10.75 Hz), 4.46 (1
H, dd, J = 2.20Hz, 10.50Hz), 4.90 (1H,
dd, J = 2.44 Hz, 12.46 Hz), 5.25 (1H, dd
d, J = 4.89Hz, 10.75Hz, 11.70Hz), 5.27
(1H, ddd, J = 2.44Hz, 3.42Hz, 8.55H
z), 5.40 (1H, dd, J = 2.20Hz, 3.42Hz),
5.94 (1H, d, J = 10.02 Hz). (c) Synthesis of compound 7-4 Compound 7-3 (510 mg) and p-toluenesulfonic acid monohydrate (150 mg) were dissolved in methanol (50 ml), Lindlar catalyst (1.50 g) was added, and the temperature was 50 psi. The catalytic reduction was performed for 7 hours. After removing the catalyst by filtration, the filtrate was concentrated under reduced pressure to obtain the target compound (590 mg).

【0076】(d) 化合物7−5の合成 アミン体化合物7−4とN−パルミトイルオキシスクシ
ンイミド(102mg )を塩化メチレン(20ml)に溶解し、
トリエチルアミン(58mg)を加え、室温で6時間撹拌し
た。反応液を塩化メチレンで希釈し、水、クエン酸水及
び水で順次洗浄し、乾燥後溶媒を減圧下留去した。残渣
をシリカゲル(50g)を用いるカラムクロマトグラフィ
ー(クロロホルム−メタノール 150:1→クロロホルム
−メタノール 100 :1)で精製し、目的化合物(181m
g )を無色油状物として得た。
(D) Synthesis of Compound 7-5 The amine compound 7-4 and N-palmitoyloxysuccinimide (102 mg) were dissolved in methylene chloride (20 ml),
Triethylamine (58 mg) was added, and the mixture was stirred at room temperature for 6 hours. The reaction solution was diluted with methylene chloride, washed successively with water, citric acid water and water, dried and the solvent was evaporated under reduced pressure. The residue was purified by column chromatography using silica gel (50 g) (chloroform-methanol 150: 1 → chloroform-methanol 100: 1) to obtain the target compound (181 m
g) was obtained as a colorless oil.

【0077】[α]D +9.5 °(c 0.94,CHC
3 ).1 H−NMR(CDCl3 )δ:0.88(3H,t,J=
6.59Hz),1.20−1.36(24H,m),1.62(2H,
m),1.86(3H,s),1.90(1H,dd,J=11.7
3 Hz,12.70 Hz),2.02(3H,s),2.03(3
H,s),2.05(3H,s),2.15(3H,s),2.19
(2H,m),2.42(1H,dd,J=4.89Hz,12.7
0 Hz),3.28−3.35(1H,m),3.48−3.74(10
H,m),3.80(3H,s),3.80−3.90(1H,
m),4.12(1H,dd,J=8.55Hz,12.22 H
z),4.12(1H,ddd,J=10.50 Hz,10.75 H
z),4.52(1H,dd,J=2.20Hz,10.50 H
z),4.90(1H,dd,J=2.44Hz,12.2Hz),
5.25(1H,ddd,J=2.44Hz,3.17Hz,8.55H
z),5.27(1H,ddd,J=4.89Hz,10.75 H
z,11.73 Hz),5.41(1H,dd,J=2.20Hz,
3.17Hz),6.37−6.40(2H,m). (e) 化合物7−6の合成 化合物7−5(170mg )をメタノール(4ml)に溶解
し、28%ナトリウムメトキシドメタノール溶液(20μ
l)を加え、室温で2時間撹拌した。反応液を減圧下濃
縮し、残渣をメタノール(4ml)に溶解し、0.1 N N
aOH水(2ml)を加え室温で5時間撹拌した。反応液
に「アンバーライトIRC−50」を加え、不溶物を濾去
後濾液を減圧下濃縮乾固し、残渣をエーテルで洗浄し、
目的化合物(113mg )を無色粉末として得た。
[Α] D + 9.5 ° (c 0.94, CHC
l 3 ). 1 H-NMR (CDCl 3 ) δ: 0.88 (3H, t, J =
6.59Hz), 1.20-1.36 (24H, m), 1.62 (2H,
m), 1.86 (3H, s), 1.90 (1H, dd, J = 11.7)
3 Hz, 12.70 Hz), 2.02 (3H, s), 2.03 (3
H, s), 2.05 (3H, s), 2.15 (3H, s), 2.19
(2H, m), 2.42 (1H, dd, J = 4.89Hz, 12.7
0 Hz), 3.28-3.35 (1H, m), 3.48-3.74 (10
H, m), 3.80 (3H, s), 3.80-3.90 (1H,
m), 4.12 (1H, dd, J = 8.55Hz, 12.22H
z), 4.12 (1H, ddd, J = 10.50 Hz, 10.75 H
z), 4.52 (1H, dd, J = 2.20Hz, 10.50H
z), 4.90 (1H, dd, J = 2.44Hz, 12.2Hz),
5.25 (1H, ddd, J = 2.44Hz, 3.17Hz, 8.55H
z), 5.27 (1H, ddd, J = 4.89Hz, 10.75H
z, 11.73 Hz), 5.41 (1H, dd, J = 2.20 Hz,
3.17Hz), 6.37-6.40 (2H, m). (e) Synthesis of Compound 7-6 Compound 7-5 (170 mg) was dissolved in methanol (4 ml) and 28% sodium methoxide methanol solution (20 μm) was added.
1) was added, and the mixture was stirred at room temperature for 2 hours. The reaction solution was concentrated under reduced pressure, the residue was dissolved in methanol (4 ml), and 0.1 N N
aOH water (2 ml) was added and the mixture was stirred at room temperature for 5 hours. "Amberlite IRC-50" was added to the reaction solution, the insoluble matter was filtered off, the filtrate was concentrated to dryness under reduced pressure, and the residue was washed with ether,
The target compound (113 mg) was obtained as a colorless powder.

【0078】[α]D −17.3°(c 0.97,MeO
H).1 H−NMR(CD3 OD)δ:0.90(3H,t,J=
6.84Hz),1.24−1.36(24H,m),1.56−1.36(3
H,s),1.99(3H,s),2.20(2H,t,J=7.
33Hz),2.41(1H,dd,J=4.89Hz,12.95 H
z),3.35−3.38(2H,m),3.44−3.48(1H,
m),3.53−3.72(11H,m),3.76−4.02(5H,
m). 実施例8 本実施例における反応も図5に示す。
[Α] D -17.3 ° (c 0.97, MeO
H). 1 H-NMR (CD 3 OD) δ: 0.90 (3 H, t, J =
6.84Hz), 1.24-1.36 (24H, m), 1.56-1.36 (3
H, s), 1.99 (3H, s), 2.20 (2H, t, J = 7.
33Hz), 2.41 (1H, dd, J = 4.89Hz, 12.95H
z), 3.35-3.38 (2H, m), 3.44-3.48 (1H,
m), 3.53-3.72 (11H, m), 3.76-4.02 (5H,
m). Example 8 The reaction in this example is also shown in FIG.

【0079】(a) 化合物8−1の合成 カルボン酸(化合物4−1)(153mg )、N−ヒドロキ
シスクシイミド(35mg)およびN,N′−ジシクロヘキ
シルカルボジイミド(62mg)の塩化メチレン(40ml)と
ヘキサン(20ml)との混合溶液を室温15時間撹拌した。
反応液にアセトニトリル(20ml)に溶かしたアミン体化
合物7−4(200mg )を加え、ついでトリエチルアミン
(53mg)を加え室温で24時間撹拌した。反応液を減圧下
濃縮し、クロロホルムで希釈し、水、5%NaHCO3
水、水、クエン酸水及び水で順次洗浄し、乾燥後溶媒を
減圧下留去した。残渣をシリカゲル(50g)を用いるカ
ラムクロマトグラフィー(クロロホルム−メタノール
150 :1)で精製し、目的化合物8−1(162mg )を無
色ワックスとして得た。
(A) Synthesis of Compound 8-1 Carboxylic acid (Compound 4-1) (153 mg), N-hydroxysuccinimide (35 mg) and N, N'-dicyclohexylcarbodiimide (62 mg) in methylene chloride (40 ml) A mixed solution of hexane and hexane (20 ml) was stirred at room temperature for 15 hours.
Amine compound 7-4 (200 mg) dissolved in acetonitrile (20 ml) was added to the reaction solution, triethylamine (53 mg) was added, and the mixture was stirred at room temperature for 24 hours. The reaction mixture was concentrated under reduced pressure, diluted with chloroform, water, 5% NaHCO 3
The extract was washed successively with water, water, citric acid water and water, dried and the solvent was distilled off under reduced pressure. Column chromatography of the residue using silica gel (50 g) (chloroform-methanol)
Purification with 150: 1) gave the target compound 8-1 (162 mg) as a colorless wax.

【0080】[α]D +5.9 °(c 1.03,CHC
3 ).1 H−NMR(CDCl3 )δ:0.88(6H,t,J=
6.84Hz),1.20−1.33(56H,m),1.33−1.44(2
H,m),1.53−1.64(2H,m),1.86(3H,
s),1.90(1H,dd,J=11.48 Hz,12.94 H
z),1.99−2.05(1H,m),2.01(3H,s),2.
03(3H,s),2.05(3H,s),2.15(3H,
s),2.43(1H,dd,J=4.89Hz,12.94 H
z),3.30−3.38(1H,m),3.40−3.70(9H,
m),3.80(3H,s),3.79−3.89(1H,m),4.
12(1H,dd,J=8.55Hz,12.46 Hz),4.12
(1H,ddd,J=10.02 Hz,10.75 Hz,10.75
Hz),4.51(1H,dd,J=2.44Hz,10.75 H
z),4.91(1H,dd,J=2.44Hz,12.46 H
z),5.25(1H,ddd,J=2.44Hz,3.42Hz,
8.55Hz),5.28(1H,ddd,J=4.89Hz,10.7
5 Hz,11.48 Hz),5.41(1H,dd,J=2.44H
z,3.42Hz),6.28(1H,m),6.36(1H,d,
J=10.02 Hz). (b) 化合物8−2の合成 化合物8−1(155mg )をメタノール(4ml)に溶解
し、28%NaOMe in MeOH(20μl)を加
え、室温で3時間撹拌した。反応液を減圧下濃縮し、残
渣をメタノール(12ml)に溶解し、0.1 N NaOH水
(3ml)を加え、室温で16時間撹拌した。反応液を加熱
後「アンバーライトIRC−50」を加え、不溶物を濾去
後濾液を減圧下濃縮乾固し、残渣をエーテルで洗浄し、
目的化合物8−2(99mg)を無色粉末として得た。
[Α] D + 5.9 ° (c 1.03, CHC
l 3 ). 1 H-NMR (CDCl 3 ) δ: 0.88 (6H, t, J =
6.84Hz), 1.20-1.33 (56H, m), 1.33-1.44 (2
H, m), 1.53-1.64 (2H, m), 1.86 (3H,
s), 1.90 (1 H, dd, J = 11.48 Hz, 12.94 H
z), 1.99-2.05 (1H, m), 2.01 (3H, s), 2.
03 (3H, s), 2.05 (3H, s), 2.15 (3H,
s), 2.43 (1H, dd, J = 4.89Hz, 12.94H
z), 3.30-3.38 (1H, m), 3.40-3.70 (9H,
m), 3.80 (3H, s), 3.79-3.89 (1H, m), 4.
12 (1H, dd, J = 8.55Hz, 12.46Hz), 4.12
(1H, ddd, J = 10.02 Hz, 10.75 Hz, 10.75
Hz), 4.51 (1H, dd, J = 2.44Hz, 10.75H
z), 4.91 (1H, dd, J = 2.44Hz, 12.46H
z), 5.25 (1H, ddd, J = 2.44Hz, 3.42Hz,
8.55Hz), 5.28 (1H, ddd, J = 4.89Hz, 10.7
5 Hz, 11.48 Hz), 5.41 (1H, dd, J = 2.44H
z, 3.42Hz), 6.28 (1H, m), 6.36 (1H, d,
J = 10.02 Hz). (b) Synthesis of Compound 8-2 Compound 8-1 (155 mg) was dissolved in methanol (4 ml), 28% NaOMe in MeOH (20 μl) was added, and the mixture was stirred at room temperature for 3 hours. The reaction mixture was concentrated under reduced pressure, the residue was dissolved in methanol (12 ml), 0.1 N NaOH aqueous solution (3 ml) was added, and the mixture was stirred at room temperature for 16 hr. After heating the reaction solution, "Amberlite IRC-50" was added, the insoluble matter was filtered off, the filtrate was concentrated to dryness under reduced pressure, and the residue was washed with ether,
The target compound 8-2 (99 mg) was obtained as a colorless powder.

【0081】1H−NMR(CD3 OD)δ:0.90(6
H,t,J=6.59Hz),1.20−1.44(58H,m),1.
50−1.58(2H,m),1.63(1H,dd,J=11.72
Hz,12.95 Hz),1.99(3H,s),2.18(1H,
m),2.42(1H,dd,J=4.89Hz,12.95 H
z),3.36−3.40(2H,m),3.43−3.47(1H,
m),3.51−3.59(3H,m),3.60−3.74(8H,
m),3.76−3.83(2H,m),3.84−3.94(2H,
m),3.96−4.02(1H,m). 実施例9 本実施例における反応を図6の(a) に示す。
1 H-NMR (CD 3 OD) δ: 0.90 (6
H, t, J = 6.59Hz), 1.20-1.44 (58H, m), 1.
50-1.58 (2H, m), 1.63 (1H, dd, J = 11.72)
Hz, 12.95 Hz), 1.99 (3H, s), 2.18 (1H,
m), 2.42 (1H, dd, J = 4.89Hz, 12.95H
z), 3.36-3.40 (2H, m), 3.43-3.47 (1H,
m), 3.51-3.59 (3H, m), 3.60-3.74 (8H,
m), 3.76-3.83 (2H, m), 3.84-3.94 (2H,
m), 3.96-4.02 (1H, m). Example 9 The reaction in this example is shown in FIG.

【0082】(a) 化合物9−1の合成 トリエチレングリコールモノオクタデシルエーテル1.02
gにピリジン20mlを加えて溶かし、氷冷下攪拌した。こ
こにジフェニルフォスフォニルクロリド788 μlを加
え、室温で17.5時間攪拌した。
(A) Synthesis of Compound 9-1 Triethylene glycol monooctadecyl ether 1.02
20 ml of pyridine was added to g to dissolve, and the mixture was stirred under ice cooling. 788 μl of diphenylphosphonium chloride was added thereto, and the mixture was stirred at room temperature for 17.5 hours.

【0083】反応液を塩化メチレンで希釈し、洗液が中
性となるまで1N塩酸で洗浄した。次いで水、飽和食塩
水で洗い、硫酸マグネシウム上乾燥させた。溶媒を減圧
下留去した。残渣をシリカゲルカラムクロマトグラフィ
ーにて精製し(溶出溶媒;n−ヘキサン−酢酸エチル
1:1)、目的物を1.48gを得た。
The reaction solution was diluted with methylene chloride and washed with 1N hydrochloric acid until the washing solution became neutral. Then, it was washed with water and saturated saline and dried over magnesium sulfate. The solvent was distilled off under reduced pressure. The residue is purified by silica gel column chromatography (elution solvent; n-hexane-ethyl acetate).
1: 1), 1.48 g of the desired product was obtained.

【0084】1H−NMR(δ,CDCl3 ):0.88
(t,3H,J=7.0 Hz),1.25(s,30H),1.54
−1.58(m,2H),3.43(t,2H,J=6.8 H
z),3.55−3.57(m,2H),3.61−3.63(m,6
H),3.72−3.74(m,2H),4.36−4.40(m,2
H),7.17−7.20(m,2H),7.23−7.25(m,4
H),7.32−7.35(m,4H). (b) 化合物9−2の合成 化合物9−1、1.46gに酢酸エチル20mlを加えて溶か
し、ここに酸化白金0.065 gを加えて常圧で23時間接触
還元した。
1 H-NMR (δ, CDCl 3 ): 0.88
(T, 3H, J = 7.0 Hz), 1.25 (s, 30H), 1.54
-1.58 (m, 2H), 3.43 (t, 2H, J = 6.8H
z), 3.55-3.57 (m, 2H), 3.61-3.63 (m, 6
H), 3.72-3.74 (m, 2H), 4.36-4.40 (m, 2)
H), 7.17-7.20 (m, 2H), 7.23-7.25 (m, 4
H), 7.32-7.35 (m, 4H). (b) Synthesis of compound 9-2 20 ml of ethyl acetate was added to 1.46 g of compound 9-1 to dissolve it, and 0.065 g of platinum oxide was added thereto and catalytically reduced at normal pressure for 23 hours.

【0085】触媒を濾去し、溶媒を減圧下留去した。残
渣をPharmacia 製ゲル濾過樹脂「Sephadex L
H−20」によるゲル濾過により精製した(溶出溶媒;メ
タノール)。溶媒を減圧下留去し、目的物を1.02g得
た。
The catalyst was filtered off and the solvent was distilled off under reduced pressure. The residue is a Sephadex L gel filtration resin manufactured by Pharmacia.
It was purified by gel filtration on "H-20" (elution solvent; methanol). The solvent was distilled off under reduced pressure to obtain 1.02 g of the desired product.

【0086】1H−NMR(δ,CDCl3 ):0.88
(t,3H,J=7.0 Hz),1.21−1.31(m,30
H),1.58(m,2H),3.47(t,2H,J=7.0 H
z),3.60−3.63(m,2H),3.65−3.72(m,8
H),4.09(bs,2H),4.19−4.22(m,2H). FAB−MS:[M+H]+ ;m/z=483 . 実施例10 本実施例における反応を図6の(b) に示す。
1 H-NMR (δ, CDCl 3 ): 0.88
(T, 3H, J = 7.0 Hz), 1.21-1.31 (m, 30
H), 1.58 (m, 2H), 3.47 (t, 2H, J = 7.0 H
z), 3.60-3.63 (m, 2H), 3.65-3.72 (m, 8)
H), 4.09 (bs, 2H), 4.19-4.22 (m, 2H). FAB-MS: [M + H] + ; m / z = 483. Example 10 The reaction in this example is shown in FIG. 6 (b).

【0087】(a) 化合物10−1の合成 トリエチレングリコールモノオクタデシルエーテル1.09
gにテトラヒドロフラン5mlおよびN,N−ジメチルホ
ルムアミド5mlを加えて溶かした。ここにトリフェニル
フォスフィン1.07gおよびピリジン 219μlを加え、氷
冷下攪拌した。ここに臭素 210μlを加え、室温で17時
間攪拌した。
(A) Synthesis of Compound 10-1 Triethylene glycol monooctadecyl ether 1.09
To g, 5 ml of tetrahydrofuran and 5 ml of N, N-dimethylformamide were added and dissolved. To this, 1.07 g of triphenylphosphine and 219 μl of pyridine were added, and the mixture was stirred under ice cooling. 210 μl of bromine was added thereto, and the mixture was stirred at room temperature for 17 hours.

【0088】溶媒を減圧下留去した。残渣をシリカゲル
カラムクロマトグラフィーにて精製し(溶出溶媒:n−
ヘキサン−酢酸エチル 8:1)、目的物を1.21g得
た。
The solvent was distilled off under reduced pressure. The residue is purified by silica gel column chromatography (elution solvent: n-
Hexane-ethyl acetate 8: 1), 1.21 g of the desired product was obtained.

【0089】1H−NMR(δ,CDCl3 ):0.88
(t,3H,J=7.0 Hz),1.18−1.34(m,30
H),1.55−1.60(m,2H),3.45(t,2H,J=
6.5 Hz),3.47(t,2H,J=6.4 Hz)3.58−3.
89(m,2H),3.64−3.70(m,6H),3.82(t,
2H,J=6.4 Hz). (b) 化合物10−2の合成 化合物10−1、1.91gにトリエチルフォスファイト2.2m
l を加え、アルゴン雰囲気下に 150℃で17時間攪拌し
た。
1 H-NMR (δ, CDCl 3 ): 0.88
(T, 3H, J = 7.0 Hz), 1.18-1.34 (m, 30
H), 1.55-1.60 (m, 2H), 3.45 (t, 2H, J =
6.5 Hz), 3.47 (t, 2H, J = 6.4 Hz) 3.58-3.
89 (m, 2H), 3.64-3.70 (m, 6H), 3.82 (t,
2H, J = 6.4 Hz). (b) Synthesis of compound 10-2 Compound 1.-1, 1.91 g of triethylphosphite 2.2 m
l was added and the mixture was stirred at 150 ° C. for 17 hours under an argon atmosphere.

【0090】減圧下トリエチルフォスファイトを留去し
た。残渣をシリカゲルカラムクロマトグラフィーにて精
製し(溶出溶媒;塩化メチレン−メタノール 50:
1)、目的物を1.35g得た。
Triethylphosphite was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (elution solvent: methylene chloride-methanol 50:
1), 1.35 g of the desired product was obtained.

【0091】1H−NMR(δ,CDCl3 ):0.88
(t,3H,J=6.8 Hz),1.23−1.31(m,30
H),1.54−1.60(m,2H),2.13(dt,2H,J
=9.5 Hz,7.5 Hz),3.44(t,2H,J=6.8 H
z),3.56−3.66(m,8H),3.72(dt,2H,J
=11.0Hz,7.5 Hz),4.06−4.14(m,4H). (c) 化合物10−3の合成 化合物10−2、0.60gに塩化メチレン10mlを加えて溶か
した。アルゴン雰囲気下、トリメチルシリルブロミド3.
05mlを加え、室温で7日間攪拌した。溶媒を減圧下留去
した後、塩化メチレン2mlに溶かし、アセトン1mlおよ
び水 0.5mlを加えて30分間攪拌した。
1 H-NMR (δ, CDCl 3 ): 0.88
(T, 3H, J = 6.8 Hz), 1.23-1.31 (m, 30
H), 1.54-1.60 (m, 2H), 2.13 (dt, 2H, J
= 9.5 Hz, 7.5 Hz), 3.44 (t, 2H, J = 6.8 H
z), 3.56-3.66 (m, 8H), 3.72 (dt, 2H, J
= 11.0 Hz, 7.5 Hz), 4.06-4.14 (m, 4H). (c) Synthesis of Compound 10-3 To 0.60 g of Compound 10-2, 10 ml of methylene chloride was added and dissolved. Trimethylsilyl bromide under argon atmosphere 3.
05 ml was added, and the mixture was stirred at room temperature for 7 days. The solvent was distilled off under reduced pressure, the residue was dissolved in 2 ml of methylene chloride, 1 ml of acetone and 0.5 ml of water were added, and the mixture was stirred for 30 minutes.

【0092】溶媒を減圧下留去し、塩化メチル−n−ヘ
キサンから再沈澱させて無色粉末として目的物を0.26g
得た。
The solvent was distilled off under reduced pressure and reprecipitated from methyl chloride-n-hexane to give 0.26 g of the desired product as a colorless powder.
Obtained.

【0093】1H−NMR(δ,CDCl3 ):0.88
(t,3H,J=6.8 Hz),1.18−1.34(m,30
H),1.58(m,2H),2.16−2.21(bs,2H),
3.46(t,2H,J=7.0 Hz),3.58−3.70(m,8
H),3.81−3.84(m,2H),6.95(bs,2H). FAB−MS:[M+H]+ ;m/z=466 . 実施例11 本実施例における反応を図7に示す。
1 H-NMR (δ, CDCl 3 ): 0.88
(T, 3H, J = 6.8 Hz), 1.18-1.34 (m, 30
H), 1.58 (m, 2H), 2.16-2.21 (bs, 2H),
3.46 (t, 2H, J = 7.0 Hz), 3.58-3.70 (m, 8
H), 3.81-3.84 (m, 2H), 6.95 (bs, 2H). FAB-MS: [M + H] + ; m / z = 466. Example 11 The reaction in this example is shown in FIG.

【0094】(a) 化合物11−1の合成 水素化ナトリウム(60%, 2.955g)をヘキサンで3回
洗浄し、50mlのDMFを加えた。懸濁液にマロン酸ジベ
ンジル(20g)を氷冷下滴下し、室温で30分攪拌した。
得られた溶液を氷冷し、臭化セチル( 51.56g)を滴下
した。室温で1時間攪拌した後50℃で15時間加熱攪拌し
た。
(A) Synthesis of compound 11-1 Sodium hydride (60%, 2.955 g) was washed with hexane three times, and 50 ml of DMF was added. Dibenzyl malonate (20 g) was added dropwise to the suspension under ice cooling, and the mixture was stirred at room temperature for 30 minutes.
The resulting solution was ice-cooled and cetyl bromide (51.56g) was added dropwise. After stirring at room temperature for 1 hour, the mixture was heated with stirring at 50 ° C. for 15 hours.

【0095】溶液を2:1ヘキサン−酢酸エチル混合溶
媒 500mlで2回抽出した。有機層を水洗し、無水硫酸ナ
リトウムで乾燥した。溶液を濾過し、溶媒を減圧下留去
した後、 1,000mlのシリカゲルカラムクロマトグラフィ
ー(ヘキサン:トルエン=2:1−1:1.5 )にて分離
し、目的物を得た。43.423g。
The solution was extracted twice with 500 ml of a 2: 1 hexane-ethyl acetate mixed solvent. The organic layer was washed with water and dried over anhydrous sodium sulfate. The solution was filtered, the solvent was evaporated under reduced pressure, and then the residue was separated by 1,000 ml of silica gel column chromatography (hexane: toluene = 2: 1-1: 1.5) to obtain the desired product. 43.423 g.

【0096】m.p.43−43.5℃.1 H−NMR(δ,CDCl3 ):0.880 (t,6H,
J=6.9 Hz),1.02−1.07(m,2H),1.16−1.32
(m,52H),1.86−1.89(m,2H2 ),5.098
(s,2H),7.24−7.31(m,10H). (b) 化合物11−2を経由する化合物11−3の合成 化合物11−1(35.605g)を 200mlの酢酸エチルに溶解
し、10%パラジウム−炭素( 700mg)を加え、50psi に
て水素添加を行った。生成した結晶及び触媒を濾取し、
600mlのクロロフォルムを加え、50℃で加熱して触媒を
濾過した。濾液を集め、溶媒を減圧下留去すると、化合
物11−2の粗生成物が得られた。m.p.=88.5−89.5
℃、26.36 g。
M. p. 43-43.5 ° C. 1 H-NMR (δ, CDCl 3 ): 0.880 (t, 6H,
J = 6.9 Hz), 1.02-1.07 (m, 2H), 1.16-1.32
(M, 52H), 1.86-1.89 ( m, 2H 2), 5.098
(S, 2H), 7.24-7.31 (m, 10H). (b) Synthesis of compound 11-3 via compound 11-2 Compound 11-1 (35.605 g) was dissolved in 200 ml of ethyl acetate, 10% palladium-carbon (700 mg) was added, and hydrogenation was performed at 50 psi. went. The crystals and catalyst formed are filtered off,
600 ml of chloroform was added and heated at 50 ° C. to filter the catalyst. The filtrate was collected and the solvent was evaporated under reduced pressure to give a crude product of compound 11-2. m. p. = 88.5-89.5
° C, 26.36 g.

【0097】化合物11−2の粗生成物を無溶媒で 170℃
で4時間加熱した。残渣をクロロフォルム/メタノール
にて再結晶して化合物11−3を得た。21.545g。
The crude product of compound 11-2 was heated at 170 ° C. without solvent.
Heated for 4 hours. The residue was recrystallized from chloroform / methanol to obtain compound 11-3. 21.545g.

【0098】m.p.77.0−79.0℃.1 H−NMR(δ,CDCl3 ):0.880 (t,6H,
J=6.9 Hz),1.02−1.33(m,52H),1.43−1.50
(m,52H),1.58−1.66(m,2H),2.32−2.37
(m,1H). (c) 化合物11−4の合成 化合物11−3、2.98gに塩化チオニル10mlを加え、2時
間加熱下還流させた。塩化チオニルを減圧下留去し、こ
こにベンゼンを加えて溶かし、再びベンゼンを減圧下留
去して化合物11−4を得た。これは精製せずに次の反応
に用いた。
M. p. 77.0-79.0 ° C. 1 H-NMR (δ, CDCl 3 ): 0.880 (t, 6H,
J = 6.9 Hz), 1.02-1.33 (m, 52H), 1.43-1.50
(M, 52H), 1.58-1.66 (m, 2H), 2.32-2.37
(M, 1H). (c) Synthesis of compound 11-4 10 ml of thionyl chloride was added to 2.98 g of compound 11-3 and refluxed under heating for 2 hours. Thionyl chloride was distilled off under reduced pressure, benzene was added and dissolved therein, and benzene was distilled off again under reduced pressure to obtain compound 11-4. This was used in the next reaction without purification.

【0099】(d) 化合物11−5の合成 2−[2−(2−クロロエトキシ)エトキシ]エタノー
ル30.6gにN,N−ジメチルホルムアミド 150mlを加え
て溶かした。ここにアジ化ナトリウム17.7gを加え、ア
ルゴン雰囲気下80℃で13時間攪拌した。
(D) Synthesis of compound 11-5 To 30.6 g of 2- [2- (2-chloroethoxy) ethoxy] ethanol, 150 ml of N, N-dimethylformamide was added and dissolved. 17.7 g of sodium azide was added thereto, and the mixture was stirred at 80 ° C. for 13 hours under an argon atmosphere.

【0100】沈澱を濾去した後、溶媒を減圧下留去し
た。ここに酢酸エチルを加え、生じた沈澱を濾去し、再
び溶媒を減圧下留去した。残渣を水 300mlに溶かし、三
菱化成(株)製の架橋ポリエスチレン樹脂「CHP−2
0」を充填したカラムに吸着させ、水に流して脱塩し、
ついで溶媒をメタノールに換えて目的物を溶出させた。
溶媒を減圧下留去し、さらにベンゼン、エタノールによ
り残存する水を共沸により除去し、目的物を無色油状物
として30.1g得た。
After the precipitate was filtered off, the solvent was distilled off under reduced pressure. Ethyl acetate was added thereto, the resulting precipitate was filtered off, and the solvent was distilled off again under reduced pressure. The residue was dissolved in 300 ml of water, and the cross-linked polyethylene resin “CHP-2” manufactured by Mitsubishi Kasei Co., Ltd.
It is adsorbed on a column packed with "0" and poured into water to desalt,
Then, the solvent was changed to methanol to elute the desired product.
The solvent was distilled off under reduced pressure, and the remaining water was removed azeotropically with benzene and ethanol to obtain 30.1 g of the desired product as a colorless oil.

【0101】1H−NMR(δ,CDCl3 ):2.27
(t,1H,J=6.0 Hz),3.40(t,2H,J=5.
0 Hz),3.62−3.63(m,2H),3.67−3.71(6
H,m),3.73−3.76(m,2H). (e) 化合物11−6の合成 化合物11−5、 5.0gをメタノール 150mlに溶かし、リ
ンドラー触媒2gを加え、約40psi の加圧下で21時間接
触還元した。
1 H-NMR (δ, CDCl 3 ): 2.27
(T, 1H, J = 6.0 Hz), 3.40 (t, 2H, J = 5.
0 Hz), 3.62-3.63 (m, 2H), 3.67-3.71 (6
H, m), 3.73-3.76 (m, 2H). (e) Synthesis of compound 11-6 5.0 g of compound 11-5 was dissolved in 150 ml of methanol, 2 g of Lindlar catalyst was added, and catalytic reduction was performed for 21 hours under a pressure of about 40 psi.

【0102】触媒を濾去した後、溶媒を減圧下留去し、
目的物を無色油状物として 4.3g得た。
After the catalyst was filtered off, the solvent was distilled off under reduced pressure,
4.3 g of the desired product was obtained as a colorless oil.

【0103】1H−NMR(δ,CDCl3 ):1.94
(bs,3H),2.88(t,2H,J=5.3 Hz),3.
56(t,2H,J=5.3 Hz),3.61−3.63(m,2
H),3.64−3.66(m,2H),3.68−3.70(m,2
H),3.73−3.74(m,2H). (f) 化合物11−7の合成 化合物11−6、2.62gを塩化メチレン20mlに溶かし、氷
冷下攪拌した。ここに、上記の方法で得た化合物11−4
全量を塩化メチレン10mlに溶かして加え、室温で17.5時
間攪拌した。
1 H-NMR (δ, CDCl 3 ): 1.94
(Bs, 3H), 2.88 (t, 2H, J = 5.3 Hz), 3.
56 (t, 2H, J = 5.3 Hz), 3.61-3.63 (m, 2
H), 3.64-3.66 (m, 2H), 3.68-3.70 (m, 2)
H), 3.73-3.74 (m, 2H). (f) Synthesis of compound 11-7 2.62 g of compound 11-6 was dissolved in 20 ml of methylene chloride and stirred under ice cooling. Here, the compound 11-4 obtained by the above method
The whole amount was dissolved in 10 ml of methylene chloride and added, and the mixture was stirred at room temperature for 17.5 hours.

【0104】反応によって生じた沈澱を塩化メチレンを
加えて溶かし、水、次いで飽和食塩水で洗浄した。硫酸
マグネシウム上乾燥させてから触媒を減圧下留去した。
残渣をシリカゲルカラムクロトグラフィーによって精製
し(溶出溶媒;塩化メチレン−メタノール 70:1)、
目的物を無色粉末として2.90g得た。
The precipitate formed by the reaction was dissolved by adding methylene chloride and washed with water and then saturated saline. After drying over magnesium sulfate, the catalyst was distilled off under reduced pressure.
The residue was purified by silica gel column chromatography (elution solvent; methylene chloride-methanol 70: 1),
As a colorless powder, 2.90 g of the desired product was obtained.

【0105】1H−NMR(δ,CDCl3 ):0.88
(t,3H,J=7.0 Hz),1.20−1.31(m,56
H),1.36−1.42(m,2H),1.54−1.60(m,2
H),2.00(m,1H),2.45(t,1H,J=6.0 H
z),3.48(dt,2H,J=5.3 Hz),3.57(t,
2H,J=5.3 Hz),3.62−3.64(m,4H),3.67
−3.69(m,2H),3.73−3.77(m,2H),6.02
(t,1H,J=5.3 Hz). (g) 化合物11−8の合成 化合物11−7、 0.100gにピリジン2mlおよび塩化メチ
レン1mlを加えて溶かし、氷冷下攪拌した。ここにジフ
ェニルフォスフォニルクロリド48.4μlを加え、室温で
22時間攪拌した。
1 H-NMR (δ, CDCl 3 ): 0.88
(T, 3H, J = 7.0 Hz), 1.20-1.31 (m, 56
H), 1.36-1.42 (m, 2H), 1.54-1.60 (m, 2)
H), 2.00 (m, 1H), 2.45 (t, 1H, J = 6.0 H
z), 3.48 (dt, 2H, J = 5.3 Hz), 3.57 (t,
2H, J = 5.3 Hz), 3.62-3.64 (m, 4H), 3.67
-3.69 (m, 2H), 3.73-3.77 (m, 2H), 6.02
(T, 1H, J = 5.3 Hz). (g) Synthesis of compound 11-8 To 0.100 g of compound 11-7, 2 ml of pyridine and 1 ml of methylene chloride were added and dissolved, and the mixture was stirred under ice cooling. Diphenyl phosphonyl chloride 48.4μl was added here, at room temperature
It was stirred for 22 hours.

【0106】反応液を塩化メチレンで希釈し、洗液が中
性となるまで1N塩酸で洗浄した。次いで、水、飽和食
塩水で洗い、硫酸マグネシウム上乾燥させた。溶媒を減
圧下留去した。残渣をシリカゲルカラムクロマトグラフ
ィーにて精製し(溶出溶媒;n−ヘキサン−酢酸エチル
2:1)、目的物を0.110 g得た。
The reaction solution was diluted with methylene chloride and washed with 1N hydrochloric acid until the washing solution became neutral. Then, it was washed with water and saturated saline and dried over magnesium sulfate. The solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (elution solvent; n-hexane-ethyl acetate 2: 1) to obtain 0.110 g of the desired product.

【0107】1H−NMR(δ,CDCl3 ):0.88
(t,6H,J=6.8 Hz),1.18−1.30(m,58
H),1.52−1.60(m,2H),1.98(m,1H),3.
42−3.45(m,2H),3.51(t,2H,J=5.0 H
z),3.56−3.58(m,2H),3.61−3.63(m,2
H),3.74−3.76(m,2H),4.38−4.42(m,2
H),6.06(t,1H,J=5.5 Hz),7.18−7.25
(m,6H),7.34(t,4H,J=8.0 Hz). (h) 化合物11−9の合成 化合物11−8、 0.099gに酢酸エチル2mlおよびテトラ
ヒドロフラン2mlを加えて溶かし、ここに酸化白金 0.0
08gを加え、常圧で14時間接触還元した。
1 H-NMR (δ, CDCl 3 ): 0.88
(T, 6H, J = 6.8 Hz), 1.18-1.30 (m, 58
H), 1.52-1.60 (m, 2H), 1.98 (m, 1H), 3.
42-3.45 (m, 2H), 3.51 (t, 2H, J = 5.0 H
z), 3.56-3.58 (m, 2H), 3.61-3.63 (m, 2
H), 3.74-3.76 (m, 2H), 4.38-4.42 (m, 2)
H), 6.06 (t, 1H, J = 5.5 Hz), 7.18-7.25
(M, 6H), 7.34 (t, 4H, J = 8.0 Hz). (h) Synthesis of compound 11-9 To 0.099 g of compound 11-8, 2 ml of ethyl acetate and 2 ml of tetrahydrofuran were added and dissolved, and platinum oxide 0.0
08 g was added, and catalytic reduction was carried out at normal pressure for 14 hours.

【0108】触媒を濾去し、溶媒を減圧下留去した。残
渣を「Sephadex LH−20」によるゲル濾過に
より精製した(溶出溶媒;塩化メチレン−メタノール
2:1)。溶媒を減圧下留去し、目的物を 0.075g得
た。
The catalyst was filtered off, and the solvent was distilled off under reduced pressure. The residue was purified by gel filtration with "Sephadex LH-20" (elution solvent; methylene chloride-methanol).
2: 1). The solvent was distilled off under reduced pressure to obtain 0.075 g of the desired product.

【0109】1H−NMR(δ,CDCl3 ):0.88
(t,6H,J=7.0 Hz),1.16−1.31(m,56
H),1.35−1.42(m,2H),1.54−1.62(m,2
H),2.04−2.10(m,1H),2.67(bs,2H),
3.49(bs,2H),3.64−3.70(m,8H),4.19−
4.23(m,2H). FAB−MS:[M+H]+ ;m/z=720 . 実施例12 本実施例における反応を図8に示す。
1 H-NMR (δ, CDCl 3 ): 0.88
(T, 6H, J = 7.0 Hz), 1.16-1.31 (m, 56
H), 1.35-1.42 (m, 2H), 1.54-1.62 (m, 2)
H), 2.04-2.10 (m, 1H), 2.67 (bs, 2H),
3.49 (bs, 2H), 3.64-3.70 (m, 8H), 4.19-
4.23 (m, 2H). FAB-MS: [M + H] + ; m / z = 720. Example 12 The reaction in this example is shown in FIG.

【0110】(a) 化合物12−3の合成 1,6−アンヒドロラクトースパーアセテート(化合物
12−1)(50g,86.7mmol)、28%ナトリウムメチラー
ト2mlおよびメタノール 600mlの混合物を室温で4時間
攪拌し、常法で処理して1,6−アンヒドロラクトース
(化合物12−2)(28.5g)を得た。
(A) Synthesis of compound 12-3 1,6-anhydrolactose peracetate (compound
12-1) (50 g, 86.7 mmol), 28% sodium methylate (2 ml) and methanol (600 ml) were stirred at room temperature for 4 hours and treated by a conventional method to prepare 1,6-anhydrolactose (compound 12-2) ( 28.5 g) was obtained.

【0111】[α]D −46.5°(c 1.0 ,H2 O). 化合物12−2(16.2g)をピリジン 150mlに溶解し、塩
化トリチル(20.9g)を加えて50℃で2時間反応させ
た。次いで、室温で塩化ベンゾイルのピリジン溶液(5
0.6g)を加えて1晩攪拌した。
[Α] D −46.5 ° (c 1.0, H 2 O). Compound 12-2 (16.2 g) was dissolved in pyridine (150 ml), trityl chloride (20.9 g) was added, and the mixture was reacted at 50 ° C for 2 hr. Then, at room temperature, a solution of benzoyl chloride in pyridine (5
0.6 g) was added and the mixture was stirred overnight.

【0112】反応液を氷水中に注ぎ、クロロホルムで抽
出して、シリカゲルカラムクロマトグラフィー(酢酸エ
チル−ヘキサン、1:1)で精製して、化合物12−3
(35g)を得た。
The reaction solution was poured into ice water, extracted with chloroform and purified by silica gel column chromatography (ethyl acetate-hexane, 1: 1) to give compound 12-3.
(35 g) was obtained.

【0113】C665415としての元素分析値は、計算
値:C, 72.93;H,5.01に対し実測値C, 72.63;
H,5.30であった。
The elemental analysis values as C 66 H 54 O 15 are calculated values: C, 72.93; H, 5.01 but actually measured values, C, 72.63;
It was H, 5.30.

【0114】[α]D +54.2°(c 1.0 ,CHC
3 ).1 H−NMR(CDCl3 ):3.16(1H,dd,J=
9.5 Hz,8.8 Hz),3.35(1H,dd,J=9.5 H
z,5.6 Hz),3.74(1H,s),3.76(1H,d
d,J=7.6 Hz,6.0 Hz),4.01(1H,d,J=
7.6 Hz),4.08(1H,dd,J=8.8 Hz,5.6 H
z),4.53(1H,d,J=5.4 Hz),4.94(1H,
s),5.24(1H,d,J=8.1 Hz),5.63(1H,
dd,J=10.3Hz,3.4 Hz),5.64−5.65(2H,
m),5.78(1H,dd,J=10.3Hz,8.1 Hz),
7.0 −8.1 (40H,m). (b) 化合物12−4の合成 化合物12−3(34.5g)をクロロホルム−メタノール−
水( 100: 100:1)の混合溶媒 400mlに溶解し、パラ
トルエンスルホン酸( 1.2g)を添加し、50℃で6時間
反応させた。
[Α] D + 54.2 ° (c 1.0, CHC
l 3 ). 1 H-NMR (CDCl 3 ): 3.16 (1 H, dd, J =
9.5 Hz, 8.8 Hz), 3.35 (1H, dd, J = 9.5H
z, 5.6 Hz), 3.74 (1H, s), 3.76 (1H, d
d, J = 7.6 Hz, 6.0 Hz), 4.01 (1H, d, J =
7.6 Hz), 4.08 (1H, dd, J = 8.8 Hz, 5.6 H
z), 4.53 (1H, d, J = 5.4 Hz), 4.94 (1H,
s), 5.24 (1H, d, J = 8.1 Hz), 5.63 (1H,
dd, J = 10.3Hz, 3.4Hz), 5.64-5.65 (2H,
m), 5.78 (1H, dd, J = 10.3Hz, 8.1Hz),
7.0-8.1 (40H, m). (b) Synthesis of Compound 12-4 Compound 12-3 (34.5 g) was added to chloroform-methanol-
It was dissolved in 400 ml of a mixed solvent of water (100: 100: 1), paratoluenesulfonic acid (1.2 g) was added, and the mixture was reacted at 50 ° C. for 6 hours.

【0115】反応液を飽和重曹水で中和し、溶媒を留去
し、クロロホルムで抽出し、シリカゲルカラムクロマト
グラフィー(酢酸エチル−ヘキサン、1:1)で精製し
て化合物12−4(18.6g)を得た。
The reaction mixture was neutralized with saturated aqueous sodium hydrogen carbonate, the solvent was evaporated, the mixture was extracted with chloroform and purified by silica gel column chromatography (ethyl acetate-hexane, 1: 1) to give compound 12-4 (18.6 g). ) Got.

【0116】C474015としての元素分析値は、計算
値:C,66.86 ;H,4.77に対し実測値:C,66.43 ;
H,4.95であった。
Elemental analysis values as C 47 H 40 O 15 were calculated values: C, 66.86; H, 4.77 actually measured value: C, 66.43;
H, 4.95.

【0117】[α]D + 104.3°(c 1.02,CHCl
3 ). (c) 化合物12−5の合成 化合物12−4(18.5g)をビリジン90mlに溶解して氷冷
し、ジフェニルホスホロクロリデート(8.27g)を加
え、室温に戻して1時間攪拌した。
[Α] D + 104.3 ° (c 1.02, CHCl
3 ). (c) Synthesis of Compound 12-5 Compound 12-4 (18.5 g) was dissolved in 90 ml of pyridine and ice-cooled, diphenylphosphorochloridate (8.27 g) was added, and the mixture was returned to room temperature and stirred for 1 hour.

【0118】反応液を氷水中に注加し、クロロホルムで
抽出し、シリカゲルカラムクロマトグラフィー(酢酸エ
チル−ヘキサン、1:1)により精製して、化合物12−
5(18.6g)を得た。
The reaction solution was poured into ice water, extracted with chloroform, and purified by silica gel column chromatography (ethyl acetate-hexane, 1: 1) to give compound 12-
5 (18.6 g) was obtained.

【0119】C594918Pとしての元素分析値は、計
算値:C,65.79 ;H,4.59;P,2.88に対し実測値
C,65.66 ;H,4.83;P,3.24であった。
The elemental analysis values for C 59 H 49 O 18 P were the calculated values: C, 65.79; H, 4.59; P, 2.88, whereas the measured values were C, 65.66; H, 4.83; P, 3.24.

【0120】[α]D + 53.8 °(c 0.976 ,CHC
3 ).1 H−NMR(CDCl3 ):3.78(2H,m),4.02
(1H,d,J=7.6Hz),4.04(1H,ddd,J
=10.5Hz,7.5 Hz,7.0 Hz),4.22(1H,dd
d,J=10.5Hz,8.0 Hz,7.0 Hz),4.34(1
H,t,J=6.0Hz),4.56(1H,d,J=5.4 H
z),4.96(1H,s),5.31(1H,d,J=8.1 H
z),5.58(1H,dd,J=10.4Hz,3.4 Hz),
5.67(2H,m),5.86(1H,dd,J=10.4Hz,
8.1 Hz),7.0 −8.1 (35H,m). (d) 化合物12−6の合成 化合物12−5(18.2g)、トリフロロ酢酸29mlおよび無
水酢酸 356mlの混合物を室温で20時間攪拌した。
[Α] D + 53.8 ° (c 0.976, CHC
l 3 ). 1 H-NMR (CDCl 3 ): 3.78 (2H, m), 4.02
(1H, d, J = 7.6Hz), 4.04 (1H, ddd, J
= 10.5Hz, 7.5Hz, 7.0Hz), 4.22 (1H, dd
d, J = 10.5Hz, 8.0Hz, 7.0Hz), 4.34 (1
H, t, J = 6.0Hz), 4.56 (1H, d, J = 5.4H)
z), 4.96 (1H, s), 5.31 (1H, d, J = 8.1 H
z), 5.58 (1H, dd, J = 10.4Hz, 3.4Hz),
5.67 (2H, m), 5.86 (1H, dd, J = 10.4Hz,
8.1 Hz), 7.0-8.1 (35 H, m). (d) Synthesis of compound 12-6 A mixture of compound 12-5 (18.2 g), trifluoroacetic acid 29 ml and acetic anhydride 356 ml was stirred at room temperature for 20 hours.

【0121】反応液を減圧濃縮し、残固体をシリカゲル
カラムクロマトグラフィー(酢酸エチル−ヘキサン、
1:1)により精製して化合物12−6(α/β=71/2
9、17g)を得た。
The reaction solution was concentrated under reduced pressure, and the residual solid was subjected to silica gel column chromatography (ethyl acetate-hexane,
Compound 12-6 (α / β = 71/2) after purification by 1: 1)
9, 17 g) was obtained.

【0122】C635521Pとしての元素分析値は、計
算値:C,64.18 ;H,4.70;P,2.63に対し実測値:
C,64.10 ;H,4.79;P,2.88であった。
Elemental analysis values as C 63 H 55 O 21 P were calculated values: C, 64.18; H, 4.70; P, 2.63, but actually measured values:
C, 64.10; H, 4.79; P, 2.88.

【0123】[α]D +50.5°(c 1.02,CHC
3 ).1 H−NMR(CDCl3 ):(α−アノマー);2.0
3,2.14(each s),3.43(dt,J=10.5Hz,7.0
Hz,7.0 Hz),3.63(dt,J=10.5Hz,10.5H
z,7.0 Hz),3.90(t,J=7.0 Hz),4.03
(m),4.06(t,J=10.3Hz),4.22(dd,J=
11.4Hz,3.4 Hz),4.27(dd,J=11.4Hz,1.
7 Hz),4.77(d,J=8Hz),5.37(dd,J=
8.5 Hz,3.5Hz),5.67(dd,J=10.2Hz,7.8
Hz),5.69(s),5.97(dd,J=10.3Hz,8.5
Hz),6.47(d,J=3.5 Hz),7.1 −8.0
(m). (β−アノマー);2.02,2.10(each s,2×OA
c),3.40(dt,J=10.5Hz,7.0 Hz),3.56
(dt,J=10.5Hz,10.5Hz,7.0 Hz),3.77
(m),4.71(d,J=7.8 Hz),5.50(dd,J=
10.0Hz,8.3 Hz),5.64(dd,J=10.5Hz,7.
8 Hz),5.74(t,J=9.5 Hz),5.86(d,J=
8.3 Hz),7.1 −8.0 (m). (e) 化合物12−7の合成 化合物12−6(10g)、トリエチレングリコールn−オ
クタデシルエーテル(3.4 g)、塩化メチレン 150mlお
よび「モレキュラーシーブ4A」(MS4A)の混合物
を氷冷し、トリメチルシリルトリフレート(2.82g)を
滴下し、室温で3時間反応させた。
[Α] D + 50.5 ° (c 1.02, CHC
l 3 ). 1 H-NMR (CDCl 3 ): (α-anomer); 2.0
3, 2.14 (each s), 3.43 (dt, J = 10.5Hz, 7.0
Hz, 7.0 Hz), 3.63 (dt, J = 10.5Hz, 10.5H
z, 7.0 Hz), 3.90 (t, J = 7.0 Hz), 4.03
(M), 4.06 (t, J = 10.3Hz), 4.22 (dd, J =
11.4Hz, 3.4Hz), 4.27 (dd, J = 11.4Hz, 1.
7 Hz), 4.77 (d, J = 8 Hz), 5.37 (dd, J =
8.5 Hz, 3.5 Hz), 5.67 (dd, J = 10.2 Hz, 7.8
Hz), 5.69 (s), 5.97 (dd, J = 10.3 Hz, 8.5
Hz), 6.47 (d, J = 3.5 Hz), 7.1-8.0
(M). (Β-anomer); 2.02, 2.10 (each s, 2 × OA
c), 3.40 (dt, J = 10.5Hz, 7.0Hz), 3.56
(Dt, J = 10.5Hz, 10.5Hz, 7.0Hz), 3.77
(M), 4.71 (d, J = 7.8 Hz), 5.50 (dd, J =
10.0Hz, 8.3Hz), 5.64 (dd, J = 10.5Hz, 7.
8 Hz), 5.74 (t, J = 9.5 Hz), 5.86 (d, J =
8.3 Hz), 7.1-8.0 (m). (e) Synthesis of compound 12-7 A mixture of compound 12-6 (10 g), triethylene glycol n-octadecyl ether (3.4 g), methylene chloride 150 ml and "Molecular Sieve 4A" (MS4A) was ice-cooled and trimethylsilyl triflate. The rate (2.82 g) was added dropwise, and the mixture was reacted at room temperature for 3 hours.

【0124】反応液を10%重曹水中に注加し、有機層を
シリカゲルカラムクロマトグラフィー(ベンゼン−酢酸
エチル−ヘキサン、1:1:1)により精製し化合物12
−7( 2.7g)を得た。
The reaction solution was poured into 10% aqueous sodium hydrogen carbonate, and the organic layer was purified by silica gel column chromatography (benzene-ethyl acetate-hexane, 1: 1: 1) to give compound 12
-7 (2.7 g) was obtained.

【0125】mp:39〜40℃. C85101 23Pとしての元素分析値は、計算値:C,
67.08 ;H,6.69に対し実測値:C,66.65 ;H,6.72
であった。
Mp: 39-40 ° C. The elemental analysis value as C 85 H 101 O 23 P was calculated value: C,
67.08 ; H, 6.69 Actual value: C, 66.65 ; H, 6.72
Met.

【0126】[α]D +18.4°(c 0.964 ,CHCl
3 ).1 H−NMR(CDCl3 ):0.89(3H,t,J=7.0
Hz),1.27(30H,s),1.57(2H,m),2.00
(3H,s),3.3 −3.7 (14H,m),3.65(1H,
ddd,J=9.4 Hz,5.0 Hz,1.7 Hz),3.98
(1H,t,J=9.4 Hz),4.15(1H,dd,J=
12.0Hz,5.0 Hz),4.32(1H,dd,J=12.0H
z,1.7 Hz),4.72(1H,d,J=7.9 Hz),4.
74(1H,d,J=7.9 Hz),5.34(1H,dd,J
=10.0Hz,3.0 Hz),5.37(1H,dd,J=10.0
Hz,7.9 Hz),5.64(1H,dd,J=10.0Hz,
7.9Hz),5.67(1H,m),5.69(1H,t,J=1
0.0Hz),7.1 −8.0 (35H). (f) 化合物12−8の合成 化合物12−7( 0.9g)を酢酸エチル18mlに溶解し、酸
化白金を触媒に用いて常温常圧で20時間接触還元した。
触媒を濾去し、28%ナトリウムメチラートで中和後(p
H6)溶媒を留去した。残固体をベンゼン−メタノール
(1:1、24ml)に溶解し、28%ナトリウムメチラート
0.6mlを添加して室温で20時間攪拌した。
[Α] D + 18.4 ° (c 0.964, CHCl
3 ). 1 H-NMR (CDCl 3 ): 0.89 (3H, t, J = 7.0
Hz), 1.27 (30H, s), 1.57 (2H, m), 2.00
(3H, s), 3.3-3.7 (14H, m), 3.65 (1H,
ddd, J = 9.4 Hz, 5.0 Hz, 1.7 Hz), 3.98
(1H, t, J = 9.4 Hz), 4.15 (1H, dd, J =
12.0Hz, 5.0Hz), 4.32 (1H, dd, J = 12.0H)
z, 1.7 Hz), 4.72 (1H, d, J = 7.9 Hz), 4.
74 (1H, d, J = 7.9 Hz), 5.34 (1H, dd, J
= 10.0Hz, 3.0Hz), 5.37 (1H, dd, J = 10.0
Hz, 7.9 Hz), 5.64 (1H, dd, J = 10.0Hz,
7.9Hz), 5.67 (1H, m), 5.69 (1H, t, J = 1
0.0Hz), 7.1-8.0 (35H). (f) Synthesis of compound 12-8 Compound 12-7 (0.9 g) was dissolved in 18 ml of ethyl acetate and catalytically reduced at room temperature and atmospheric pressure for 20 hours using platinum oxide as a catalyst.
After removing the catalyst by filtration and neutralizing with 28% sodium methylate (p
H6) The solvent was distilled off. The remaining solid was dissolved in benzene-methanol (1: 1, 24 ml) and 28% sodium methylate was added.
0.6 ml was added and stirred at room temperature for 20 hours.

【0127】反応液に1N HCl 3.1mlを加えてから
溶媒を留去し、カラムクロマトグラフィー(「CHP−
20」、22mm×40cm、0〜50%アセトニトリル)により精
製して化合物12−8の粉末を得た( 0.402g,80%)。
この一部を 0.5N NaOH−エタノールで再結晶して
化合物12−8の二ナトリウム塩として分析用試料とし
た。
To the reaction solution was added 3.1 ml of 1N HCl, the solvent was distilled off, and column chromatography (“CHP-
20 ", 22 mm x 40 cm, 0-50% acetonitrile) to give a powder of compound 12-8 (0.402 g, 80%).
A portion of this was recrystallized from 0.5N NaOH-ethanol to give a disodium salt of compound 12-8 as an analytical sample.

【0128】mp:195 〜199 ℃(dec). C366917PNa2 ・4H2 Oとしての元素分析値
は、計算値:C,46.85;H,8.40;P,3.36;Na,
4.98に対し実測値C,47.06 ;H,8.32;P,3.31;N
a,4.83であった。
Mp: 195-199 ° C. (dec). The elemental analysis values as C 36 H 69 O 17 PNa 2 .4H 2 O are calculated values: C, 46.85; H, 8.40; P, 3.36; Na,
Measured values for 4.98 C, 47.06; H, 8.32; P, 3.31; N
It was a, 4.83.

【0129】[α]D − 4.5°(c 0.8,H2 O).1 H−NMR(D2 O):0.91(3H,bs),1.33(3
0H,bs),1.60(2H,bs),3.3 −4.5 (28
H,bm). 実施例13 本実施例における反応を図9に示す。
[Α] D −4.5 ° (c 0.8, H 2 O). 1 H-NMR (D 2 O): 0.91 (3 H, bs), 1.33 (3
0H, bs), 1.60 (2H, bs), 3.3-4.5 (28
H, bm). Example 13 The reaction in this example is shown in FIG.

【0130】(a) 化合物13−1の合成 マンノースパーアセテート(7.457 g)およびトリエチ
レングリコールモノステアリルエーテル(10g)の塩化
メチレン(200ml )溶液にボロントリフルオライドエー
テル錯体(9.40ml)の塩化メチレン溶液(30ml)を氷冷
下加え、一晩室温にて撹拌した。得られた溶液を氷水に
加え、クロロフォルム150ml を加えて抽出した。有機層
を2回水洗し、無水硫酸ナトリウムにて乾燥した。溶媒
を減圧下濃縮し、残渣を100ml のシリカゲルカラムクロ
マトグラフィーにて分離し(クロロフォルム:アセトニ
トリル=100 :1−100 :1.5 )、目的物と原料のアル
コールとの混合物を得た。4.9162g。
(A) Synthesis of compound 13-1 Mannose peracetate (7.457 g) and triethylene glycol monostearyl ether (10 g) in methylene chloride (200 ml) were dissolved in boron trifluoride ether complex (9.40 ml) in methylene chloride. (30 ml) was added under ice cooling, and the mixture was stirred overnight at room temperature. The obtained solution was added to ice water, and 150 ml of chloroform was added for extraction. The organic layer was washed twice with water and dried over anhydrous sodium sulfate. The solvent was concentrated under reduced pressure, and the residue was separated by 100 ml of silica gel column chromatography (chloroform: acetonitrile = 100: 1-100: 1.5) to obtain a mixture of the desired product and the starting alcohol. 4.9162g.

【0131】この混合物をメタノール100ml に溶解し、
ナトリウムメチラートメタノール溶液(5モル/l)を
20滴加え、室温にて5時間撹拌した。得られた溶液にD
owex社製酸性イオン交換樹脂「ダウエックス50W×
8」を加え中和した後、樹脂を濾別し、溶媒を減圧下留
去した。残渣にトルエン100ml を加え、減圧下トルエン
を留去し、アルコール及び水を除いた。残渣を150ml の
ピリジンに溶解し、トリチルクロリド(3.511 g)を加
え、50℃で5時間加熱撹拌した。
This mixture was dissolved in 100 ml of methanol,
Sodium methylate methanol solution (5 mol / l)
20 drops were added, and the mixture was stirred at room temperature for 5 hours. D in the resulting solution
owex acidic ion exchange resin "Dowex 50W x
8 "was added for neutralization, the resin was filtered off, and the solvent was distilled off under reduced pressure. Toluene 100 ml was added to the residue, and toluene was distilled off under reduced pressure to remove alcohol and water. The residue was dissolved in 150 ml of pyridine, trityl chloride (3.511 g) was added, and the mixture was heated with stirring at 50 ° C. for 5 hours.

【0132】得られた溶液を氷水に加え、クロロフォル
ム300ml にて抽出した。有機層を2N塩酸で1回、水で
3回洗浄し、無水硫酸ナトリウムにて乾燥した。溶媒を
減圧下濃縮し、残渣を500ml のシリカゲルカラムクロマ
トグラフィーにて分離し(クロロフォルム:メタノール
=100 :1−100 :2)、目的物を得た。3.2270g。
The obtained solution was added to ice water and extracted with 300 ml of chloroform. The organic layer was washed once with 2N hydrochloric acid and three times with water, and dried over anhydrous sodium sulfate. The solvent was concentrated under reduced pressure, and the residue was separated by silica gel column chromatography (500 ml) (chloroform: methanol = 100: 1-100: 2) to obtain the desired product. 3.2270g.

【0133】[α]D 27=+10.3°(c 1.25、CHC
3 ).1 H−NMR(CDCl3 ,δ):0.879 (3H,t,
J=6.9 Hz),1.17−1.32(30H),1.52−1.59(2
H,m),2.742 (1H,d),2.57−2.58(2H,
m),3.429 (3H,t,J=6.9 Hz),3.56−3.78
(15H),3.80−3.85(1H,m),3.96(1H,br
dt),4.905 (1H,d,J=1.5 Hz),7.23−7.
46(15H). (b) 化合物13−2の合成 化合物13−1(3.2070g)のピリジン(50ml)溶液にベ
ンゾイルクロリド(2.01g)を加え、一晩室温で撹拌し
た。
[Α] D 27 = + 10.3 ° (c 1.25, CHC
l 3 ). 1 H-NMR (CDCl 3 , δ): 0.879 (3H, t,
J = 6.9 Hz), 1.17-1.32 (30H), 1.52-1.59 (2
H, m), 2.742 (1H, d), 2.57-2.58 (2H,
m), 3.429 (3H, t, J = 6.9 Hz), 3.56-3.78
(15H), 3.80-3.85 (1H, m), 3.96 (1H, br
dt), 4.905 (1H, d, J = 1.5 Hz), 7.23-7.
46 (15H). (b) Synthesis of compound 13-2 To a solution of compound 13-1 (3.2070 g) in pyridine (50 ml) was added benzoyl chloride (2.01 g), and the mixture was stirred overnight at room temperature.

【0134】溶液を氷水に加え、クロロフォルム(100m
l )にて抽出した。有機層を2N塩酸で1回、水で2回
洗浄し、無水硫酸ナトリウムにて乾燥した。溶媒を減圧
下留去し、残渣を350ml のシリカゲルカラムクロマトグ
ラフィーにて分離し(ヘキサン:酢酸エチル=5:1−
4:1)、目的物を得た。3.9575g。
The solution was added to ice water, and chloroform (100 m
l). The organic layer was washed once with 2N hydrochloric acid and twice with water, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the residue was separated by 350 ml silica gel column chromatography (hexane: ethyl acetate = 5: 1−).
4: 1), the desired product was obtained. 3.9575g.

【0135】[α]D 29=−67.1°(c 1.12、CHC
3 ).1 H−NMR(CDCl3 ,δ):0.877 (t,3H,
J=6.9 Hz),1.22−1.30(m,30H),1.52−1.58
(m,2H),3.413 (t,3H,J=6.8 Hz),3.
39−3.83(m,12H),3.247 (dd,1H,J=4.4
Hz,10.5Hz),3.94−3.99(m,1H),4.240
(m,1H),5.187 (d,1H,J=1.5 Hz),5.
717 (dd,1H,J=3.4 Hz),5.795 (dd,1
H),6.080 (t,1H,J=10.0Hz),7.07−7.50
(m),7.72−8.17(m,6H). (c) 化合物13−3の合成 化合物13−2(3.5800g)およびパラトルエンスルホン
酸(200mg )をクロロフォルム:メタノール:水=65:
15:1の混合溶媒(40ml)に溶解し、溶液を50℃にて7
時間加熱撹拌した。
[Α] D 29 = -67.1 ° (c 1.12, CHC
l 3 ). 1 H-NMR (CDCl 3 , δ): 0.877 (t, 3H,
J = 6.9 Hz), 1.22-1.30 (m, 30H), 1.52-1.58
(M, 2H), 3.413 (t, 3H, J = 6.8 Hz), 3.
39-3.83 (m, 12H), 3.247 (dd, 1H, J = 4.4
Hz, 10.5Hz), 3.94-3.99 (m, 1H), 4.240
(M, 1H), 5.187 (d, 1H, J = 1.5 Hz), 5.
717 (dd, 1H, J = 3.4 Hz), 5.795 (dd, 1
H), 6.080 (t, 1H, J = 10.0Hz), 7.07-7.50
(M), 7.72-8.17 (m, 6H). (C) Synthesis of compound 13-3 Compound 13-2 (3.5800 g) and paratoluenesulfonic acid (200 mg) were mixed with chloroform: methanol: water = 65:
Dissolve in a 15: 1 mixed solvent (40 ml) and mix the solution at 50 ° C for 7
The mixture was heated and stirred for an hour.

【0136】得られた溶液を室温まで冷却した後、トリ
エチルアミンにて中和した。溶媒を減圧下留去し、残渣
を水及びクロロフォルムの混合溶媒にて抽出した。有機
層を水洗し、無水硫酸ナトリウムにて乾燥した。溶媒を
減圧下留去し、残渣を200mlのシリカゲルカラムクロマ
トグラフィーにて分離し(ヘキサン:酢酸エチル=2:
1−2:1.5 )、目的物を得た。2.795 g。
The obtained solution was cooled to room temperature and then neutralized with triethylamine. The solvent was evaporated under reduced pressure, and the residue was extracted with a mixed solvent of water and chloroform. The organic layer was washed with water and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure, and the residue was separated by 200 ml silica gel column chromatography (hexane: ethyl acetate = 2:
1-2: 1.5), the target product was obtained. 2.795 g.

【0137】[α]D 23=−84.2°(c 1.04、CHC
3 ).1 H−NMR(CDCl3 ,δ):0.878 (t,3H,
J=6.9 Hz),1.18−1.31(m,30H),1.50−1.57
(m,2H),3.369 (t,2H,J=6.8 Hz),3.
53−3.55(m,2H),3.63−3.65(m,2H),3.68
−3.84(m,9H),3.93−3.97(m,1H),4.196
(brd,1H),5.157 (d,1H,J=1.5 H
z),5.692 (dd,1H,J=3.4 Hz),5.811
(t,1H,J=10.0Hz),5,980 (dd,1H),
7.23−7.62(m,9H),7.80−8.11(m,6H). (d) 化合物13−4の合成 化合物13−3(2.2457g)のピリジン(5ml)溶液に氷
冷下ジフェニル燐酸クロリド(1.050 g)のピリジン溶
液(6ml)を滴下し、室温で一晩撹拌した。
[Α] D 23 = -84.2 ° (c 1.04, CHC
l 3 ). 1 H-NMR (CDCl 3 , δ): 0.878 (t, 3H,
J = 6.9 Hz), 1.18-1.31 (m, 30H), 1.50-1.57
(M, 2H), 3.369 (t, 2H, J = 6.8 Hz), 3.
53-3.55 (m, 2H), 3.63-3.65 (m, 2H), 3.68
-3.84 (m, 9H), 3.93-3.97 (m, 1H), 4.196
(Brd, 1H), 5.157 (d, 1H, J = 1.5 H
z), 5.692 (dd, 1H, J = 3.4 Hz), 5.811
(T, 1H, J = 10.0Hz), 5,980 (dd, 1H),
7.23-7.62 (m, 9H), 7.80-8.11 (m, 6H). (d) Synthesis of compound 13-4 To a solution of compound 13-3 (2.2457 g) in pyridine (5 ml) was added dropwise a solution of diphenylphosphoric acid chloride (1.050 g) in pyridine (6 ml) under ice cooling, and the mixture was stirred at room temperature overnight. .

【0138】反応溶液を氷水に加え、クロロフォルム10
0ml にて抽出した。有機層を2N塩酸で1回、水で3回
洗浄し、無水硫酸ナトリウムにて乾燥した。溶媒を減圧
下留去し、残渣を250ml のシリカゲルカラムクロマトグ
ラフィーにて分離し(ヘキサン:酢酸エチル=2:1−
4:3)、目的物を得た。2.7398g。
The reaction solution was added to ice water, and chloroform 10
It was extracted with 0 ml. The organic layer was washed once with 2N hydrochloric acid and three times with water, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure and the residue was separated by 250 ml silica gel column chromatography (hexane: ethyl acetate = 2: 1−).
4: 3), and the target product was obtained. 2.7398 g.

【0139】[α]D 26=−55.9°(c 1.34、CHC
3 ).1 H−NMR(CDCl3 ,δ):0.887 (t,3H,
J=6.8 Hz),1.24−1.31(m,30H),3.411
(t,1H,J=6.8 Hz),3,58−3.73(m,11
H),3.83−3.88(m,1H),4.39−4.43(m,1
H),4.44−4.48(m,2H),5.084 (d,1H,J
=1.7 Hz),5.679 (dd,1H,J=2.7 Hz),
5.86−5.91(m,2H),7.09−7.59(m,19H),7.
80−8.09(m,6H). (e) 化合物13−5の合成 化合物13−4(700mg )および酸化白金50mgに酢酸エチ
ル8mlおよびメタノール4mlを加え、一晩常圧の水素雰
囲気下撹拌した。触媒を濾過し、溶媒を減圧下留去し
た。残渣にメタノール8mlおよびベンゼン2mlを加え溶
解し、ナトリウムメチラートメタノール溶液(5モル/
l)を20滴加えてpHを11とし、室温にて一晩撹拌した。
[Α] D 26 = -55.9 ° (c 1.34, CHC
l 3 ). 1 H-NMR (CDCl 3 , δ): 0.887 (t, 3H,
J = 6.8 Hz), 1.24-1.31 (m, 30H), 3.411
(T, 1H, J = 6.8 Hz), 3,58-3.73 (m, 11
H), 3.83-3.88 (m, 1H), 4.39-4.43 (m, 1)
H), 4.44-4.48 (m, 2H), 5.084 (d, 1H, J
= 1.7 Hz), 5.679 (dd, 1H, J = 2.7 Hz),
5.86-5.91 (m, 2H), 7.09-7.59 (m, 19H), 7.
80-8.09 (m, 6H). (e) Synthesis of compound 13-5 To compound 13-4 (700 mg) and platinum oxide (50 mg) were added ethyl acetate (8 ml) and methanol (4 ml), and the mixture was stirred overnight under a hydrogen atmosphere at normal pressure. The catalyst was filtered and the solvent was distilled off under reduced pressure. To the residue was added 8 ml of methanol and 2 ml of benzene to dissolve, and a sodium methylate methanol solution (5 mol / mol) was added.
The pH was adjusted to 11 by adding 20 drops of 1) and the mixture was stirred overnight at room temperature.

【0140】溶液を1N塩酸にて中和した後、溶媒を減
圧下留去した。残渣を水に溶解し、「CHP−20」カラ
ムクロマトグラフィー(22mmφ×400mm 、10%アセトニ
トリル−90%アセトニトリルのグラジエント溶離、総量
1000ml、125 フラクション)にて分離した。フラクショ
ン61−82を濃縮した。残渣を水50mlに溶解し、酸性イオ
ン交換樹脂「ダウエックス50W×8」にて処理した後樹
脂を濾過した。濾液を凍結乾燥して目的物を得た。282m
g 。
After the solution was neutralized with 1N hydrochloric acid, the solvent was distilled off under reduced pressure. The residue was dissolved in water and "CHP-20" column chromatography (22 mmφ x 400 mm, 10% acetonitrile-90% acetonitrile gradient elution, total amount
It was separated with 1000 ml, 125 fractions). Fractions 61-82 were concentrated. The residue was dissolved in 50 ml of water, treated with an acidic ion exchange resin “Dowex 50W × 8”, and then the resin was filtered. The filtrate was freeze-dried to obtain the desired product. 282m
g.

【0141】[α]D 19=+21.2°(c 1.50、クロロ
フォルム:メタノール:水=10:10:1).1 H−NMR(DMSO,δ):0.860 (t,3H,J
=6.9 Hz),1.19−1.31(m,30H),1.45−1.51
(m,2H),3.364 (t,2H,J=6.6 Hz),3.
43−3.57(m,14H),3.626 (brs),3.66−3.70
(m,1H),3.88−3.93(m,1H),4.045 (br
dd,1H,J=10.3Hz,6.2 Hz),4.646 (d,
1H,J=1.5 Hz).13 C−NMR(DMSO,δ):13.87 ,22.07 ,25.6
2 ,28.6−29.2,31.27 ,65.01 (J=4.7 Hz),6
5.89 ,66.44 ,69.46 ,69.51 ,69.82 ,70.18 ,70.
37 ,70.66 ,72.10 (J=7.6 Hz),100.05. 実施例14 本実施例における反応を図10に示す。
[Α] D 19 = + 21.2 ° (c 1.50, chloroform: methanol: water = 10: 10: 1). 1 H-NMR (DMSO, δ): 0.860 (t, 3H, J
= 6.9 Hz), 1.19-1.31 (m, 30H), 1.45-1.51
(M, 2H), 3.364 (t, 2H, J = 6.6 Hz), 3.
43-3.57 (m, 14H), 3.626 (brs), 3.66-3.70
(M, 1H), 3.88-3.93 (m, 1H), 4.045 (br
dd, 1H, J = 10.3Hz, 6.2Hz), 4.646 (d,
1H, J = 1.5 Hz). 13 C-NMR (DMSO, δ): 13.87, 22.07, 25.6.
2, 28.6-29.2, 31.27, 65.01 (J = 4.7 Hz), 6
5.89, 66.44, 69.46, 69.51, 69.82, 70.18, 70.
37, 70.66, 72.10 (J = 7.6 Hz), 100.05. Example 14 The reaction in this Example is shown in FIG.

【0142】(a) 化合物14−1の合成 マンノースパーアセテート(20.0g,51.24mmol )およ
び2−[2−(2−クロロエトキシ)エトキシ]エタノ
ール(11.232g)の塩化メチレン(300ml )溶液にボロ
ントリフルオライドエーテル錯体(25.21ml )の塩化メ
チレン(25ml)溶液を氷冷下加え、一晩室温にて撹拌し
た。
(A) Synthesis of compound 14-1 Mannose peracetate (20.0 g, 51.24 mmol) and 2- [2- (2-chloroethoxy) ethoxy] ethanol (11.232 g) in methylene chloride (300 ml) were dissolved in boron. A solution of trifluoride ether complex (25.21 ml) in methylene chloride (25 ml) was added under ice cooling, and the mixture was stirred overnight at room temperature.

【0143】得られた溶液を氷水に加え、クロロフォル
ム200ml を加えて抽出した。有機層を4回水洗し、無水
硫酸ナトリウムにて乾燥した。溶媒を減圧下濃縮し、残
渣を1700mlのシリカゲルカラムクロマトグラフィーにて
分離し(ヘキサン:酢酸エチル=2:1−1:1)、目
的物を得た。6.861 g。
The obtained solution was added to ice water and 200 ml of chloroform was added for extraction. The organic layer was washed 4 times with water and dried over anhydrous sodium sulfate. The solvent was concentrated under reduced pressure, and the residue was separated by 1700 ml silica gel column chromatography (hexane: ethyl acetate = 2: 1-1: 1) to obtain the desired product. 6.861 g.

【0144】[α]D 23=+33.3°(c 1.35、CHC
3 ).1 H−NMR(CDCl3 ,δ):1.987, 2.039, 2,10
0. 2.153(4s,3H),3.397 (t,2H,J=5.1
Hz),3.61−3.85(m,10H),4.064 (m,1
H),4.107 (dd,1H,J=2.4 Hz,12.2H
z),4.286 (dd,1H,J=5.1 Hz),4.873
(d,1H,J=1.7 Hz),5.270 (dd,1H,J
=3.4 Hz),5.288 (t,1H,J=10.0Hz),5.
364 (dd,1H). (b) 化合物14−2の合成 化合物14−1(5.861 g)およびナトリウムアジド(1.
146 g)にDMF(50ml)を加え、60℃にて17時間加熱
撹拌した。
[Α] D 23 = + 33.3 ° (c 1.35, CHC
l 3 ). 1 H-NMR (CDCl 3 , δ): 1.987, 2.039, 2,10
0.2.153 (4s, 3H), 3.397 (t, 2H, J = 5.1
Hz), 3.61-3.85 (m, 10H), 4.064 (m, 1
H), 4.107 (dd, 1H, J = 2.4 Hz, 12.2H
z), 4.286 (dd, 1H, J = 5.1 Hz), 4.873
(D, 1H, J = 1.7 Hz), 5.270 (dd, 1H, J
= 3.4 Hz), 5.288 (t, 1H, J = 10.0 Hz), 5.
364 (dd, 1H). (b) Synthesis of compound 14-2 Compound 14-1 (5.861 g) and sodium azide (1.
DMF (50 ml) was added to 146 g) and the mixture was heated with stirring at 60 ° C. for 17 hours.

【0145】得られた溶液に水100ml 加え、酢酸エチル
で抽出した。有機層を3回水洗し、無水硫酸ナトリウム
にて乾燥した。溶媒を減圧下留去し、残渣を350ml のシ
リカゲルカラムクロマトグラフィーにて分離し(ヘキサ
ン:酢酸エチル=1:1)、目的物を得た。4.468 g。
100 ml of water was added to the obtained solution and the mixture was extracted with ethyl acetate. The organic layer was washed 3 times with water and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure, and the residue was separated by 350 ml silica gel column chromatography (hexane: ethyl acetate = 1: 1) to obtain the desired product. 4.468 g.

【0146】[α]D 21=+35.6°(c 1.04、CHC
3 1 H−NMR(CDCl3 ,δ):1.988, 2.040,2.100,
2.153(4s,3H),3.640 (t,2H,J=5.9 H
z),3.64−3.84(m,10H),4.068 (m,1H),
4.117 (dd,1H,J=2.4 Hz,12.2Hz),4.28
7 (dd,1H,J=5.1 Hz),4.874 (d,1H,
J=1.5 Hz),5.267 (dd,1H,J=3.7 H
z),5.289 (t,1H,J=10.0Hz),5.362 (d
d,1H). (c) 化合物14−3の合成 化合物14−2(4.4676g)のメタノール(100ml )溶液
にナトリウムメチラートメタノール溶液(5モル/l)
を10滴加え、室温にて3時間撹拌した。得られた溶液に
酸性イオン交換樹脂「ダウエックス50W×8」を加え中
和した後、樹脂を濾別し、溶媒を減圧下留去した。残渣
を100ml のピリジンに溶解し、トリチルクロリド(3.20
3 g)を加え、50℃で3時間加熱撹拌した。さらにトリ
チルクロリド(1.231 g)を加え、70℃で14時間加熱し
た。得られた溶液を室温まで冷却し、ベンゾイルクロリ
ド(3.692ml )を加え、一晩室温で撹拌した。溶液を氷
水に加え、クロロフォルム200ml にて抽出した。有機層
を2N塩酸で2回、水で3回洗浄し、無水硫酸ナトリウ
ムにて乾燥した。溶媒を減圧下濃縮し、残渣にパラトル
エンスルホン酸200mg を加え、クロロフォルム:メタノ
ール:水=65:15:1の混合溶媒を50ml加えて溶解し、
50℃にて5時間加熱撹拌した。
[Α] D 21 = + 35.6 ° (c 1.04, CHC
l 3 ) 1 H-NMR (CDCl 3 , δ): 1.988, 2.040, 2.100,
2.153 (4s, 3H), 3.640 (t, 2H, J = 5.9H
z), 3.64-3.84 (m, 10H), 4.068 (m, 1H),
4.117 (dd, 1H, J = 2.4 Hz, 12.2 Hz), 4.28
7 (dd, 1H, J = 5.1 Hz), 4.874 (d, 1H,
J = 1.5 Hz), 5.267 (dd, 1H, J = 3.7 H)
z), 5.289 (t, 1H, J = 10.0Hz), 5.362 (d
d, 1H). (c) Synthesis of Compound 14-3 A solution of Compound 14-2 (4.4676 g) in methanol (100 ml) was dissolved in sodium methylate in methanol (5 mol / l).
10 drops of was added and stirred at room temperature for 3 hours. To the resulting solution was added an acidic ion exchange resin "Dowex 50W x 8" for neutralization, the resin was filtered off, and the solvent was distilled off under reduced pressure. The residue was dissolved in 100 ml of pyridine and trityl chloride (3.20
3 g) was added and the mixture was heated with stirring at 50 ° C. for 3 hours. Further, trityl chloride (1.231 g) was added, and the mixture was heated at 70 ° C for 14 hours. The resulting solution was cooled to room temperature, benzoyl chloride (3.692 ml) was added, and the mixture was stirred overnight at room temperature. The solution was added to ice water and extracted with 200 ml of chloroform. The organic layer was washed twice with 2N hydrochloric acid and three times with water, and dried over anhydrous sodium sulfate. The solvent was concentrated under reduced pressure, 200 mg of paratoluenesulfonic acid was added to the residue, and 50 ml of a mixed solvent of chloroform: methanol: water = 65: 15: 1 was added and dissolved.
The mixture was heated and stirred at 50 ° C for 5 hours.

【0147】得られた溶液をトリエチルアミンにて中和
し、溶媒を減圧下留去した。残渣に水50mlを加え、クロ
ロフォルムにて抽出した。溶媒を減圧下留去し、残渣を
500ml のシリカゲルカラムクロマトグラフィーにて分離
し(ヘキサン:酢酸エチル=2:1−1:1)、目的物
を得た。2.4106g,42.0%。
The obtained solution was neutralized with triethylamine, and the solvent was evaporated under reduced pressure. 50 ml of water was added to the residue and extracted with chloroform. The solvent was distilled off under reduced pressure, and the residue was
Separation was performed by 500 ml of silica gel column chromatography (hexane: ethyl acetate = 2: 1-1: 1) to obtain the desired product. 2.4106g, 42.0%.

【0148】[α]D 23=−107.2 °(c 1.75、CH
Cl3 ).1 H−NMR(CDCl3 ,δ):3.376 (t,2H,
J=5.1 Hz),3.68−3.86(m,12H),3.92−3.96
(m,1H),4.166 (brd,dd),4.196 (br
d,1H),5.168 (d,1H,J=1.5 Hz),5.70
2 (dd,1H,J=3.4 Hz),5.823 (t,1H,
J=10.0Hz),5.993 (dd,1H),7.23−7.63
(m,9H),7.80−8.12(m,6H). (d) 化合物14−4の合成 化合物14−3(2.4066g)のピリジン(20ml)溶液に氷
冷下ジフェニル燐酸クロリド(1.493 g)のピリジン
(3ml)溶液を滴下し、室温で一晩撹拌した。得られた
溶液を氷水に加え、クロロフォルム(100ml )にて抽出
した。有機層を2N塩酸で2回、飽和食塩水で3回洗浄
し、無水硫酸ナトリウムにて乾燥した。溶媒を減圧下留
去し、残渣を500ml のシリカゲルカラムクロマトグラフ
ィーにて分離し(ヘキサン:酢酸エチル=2:1)、目
的物を得た。2.848 g,87.2%。
[Α] D 23 = −107.2 ° (c 1.75, CH
Cl 3 ). 1 H-NMR (CDCl 3 , δ): 3.376 (t, 2H,
J = 5.1 Hz), 3.68-3.86 (m, 12H), 3.92-3.96
(M, 1H), 4.166 (brd, dd), 4.196 (br
d, 1H), 5.168 (d, 1H, J = 1.5 Hz), 5.70
2 (dd, 1H, J = 3.4 Hz), 5.823 (t, 1H,
J = 10.0Hz), 5.993 (dd, 1H), 7.23-7.63
(M, 9H), 7.80-8.12 (m, 6H). (d) Synthesis of compound 14-4 To a solution of compound 14-3 (2.4066 g) in pyridine (20 ml) was added dropwise a solution of diphenylphosphoric acid chloride (1.493 g) in pyridine (3 ml) under ice cooling, and the mixture was stirred at room temperature overnight. . The resulting solution was added to ice water and extracted with chloroform (100 ml). The organic layer was washed twice with 2N hydrochloric acid and three times with saturated brine, and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure, and the residue was separated by 500 ml silica gel column chromatography (hexane: ethyl acetate = 2: 1) to obtain the desired product. 2.848 g, 87.2%.

【0149】[α]D 27=−58.6°(c 1.04、CHC
3 ).1 H−NMR(CDCl3 ,δ):3.384 (t,2H,
J=5.0 Hz),3.68−3.75(m,9H),3.83−3.89
(m,1H),4.39−4.43(m,1H),4.45−4.48
(m,2H),5.092 (d,1H,J=1.7 Hz),5.
683 (dd,1H,J=2.5 Hz),5.86−5.92(m,
2H),7.10−7.59(m,19H),7.80−8.08(m,6
H). (e) 化合物の14−5の合成 化合物14−4(2.8443g)およびパラトルエンスルホン
酸1水和物(613.5mg)をメタノール20mlおよび酢酸エ
チル20mlの混合溶媒に溶解し、リンドラー触媒(1.0
g)を加え、50psi の水素雰囲気下6時間撹拌した。さ
らにリンドラー触媒(1.0 g)を加え、50psi の水素雰
囲気下3時間撹拌した。
[Α] D 27 = -58.6 ° (c 1.04, CHC
l 3 ). 1 H-NMR (CDCl 3 , δ): 3.384 (t, 2H,
J = 5.0 Hz), 3.68-3.75 (m, 9H), 3.83-3.89
(M, 1H), 4.39-4.43 (m, 1H), 4.45-4.48
(M, 2H), 5.092 (d, 1H, J = 1.7 Hz), 5.
683 (dd, 1H, J = 2.5 Hz), 5.86-5.92 (m,
2H), 7.10-7.59 (m, 19H), 7.80-8.08 (m, 6
H). (e) Synthesis of Compound 14-5 Compound 14-4 (2.8443 g) and paratoluenesulfonic acid monohydrate (613.5 mg) were dissolved in a mixed solvent of 20 ml of methanol and 20 ml of ethyl acetate, and the Lindlar catalyst (1.0
g) was added, and the mixture was stirred under a hydrogen atmosphere of 50 psi for 6 hours. A Lindlar catalyst (1.0 g) was further added, and the mixture was stirred under a hydrogen atmosphere of 50 psi for 3 hours.

【0150】触媒を濾過し、溶媒を減圧下留去して目的
物を得た。3.075 g。この化合物は特に精製をする事な
く次の段階の合成に用いた。
The catalyst was filtered and the solvent was distilled off under reduced pressure to obtain the desired product. 3.075 g. This compound was used for the next step synthesis without any particular purification.

【0151】(f) 化合物14−6の合成 化合物14−5(0.972 g)の塩化メチレン(20ml)溶液
にN−パルミトイルオキシスクシイミド(400mg )およ
びトリエチルアミン(0.171ml )を加え、一晩撹拌し
た。
(F) Synthesis of Compound 14-6 To a solution of Compound 14-5 (0.972 g) in methylene chloride (20 ml) was added N-palmitoyloxysuccinimide (400 mg) and triethylamine (0.171 ml), and the mixture was stirred overnight. did.

【0152】得られた溶液を氷水に加え、目的物を抽出
した。溶液を無水硫酸ナトリウムで乾燥した後、溶媒を
減圧下留去した。残渣を100ml のシリカゲルカラムクロ
マトグラフィーにて分離し(ヘキサン:酢酸エチル=
1:1.5 )、目的物を得た。0.6493g。
The obtained solution was added to ice water to extract the desired product. After the solution was dried over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure. The residue was separated by 100 ml silica gel column chromatography (hexane: ethyl acetate =
1: 1.5) to obtain the desired product. 0.6493g.

【0153】[α]D 23=−55.2°(c 1.47、CHC
3 ).1 H−NMR(CDCl3 ,δ):0.877 (t,3H,
J=6.9 Hz),1.23−1.31(m,24H),1.55−1.62
(m,2H),2.129 (t,2H,J=7.6 Hz),3.
42−3.46(m,2H),3.561 (t,2H),3.64−3.
76(m,7H),3.87−3.91(m,1H),4.43−4.50
(m,3H),5.112 (ds,1H,J=1.9 Hz),
5.685 (dd,1H,J=2.9 Hz),5.87−5.93
(m,2H),7.11−7.61(m,19H),7.81−8.08
(m,6H). (g) 化合物14−7の合成 化合物14−6(0.630 g)および酸化白金50mgに酢酸エ
チル15mlおよびメタノール15mlを加え、一晩常圧の水素
雰囲気下撹拌した。触媒を濾過し、溶媒を減圧下留去し
た。残渣にメタノール8mlを加え溶解し、ナトリウムメ
チラートメタノール溶液(5モル/l)を25滴加えてpH
を11とし、室温にて5時間撹拌した。
[Α] D 23 = -55.2 ° (c 1.47, CHC
l 3 ). 1 H-NMR (CDCl 3 , δ): 0.877 (t, 3H,
J = 6.9 Hz), 1.23-1.31 (m, 24H), 1.55-1.62
(M, 2H), 2.129 (t, 2H, J = 7.6 Hz), 3.
42-3.46 (m, 2H), 3.561 (t, 2H), 3.64-3.
76 (m, 7H), 3.87-3.91 (m, 1H), 4.43-4.50
(M, 3H), 5.112 (ds, 1H, J = 1.9 Hz),
5.685 (dd, 1H, J = 2.9 Hz), 5.87-5.93
(M, 2H), 7.11-7.61 (m, 19H), 7.81-8.08
(M, 6H). (g) Synthesis of compound 14-7 To compound 14-6 (0.630 g) and platinum oxide (50 mg) were added ethyl acetate (15 ml) and methanol (15 ml), and the mixture was stirred overnight under a hydrogen atmosphere at normal pressure. The catalyst was filtered and the solvent was distilled off under reduced pressure. To the residue was added 8 ml of methanol to dissolve it, and 25 drops of sodium methylate methanol solution (5 mol / l) was added to adjust the pH.
Was set to 11, and the mixture was stirred at room temperature for 5 hours.

【0154】溶液を1N塩酸にて中和した後、溶媒を減
圧下留去した。残渣を水に溶解し「CHP−20」カラム
クロマトグラフィー(22mmφ×400mm 、10%アセトニト
リル−90%アセトニトリルのグラジエント溶離、総量10
00ml、103 フラクション)にて分離した。フラクション
40−49を濃縮した。残渣を水に溶解し、酸性イオン交換
樹脂「ダウエックス50W×8」にて処理した後、樹脂を
濾過した。濾液を凍結乾燥にて目的物を得た。295.2mg,
81.4 %。
After the solution was neutralized with 1N hydrochloric acid, the solvent was distilled off under reduced pressure. The residue was dissolved in water and "CHP-20" column chromatography (22 mmφ x 400 mm, gradient elution with 10% acetonitrile-90% acetonitrile, total 10
It was separated with 00 ml, 103 fractions). Fraction
40-49 was concentrated. The residue was dissolved in water, treated with an acidic ion exchange resin "Dowex 50W x 8", and then the resin was filtered. The target substance was obtained by freeze-drying the filtrate. 295.2 mg,
81.4%.

【0155】[α]D 23=+22.1°(c 1.00、クロロ
フォルム:メタノール:水=10:10:3).1 H−NMR(DMSO,δ):0.857 (t,3H,J
=6.9 Hz),1.18−1.29(m,24H),1.43−1.49
(m,2H),2.047 (t,3H,J=7.6 Hz),3.
186 (brq,2H,J=5.6 −5.9 Hz),3.396
(t,2H,J=5.9 Hz),3.42−3.61(m,10
H),3.610 (brs,1H),3.66−3.70(m,1
H),3.85−3.90(m,1H),4.043 (brdd,1
H,J=10.3Hz,6.3 Hz),4.642(d, 1H,J=
1.2 Hz),7.816 (t,1H,J=5.6 Hz).13 C−NMR(DMSO,δ):13.86 ,22.03 ,25.2
2 ,31.24 ,35.28 (CO−CH2 ),38,42 ,65.03
(J=4.7 Hz),65.84 ,66.45 ,69.18 ,69.48 ,
69.54 ,69.71 ,70.15 ,70.62 ,72.11 (J=7.8 H
z),100.02,172.22. 実施例15 本実施例における反応も図10に示す。
[Α] D 23 = + 22.1 ° (c 1.00, chloroform: methanol: water = 10: 10: 3). 1 H-NMR (DMSO, δ): 0.857 (t, 3H, J
= 6.9 Hz), 1.18-1.29 (m, 24H), 1.43-1.49
(M, 2H), 2.047 (t, 3H, J = 7.6 Hz), 3.
186 (brq, 2H, J = 5.6-5.9 Hz), 3.396
(T, 2H, J = 5.9 Hz), 3.42-3.61 (m, 10
H), 3.610 (brs, 1H), 3.66-3.70 (m, 1
H), 3.85-3.90 (m, 1H), 4.043 (brdd, 1
H, J = 10.3Hz, 6.3Hz), 4.642 (d, 1H, J =
1.2 Hz), 7.816 (t, 1H, J = 5.6 Hz). 13 C-NMR (DMSO, δ): 13.86, 22.03, 25.2.
2, 31.24, 35.28 (CO- CH 2), 38,42, 65.03
(J = 4.7 Hz), 65.84, 66.45, 69.18, 69.48,
69.54, 69.71, 70.15, 70.62, 72.11 (J = 7.8 H
z), 100.02, 172.22. Example 15 The reaction in this example is also shown in FIG.

【0156】(a) 化合物15−1の合成 化合物14−5(2.1047)、2−パルミチルステアリン酸
(1.354 g)、N−ヒドロキシスクシイミド(306mg )
およびトリエチルアミン(0.683ml )の混合物を塩化メ
チレン40mlおよびヘキサン20mlに溶解し、この溶液にD
CC(549mg )を加え、室温下一晩撹拌した。溶液を氷
水に加えクロロフォルムにて抽出した。有機層を水洗
し、無水硫酸ナトリウムにて乾燥した。溶媒を減圧下留
去し、残渣を200ml のシリカゲルカラムクロマトグラフ
ィーにて分離し(ヘキサン:酢酸エチル=2:1−1:
1)、目的物を得た。796mg 。
(A) Synthesis of Compound 15-1 Compound 14-5 (2.1047), 2-palmitylstearic acid (1.354 g), N-hydroxysuccinimide (306 mg)
And a mixture of triethylamine (0.683 ml) are dissolved in 40 ml of methylene chloride and 20 ml of hexane and D is added to this solution.
CC (549 mg) was added, and the mixture was stirred overnight at room temperature. The solution was added to ice water and extracted with chloroform. The organic layer was washed with water and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the residue was separated by 200 ml silica gel column chromatography (hexane: ethyl acetate = 2: 1-1:
1), the desired product was obtained. 796 mg.

【0157】[α]D 27=−52.4(c 1.11、CHCl
3 ).1 H−NMR(CDCl3 ,δ):0.876 (t,6H,
J=6.9 Hz),1.18−1.39(m,56H),1.52−1.60
(m,4H),1.95−2.01(m,1H),3.43−3.47
(m,2H),3.538(m,2H),3.62−3.77(m,11
H),3.85−3.89(m,1H),4.39−4.48(m,3
H),5.103 (d,1H,J=1.8 Hz),5.679(d
d,1H,J=2.7 Hz),5.86−5.93(m,2H),
6.062(br t,1H),7.09−7.59(m,19H),7.
80−8.08(m,6H). (b) 化合物15−2の合成 化合物15−1(780mg )および酸化白金50mgに酢酸エチ
ル20mlおよびメタノール10mlを加え、一晩常圧の水素雰
囲気下で撹拌した。触媒を濾過し、溶媒を減圧下留去し
た。残渣にベンゼン2mlおよびメタノール6mlを加え溶
解し、ナトリウムメチラートメタノール溶液(5モル/
l)を30滴加えてpHを11とし、室温にて一晩撹拌した。
[Α] D 27 = -52.4 (c 1.11, CHCl
3 ). 1 H-NMR (CDCl 3 , δ): 0.876 (t, 6H,
J = 6.9 Hz), 1.18-1.39 (m, 56H), 1.52-1.60
(M, 4H), 1.95-2.01 (m, 1H), 3.43-3.47
(M, 2H), 3.538 (m, 2H), 3.62-3.77 (m, 11
H), 3.85-3.89 (m, 1H), 4.39-4.48 (m, 3
H), 5.103 (d, 1H, J = 1.8 Hz), 5.679 (d
d, 1H, J = 2.7 Hz), 5.86-5.93 (m, 2H),
6.062 (brt, 1H), 7.09-7.59 (m, 19H), 7.
80-8.08 (m, 6H). (b) Synthesis of compound 15-2 To compound 15-1 (780 mg) and platinum oxide (50 mg) were added ethyl acetate (20 ml) and methanol (10 ml), and the mixture was stirred overnight under a normal pressure hydrogen atmosphere. The catalyst was filtered and the solvent was distilled off under reduced pressure. To the residue, 2 ml of benzene and 6 ml of methanol were added and dissolved, and a sodium methylate methanol solution (5 mol /
The pH was adjusted to 11 by adding 30 drops of l), and the mixture was stirred overnight at room temperature.

【0158】溶液を1N塩酸にて中和した後、溶媒を減
圧下留去した。残渣をクロロフォルム:メタノール:水
=65:15:1の混合溶媒2mlに溶解し、150ml のシリカ
ゲルカラムクロマトグラフィー(クロロフォルム:メタ
ノール:水=65:25:3から60:35:7までのグラジエ
ント溶離、総量2000ml、100 フラクション)にて分離し
た。フラクション38−47を濃縮した。残渣をクロロフォ
ルム:メタノール:水=65:15:1の混合溶媒に溶解
し、強酸性イオン交換樹脂「ダウエックス50W×8」に
て処理した後、樹脂を濾去した。溶媒を減圧下濃縮し、
クロロフォルム:メタノール=9:1の混合溶媒に溶解
し、「Sephadex LH−20」(22mmφ×400mm
、クロロフォルム:メタノール=9:1溶離)にて分
離した。フラクション5−10を濃縮して目的物を得た。
230mg ,65.8%。
After the solution was neutralized with 1N hydrochloric acid, the solvent was distilled off under reduced pressure. The residue was dissolved in 2 ml of a mixed solvent of chloroform: methanol: water = 65: 15: 1 and subjected to 150 ml of silica gel column chromatography (chloroform: methanol: water = gradient elution from 65: 25: 3 to 60: 35: 7, The total amount was 2000 ml and 100 fractions) were separated. Fractions 38-47 were concentrated. The residue was dissolved in a mixed solvent of chloroform: methanol: water = 65: 15: 1, treated with a strongly acidic ion exchange resin “Dowex 50W × 8”, and then the resin was filtered off. The solvent is concentrated under reduced pressure,
Dissolved in a mixed solvent of chloroform: methanol = 9: 1, "Sephadex LH-20" (22mmφ x 400mm
, Chloroform: methanol = 9: 1 elution). Fractions 5-10 were concentrated to obtain the desired product.
230 mg, 65.8%.

【0159】[α]D 23=+15.3°(c 1.12、クロロ
フォルム:メタノール=9:1). 実施例16 本実施例における反応を図11に示す。
[Α] D 23 = + 15.3 ° (c 1.12, chloroform: methanol = 9: 1). Example 16 The reaction in this example is shown in FIG.

【0160】(a) 化合物16−1の合成 ガラクトースパーアセテート(19.60 g)およびトリエ
チレングリコールモノ−n−オクタデシルエーテル(2
4.70 g)の塩化メチレン(500ml )溶液にボロントリ
フルオライドエーテル錯体(27.8ml)の塩化メチレン
(50ml)溶液を氷冷下加え、一晩室温にて撹拌した。
(A) Synthesis of Compound 16-1 Galactose peracetate (19.60 g) and triethylene glycol mono-n-octadecyl ether (2
A solution of boron trifluoride ether complex (27.8 ml) in methylene chloride (50 ml) was added to a solution of 4.70 g) in methylene chloride (500 ml) under ice cooling, and the mixture was stirred overnight at room temperature.

【0161】得られた溶液を氷水に加え、クロロフォル
ム(300ml )を加えて抽出した。有機層を4回水洗し、
無水硫酸ナトリウムにて乾燥した。溶媒を減圧下留去
し、残渣を1000mlのシリカゲラカラムクロマトグラフィ
ーにて分離し(トルエン:酢酸エチル=2:1−2:1.
5 )、目的物を得た。20.95 g。
The obtained solution was added to ice water and chloroform (300 ml) was added for extraction. Wash the organic layer 4 times with water,
It was dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the residue was separated by 1000 ml silica gel column chromatography (toluene: ethyl acetate = 2: 1-2: 1.
5), the desired product was obtained. 20.95 g.

【0162】[α]D 26=−4.4 °(c 1.10、CHC
3 ).1 H−NMR(CDCl3 ,δ):0.876 (t,3H,
J=6.9 Hz), 1.21−1.36(m,30H),1.53−1.60
(m,2H),1.984 (s,3H),2.048 (s,3
H),2.060 (s,3H),2.148 (s,3H),3.43
9 (t,2H,J=6.9 Hz),3.56−3.69(m,10
H),3.65−3.77(m,1H),3.906 (brt,1
H),3.92−3.98(m,1H),4.13(dd,1H,J
=6.8 Hz,J=11.1Hz),4.167 (dd,1H,J
=6.3 Hz),4.563 (d,1H,J=7,8 Hz),5.
012 (dd,1H,J=3.4 Hz),5.203 (dd,1
H,J=10.4Hz),5.381(brd,1H). (b) 化合物16−2の合成 化合物16−1(5.12g)のメタノール(70ml)溶液にナ
リトウムメチラートメタノール溶液(5モル/l)を10
滴加え、室温にて3時間撹拌した。溶液に酸性イオン交
換樹脂「ダウエックス50W×8」を加え中和した後、溶
媒を減圧下留去した。残渣をピリジン(100ml)に溶解
し、この溶液に氷冷下ジフェニル燐酸クロリド(2.439
g)のピリジン(10ml)溶液を滴下し、室温で4時間撹
拌した。得られた溶液に無水酢酸(10.0ml)を加え一晩
撹拌した。
[Α] D 26 = −4.4 ° (c 1.10, CHC
l 3 ). 1 H-NMR (CDCl 3 , δ): 0.876 (t, 3H,
J = 6.9 Hz), 1.21-1.36 (m, 30H), 1.53-1.60
(M, 2H), 1.984 (s, 3H), 2.048 (s, 3)
H), 2.060 (s, 3H), 2.148 (s, 3H), 3.43
9 (t, 2H, J = 6.9 Hz), 3.56-3.69 (m, 10
H), 3.65-3.77 (m, 1H), 3.906 (brt, 1
H), 3.92-3.98 (m, 1H), 4.13 (dd, 1H, J
= 6.8 Hz, J = 11.1 Hz), 4.167 (dd, 1H, J
= 6.3 Hz), 4.563 (d, 1H, J = 7,8 Hz), 5.
012 (dd, 1H, J = 3.4 Hz), 5.203 (dd, 1
H, J = 10.4 Hz), 5.381 (brd, 1H). (b) Synthesis of Compound 16-2 To a solution of Compound 16-1 (5.12 g) in methanol (70 ml) was added 10% methanol solution of Nalium methylate (5 mol / l).
The mixture was added dropwise and stirred at room temperature for 3 hours. The solution was neutralized by adding an acidic ion exchange resin “Dowex 50W × 8”, and the solvent was distilled off under reduced pressure. The residue was dissolved in pyridine (100 ml), and diphenylphosphoric chloride (2.439
A solution of g) in pyridine (10 ml) was added dropwise, and the mixture was stirred at room temperature for 4 hours. Acetic anhydride (10.0 ml) was added to the resulting solution and stirred overnight.

【0163】溶液を氷水に加え、クロロフォルム(200m
l )にて抽出した。有機層2N塩酸で2回、飽和食塩水
で3回洗浄し、無水硫酸ナトリウムにて乾燥した。溶媒
を減圧下留去し、残渣を500ml のシリカゲルカラムクロ
マトグラフィーにて分離し(ヘキサン:酢酸エチル=
2:1.5 )、目的物を得た。3.317 g。
The solution was added to ice water, and chloroform (200 m
l). The organic layer was washed twice with 2N hydrochloric acid and three times with saturated saline, and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure, and the residue was separated by 500 ml silica gel column chromatography (hexane: ethyl acetate =
2: 1.5), and the target product was obtained. 3.317 g.

【0164】[α]D 21=−9.9 °(c 1.04、CHC
3 ).1 H−NMR(CDCl3 ,δ):0.879 (t,3H,
J=6.9 Hz),1.17−1.30(m,30H),1.54−1.60
(m,2H),1.986 ,2.051 ,2.105 (4s,3
H),3.434(t,2H,J=6.9 Hz),3.56−3.69
(m,11H),3.87−3.92(m,2H),4.215 (1
H,ddd,J=6.1 Hz,10.6Hz,8.3 Hz),4.
341 (ddd,1H,J=6.8 Hz,8.1 Hz),4.51
7 (d,1H,J=8.1 Hz),4.980 (dd,1H,
J=3.7 Hz),5.195 (dd,1H,J=10.5H
z),5.415 (brd,1H),7.19−7.37(m,10
H). (c) 化合物16−3の合成 化合物16−2(622mg )および酸化白金(120mg )に酢
酸エチル(10ml)およびメタノール(10ml)を加え、一
晩常圧の水素雰囲気下撹拌した。触媒を濾過し、溶媒を
減圧下留去した。残渣にメタノール(20ml)およびベン
ゼン(5ml)を加えて溶解し、ナトリウムメチラートメ
タノール溶液(5モル/l)を40滴加えてpHを11とし、
室温にて一晩撹拌した。
[Α] D 21 = −9.9 ° (c 1.04, CHC
l 3 ). 1 H-NMR (CDCl 3 , δ): 0.879 (t, 3H,
J = 6.9 Hz), 1.17-1.30 (m, 30H), 1.54-1.60
(M, 2H), 1.986, 2.051, 2.105 (4s, 3
H), 3.434 (t, 2H, J = 6.9 Hz), 3.56-3.69
(M, 11H), 3.87-3.92 (m, 2H), 4.215 (1
H, ddd, J = 6.1 Hz, 10.6 Hz, 8.3 Hz), 4.
341 (ddd, 1H, J = 6.8 Hz, 8.1 Hz), 4.51
7 (d, 1H, J = 8.1 Hz), 4.980 (dd, 1H,
J = 3.7 Hz), 5.195 (dd, 1H, J = 10.5H)
z), 5.415 (brd, 1H), 7.19-7.37 (m, 10
H). (c) Synthesis of compound 16-3 Ethyl acetate (10 ml) and methanol (10 ml) were added to compound 16-2 (622 mg) and platinum oxide (120 mg), and the mixture was stirred overnight under a hydrogen atmosphere at normal pressure. The catalyst was filtered and the solvent was distilled off under reduced pressure. Methanol (20 ml) and benzene (5 ml) were added to the residue to dissolve it, and 40 drops of sodium methylate methanol solution (5 mol / l) was added to adjust the pH to 11,
Stir overnight at room temperature.

【0165】溶液を1N塩酸にて中和した後、溶媒を減
圧下留去した。残渣を水に溶解し、「CHP−20」カラ
ムクロマトグラフィー(22mmφ×400mm 、10%アセトニ
トリル−90%アセトニトリルのグラジエント溶離、総量
1000ml、100 フラクション)にて分離した。フランショ
ン54−63を濃縮した。残渣を水に溶解し、酸性イオン交
換樹脂「ダウエックス50W×8」にて処理した後樹脂を
濾過した。濾液を凍結乾燥して目的物を得た。350mg, 7
9.2 %。
After the solution was neutralized with 1N hydrochloric acid, the solvent was distilled off under reduced pressure. The residue was dissolved in water and "CHP-20" column chromatography (22 mmφ x 400 mm, 10% acetonitrile-90% acetonitrile gradient elution, total amount
It was separated in 1000 ml, 100 fractions). Fractions 54-63 were concentrated. The residue was dissolved in water, treated with an acidic ion exchange resin “Dowex 50W × 8”, and then the resin was filtered. The filtrate was freeze-dried to obtain the desired product. 350mg, 7
9.2%.

【0166】[α]D 28=−2.0 °(c 0.98、クロロ
フォルム:メタノール:水=10:10:3) Mass M/Z:645 (M+H),667 (M+N
a),683 (M+K).1 H−NMR(DMSO,δ):0.857 (t,3H,J
=6.9 Hz),1.20−1.30(m,30H),1.45−1.49
(m,2H),3.28−3.32(m,2H),3.358(t,
2H,J=5.9 Hz),3.45−3.65(m,12H),3.64
3 (brd,1H,J=1.0 Hz),3.81−3.88(m,
2H),3.918 (ddd,1H,J=5.9Hz,10.5H
z,7.8 Hz),4.130 (d,1H, J=7.6 Hz).13 C−NMR(DMSO,δ):13.85 ,22.02 ,25.5
8 ,31.22 ,64.15 (J=4.4 Hz),67.75 ,67.92
,69.41 ,69.67 ,69.74 ,70.26 ,70.30 ,73.05
,73.17(J=7.5 Hz),103.44. 実施例17 本実施例における反応を図12に示す。
[Α] D 28 = −2.0 ° (c 0.98, chloroform: methanol: water = 10: 10: 3) Mass M / Z: 645 (M + H), 667 (M + N)
a), 683 (M + K). 1 H-NMR (DMSO, δ): 0.857 (t, 3H, J
= 6.9 Hz), 1.20-1.30 (m, 30H), 1.45-1.49
(M, 2H), 3.28-3.32 (m, 2H), 3.358 (t,
2H, J = 5.9 Hz), 3.45-3.65 (m, 12H), 3.64
3 (brd, 1H, J = 1.0 Hz), 3.81-3.88 (m,
2H), 3.918 (ddd, 1H, J = 5.9Hz, 10.5H
z, 7.8 Hz), 4.130 (d, 1H, J = 7.6 Hz). 13 C-NMR (DMSO, δ): 13.85, 22.02, 25.5.
8, 31.22, 64.15 (J = 4.4 Hz), 67.75, 67.92
, 69.41, 69.67, 69.74, 70.26, 70.30, 73.05
, 73.17 (J = 7.5 Hz), 103.44. Example 17 The reaction in this example is shown in FIG.

【0167】(a) 化合物17−1の合成 ガラクトースパーアセテート(10.0g)および2−[2
−(クロロエトキシ)エトキシ]−エタノール(5.616
g)の塩化メチレン(150ml )溶液にボロントリフルオ
ライドエーテル錯体(12.6ml)の塩化メチレン(30ml)
溶液を氷冷下加え、一晩室温にて撹拌した。
(A) Synthesis of compound 17-1 Galactose peracetate (10.0 g) and 2- [2
-(Chloroethoxy) ethoxy] -ethanol (5.616
g) in methylene chloride (150 ml) solution of boron trifluoride ether complex (12.6 ml) in methylene chloride (30 ml)
The solution was added under ice cooling and stirred overnight at room temperature.

【0168】得られた溶液を氷水に加え、クロロフォル
ム(150ml )を加えて抽出した。有機層を2回水洗し、
無水硫酸ナトリウムにて乾燥した。溶媒を減圧下留去
し、残渣を1000mlのシリカゲルカラムクロマトグラフィ
ーにて分離し(ヘキサン:酢酸エチル=2:1−1:
1)、目的物を得た。6.51g。
The obtained solution was added to ice water, and chloroform (150 ml) was added for extraction. Wash the organic layer twice with water,
It was dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the residue was separated by 1000 ml silica gel column chromatography (hexane: ethyl acetate = 2: 1-1:
1), the desired product was obtained. 6.51 g.

【0169】[α]D 20=−0.4 °(c 1.098 、クロ
ロフォルム).1 H−NMR(CDCl3 ,δ):1.986 ,2.051 ,2.0
63 ,2.152 (4s,3H),3.63−3.78(m,11
H),3.95−3.98(m,1H),3.917 (brt,1
H),4.131 (dd,1H,J=6.8 Hz,11.2H
z),4.178 (dd,1H,J=6.6 Hz),4.576
(d,1H,J=8.1 Hz),5.023 (dd,1H,J
=3.4 Hz),5.212 (dd,1H,J=10.5Hz),
5.390 (brd,1H). (b) 化合物17−2の合成 化合物17−1(6.445 g)およびナトリウムアジド(1.
26g)にDMF(50ml)を加え、60℃にて17時間加熱撹
拌した。
[Α] D 20 = −0.4 ° (c 1.098, chloroform). 1 H-NMR (CDCl 3 , δ): 1.986, 2.051, 2.0
63, 2.152 (4s, 3H), 3.63-3.78 (m, 11
H), 3.95-3.98 (m, 1H), 3.917 (brt, 1
H), 4.131 (dd, 1H, J = 6.8 Hz, 11.2H
z), 4.178 (dd, 1H, J = 6.6 Hz), 4.576
(D, 1H, J = 8.1 Hz), 5.023 (dd, 1H, J
= 3.4 Hz), 5.212 (dd, 1H, J = 10.5Hz),
5.390 (brd, 1H). (b) Synthesis of Compound 17-2 Compound 17-1 (6.445 g) and sodium azide (1.
DMF (50 ml) was added to 26 g) and the mixture was heated with stirring at 60 ° C. for 17 hours.

【0170】得られた溶液に水(100ml )を加え、酢酸
エチルで抽出した。有機層を水洗し、無水硫酸ナトリウ
ムにて乾燥した。溶媒を減圧下留去し、残渣を500ml の
シリカゲルカラムクロマトグラフィーにて分離し(ヘキ
サン:酢酸エチル=2:1.5−1:1)、目的物を得
た。5.30g。
Water (100 ml) was added to the obtained solution and the mixture was extracted with ethyl acetate. The organic layer was washed with water and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure, and the residue was separated by 500 ml silica gel column chromatography (hexane: ethyl acetate = 2: 1.5-1: 1) to obtain the desired product. 5.30g.

【0171】[α]D 17=−3.2 °(c 1.04、CHC
3 ).1 H−NMR(CDCl3 ,δ):1.984 ,2.048 ,2.0
60 ,2.148 (4s,3H),3.398 (t,2H,J=
5.0 Hz),3.63−3.69(m,8H),3.73−3.78
(m,1H),3.95−3.98(m,1H),3.910 (br
t,1H),4.131 (dd,1H,J=6.8 Hz,1
1.2Hz),4.176 (dd,1H,J=6.3 Hz),4,5
71 (d,1H,J=7.8 Hz),5.023 (dd,1
H,J=3.4 Hz),5.210 (dd,1H,J=10.5H
z),5.387 (dd,1H,J=1.0 Hz). (c) 化合物17−3の合成 化合物17−2(4.957 g)のメタノール(70ml)溶液に
ナトリウムメチラートメタノール溶液(5モル/l)を
10滴加え、室温にて3時間撹拌した。溶液に酸性イオン
交換樹脂「ダウエックス50W×8」を加えて中和した
後、溶媒を減圧下留去した。残渣をピリジン(30ml)に
溶解し、この溶液に氷冷下ジフェニル燐酸クロリド(3.
688 g)のピリジン溶液を滴下し、室温で8時間撹拌し
た。得られた溶液にベンゾイルクロリド(4.55ml)を加
え、一晩撹拌した。
[Α] D 17 = −3.2 ° (c 1.04, CHC
l 3 ). 1 H-NMR (CDCl 3 , δ): 1.984, 2.048, 2.0
60, 2.148 (4s, 3H), 3.398 (t, 2H, J =
5.0 Hz), 3.63-3.69 (m, 8H), 3.73-3.78
(M, 1H), 3.95-3.98 (m, 1H), 3.910 (br
t, 1H), 4.131 (dd, 1H, J = 6.8 Hz, 1
1.2Hz), 4.176 (dd, 1H, J = 6.3Hz), 4,5
71 (d, 1H, J = 7.8 Hz), 5.023 (dd, 1
H, J = 3.4 Hz), 5.210 (dd, 1H, J = 10.5H
z), 5.387 (dd, 1H, J = 1.0 Hz). (c) Synthesis of compound 17-3 To a solution of compound 17-2 (4.957 g) in methanol (70 ml) was added sodium methylate methanol solution (5 mol / l).
10 drops were added, and the mixture was stirred at room temperature for 3 hours. The solution was neutralized by adding an acidic ion exchange resin “Dowex 50W × 8”, and the solvent was evaporated under reduced pressure. The residue was dissolved in pyridine (30 ml), and diphenylphosphoric chloride (3.
A pyridine solution of 688 g) was added dropwise, and the mixture was stirred at room temperature for 8 hours. Benzoyl chloride (4.55 ml) was added to the resulting solution, and the mixture was stirred overnight.

【0172】溶液を氷水に加え、クロロフォルム(200m
l )にて抽出した。有機層を2N塩酸で2回、飽和食塩
水で3回洗浄し、無水硫酸ナトリウムにて乾燥した。溶
媒を減圧下留去し、残渣を500ml のシリカゲルカラムク
ロマトグラフィーにて分離し(ヘキサン:酢酸エチル=
2:1−1:1)、目的物を得た。3.468 g。
The solution was added to ice water, and chloroform (200 m
l). The organic layer was washed twice with 2N hydrochloric acid and three times with saturated brine, and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure, and the residue was separated by 500 ml silica gel column chromatography (hexane: ethyl acetate =
2: 1-1: 1), the target product was obtained. 3.468 g.

【0173】[α]D 21=+91.8°(c 1.02、CHC
3 ).1 H−NMR(CDCl3 ,δ):3.305 (t,2H,
J=5.0 Hz),3.35−3.63(m,8H),3.753
(m,1H),3.978 (m,1H),4.196 (brt,
1H),4.364 (ddd,1H,J=5.6 Hz,10.7H
z,8.3 Hz),4.467 (ddd,1H,J=7.1 H
z,9.0 Hz),4.859 (d,1H,J=8.1 Hz),
5.524 (dd,1H,J=3.4 Hz),5.746 (dd,
1H,J=10.5Hz),5.881 (brd,1H),7.14
−7.62(m,19H),7.78−8.05(m,6H). (d) 化合物17−4の合成 化合物17−3(3.424 g)およびパラトルエンスルホン
酸1水和物(739mg )をメタノール(20ml)および酢酸
エチル(120ml )の混合溶媒に溶解し、リンドラー触媒
(1.2 g)を加え、50psi の水素雰囲気下7時間撹拌し
た。
[Α] D 21 = + 91.8 ° (c 1.02, CHC
l 3 ). 1 H-NMR (CDCl 3 , δ): 3.305 (t, 2H,
J = 5.0 Hz), 3.35-3.63 (m, 8H), 3.753
(M, 1H), 3.978 (m, 1H), 4.196 (brt,
1H), 4.364 (ddd, 1H, J = 5.6 Hz, 10.7H
z, 8.3 Hz), 4.467 (ddd, 1H, J = 7.1 H
z, 9.0 Hz), 4.859 (d, 1H, J = 8.1 Hz),
5.524 (dd, 1H, J = 3.4 Hz), 5.746 (dd,
1H, J = 10.5Hz), 5.881 (brd, 1H), 7.14
-7.62 (m, 19H), 7.78-8.05 (m, 6H). (d) Synthesis of Compound 17-4 Compound 17-3 (3.424 g) and paratoluenesulfonic acid monohydrate (739 mg) were dissolved in a mixed solvent of methanol (20 ml) and ethyl acetate (120 ml) to give a Lindlar catalyst ( 1.2 g) was added, and the mixture was stirred under a hydrogen atmosphere of 50 psi for 7 hours.

【0174】触媒を濾過し、溶媒を減圧下留去して目的
物(4.00g)を得た。この化合物は特に精製をする事な
く次の段階の合成に用いた。
The catalyst was filtered and the solvent was distilled off under reduced pressure to obtain the desired product (4.00 g). This compound was used for the next step synthesis without any particular purification.

【0175】(e) 化合物17−5の合成 化合物17−4(2.001 g)の塩化メチレン(50ml)溶液
にN−パルミトイルオキシスクシイミド(825mg )を加
え、一晩撹拌した。
(E) Synthesis of Compound 17-5 To a solution of Compound 17-4 (2.001 g) in methylene chloride (50 ml) was added N-palmitoyloxysuccinimide (825 mg), and the mixture was stirred overnight.

【0176】得られた溶液を氷水に加え、目的物を抽出
した。溶液を無水硫酸ナトリウムで乾燥した後、溶媒を
減圧下留去した。残渣を200ml のシリカゲルカラムクロ
マトグラフィーにて分離し(ヘキサン:酢酸エチル=
1:1−1:1.5 )、目的物を得た。1.942 g。
The obtained solution was added to ice water to extract the desired product. After the solution was dried over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure. The residue was separated by 200 ml silica gel column chromatography (hexane: ethyl acetate =
1: 1-1: 1.5) to obtain the desired product. 1.942 g.

【0177】[α]D 21=+70.7°(c 1.00、CHC
3 ).1 H−NMR(CDCl3 ,δ):0.877 (t,3H,
J=6.9 Hz),1.23−1.31(m,24H),1.55−1.62
(m,2H),2.127 (t,2H,J=7.5 Hz),3.
31−3.63(m,10H),3.73−3.78(m,1H),3.97
−4.01(m,1H),4.207 (br t,1H),4.35
9 (ddd,1H,J=5.6 Hz,10.7Hz,8.5 H
z),4.473 (ddd,1H,J=7.1 Hz,8.8 H
z),4.857(d,1H,J=8.1 Hz),5.529 (d
d,1H,J=3.5 Hz),5.750 (dd,1H,J=
10.4Hz),5.883 (brd,1H),6.014 (br
t,1H),7.13−7.63(m,19H),7.77−8.05
(m,6H). (f) 化合物17−6の合成 化合物17−5(1.0215g)および酸化白金(100mg )に
酢酸エチル(15ml)およびメタノール(15ml)を加え、
一晩常圧の水素雰囲気下撹拌した。触媒を濾過し、溶媒
を減圧下留去した。残渣にメタノール(15ml)を加え溶
解し、ナトリウムメチラートメタノール溶液(5モル/
l)を60滴加えてpHを11とし、室温にて5時間撹拌し
た。
[Α] D 21 = + 70.7 ° (c 1.00, CHC
l 3 ). 1 H-NMR (CDCl 3 , δ): 0.877 (t, 3H,
J = 6.9 Hz), 1.23-1.31 (m, 24H), 1.55-1.62
(M, 2H), 2.127 (t, 2H, J = 7.5 Hz), 3.
31-3.63 (m, 10H), 3.73-3.78 (m, 1H), 3.97
-4.01 (m, 1H), 4.207 (brt, 1H), 4.35
9 (ddd, 1H, J = 5.6 Hz, 10.7 Hz, 8.5 H
z), 4.473 (ddd, 1H, J = 7.1 Hz, 8.8 H
z), 4.857 (d, 1H, J = 8.1 Hz), 5.529 (d
d, 1H, J = 3.5 Hz), 5.750 (dd, 1H, J =
10.4Hz), 5.883 (brd, 1H), 6.014 (br
t, 1H), 7.13-7.63 (m, 19H), 7.77-8.05
(M, 6H). (f) Synthesis of compound 17-6 Ethyl acetate (15 ml) and methanol (15 ml) were added to compound 17-5 (1.0215 g) and platinum oxide (100 mg),
The mixture was stirred overnight under a normal pressure hydrogen atmosphere. The catalyst was filtered and the solvent was distilled off under reduced pressure. Methanol (15 ml) was added to the residue to dissolve it, and sodium methylate methanol solution (5 mol / mol)
The pH was adjusted to 11 by adding 60 drops of 1) and the mixture was stirred at room temperature for 5 hours.

【0178】溶液を1N塩酸にて中和した後、溶媒を減
圧下留去した。残渣をメタノール−水 95:5の混合溶
媒に溶解し、「CHP−20」カラムクロマトグラフィー
(22mmφ×400mm 、10%アセトニトリル−90%アセトニ
トリルのグラジエント溶離、総量1000ml、97フラクショ
ン)にて分離した。フラクション46−61を濃縮した。残
渣を水に溶解し、酸性イオン交換樹脂「ダウエックス50
W×8」にて処理した後樹脂を濾去した。濾液を凍結乾
燥して目的物を得た。365mg 。
After the solution was neutralized with 1N hydrochloric acid, the solvent was distilled off under reduced pressure. The residue was dissolved in a mixed solvent of methanol-water 95: 5 and separated by "CHP-20" column chromatography (22 mmφ x 400 mm, gradient elution with 10% acetonitrile-90% acetonitrile, total volume 1000 ml, 97 fractions). Fractions 46-61 were concentrated. The residue is dissolved in water and the acidic ion exchange resin “Dowex 50
After treating with "W × 8", the resin was filtered off. The filtrate was freeze-dried to obtain the desired product. 365 mg.

【0179】[α]D 28=−1.8 °(c 1.13、水). Mass M/Z:630 (M+H),652 (M+N
a).1 H−NMR(DMSO,δ):0.858 (t,3H,J
=6.9 Hz),1.19−1.29(m,24H),1.43−1.50
(m,2H),2.048 (t,2H,J=7.4 Hz),3.
185 (q,2H,J=5.9 Hz),3.28−3.32(m,2
H),3.395 (t,2H,J=5.9 Hz),3.48−3.61
(m,8H),3.650 (brd,1H,J=1.0 H
z),3.82−3.87(m,2H),3.915 (ddd,1
H,J=6.1 Hz,10.5Hz,8.1 Hz),4.133
(d,1H,J=7.7 Hz),7.819 (t,1H,J=
5.9 Hz).13 C−NMR(DMSO−d6 ,δ):13.86 ,22.03
,25.21 ,28.6−29.0,31.23 ,35.28 ,38.41 ,64.
04 (J=4.9 Hz,67.77,67.90 ,69.17 ,69.54 ,6
9.69 ,70.29 ,73.06 ,73.19 (J=7.3 Hz),10
3.45,172.20. 実施例18 本実施例における反応も図12に示す。
[Α] D 28 = −1.8 ° (c 1.13, water). Mass M / Z: 630 (M + H), 652 (M + N)
a). 1 H-NMR (DMSO, δ): 0.858 (t, 3H, J
= 6.9 Hz), 1.19-1.29 (m, 24H), 1.43-1.50
(M, 2H), 2.048 (t, 2H, J = 7.4 Hz), 3.
185 (q, 2H, J = 5.9 Hz), 3.28-3.32 (m, 2
H), 3.395 (t, 2H, J = 5.9 Hz), 3.48-3.61
(M, 8H), 3.650 (brd, 1H, J = 1.0H
z), 3.82-3.87 (m, 2H), 3.915 (ddd, 1
H, J = 6.1 Hz, 10.5 Hz, 8.1 Hz), 4.133
(D, 1H, J = 7.7 Hz), 7.819 (t, 1H, J =
5.9 Hz). 13 C-NMR (DMSO-d 6 , δ): 13.86, 22.03.
, 25.21, 28.6-29.0, 31.23, 35.28, 38.41, 64.
04 (J = 4.9 Hz, 67.77, 67.90, 69.17, 69.54, 6
9.69, 70.29, 73.06, 73.19 (J = 7.3 Hz), 10
3.45, 172.20. Example 18 The reaction in this example is also shown in FIG.

【0180】(a) 化合物18−1の合成 化合物17−4(2.00g)、2−パルミチルステアリン酸
(1.188 g)、N−ヒドロキシスクシイミド(269mg )
および4−ジメチルアミノピリジン(523mg )のDMF
(100ml)溶液にN,N′ージシクロヘキシルカルボジイ
ミド(482mg )を加え、室温下一晩撹拌した。N,N′
−ジシクロエキシルカルボジイミド(200mg )をさらに
加え、さらに一晩撹拌した。
(A) Synthesis of Compound 18-1 Compound 17-4 (2.00 g), 2-palmitylstearic acid (1.188 g), N-hydroxysuccinimide (269 mg)
And 4-dimethylaminopyridine (523 mg) in DMF
N, N'-Dicyclohexylcarbodiimide (482 mg) was added to the (100 ml) solution, and the mixture was stirred overnight at room temperature. N, N '
-Dicyclohexylcarbodiimide (200 mg) was further added, and the mixture was further stirred overnight.

【0181】折出したN,N′−ジシクロヘキシル尿素
を濾去し、40℃にて溶媒を留去した。残渣に酢酸エチル
(40ml)を加え、不溶物を濾別した。濾液を減圧下濃縮
し、残渣を200ml のシリカゲルカラムクロマトグラフィ
ーにて分離し(ヘキサン:酢酸エチル=2:1−1:
1)、目的物を得た。773mg 。
The N, N'-dicyclohexylurea that had separated out was filtered off, and the solvent was distilled off at 40 ° C. Ethyl acetate (40 ml) was added to the residue, and the insoluble material was filtered off. The filtrate was concentrated under reduced pressure and the residue was separated by 200 ml silica gel column chromatography (hexane: ethyl acetate = 2: 1-1:
1), the desired product was obtained. 773 mg.

【0182】[α]D 21=+58.9°(c 1.13、CHC
3 ).1 H−NMR(CDCl3 ,δ):0.877 (t,6H,
J=6.9 Hz),1.16−1.34(m,56H),1.52−1.61
(m,4H),1.91−1.99(m,1H),3.30−3.33
(m,2H),3.35−3.63(m,8H),3.73−3.77
(m,1H),3.97−4.01(m,1H),4.196 (br
t,1H),4.357 (ddd,1H,J=5.6 Hz,
10.7Hz,8.5 Hz),4.468 (ddd,1H,J=7.
1 Hz,9.0Hz),4.848 (d,1H,J=8.1 H
z),5.523 (dd,1H,J=3.5 Hz),5.747
(dd,1H,J=10.4Hz),5.878 (brd,1
H),7.13−7.62(m,19H),7.77−8.05(m,6
H). (b) 化合物18−2の合成 化合物18−1(506mg )および酸化白金(50mg)にテト
ラヒドロフラン(20ml)およびメタノール(10ml)を加
え、一晩常圧の水素雰囲気下撹拌した。触媒を濾過し、
溶媒を減圧下留去した。残渣にメタノール(15ml)を加
え溶解し、ナトリウムメチラートメタノール溶液(5モ
ル/l)を20滴加えてpHを11とし、室温にて5時間撹拌
した。
[Α] D 21 = + 58.9 ° (c 1.13, CHC
l 3 ). 1 H-NMR (CDCl 3 , δ): 0.877 (t, 6H,
J = 6.9 Hz), 1.16-1.34 (m, 56H), 1.52-1.61
(M, 4H), 1.91-1.99 (m, 1H), 3.30-3.33
(M, 2H), 3.35-3.63 (m, 8H), 3.73-3.77
(M, 1H), 3.97-4.01 (m, 1H), 4.196 (br
t, 1H), 4.357 (ddd, 1H, J = 5.6 Hz,
10.7Hz, 8.5Hz), 4.468 (ddd, 1H, J = 7.
1 Hz, 9.0 Hz), 4.848 (d, 1H, J = 8.1 H
z), 5.523 (dd, 1H, J = 3.5 Hz), 5.747
(Dd, 1H, J = 10.4Hz), 5.878 (brd, 1
H), 7.13-7.62 (m, 19H), 7.77-8.05 (m, 6
H). (b) Synthesis of Compound 18-2 Tetrahydrofuran (20 ml) and methanol (10 ml) were added to Compound 18-1 (506 mg) and platinum oxide (50 mg), and the mixture was stirred overnight under a hydrogen atmosphere at normal pressure. Filter the catalyst,
The solvent was distilled off under reduced pressure. Methanol (15 ml) was added to the residue to dissolve it, and 20 drops of sodium methylate methanol solution (5 mol / l) was added to adjust the pH to 11, and the mixture was stirred at room temperature for 5 hours.

【0183】溶液を1N塩酸にて中和した後、溶媒を減
圧下留去した。残渣をクロロフォルム:メタノール=
1:1の混合溶媒に溶解し、2.5 gのシリカゲルを加
え、溶媒を減圧下留去した。得られた乾燥シリカゲルを
150ml のクロロフォルム:メタノール:水=65:25:4
の溶媒混合物で充填したシリカゲルカラムに詰め、目的
物を含むフラクションを採取した(22mmφ×400mm 、ク
ロロフォルム:メタノール:水=65:25:4から2:
2:0.5 までのグラジエント溶離、総量1000ml、100フ
ラクション)。フラクション13−41を濃縮した。残渣を
クロロフォルム:メタノール=9:1の混合溶媒に溶解
し、同溶剤で詰めた「Sephadex LH−20」
(22mmφ×400mm 、クロロフォルム:メタノール=9:
1溶離)にて分離した。フラクション5−8を濃縮して
目的物を得た。201mg 。
After neutralizing the solution with 1N hydrochloric acid, the solvent was distilled off under reduced pressure. The residue is chloroform: methanol =
It was dissolved in a 1: 1 mixed solvent, 2.5 g of silica gel was added, and the solvent was evaporated under reduced pressure. The dried silica gel obtained
150 ml of chloroform: methanol: water = 65: 25: 4
The mixture was packed in a silica gel column packed with the solvent mixture described above, and the fraction containing the desired product was collected (22 mmφ × 400 mm, chloroform: methanol: water = 65: 25: 4 to 2 :).
2: Gradient elution up to 0.5, total volume 1000 ml, 100 fractions). Fractions 13-41 were concentrated. The residue was dissolved in a mixed solvent of chloroform: methanol = 9: 1 and filled with the same solvent "Sephadex LH-20".
(22mmφ × 400mm, chloroform: methanol = 9:
(1 elution). Fractions 5-8 were concentrated to give the desired product. 201 mg.

【0184】[α]D 28=−3.8 °(c 1.09、クロロ
フォルム:メタノール=9:1). Mass M/Z:882 (M+H).1 H−NMR(CDCl3 −CD3 OD=5/1,
δ):0.884 (t,6H),1.20−1.33(m,56H),
1.36−1.44(m,2H),1.51−1.59(m,2H),2.
05−2.11(m,1H),3.416 (br t,2H,J=
5.0 Hz),3.51−3.77(m,12H),3.931 (br
d,1H,J=1.0 Hz),4.01−4.20(m,3H),
4.267 (d,1H,J=7.6 Hz).13 C−NMR(CDCl3 −CD3 OD=5/1,
δ):14.16 ,22.87 ,27.83 ,32.13 ,33.18 ,39.1
8 ,47.88 ,64.55 (J=4.9 Hz),67.97 ,68.53
,70.17 ,70.31 ,70.51 ,70.60 ,71.51 ,73.33
,73.54 (J=8.1 Hz),103.77,177.71. 実施例19 本実施例における反応を図13に示す。
[Α] D 28 = −3.8 ° (c 1.09, chloroform: methanol = 9: 1). Mass M / Z: 882 (M + H). 1 H-NMR (CDCl 3 -CD 3 OD = 5/1,
δ): 0.884 (t, 6H), 1.20-1.33 (m, 56H),
1.36-1.44 (m, 2H), 1.51-1.59 (m, 2H), 2.
05-2.11 (m, 1H), 3.416 (brt, 2H, J =
5.0 Hz), 3.51-3.77 (m, 12H), 3.931 (br
d, 1H, J = 1.0 Hz), 4.01-4.20 (m, 3H),
4.267 (d, 1H, J = 7.6 Hz). 13 C-NMR (CDCl 3 -CD 3 OD = 5/1,
δ): 14.16, 22.87, 27.83, 32.13, 33.18, 39.1
8, 47.88, 64.55 (J = 4.9 Hz), 67.97, 68.53
, 70.17, 70.31, 70.51, 70.60, 71.51, 73.33
, 73.54 (J = 8.1 Hz), 103.77, 177.71. Example 19 The reaction in this example is shown in FIG.

【0185】(a) 化合物19−1の合成 化合物16−1(38.939g)の無水メタノール(500ml )
溶液にナトリウムメトキシドのメタノール溶液(5モル
/l)を0.3ml 加え、室温にて1昼夜撹拌した。得られ
た溶液を酸性イオン交換樹脂「ダウエックス50W×8」
にて中和し、樹脂を濾過後、溶媒を減圧下留去した。残
渣にトリチルクロリド(19.255g,1.3eq )を加え、20
0ml のピリジンに溶解し、50℃にて6時間加熱した。
(A) Synthesis of Compound 19-1 Compound 16-1 (38.939 g) in anhydrous methanol (500 ml)
0.3 ml of a methanol solution of sodium methoxide (5 mol / l) was added to the solution, and the mixture was stirred at room temperature for one day. The resulting solution is an acidic ion exchange resin "Dowex 50W x 8"
After neutralizing with, the resin was filtered, and the solvent was distilled off under reduced pressure. Trityl chloride (19.255g, 1.3eq) was added to the residue, and 20
It was dissolved in 0 ml of pyridine and heated at 50 ° C for 6 hours.

【0186】得られた溶液を氷水に加え、クロロフォル
ムにて抽出した。有機層を水洗し、無水硫酸ナトリウム
で乾燥した。乾燥剤を濾過し、溶媒を減圧下留去し、残
渣を1000mlのシリカゲルカラムにて分離した。クロロフ
ォルムのみにてトリチルクロリドが溶出し、0.5 −3%
メタノール−クロロフォルムにて目的物が溶出できた。
33.093g。
The obtained solution was added to ice water and extracted with chloroform. The organic layer was washed with water and dried over anhydrous sodium sulfate. The desiccant was filtered, the solvent was distilled off under reduced pressure, and the residue was separated on a 1000 ml silica gel column. Trityl chloride was eluted only with chloroform, 0.5 -3%
The target substance could be eluted with methanol-chloroform.
33.093g.

【0187】[α]D 26=−16.1°(c 1.06,CHC
3 ).1 H−NMR(CDCl3 ,δ):0.879 (3H,t,
J=6.9 Hz),1.21−1.32(m,30H),1.56−1.59
(2H,m),2.325 (d,1H),2.776 (d,1
H),3.440 (t,2H,J=6.9 Hz),3.39−3.42
(m,1H),3.55−3.67(m,14H),3.69−3.76
(m,1H),4.01−4.07(m,1H),4.061 (br
t,1H),4.268 (d,1H,J=7.6 Hz),4.
563 (brs,1H),7.22−7.46(m,15H). (b) 化合物19−2の合成 化合物19−1(6.023 g)のピリジン(150ml )溶液に
氷冷下ベンゾイルクロリド(2.622 g)を滴下し、室温
にて2昼夜撹拌した。
[Α] D 26 = -16.1 ° (c 1.06, CHC
l 3 ). 1 H-NMR (CDCl 3 , δ): 0.879 (3H, t,
J = 6.9 Hz), 1.21-1.32 (m, 30H), 1.56-1.59
(2H, m), 2.325 (d, 1H), 2.776 (d, 1)
H), 3.440 (t, 2H, J = 6.9 Hz), 3.39-3.42
(M, 1H), 3.55-3.67 (m, 14H), 3.69-3.76
(M, 1H), 4.01-4.07 (m, 1H), 4.061 (br
t, 1H), 4.268 (d, 1H, J = 7.6 Hz), 4.
563 (brs, 1H), 7.22-7.46 (m, 15H). (b) Synthesis of compound 19-2 To a solution of compound 19-1 (6.023 g) in pyridine (150 ml) was added dropwise benzoyl chloride (2.622 g) under ice cooling, and the mixture was stirred at room temperature for 2 days.

【0188】得られた溶液を氷水に加え、クロロフォル
ムにて抽出した。有機層を水洗し、無水硫酸ナトリウム
で乾燥した。乾燥剤を濾過し、溶媒を減圧下留去し、残
渣を500ml のシリカゲルカラムにて分離した。トルエ
ン:酢酸エチル=10:1にて目的化合物19−2(2.4649
g)が溶出された。
The obtained solution was added to ice water and extracted with chloroform. The organic layer was washed with water and dried over anhydrous sodium sulfate. The desiccant was filtered, the solvent was distilled off under reduced pressure, and the residue was separated with a 500 ml silica gel column. Target compound 19-2 (2.4649) in toluene: ethyl acetate = 10: 1
g) was eluted.

【0189】[α]D 26=−29.5°(c 1.07,CHC
3 ).1 H−NMR(CDCl3 ,δ):0.878 (t,3H,
J=6.9 Hz),1.20−1.32(m,30H),1.51−1.56
(m,2H),3.38−3.65(m,14H),3.76−3.83
(m,2H),3.98−4.03(m,1H),4.359 (br
s,1H),4.767 (d,1H,J=8.1 Hz),5.28
1 (dd,1H,J=2.9 Hz),5.747(dd,1
H,J=10.3Hz),7.23−7.52(m,21H),7.96−
8.00(m,4H). (c) 化合物19−3の合成 化合物19−2(2.450 g)のピリジン(10ml)溶液にジ
フェニル燐酸クロリド(2.6 g)のピリジン(10ml)溶
液を滴下し、室温にて2昼夜撹拌した。
[Α] D 26 = -29.5 ° (c 1.07, CHC
l 3 ). 1 H-NMR (CDCl 3 , δ): 0.878 (t, 3H,
J = 6.9 Hz), 1.20-1.32 (m, 30H), 1.51-1.56
(M, 2H), 3.38-3.65 (m, 14H), 3.76-3.83
(M, 2H), 3.98-4.03 (m, 1H), 4.359 (br
s, 1H), 4.767 (d, 1H, J = 8.1 Hz), 5.28
1 (dd, 1H, J = 2.9 Hz), 5.747 (dd, 1
H, J = 10.3Hz), 7.23-7.52 (m, 21H), 7.96-
8.00 (m, 4H). (c) Synthesis of Compound 19-3 A solution of compound 19-2 (2.450 g) in pyridine (10 ml) was added dropwise with a solution of diphenylphosphoric chloride (2.6 g) in pyridine (10 ml), and the mixture was stirred at room temperature for 2 days.

【0190】得られた溶液を氷水に加え、クロロフォル
ムにて抽出した。有機層を水洗し、無水硫酸ナトリウム
で乾燥した。乾燥剤を濾過し、溶媒を減圧下留去し、残
渣を500ml のシリカゲルカラムにて分離した。トルエ
ン:酢酸エチル=12:1にて目的物(2.3174g)が溶出
された。
The obtained solution was added to ice water and extracted with chloroform. The organic layer was washed with water and dried over anhydrous sodium sulfate. The desiccant was filtered, the solvent was distilled off under reduced pressure, and the residue was separated with a 500 ml silica gel column. The target substance (2.3174 g) was eluted with toluene: ethyl acetate = 12: 1.

【0191】[α]D 25=+13.5°(c 1.26, CHC
3 ).1 H−NMR(CDCl3 ,δ):0.878 (t,3H,
J=6.9 Hz),1.21−1.32(m,30H),1.52−1.58
(m,2H),3.35−3.69(m,15H),3.81−3.85
(m,1H),4.03−4.07(m,1H),4.761 (d,
1H,J=7.9 Hz),5.219 (dd,1H,J=9.3
Hz,2.9 Hz),5.317 (brd,1H),5.775
(dd,1H,J=10.5Hz),6.96−7.52(m,31
H),7.73−7.98(m,4H). (d) 化合物19−4の合成 化合物19−3(2.3012g)およびパラトルエンスルホン
酸二水和物(230mg )をクロロフォルム:メタノール:
水=65:15:1の混合溶媒10mlに溶解し、50℃にて1.5
時間加熱撹拌した。
[Α] D 25 = + 13.5 ° (c 1.26, CHC
l 3 ). 1 H-NMR (CDCl 3 , δ): 0.878 (t, 3H,
J = 6.9 Hz), 1.21-1.32 (m, 30H), 1.52-1.58
(M, 2H), 3.35-3.69 (m, 15H), 3.81-3.85
(M, 1H), 4.03-4.07 (m, 1H), 4.761 (d,
1H, J = 7.9 Hz), 5.219 (dd, 1H, J = 9.3
Hz, 2.9 Hz), 5.317 (brd, 1H), 5.775
(Dd, 1H, J = 10.5Hz), 6.96-7.52 (m, 31
H), 7.73-7.98 (m, 4H). (d) Synthesis of Compound 19-4 Compound 19-3 (2.3012 g) and paratoluenesulfonic acid dihydrate (230 mg) were combined with chloroform: methanol:
Dissolve in 10 ml of a mixed solvent of water = 65: 15: 1,
The mixture was heated and stirred for an hour.

【0192】得られた溶液を室温まで冷却した後トリエ
チルアミンにて溶液を中和し、溶媒を減圧下留去した。
残渣に水を加え、クロロフォルムにて抽出した。有機層
を水洗し、無水硫酸ナトリウムで乾燥した。乾燥剤を濾
過し、溶媒を減圧下留去し、残渣を200ml のシリカゲル
カラムにて分離した。ヘキサン:酢酸エチル=1:1.5
の混合溶媒にて目的物(879.4mg )が溶出された。
The obtained solution was cooled to room temperature, neutralized with triethylamine, and the solvent was evaporated under reduced pressure.
Water was added to the residue and extracted with chloroform. The organic layer was washed with water and dried over anhydrous sodium sulfate. The desiccant was filtered, the solvent was distilled off under reduced pressure, and the residue was separated with a 200 ml silica gel column. Hexane: ethyl acetate = 1: 1.5
The target product (879.4 mg) was eluted with the mixed solvent of.

【0193】[α]D 24=+65.5°(c 1.14,CHC
3 ).1 H−NMR(CDCl3 ,δ):0.878 (t,3H,
J=6.9 Hz),1.21−1.31(m,30H),1.52−1.58
(m,2H),3.41−3.84(m,12H),3.90−3.95
(m,2H),3.96−4.01(m,1H),4.868 (d,
1H,J=8.1 Hz),5.37−5.43(m,2H),5.78
8 (dd,1H,J=10.2Hz),6.76−7.54(m,16
H),7.75−8.02(m,4H). (e) 化合物19−5の合成 化合物19−4(874mg )のピリジン(5ml)溶液にベン
ゾイルクロリド(151μl,1.5eq )を滴下し、室温に
て一昼夜撹拌した。
[Α] D 24 = + 65.5 ° (c 1.14, CHC
l 3 ). 1 H-NMR (CDCl 3 , δ): 0.878 (t, 3H,
J = 6.9 Hz), 1.21-1.31 (m, 30H), 1.52-1.58
(M, 2H), 3.41-3.84 (m, 12H), 3.90-3.95
(M, 2H), 3.96-4.01 (m, 1H), 4.868 (d,
1H, J = 8.1 Hz), 5.37-5.43 (m, 2H), 5.78
8 (dd, 1H, J = 10.2Hz), 6.76-7.54 (m, 16
H), 7.75-8.02 (m, 4H). (e) Synthesis of Compound 19-5 Benzoyl chloride (151 μl, 1.5 eq) was added dropwise to a solution of compound 19-4 (874 mg) in pyridine (5 ml), and the mixture was stirred at room temperature overnight.

【0194】得られた溶液を氷水に加え、クロロフォル
ムにて抽出した。有機層を水洗し、無水硫酸ナトリウム
で乾燥した。乾燥剤を濾過し、溶媒を減圧下留去し、残
渣を80mlのシリカゲルカラムにて分離した。トルエン:
酢酸エチル=4:1−4:1.5 の混合溶媒にて目的物
(858mg )が溶出された。目的物は結晶として得ること
ができた。融点51.7−52.8℃。
The obtained solution was added to ice water and extracted with chloroform. The organic layer was washed with water and dried over anhydrous sodium sulfate. The desiccant was filtered, the solvent was distilled off under reduced pressure, and the residue was separated on an 80 ml silica gel column. toluene:
The target product (858 mg) was eluted with a mixed solvent of ethyl acetate = 4: 1-4: 1.5. The target substance could be obtained as crystals. Melting point 51.7-52.8 ° C.

【0195】[α]D 19=+17.2°(c 1.04,CHC
3 ).1 H−NMR(CDCl3 ,δ):0.878 (t,3H,
J=6.9 Hz),1.22−1.32(m,30H),1.51−1.57
(m,2H),3.38−3.67(m,12H),3.79−3.85
(m,1H),3.98−4.04(m,1H),4.20(br
t,1H),4.337(dd,1H,J=7.3 Hz,11.2
Hz),4.674 (dd,1H,J=6.3 Hz),4.905
(d,1H,J=7.8 Hz),5.419 (dd,1H,J
=9.0 Hz),5.470 (dd,1H,J=2.8 Hz),
5.839 (dd,1H,J=10.5Hz−2),7.06−7.57
(m,19H),7.78−7.99(m,6H). (f) 化合物19−6の合成 化合物19−5(500mg )をこれにメタノール(5ml)お
よび酢酸エチル(5ml)を加えて溶解し、酸化白金(50
mg)を加えて常温常圧下一晩水素還元を行った。触媒を
濾過した後溶液を1Nナトリウムメチラートメタノール
溶液で中和した。溶液を減圧下濃縮し、残渣をメタノー
ル(7ml)に溶解し、ナトリウムメチラート(5モル/
lメタノール溶液,20滴)を加え、室温で一晩撹拌し
た。さらに、ナトリウムメチラート(5モル/lメタノ
ール溶液,10滴)を加え、室温で7時間撹拌した。
[Α] D 19 = + 17.2 ° (c 1.04, CHC
l 3 ). 1 H-NMR (CDCl 3 , δ): 0.878 (t, 3H,
J = 6.9 Hz), 1.22-1.32 (m, 30H), 1.51-1.57
(M, 2H), 3.38-3.67 (m, 12H), 3.79-3.85
(M, 1H), 3.98-4.04 (m, 1H), 4.20 (br
t, 1H), 4.337 (dd, 1H, J = 7.3 Hz, 11.2
Hz), 4.674 (dd, 1H, J = 6.3 Hz), 4.905
(D, 1H, J = 7.8 Hz), 5.419 (dd, 1H, J
= 9.0 Hz), 5.470 (dd, 1H, J = 2.8 Hz),
5.839 (dd, 1H, J = 10.5Hz-2), 7.06-7.57
(M, 19H), 7.78-7.99 (m, 6H). (f) Synthesis of Compound 19-6 Compound 19-5 (500 mg) was dissolved by adding methanol (5 ml) and ethyl acetate (5 ml) thereto, and then adding platinum oxide (50 mg).
mg) was added and hydrogen reduction was performed overnight at room temperature and atmospheric pressure. After filtering the catalyst, the solution was neutralized with 1N sodium methylate methanol solution. The solution was concentrated under reduced pressure, the residue was dissolved in methanol (7 ml) and sodium methylate (5 mol / mol) was added.
1 methanol solution, 20 drops) was added, and the mixture was stirred at room temperature overnight. Furthermore, sodium methylate (5 mol / l methanol solution, 10 drops) was added, and the mixture was stirred at room temperature for 7 hours.

【0196】溶液を1N塩酸で中和し、減圧下濃縮し
た。残渣を水(50ml)に溶解し、「CHP−20」カラム
(22mmφ×400mm )にて精製した。すなわち、500ml
水、次いで10−90%アセトニトリル−水 直線グラジエ
ントで溶出した(総量1000ml,99フラクション)。フラ
クション44−53を濃縮した。残渣に水(40ml)、H型酸
性イオン交換樹脂「Dowex 50W×8」のH型を加
え、撹拌した。樹脂を濾過し、濾液を凍結乾燥して目的
物を得た。66.6mg。
The solution was neutralized with 1N hydrochloric acid and concentrated under reduced pressure. The residue was dissolved in water (50 ml) and purified with a “CHP-20” column (22 mmφ × 400 mm). That is, 500 ml
Elution was performed with a linear gradient of water and then 10-90% acetonitrile-water (total volume 1000 ml, 99 fractions). Fractions 44-53 were concentrated. Water (40 ml) and H type of H type acidic ion exchange resin “Dowex 50W × 8” were added to the residue and stirred. The resin was filtered and the filtrate was lyophilized to obtain the desired product. 66.6 mg.

【0197】[α]D 21=−6.9 °(c 1.01, ピリジ
ン:水=1:1).13 C−NMR(DMSO−d6 ,δ):13.85 ,22.01
,25.58 ,28.6−29.1,31.22 ,59.43 ,67.76 ,69.
40 ,69.65 ,9.73,70.28 ,70.83 ,72.18 (d,J
=4.6 Hz),72.41 ,73.72 (J=4.2 Hz),103.
31.1 H−NMR(DMSO,δ):0.856 (t,3H,J
=6.9 Hz),1.18−1.30(m,30H),1.45−1.51
(m,2H),3.247 (dd,1H,J=7.8 Hz,9,
5 Hz),3.358 (t,2H,J=6.6 Hz),3.38−
3.60(m,15H),3.80−3.83(m,1H),4.140
(d,1H,J=7.8 Hz),4.332 (dd,1H,J
=10.3Hz,3.0 Hz). 実施例20 本実施例における反応も図13に示す。
[Α] D 21 = −6.9 ° (c 1.01, pyridine: water = 1: 1). 13 C-NMR (DMSO-d 6 , δ): 13.85, 22.01.
, 25.58, 28.6-29.1, 31.22, 59.43, 67.76, 69.
40, 69.65, 9.73, 70.28, 70.83, 72.18 (d, J
= 4.6 Hz), 72.41, 73.72 (J = 4.2 Hz), 103.
31. 1 H-NMR (DMSO, δ): 0.856 (t, 3H, J
= 6.9 Hz), 1.18-1.30 (m, 30H), 1.45-1.51
(M, 2H), 3.247 (dd, 1H, J = 7.8 Hz, 9,
5 Hz), 3.358 (t, 2H, J = 6.6 Hz), 3.38-
3.60 (m, 15H), 3.80-3.83 (m, 1H), 4.140
(D, 1H, J = 7.8 Hz), 4.332 (dd, 1H, J
= 10.3 Hz, 3.0 Hz). Example 20 The reaction in this example is also shown in FIG.

【0198】(a) 化合物20−1の合成 化合物19−1(3.50g)およびカルボニルジイミダゾー
ル(1.758 g)をベンゼン(30ml)に溶解し、80℃にて
11時間加熱撹拌した。
(A) Synthesis of Compound 20-1 Compound 19-1 (3.50 g) and carbonyldiimidazole (1.758 g) were dissolved in benzene (30 ml) and the mixture was heated at 80 ° C.
The mixture was heated and stirred for 11 hours.

【0199】得られた溶液を室温まで冷却した後、氷水
に加え、酢酸エチルにて抽出した。有機層を水洗し、無
水硫酸ナトリウムで乾燥した。乾燥剤を濾過し、溶媒を
減圧下留去し、残渣を350ml のシリカゲルカラムクロマ
トグラフィーにて分離した。ヘキサン:酢酸エチル=
1:1の混合溶媒にて目的物(2.6288g)が溶出され
た。
The obtained solution was cooled to room temperature, added to ice water, and extracted with ethyl acetate. The organic layer was washed with water and dried over anhydrous sodium sulfate. The desiccant was filtered, the solvent was distilled off under reduced pressure, and the residue was separated by 350 ml of silica gel column chromatography. Hexane: Ethyl acetate =
The desired product (2.6288 g) was eluted with a 1: 1 mixed solvent.

【0200】[α]D 17=−25.5°(c 1.02,CHC
3 ).1 H−NMR(CDCl3 ,δ):0.879 (t,3H,
J=6.9 Hz),1.21−1.31(M,30H),1.56−1.61
(m,2H),3.378 (dd,1H,J=6.7Hz,9.8
Hz),3.450 (t,2H,J=6.9 Hz),3.551
(dd,1H,J=6.4 Hz),3.56−3.75(m,11
H),3.782 (dt,1H),3.97−4.01(m,1
H),4.397 (d,1H,J=7.1 Hz),4.644 (d
d,1H,J=7.2 Hz),4.762 (dd,1H,J=
2.0 Hz),4.901 (d,1H,J=2.9 Hz),7.23
−7.45(m,15H). (b) 化合物20−2合成 化合物20−1(2.5016g)のピリジン(10ml)溶液にジ
フェニル燐酸クロリド(1.60g,6eq)ピリジン(6m
l)溶液を滴下し、室温にて2昼夜撹拌した。
[Α] D 17 = −25.5 ° (c 1.02, CHC
l 3 ). 1 H-NMR (CDCl 3 , δ): 0.879 (t, 3H,
J = 6.9 Hz), 1.21-1.31 (M, 30H), 1.56-1.61
(M, 2H), 3.378 (dd, 1H, J = 6.7Hz, 9.8
Hz), 3.450 (t, 2H, J = 6.9 Hz), 3.551
(Dd, 1H, J = 6.4 Hz), 3.56-3.75 (m, 11
H), 3.782 (dt, 1H), 3.97-4.01 (m, 1
H), 4.397 (d, 1H, J = 7.1 Hz), 4.644 (d
d, 1H, J = 7.2 Hz), 4.762 (dd, 1H, J =
2.0 Hz), 4.901 (d, 1H, J = 2.9 Hz), 7.23
-7.45 (m, 15H). (b) Synthesis of Compound 20-2 A solution of Compound 20-1 (2.5016 g) in pyridine (10 ml) was added with diphenylphosphoric chloride (1.60 g, 6 eq) pyridine (6 m
l) The solution was added dropwise and stirred at room temperature for 2 days and nights.

【0201】得られた溶液を氷水に加え、クロロフォル
ムにて抽出した。有機層を水洗し、無水硫酸ナトリウム
で乾燥した。乾燥剤を濾去し、溶媒を減圧下留去し、残
渣を300ml のシリカゲルカラムクロマトグラフィーにて
分離した。ヘキサン:酢酸エチル=3:1−2:1の混
合溶媒にて目的物(2.7845g)が溶出された。
The obtained solution was added to ice water and extracted with chloroform. The organic layer was washed with water and dried over anhydrous sodium sulfate. The desiccant was filtered off, the solvent was evaporated under reduced pressure, and the residue was separated by 300 ml silica gel column chromatography. The target product (2.7845 g) was eluted with a mixed solvent of hexane: ethyl acetate = 3: 1-2: 1.

【0202】[α]D 21=−17.3°(c 1.01,CHC
3 ).1 H−NMR(CDCl3 ,δ):0.879 (t,3H,
J=7.0 Hz),1.21−1.31(m,30H),1.52−1.58
(m,2H),3.306 (dd,1H,J=6.8Hz,J
9.5 Hz),3.414 (t,2H,J=6.8 Hz),3.48
3 (dd,1H,J=6.3 Hz),3.53−3.63(m,11
H),3.906 (dt,1H),4.711 (dt,1H,J
=3.2 Hz,10.5Hz),4.795 (dd,1H,J=8.
3 Hz,1.0 Hz),4.856 (dd,1H,J=1.8 H
z),4.951 (d,1H,J=3.7 Hz),7.21−7.44
(m,25H). (c) 化合物20−3の合成 化合物20−2(2.750 g)およびパラトルエンスルホン
酸二水和物(210mg )をクロロフォルム:メタノール:
水=65:15:1の混合溶媒(50ml)に溶解し、50℃にて
5時間加熱撹拌した。
[Α] D 21 = -17.3 ° (c 1.01, CHC
l 3 ). 1 H-NMR (CDCl 3 , δ): 0.879 (t, 3H,
J = 7.0 Hz), 1.21-1.31 (m, 30H), 1.52-1.58
(M, 2H), 3.306 (dd, 1H, J = 6.8Hz, J
9.5 Hz), 3.414 (t, 2H, J = 6.8 Hz), 3.48
3 (dd, 1H, J = 6.3 Hz), 3.53-3.63 (m, 11
H), 3.906 (dt, 1H), 4.711 (dt, 1H, J
= 3.2 Hz, 10.5 Hz), 4.795 (dd, 1H, J = 8.
3 Hz, 1.0 Hz), 4.856 (dd, 1H, J = 1.8 H
z), 4.951 (d, 1H, J = 3.7 Hz), 7.21-7.44
(M, 25H). (c) Synthesis of Compound 20-3 Compound 20-2 (2.750 g) and paratoluenesulfonic acid dihydrate (210 mg) were combined with chloroform: methanol:
It was dissolved in a mixed solvent (50 ml) of water = 65: 15: 1 and heated and stirred at 50 ° C. for 5 hours.

【0203】得られた溶液を室温まで冷却した後トリエ
チルアミンにて溶液を中和し、溶媒を減圧下留去した。
残渣に水を加え、クロロフォルムにて抽出した。有機層
を水洗し、無水硫酸ナトリウムで乾燥した。乾燥剤を濾
去し、溶媒を減圧下留去し、残渣を250ml のシリカゲル
カラムにて分離した。クロロフォルム:メタノール=10
0 :1−100 :1.5 の混合溶媒にて目的物(1.074 g)
が溶出された。
The obtained solution was cooled to room temperature, neutralized with triethylamine, and the solvent was evaporated under reduced pressure.
Water was added to the residue and extracted with chloroform. The organic layer was washed with water and dried over anhydrous sodium sulfate. The desiccant was filtered off, the solvent was distilled off under reduced pressure, and the residue was separated on a 250 ml silica gel column. Chloroform: Methanol = 10
Target compound (1.074 g) in a mixed solvent of 0: 1-100: 1.5
Was eluted.

【0204】[α]D 20−2.9 °(c 1.24,CHCl
3 ).1 H−NMR(CDCl3 ,δ):0.879 (t,3H,
J=6.9 Hz),1.20−1.34(m,30H),1.54−1.60
(m,2H),2.663 (dd,1H,J=4.4,7.8 H
z),3.433 (t,2H,J=6.8 Hz),3.52−3.66
(m,10H),3.68−4.00(m,5H),4.696 (d
t,1H,J=3.9 Hz,9.5 Hz),4.785 (dd,
1H,J=2.0 Hz),4.836 (dd,1H,J=8.3
Hz),4.957 (d,1H,J=4.6 Hz),7.20−7.
39(m,10H). (d) 化合物20−4の合成 化合物20−3(1.0628g)のピリジン(6ml)溶液にベ
ンゾイルクロリド(218mg ,1.2eq )を滴下し、室温に
て一昼夜撹拌した。
[Α] D 20 −2.9 ° (c 1.24, CHCl
3 ). 1 H-NMR (CDCl 3 , δ): 0.879 (t, 3H,
J = 6.9 Hz), 1.20-1.34 (m, 30H), 1.54-1.60
(M, 2H), 2.663 (dd, 1H, J = 4.4, 7.8H
z), 3.433 (t, 2H, J = 6.8 Hz), 3.52-3.66
(M, 10H), 3.68-4.00 (m, 5H), 4.696 (d
t, 1H, J = 3.9 Hz, 9.5 Hz), 4.785 (dd,
1H, J = 2.0 Hz), 4.836 (dd, 1H, J = 8.3
Hz), 4.957 (d, 1H, J = 4.6 Hz), 7.20-7.
39 (m, 10H). (d) Synthesis of Compound 20-4 Benzoyl chloride (218 mg, 1.2 eq) was added dropwise to a solution of compound 20-3 (1.0628 g) in pyridine (6 ml), and the mixture was stirred at room temperature overnight.

【0205】得られた溶液を氷水に加え、クロロフォル
ムにて抽出した。有機層を水洗し、無水硫酸ナトリウム
で乾燥した。乾燥剤を濾去し、溶媒を減圧下留去し、残
渣を150ml のシリカゲルカラムグラフィーにて分離し
た。トルエン:酢酸エチル=3:1の混合溶媒にて目的
物(888mg )が溶出された。目的物は結晶として得るこ
とができた。融点46.8−47.3℃。
The obtained solution was added to ice water and extracted with chloroform. The organic layer was washed with water and dried over anhydrous sodium sulfate. The desiccant was filtered off, the solvent was distilled off under reduced pressure, and the residue was separated by 150 ml of silica gel column chromatography. The target product (888 mg) was eluted with a mixed solvent of toluene: ethyl acetate = 3: 1. The target substance could be obtained as crystals. Melting point 46.8-47.3 [deg.] C.

【0206】[α]D 22=+9.5 °(c 1.02,CHC
3 ).1 H−NMR(CDCl3 ,δ):0.879 (t,3H,
J=6.9 Hz),1.20−1.32(m,30H),1.51−1.55
(m,2H),3.421 (t,2H,J=6.8 Hz),3.
54−3.70(m,11H),3.87−3.91(m,1H),4.22
7 (br t,1H),4.491 (dd,1H,J=6.3
Hz,11.5Hz),4.605 (dd,1H,J=6.6 H
z),4.771 (dt,1H,J=10.3Hz,3.2 H
z),4.849 (brs,2H),5.059 (d,1H,J
=3.4 Hz),7.18−7.62(m,13H),8.04−8.06
(m,2H). (e) 化合物20−5の合成 化合物20−4(500mg )をこれにメタノール(6ml)お
よび酢酸エチル(4ml)を加えて溶解し、酸化白金(50
mg)を加えて常温常圧下一晩水素還元を行った。触媒を
濾過した後溶液を、1Nナトリウムメチラートメタノー
ル溶液で中和した。溶液を減圧下濃縮し、残渣をメタノ
ール(2ml)およびベンゼン(2ml)に溶解し、ナトリ
ウムメチラート(5モル/lメタノール溶液,20滴)を
加え室温で一晩撹拌した。
[Α] D 22 = + 9.5 ° (c 1.02, CHC
l 3 ). 1 H-NMR (CDCl 3 , δ): 0.879 (t, 3H,
J = 6.9 Hz), 1.20-1.32 (m, 30H), 1.51-1.55
(M, 2H), 3.421 (t, 2H, J = 6.8 Hz), 3.
54-3.70 (m, 11H), 3.87-3.91 (m, 1H), 4.22
7 (br t, 1H), 4.491 (dd, 1H, J = 6.3
Hz, 11.5Hz), 4.605 (dd, 1H, J = 6.6H
z), 4.771 (dt, 1H, J = 10.3Hz, 3.2H
z), 4.849 (brs, 2H), 5.059 (d, 1H, J
= 3.4 Hz), 7.18-7.62 (m, 13H), 8.04-8.06
(M, 2H). (e) Synthesis of compound 20-5 Compound 20-4 (500 mg) was dissolved by adding methanol (6 ml) and ethyl acetate (4 ml) thereto,
mg) was added and hydrogen reduction was performed overnight at room temperature and atmospheric pressure. After filtering the catalyst, the solution was neutralized with 1N sodium methylate methanol solution. The solution was concentrated under reduced pressure, the residue was dissolved in methanol (2 ml) and benzene (2 ml), sodium methylate (5 mol / l methanol solution, 20 drops) was added, and the mixture was stirred overnight at room temperature.

【0207】溶液を1N塩酸で中和し、減圧下濃縮し
た。残渣を水(50ml)に溶解し、「CHP−20」カラム
(22mmφ×400mm )にて精製した。水(500ml )、次い
で10−90%アセトニトリル−水 直線グラジエントで溶
出した(グラジエント溶媒総量1000ml,98フラクショ
ン)。フラクション45−51を濃縮した。残渣に水(40m
l)、H型の酸性イオン交換樹脂「Dowex 50W×
8」を加えて撹拌した。樹脂を濾去し、濾液を凍結乾燥
して目的物を得た。
The solution was neutralized with 1N hydrochloric acid and concentrated under reduced pressure. The residue was dissolved in water (50 ml) and purified with a “CHP-20” column (22 mmφ × 400 mm). Elution was carried out with a linear gradient of water (500 ml) and then 10-90% acetonitrile-water (total gradient solvent 1000 ml, 98 fractions). Fractions 45-51 were concentrated. Water (40m) on the residue
l), H-type acidic ion exchange resin “Dowex 50W ×
8 ”was added and stirred. The resin was filtered off, and the filtrate was freeze-dried to obtain the desired product.

【0208】[α]D 25=−6.9 °(c 1.10,クロロ
フォルム:メタノール:水=10:10:3).13 C−NMR(DMSO−d6 ,δ):13.85 ,22.03
,25.58 ,28.6−29.2,31.23 ,60.26 ,67.50 ,67.
65 ,69.41 ,69.59 ,69.74 −69.79 ,70.32,73.15
,75.04 ,75.71 (d,J=5.8 Hz),101.19
(d,J=8.1 Hz). 実施例21 本実施例における反応を図14に示す。
[Α] D 25 = −6.9 ° (c 1.10, chloroform: methanol: water = 10: 10: 3). 13 C-NMR (DMSO-d 6 , δ): 13.85, 22.03.
, 25.58, 28.6-29.2, 31.23, 60.26, 67.50, 67.
65, 69.41, 69.59, 69.74-69.79, 70.32, 73.15
, 75.04, 75.71 (d, J = 5.8 Hz), 101.19
(D, J = 8.1 Hz). Example 21 The reaction in this example is shown in FIG.

【0209】(a) 化合物21−1合成 化合物16−1(5.200 g)のメタノール(20ml)溶液に
ナトリウムメトキシドのメタノール溶液(5M/l,10
滴)を加え、室温で5時間撹拌した。得られた溶液に強
酸性イオン交換樹脂「Dowex 50W×8」のH型を
加えて中和した。樹脂を濾去し、溶媒を減圧下留去した
後、残渣にジブチルスズオキシド(1.766 g)および無
水メタノール(40ml)を加え、3時間加熱還流した。メ
タノールを常圧下留去した後、残渣にベンゼン(50ml)
を加え、残留するメタノールをベンゼンと共に留去し
た。残渣にさらにベンゼンを加え留去することを2度行
った。残渣にヨウ化テトラブチルアンモニウム(2.621
g)、ベンゼン(30ml)および臭化アリル(30ml)を加
え、3時間加熱還流した。溶媒および臭化アリルを減圧
下留去し、残渣をピリジン(20ml)にて溶解した。得ら
れた溶液に塩化ベンゾイル(5.982g,6倍モル)を滴下
し一晩撹拌した。
(A) Synthesis of Compound 21-1 A solution of Compound 16-1 (5.200 g) in methanol (20 ml) was added to a solution of sodium methoxide in methanol (5 M / l, 10
(Droplet) was added and the mixture was stirred at room temperature for 5 hours. The resulting solution was neutralized by adding H-type of a strongly acidic ion exchange resin "Dowex 50W × 8". The resin was filtered off, the solvent was evaporated under reduced pressure, dibutyltin oxide (1.766 g) and anhydrous methanol (40 ml) were added to the residue, and the mixture was heated under reflux for 3 hours. After distilling off methanol under atmospheric pressure, benzene (50 ml) was added to the residue.
Was added and residual methanol was distilled off together with benzene. Benzene was further added to the residue and the residue was distilled off twice. Tetrabutylammonium iodide (2.621
g), benzene (30 ml) and allyl bromide (30 ml) were added and the mixture was heated under reflux for 3 hours. The solvent and allyl bromide were distilled off under reduced pressure, and the residue was dissolved with pyridine (20 ml). Benzoyl chloride (5.982 g, 6 times mol) was added dropwise to the resulting solution, and the mixture was stirred overnight.

【0210】得られた溶液を氷水に加え、クロロフォル
ムにて抽出した。有機層を無水硫酸ナトリウムにて乾燥
した。溶媒を減圧下留去し、シリカゲルカラムクロマト
グラフィー(ヘキサン:酢酸エチル=4:1−3:1)
にて分離し、目的物を得た。2.050 g,31.5%。
The obtained solution was added to ice water and extracted with chloroform. The organic layer was dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and silica gel column chromatography (hexane: ethyl acetate = 4: 1-3: 1).
And separated to obtain the desired product. 2.050 g, 31.5%.

【0211】[α]D 22=+22.8°(c 1.01,CHC
3 ).1 H−NMR(CDCl3 ,δ):0.879 (t,3H,
J=6.9 Hz),1.18−1.33(m,30H),1.52−1.58
(m,2H),3.35−3.65(m,12H),3.75−3.80
(m,1H),3.834 (dd,1H,J=10.0Hz,3.
4 Hz),3.95−4.03(m,2H),4.11−4.17(m,
2H),4.418 (dd,1H,J=6.1 Hz,11.3H
z),4.607 (dd,1H,J=6.8 Hz),4.775
(d,1H,J=8.1 Hz),5.045 (brdd,1
H,J=17.3Hz),5.159 (brdd,1H,J=1
0.4Hz),5.504 (dd,1H,J=10.4Hz),5.6
66 (m,1H,J=4.9 Hz,6.3 Hz,10.5H
z),5.838 (dd,1H,J=0.9 Hz),7.43−7.
61(m,9H),8.03−8.16(m,6H). (b) 化合物21−2の合成 化合物21−1(1.6433g)にパラトルエンスルホン酸
(300mg )、10%パラジウム炭素(300mg )およびクロ
ロフォルム:メタノール:水=65:15:1の混合溶媒
(30ml)を加え、60℃にて10時間加熱撹拌した。
[Α] D 22 = + 22.8 ° (c 1.01, CHC
l 3 ). 1 H-NMR (CDCl 3 , δ): 0.879 (t, 3H,
J = 6.9 Hz), 1.18-1.33 (m, 30H), 1.52-1.58
(M, 2H), 3.35-3.65 (m, 12H), 3.75-3.80
(M, 1H), 3.834 (dd, 1H, J = 10.0Hz, 3.
4 Hz), 3.95-4.03 (m, 2H), 4.11-4.17 (m,
2H), 4.418 (dd, 1H, J = 6.1 Hz, 11.3H
z), 4.607 (dd, 1H, J = 6.8 Hz), 4.775
(D, 1H, J = 8.1 Hz), 5.045 (brdd, 1
H, J = 17.3Hz), 5.159 (brdd, 1H, J = 1
0.4Hz), 5.504 (dd, 1H, J = 10.4Hz), 5.6
66 (m, 1H, J = 4.9 Hz, 6.3 Hz, 10.5H
z), 5.838 (dd, 1H, J = 0.9 Hz), 7.43-7.
61 (m, 9H), 8.03-8.16 (m, 6H). (b) Synthesis of Compound 21-2 Compound 21-1 (1.6433 g) was mixed with paratoluenesulfonic acid (300 mg), 10% palladium carbon (300 mg) and a mixed solvent of chloroform: methanol: water = 65: 15: 1 (30 ml). ) Was added and the mixture was heated with stirring at 60 ° C. for 10 hours.

【0212】得られた溶液を室温まで冷却し、トリエチ
ルアミンにて中和した。溶媒を減圧下留去し、残渣をシ
リカゲルカラムクロマトグラフィー(ヘキサン:酢酸エ
チル=2:1)にて分離して目的物を得た。1.176 g。
The obtained solution was cooled to room temperature and neutralized with triethylamine. The solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (hexane: ethyl acetate = 2: 1) to obtain the desired product. 1.176 g.

【0213】[α]D 21=3.2 °(c 0.94,CHCl
3 ).1 H−NMR(CDCl3 ,δ):0.878 (t,3H,
J=6.9 Hz),1.17−1.32(m,30H),1.52−1.58
(m,2H),2.742 (d,1H,J=5.9 Hz),3.
408 (t,2H,J=6.8 Hz),3.43−3.68(m,10
H),3.80−3.85(m,1H),4.00−4.05(m,1
H),4.13−4.19(m,1H),4.424 (1H,dd,
J=6.3 Hz,11.5Hz),4.599 (dd,1H,J=
6.8 Hz),4.839 (d,1H,J=7.9 Hz),5.36
0 (dd,1H,J=10.0Hz),5.779 (dd,1
H,J=3.5 Hz,0.9 Hz),7.41−7.63(m,9
H),8.02−8.17(m,6H). (c) 化合物21−3の合成 化合物21−2(811mg )のピリジン(3ml)溶液にジフ
ェニル燐酸クロリド(745mg ,3eq)のピリジン(3m
l)溶液を滴下し、室温にて1昼夜撹拌した。
[Α] D 21 = 3.2 ° (c 0.94, CHCl
3 ). 1 H-NMR (CDCl 3 , δ): 0.878 (t, 3H,
J = 6.9 Hz), 1.17-1.32 (m, 30H), 1.52-1.58
(M, 2H), 2.742 (d, 1H, J = 5.9 Hz), 3.
408 (t, 2H, J = 6.8 Hz), 3.43-3.68 (m, 10
H), 3.80-3.85 (m, 1H), 4.00-4.05 (m, 1
H), 4.13-4.19 (m, 1H), 4.424 (1H, dd,
J = 6.3 Hz, 11.5 Hz), 4.599 (dd, 1H, J =
6.8 Hz), 4.839 (d, 1H, J = 7.9 Hz), 5.36
0 (dd, 1H, J = 10.0Hz), 5.779 (dd, 1
H, J = 3.5 Hz, 0.9 Hz), 7.41-7.63 (m, 9
H), 8.02-8.17 (m, 6H). (c) Synthesis of Compound 21-3 A solution of Compound 21-2 (811 mg) in pyridine (3 ml) was charged with diphenylphosphoric chloride (745 mg, 3 eq) of pyridine (3 m).
l) The solution was added dropwise and stirred at room temperature for one day.

【0214】得られた溶液を氷水に加え、クロロフォル
ムにて抽出した。有機層を水洗し、無水硫酸ナトリウム
で乾燥した。乾燥剤を濾去し、溶媒を減圧下留去し、残
渣を100ml のシリカゲルカラムクロマトグラフィーにて
分離した。ヘキサン:酢酸エチル=2:1の混合溶媒に
て目的物(0.969 g)が溶出された。
The obtained solution was added to ice water and extracted with chloroform. The organic layer was washed with water and dried over anhydrous sodium sulfate. The desiccant was filtered off, the solvent was distilled off under reduced pressure, and the residue was separated by 100 ml of silica gel column chromatography. The target product (0.969 g) was eluted with a mixed solvent of hexane: ethyl acetate = 2: 1.

【0215】[α]D 25=+33.5°(c 1.01,CHC
3 ).1 H−NMR(CDCl3 ,δ):0.879 (t,3H,
J=6.8 Hz),1.21−1.32(m,30H),1.51−1.57
(m,2H),3.33−3.62(m,10H),3.74−3.79
(m,1H),3.95−4.00(m,1H),4.159 (br
t,1H),4.407 (dd,1H,J=6.1 Hz,1
1.4Hz),4.534 (dd,1H,J=6.6Hz),4.81
6 (d,1H,J=8.1 Hz),5.140 (dt,1H,
J=9.8 Hz),5.753 (dd,1H,J=10.0H
z),5.951 (dd,1H,J=1.0 Hz),6.77−7.
64(m,19H),7.99−8.11(m,6H). (d) 化合物21−4の合成 化合物21−3(514mg )をこれにメタノール(8ml)お
よび酢酸エチル(8ml)を加えて溶解し、酸化白金(55
mg)を加えて常温常圧下で2日間水素還元を行った。触
媒を濾過した後溶液を1Nナトリウムメチラートメタノ
ール溶液で中和した。溶液を減圧下濃縮し、残渣をメタ
ノール(8ml)に溶解し、ナトリウムメチラート(5モ
ル/lメタノール溶液,15滴)を加え室温で一晩撹拌し
た。さらにナトリウムメチラート(5モル/lメタノー
ル溶液,10滴)を加え室温で一晩撹拌した。
[Α] D 25 = + 33.5 ° (c 1.01, CHC
l 3 ). 1 H-NMR (CDCl 3 , δ): 0.879 (t, 3H,
J = 6.8 Hz), 1.21-1.32 (m, 30H), 1.51-1.57
(M, 2H), 3.33-3.62 (m, 10H), 3.74-3.79
(M, 1H), 3.95-4.00 (m, 1H), 4.159 (br
t, 1H), 4.407 (dd, 1H, J = 6.1 Hz, 1
1.4Hz), 4.534 (dd, 1H, J = 6.6Hz), 4.81
6 (d, 1H, J = 8.1 Hz), 5.140 (dt, 1H,
J = 9.8 Hz), 5.753 (dd, 1H, J = 10.0H
z), 5.951 (dd, 1H, J = 1.0 Hz), 6.77-7.
64 (m, 19H), 7.99-8.11 (m, 6H). (d) Synthesis of Compound 21-4 Compound 21-3 (514 mg) was dissolved by adding methanol (8 ml) and ethyl acetate (8 ml) to the platinum oxide (55 mg).
mg) was added and hydrogen reduction was carried out at room temperature and atmospheric pressure for 2 days. After filtering the catalyst, the solution was neutralized with 1N sodium methylate methanol solution. The solution was concentrated under reduced pressure, the residue was dissolved in methanol (8 ml), sodium methylate (5 mol / l methanol solution, 15 drops) was added, and the mixture was stirred at room temperature overnight. Further, sodium methylate (5 mol / l methanol solution, 10 drops) was added, and the mixture was stirred at room temperature overnight.

【0216】溶液を1N塩酸で中和し、減圧下濃縮し
た。残渣を水(50ml)に溶解し、「CHP−20」カラム
(22mmφ×400mm )にて精製した。水(500ml )、次い
で10−90%アセトニトリル−水 直線グラジエントで溶
出した(総量1000ml,113 フラクション)。フラクショ
ン52−68を濃縮した。残渣に水(40ml)、H型酸性イオ
ン交換樹脂(「Dowex 50W×8」のH型)を加
え、撹拌した。樹脂を濾去し、濾液を凍結乾燥して目的
物を得た。
The solution was neutralized with 1N hydrochloric acid and concentrated under reduced pressure. The residue was dissolved in water (50 ml) and purified with a “CHP-20” column (22 mmφ × 400 mm). Elution was carried out with a linear gradient of water (500 ml) and then 10-90% acetonitrile-water (total volume 1000 ml, 113 fractions). Fractions 52-68 were concentrated. Water (40 ml) and H-type acidic ion exchange resin (H-type of “Dowex 50W × 8”) were added to the residue, and the mixture was stirred. The resin was filtered off, and the filtrate was freeze-dried to obtain the desired product.

【0217】[α]D 17=−3.6 °(c 1.00,CHC
3 ).1 H−NMR(DMSO,δ):0.856 (t,1H,J
=6.9 Hz),1.16−1.31(m,30H),1.44−1.50
(m,2H),3.359 (t,2H,J=6.6 Hz),3.
44−3.61(m,12H),3.82−3.92(m,3H),4.18
7 (d,1H,J=7.6 Hz). 実施例22 本実施例における反応を図15の(a) に示す。
[Α] D 17 = −3.6 ° (c 1.00, CHC
l 3 ). 1 H-NMR (DMSO, δ): 0.856 (t, 1H, J
= 6.9 Hz), 1.16-1.31 (m, 30H), 1.44-1.50
(M, 2H), 3.359 (t, 2H, J = 6.6 Hz), 3.
44-3.61 (m, 12H), 3.82-3.92 (m, 3H), 4.18
7 (d, 1H, J = 7.6 Hz). Example 22 The reaction in this example is shown in FIG.

【0218】(a) 化合物22−1の合成 モノクロロ酢酸9.45gに1.0 Mテトラ−n−ブチルアン
モニウムヒドロキシドメタノール溶液100ml を加えて溶
かし、溶媒を減圧下留去した。残渣にトルエンを加え、
減圧下留去して水を共沸により除去した(2回)。こう
してモノクロロ酢酸のテトラ−n−ブチルアンモニウム
塩を得、このまま以下の反応に用いた。
(A) Synthesis of compound 22-1 To 9.45 g of monochloroacetic acid was added 100 ml of a 1.0 M solution of tetra-n-butylammonium hydroxide in methanol to dissolve it, and the solvent was distilled off under reduced pressure. Toluene was added to the residue,
Water was removed azeotropically by distillation under reduced pressure (twice). Thus, a tetra-n-butylammonium salt of monochloroacetic acid was obtained and used as it was in the following reaction.

【0219】少量のヘキサンで3回洗浄した水素化ナト
リウム(純度60%、3.20g)にジメチルフォルムアミモ
ド(200ml )を加え、化合物11−5(11.68 g)を滴下
した。室温で3時間撹拌した後、前述のモノクロル酢酸
の塩をジメチルフォルムアミド(20ml)と共に加え、室
温で一晩撹拌した。溶液に臭化ベンジル(19.38 g,1.
7eq )を加え、室温で3日撹拌した。
Dimethylformamimod (200 ml) was added to sodium hydride (purity 60%, 3.20 g) washed with a small amount of hexane three times, and compound 11-5 (11.68 g) was added dropwise. After stirring at room temperature for 3 hours, the above monochloroacetic acid salt was added together with dimethylformamide (20 ml), and the mixture was stirred at room temperature overnight. Benzyl bromide (19.38 g, 1.
7eq) was added, and the mixture was stirred at room temperature for 3 days.

【0220】溶液に水(700ml )および酢酸エチル(70
0ml )を加えて抽出した。有機層を2回水洗し、無水硫
酸ナトリウムで乾燥した。溶液を濾過し、濾液から減圧
下溶媒を留去したのち、残渣をシリカゲルカラムクロマ
トグラフィー(シリカゲル2000ml、ヘキサン:酢酸エチ
ル=3:1.25−2:1)にて分離して目的物を油状物質
として得た。13.03 g。
The solution was added with water (700 ml) and ethyl acetate (70
0 ml) was added for extraction. The organic layer was washed twice with water and dried over anhydrous sodium sulfate. The solution was filtered, the solvent was distilled off from the filtrate under reduced pressure, and the residue was separated by silica gel column chromatography (silica gel 2000 ml, hexane: ethyl acetate = 3: 1.25-2: 1) to give the desired product as an oily substance. Obtained. 13.03 g.

【0221】1H−NMR(CDCl3 ,δ):3.66−
3.76(m,10H),3.373 (t,2H), 4.205(s,
2H), 5.192(s,2H),7.33−7.37(m,5
H). (b) 化合物22−2の合成 化合物22−2(14.00 g)の酢酸エチル( 250ml)溶液
にリンドラー触媒(7g)を加え、50psi の水素雰囲気
下で4時間還元を行った。さらにリンドラー触媒(7
g)を加え、50psi の水素雰囲気下で4時間還元を行っ
た。触媒を濾過し、濾過された触媒をクロロフォルムで
洗浄した。濾液および触媒の洗液を集め、減圧下溶媒を
留去し、残渣を塩化メチレン( 300ml)に溶解した。化
合物11−4(11.02 gの化合物11−3より合成)の塩化
メチレン( 150ml)溶液およびトリエチルアミン(6.56
g)を加え、室温で2日撹拌した。
1 H-NMR (CDCl 3 , δ): 3.66-
3.76 (m, 10H), 3.373 (t, 2H), 4.205 (s,
2H), 5.192 (s, 2H), 7.33-7.37 (m, 5
H). (b) Synthesis of Compound 22-2 A Lindlar catalyst (7 g) was added to a solution of Compound 22-2 (14.00 g) in ethyl acetate (250 ml), and reduction was carried out under a hydrogen atmosphere of 50 psi for 4 hours. Furthermore, Lindlar catalyst (7
g) was added and reduction was carried out under a hydrogen atmosphere of 50 psi for 4 hours. The catalyst was filtered and the filtered catalyst was washed with chloroform. The filtrate and the catalyst washings were collected, the solvent was distilled off under reduced pressure, and the residue was dissolved in methylene chloride (300 ml). Compound 11-4 (synthesized from 11.02 g of compound 11-3) in methylene chloride (150 ml) and triethylamine (6.56)
g) was added, and the mixture was stirred at room temperature for 2 days.

【0222】溶液に水を加えて洗浄した。有機層を無水
硫酸ナトリウムで乾燥し、濾過した後、溶媒を減圧下留
去した。残渣をシリカゲルカラムクロマトグラフィー
(シリカゲル1000ml、ヘキサン:酢酸エチル=2:1−
2:1.5 )で分離して目的物を白色固体として得た。1
2.694g。
Water was added to the solution for washing. The organic layer was dried over anhydrous sodium sulfate, filtered, and the solvent was evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (silica gel 1000 ml, hexane: ethyl acetate = 2: 1−).
2: 1.5) and the target object was obtained as a white solid. 1
2.694 g.

【0223】1H−NMR(CDCl3 ,δ):0.880
(t,6H,J=7.1 Hz),1.20−1.37(m,56
H),1.54−1.57(m,4H),1.96−2.20(m,1
H),3.458 (brq,2H,J=5.1 −5.4 Hz),
3.536 (br t,2H,J=4.9−5.1 Hz),3.59
−3.77(m,8H),4.202 (s,2H),5.304
(s,2H),6.054 (t,1H,J=5.3 Hz),7.
35−7.37(m,5H). (c) 化合物22−3の合成 化合物22−2(10.73 g)のテトラヒドロフラン( 200
ml)溶液に10%パラジウム炭素( 0.6g)を加え、50ps
i の水素雰囲気下6時間還元を行った。触媒を濾去し、
溶媒を減圧下留去して残渣をシリカゲルクロマトグラフ
ィー(シリカゲル1000ml、クロロフォルム:メタノール
= 100:3− 100:20)で分離し、目的物を得た。9.20
2 g。
1 H-NMR (CDCl 3 , δ): 0.880
(T, 6H, J = 7.1 Hz), 1.20-1.37 (m, 56
H), 1.54-1.57 (m, 4H), 1.96-2.20 (m, 1)
H), 3.458 (brq, 2H, J = 5.1-5.4 Hz),
3.536 (brt, 2H, J = 4.9-5.1 Hz), 3.59
-3.77 (m, 8H), 4.202 (s, 2H), 5.304
(S, 2H), 6.054 (t, 1H, J = 5.3 Hz), 7.
35-7.37 (m, 5H). (c) Synthesis of Compound 22-3 Compound 22-2 (10.73 g) in tetrahydrofuran (200
10% palladium on carbon (0.6g) was added to the
Reduction was performed for 6 hours under hydrogen atmosphere of i. The catalyst is filtered off,
The solvent was evaporated under reduced pressure, and the residue was separated by silica gel chromatography (silica gel 1000 ml, chloroform: methanol = 100: 3-100: 20) to obtain the desired product. 9.20
2 g.

【0224】1H−NMR(CDCl3 ,δ):0.880
(t,6H,J=6.9 Hz),1.10−1.33(m,56
H),1.33−1.43(m,2H),1.53−1.63(m,2
H),2.07−2.14(m,1H),3.482 (brq,2
H,J=4.9 −5.1 Hz),3.552 (br t,2H,
J=4.9 Hz),4.166 (2,2H),6.263 (br
s,1H). 実施例23 本実施例における反応を図15の(b) に示す。
1 H-NMR (CDCl 3 , δ): 0.880
(T, 6H, J = 6.9 Hz), 1.10-1.33 (m, 56
H), 1.33-1.43 (m, 2H), 1.53-1.63 (m, 2)
H), 2.07-2.14 (m, 1H), 3.482 (brq, 2)
H, J = 4.9-5.1 Hz), 3.552 (brt, 2H,
J = 4.9 Hz), 4.166 (2,2H), 6.263 (br
s, 1H). Example 23 The reaction in this example is shown in FIG. 15 (b).

【0225】(a) 化合物23−1の合成 化合物22−2( 720mg)のテトラヒドロフラン(50ml)
溶液に10%パラジウム炭素(0.06g)を加え、50psi の
水素雰囲気下6時間還元を行った。触媒を濾去し、濾液
から溶媒を減圧下留去した残渣を塩化メチレン(10m
l)、N−ヒドロキシスクシイミド( 126mg)、ジベン
ジルL−グルタミン酸パラトルエンスルホン酸塩( 548
mg)、ジシクロヘキシルカルボジイミド( 207mg)およ
びトリエチルアミン( 120mg)を加え、室温で一晩撹拌
した。
(A) Synthesis of Compound 23-1 Compound 22-2 (720 mg) in tetrahydrofuran (50 ml)
10% Palladium on carbon (0.06 g) was added to the solution, and reduction was carried out under a hydrogen atmosphere of 50 psi for 6 hours. The catalyst was filtered off, and the solvent was distilled off from the filtrate under reduced pressure.
l), N-hydroxysuccinimide (126 mg), dibenzyl L-glutamic acid paratoluenesulfonate (548
mg), dicyclohexylcarbodiimide (207 mg) and triethylamine (120 mg) were added, and the mixture was stirred at room temperature overnight.

【0226】溶媒を減圧下留去した残渣に酢酸エチル
(10ml)を加え、不溶物を濾去した。溶媒を減圧下留去
し、残渣をシリカゲルクロマトグラフィー(シリカゲル
80ml、ヘキサン:酢酸エチル=2:1−1:1)で分離
して目的物を白色固体として得た。543mg 。
Ethyl acetate (10 ml) was added to the residue obtained by evaporating the solvent under reduced pressure, and the insoluble material was removed by filtration. The solvent was distilled off under reduced pressure, and the residue was chromatographed on silica gel (silica gel).
The product was separated with 80 ml of hexane: ethyl acetate = 2: 1-1: 1) to obtain the desired product as a white solid. 543 mg.

【0227】[α]D 16=−0.2 °(c 1.01,CHC
3 ).1 HNMR−(CDCl3 ,δ):0.879 (t,6H,
J=6.9 Hz),1.16−1.40(m,56H),1.52−1.54
(m,4H),1.97−2.20(m,1H),2.09−2.20
(m,1H),2.24−2.31(m,1H),2.36−2.50
(m,2H),3.39−3.72(m,12H),4.020 (d,
1H,J=15.9Hz),4.062 (d,1H,J=15.9H
z),4.721 (dt,1H,J=5.1 Hz,8.3 H
z),5.078 (d,1H,J=12.2Hz),5.113
(d,1H,J=12.2Hz),5.161 (s,2H),6.
173 (t,1H,J=5.6 Hz),7.398 (d,1H,
J=8.3 Hz),7.29−7.41(m,5H). (b) 化合物23−2の合成 化合物23−1(488.3mg )に酢酸エチル(20ml)、メタ
ノール(20ml)および10%パラジウム炭素(0.04g)を
加え、50psi の水素雰囲気下で5時間還元を行った。さ
らに10%パラジウム炭素(0.04g)を加え、50psi の水
素雰囲気下で3時間還元を行った。
[Α] D 16 = −0.2 ° (c 1.01, CHC
l 3 ). 1 HNMR- (CDCl 3 , δ): 0.879 (t, 6H,
J = 6.9 Hz), 1.16-1.40 (m, 56H), 1.52-1.54
(M, 4H), 1.97-2.20 (m, 1H), 2.09-2.20
(M, 1H), 2.24-2.31 (m, 1H), 2.36-2.50
(M, 2H), 3.39-3.72 (m, 12H), 4.020 (d,
1H, J = 15.9Hz), 4.062 (d, 1H, J = 15.9H)
z), 4.721 (dt, 1H, J = 5.1 Hz, 8.3 H
z), 5.078 (d, 1H, J = 12.2Hz), 5.113
(D, 1H, J = 12.2Hz), 5.161 (s, 2H), 6.
173 (t, 1H, J = 5.6 Hz), 7.398 (d, 1H,
J = 8.3 Hz), 7.29-7.41 (m, 5H). (b) Synthesis of compound 23-2 To compound 23-1 (488.3 mg) was added ethyl acetate (20 ml), methanol (20 ml) and 10% palladium carbon (0.04 g), and reduction was carried out under a hydrogen atmosphere of 50 psi for 5 hours. went. Further, 10% palladium carbon (0.04 g) was added, and reduction was performed for 3 hours under a hydrogen atmosphere of 50 psi.

【0228】触媒を濾去し、溶媒を減圧下留去し、残渣
を「LH−20」(22mm×400mm )にて分離して目的物を
得た。301mg 。
The catalyst was filtered off, the solvent was evaporated under reduced pressure, and the residue was separated with "LH-20" (22 mm x 400 mm) to obtain the desired product. 301 mg.

【0229】1H−NMR(CDCl3 ,δ):0.880
(t,6H,J=6.9 Hz),1.77−1.33(m,56
H),1.35−1.44(m,2H),1.52−1.62(m,2
H),1.99−2.05(m,1H),2.15−2.23(m,1
H),2.27−2.34(m,1H),2.40−2.57(m,2
H),3.464 (brq,2H,J=4.9 −5.6 Hz),
3.581 (br t,2H,J=5.4 Hz),3.39−3.72
(m,8H),4.051 (s,2H),4.61−4.66(m,
1H),6.179 (t,1H,J=5.7 Hz),7.645
(d,1H,J=7.6 Hz). 実施例24 本実施例における反応を図16に示す。
1 H-NMR (CDCl 3 , δ): 0.880
(T, 6H, J = 6.9 Hz), 1.77-1.33 (m, 56
H), 1.35-1.44 (m, 2H), 1.52-1.62 (m, 2)
H), 1.99-2.05 (m, 1H), 2.15-2.23 (m, 1)
H), 2.27-2.34 (m, 1H), 2.40-2.57 (m, 2)
H), 3.464 (brq, 2H, J = 4.9-5.6 Hz),
3.581 (brt, 2H, J = 5.4 Hz), 3.39-3.72
(M, 8H), 4.051 (s, 2H), 4.61-4.66 (m,
1H), 6.179 (t, 1H, J = 5.7 Hz), 7.645
(D, 1H, J = 7.6 Hz). Example 24 The reaction in this example is shown in FIG.

【0230】(a) 化合物24−1の合成 ヘプタエチレングリコールモノセチルエーテル( 1.0
g)のピリジン(20ml)溶液にジフェニル燐酸クロリド
( 731mg)を加え、室温で一晩撹拌した。
(A) Synthesis of Compound 24-1 Heptaethylene glycol monocetyl ether (1.0
Diphenylphosphoric acid chloride (731 mg) was added to a solution of g) in pyridine (20 ml), and the mixture was stirred at room temperature overnight.

【0231】溶液を氷水に加え、クロロフォルムで抽出
した。有機層を水洗し、無水硫酸ナトリウムで乾燥し
た。得られた溶液を濾過し、溶媒を減圧下留去した。残
渣をトリカゲルカラムクロマトグラフィー(シリカゲル
150ml 、 0.5−3.0 %メタノール−クロロフォルム)で
分離して目的物を得た。1.3674g。
The solution was added to ice water and extracted with chloroform. The organic layer was washed with water and dried over anhydrous sodium sulfate. The resulting solution was filtered and the solvent was evaporated under reduced pressure. The residue was applied to tricagel column chromatography (silica gel).
The desired product was obtained by separation with 150 ml, 0.5-3.0% methanol-chloroform). 1.3674 g.

【0232】1H−NMR(CDCl3 ,δ):0.880
(t,3H,J=6.9 Hz),1.21−1.33(m,26
H),1.54−1.59(m,2H),3.439 (t,2H,J
=6.8 Hz),3.56−3.66(m,24H),3.728 (dd
d,2H,J=1.2 ,3.4 ,4.6Hz),4.379 (dd
dd,2H,J=3.4 ,6.9 ,6.1 ,8.3 Hz). (b) 化合物24−2の合成 化合物24−2(1.401 g)にメタノール(20ml)および
酸化白金(0.08g)を加え、常圧の水素雰囲気下一晩還
元を行った。
1 H-NMR (CDCl 3 , δ): 0.880
(T, 3H, J = 6.9 Hz), 1.21-1.33 (m, 26
H), 1.54-1.59 (m, 2H), 3.439 (t, 2H, J
= 6.8 Hz), 3.56-3.66 (m, 24H), 3.728 (dd
d, 2H, J = 1.2, 3.4, 4.6Hz), 4.379 (dd
dd, 2H, J = 3.4, 6.9, 6.1, 8.3 Hz). (b) Synthesis of Compound 24-2 Methanol (20 ml) and platinum oxide (0.08 g) were added to Compound 24-2 (1.401 g), and reduction was performed overnight under a hydrogen atmosphere at normal pressure.

【0233】触媒を濾去し、溶媒を減圧下濾去し、残渣
を「LH−20」(22mm×400mm 、メタノール)にて分離
した。溶媒を減圧下留去し、残渣にメタノール(5m
l)、水(0.5ml )および酸性イオン交換樹脂「ダウエ
ックス50W×8」を加えて撹拌した。樹脂を濾去し、濾
液を濃縮して目的物を得た。1.0332g。
The catalyst was filtered off, the solvent was filtered off under reduced pressure, and the residue was separated with "LH-20" (22 mm x 400 mm, methanol). The solvent was distilled off under reduced pressure, and the residue was treated with methanol (5 m
l), water (0.5 ml) and acidic ion exchange resin "Dowex 50W x 8" were added and stirred. The resin was filtered off, and the filtrate was concentrated to obtain the desired product. 1.0332g.

【0234】1H−NMR(CDCl3 ,δ):0.880
(t,3H,J=6.9 Hz),1.18−1.34(m,26
H),1.54−1.61(m,2H),3.452 (t,2H,J
=6.9 Hz),3.58−3.68(m,24H),3.70−3.72
(m,2H,CH2 ),4.177 −4.214 (m,2H). 実施例25 本実施例における反応を図17に示す。
1 H-NMR (CDCl 3 , δ): 0.880
(T, 3H, J = 6.9 Hz), 1.18-1.34 (m, 26
H), 1.54-1.61 (m, 2H), 3.452 (t, 2H, J
= 6.9 Hz), 3.58-3.68 (m, 24H), 3.70-3.72
(M, 2H, CH 2) , 4.177 -4.214 (m, 2H). Example 25 The reaction in this example is shown in FIG.

【0235】(a) 化合物25−1の合成 β−D−グルコースペンタアセテート2.241 g及びトリ
エチレングリコールモノn−オクタデシルエーテル3.00
5 gを塩化メチレン40mlに溶かし、「モレキュラーシー
ブ4A」1/16をスパーテルで一杯加え、室温で30分間撹
拌した。これを氷冷し、三フッ化硼素ジエチルエーテル
錯体2.8ml を塩化メチレン5mlに溶かして5分間で滴下
した。室温で12時間撹拌した後、氷水にあけ、有機層を
分離した。
(A) Synthesis of compound 25-1 2.241 g of β-D-glucose pentaacetate and 3.00 of triethylene glycol mono-n-octadecyl ether
5 g was dissolved in 40 ml of methylene chloride, 1/16 of "Molecular Sieve 4A" was added with a spatula, and the mixture was stirred at room temperature for 30 minutes. This was ice-cooled, 2.8 ml of boron trifluoride diethyl ether complex was dissolved in 5 ml of methylene chloride, and the mixture was added dropwise over 5 minutes. After stirring at room temperature for 12 hours, the mixture was poured into ice water and the organic layer was separated.

【0236】3回水洗した後(水層は中性となった)、
飽和食塩水で洗い、硫酸マグネシウム上乾燥させ、溶媒
を減圧下留去した。残渣をピリジンに溶かし、無水酢酸
2.71mlを加え、室温で21.5時間撹拌した。溶媒を減圧下
留去し、残渣をシリカゲルカラムクロマトグラフィーで
精製し(溶出溶媒:トルエン−酢酸エチル 3:2)、
目的物を無色油状物として1.683 g得た。
After washing with water three times (the water layer became neutral),
The extract was washed with saturated brine, dried over magnesium sulfate, and the solvent was evaporated under reduced pressure. Dissolve the residue in pyridine and add acetic anhydride.
2.71 ml was added, and the mixture was stirred at room temperature for 21.5 hours. The solvent was evaporated under reduced pressure, the residue was purified by silica gel column chromatography (eluting solvent: toluene-ethyl acetate 3: 2),
The desired product was obtained as a colorless oily substance (1.683 g).

【0237】1H−NMR(δ,CDCl3 ):0.88
(t,3H,J=7.0 Hz),1.18−1.33(m,30
H),1.54−1.60(m,2H),2.00(s,3H),2.
02(s,3H),2.05(s,3H),2.09(s,3
H),3.44(t,2H,J=6.8 Hz),3.57−3.77
(m,12H),3.94(dt,1H,J=4.2 Hz,10.6
Hz),4.14(dd,1H,J=2.8 Hz,12.0H
z),4.26(dd,1H,J=4.8 Hz,12.0Hz),
4.61(d,1H,J=8.0 Hz),4.99(dd,1H,
J=8.0Hz,9.8 Hz),5.08(t,1H,J=9.8
Hz),5.20(t,1H,J=9.8 Hz). [α]D 26=−10.7°(c=1.12,CHCl3 ). Rf :0.32(toluene −AcOEt 3:2). (b) 化合物25−2の合成 化合物25−1、1.683 gにメタノール50mlを加えて溶か
し、氷冷下撹拌した。ここに28%ナトリウムメトキシド
メタノール溶液を7滴加えてpH=10とし、室温で12時
間撹拌した。ここに「ダウエックス50WX−8」イオン
交換樹脂(H型)を加えて中和し、樹脂を濾去した。溶
媒を減圧下留去し、目的物を無色非晶質として1.295 g
得た。
1 H-NMR (δ, CDCl 3 ): 0.88
(T, 3H, J = 7.0 Hz), 1.18-1.33 (m, 30
H), 1.54-1.60 (m, 2H), 2.00 (s, 3H), 2.
02 (s, 3H), 2.05 (s, 3H), 2.09 (s, 3)
H), 3.44 (t, 2H, J = 6.8 Hz), 3.57-3.77
(M, 12H), 3.94 (dt, 1H, J = 4.2 Hz, 10.6
Hz), 4.14 (dd, 1H, J = 2.8 Hz, 12.0H
z), 4.26 (dd, 1H, J = 4.8 Hz, 12.0 Hz),
4.61 (d, 1H, J = 8.0 Hz), 4.99 (dd, 1H,
J = 8.0Hz, 9.8Hz), 5.08 (t, 1H, J = 9.8
Hz), 5.20 (t, 1H, J = 9.8 Hz). [Α] D 26 = −10.7 ° (c = 1.12, CHCl 3 ). Rf : 0.32 (toluene-AcOEt 3: 2). (b) Synthesis of Compound 25-2 50 ml of methanol was added to 1.683 g of Compound 25-1 to dissolve it, and the mixture was stirred under ice cooling. Seven drops of 28% sodium methoxide methanol solution was added thereto to adjust the pH to 10, and the mixture was stirred at room temperature for 12 hours. "Dowex 50WX-8" ion exchange resin (H type) was added thereto for neutralization, and the resin was filtered off. The solvent was evaporated under reduced pressure to give the desired product as a colorless amorphous substance, 1.295 g.
Obtained.

【0238】1H−NMR(δ,pyridine−d5 −D2
O):0.88(t,3H,J=6.8 Hz),1.22−1.38
(m,30H),1.58−1.64(m,2H),3.45(t,2
H,J=6.5 Hz),3.59−3.76(m,10H),3.90−
3.95(m,2H),4.02(t,1H,J=8.3 Hz),
4.18−4.28(m,3H),4.34(dd,1H,J=5.5
Hz,12.0Hz),4.53(dd,1H,J=2.5 Hz,
12.0Hz),4.85(d,1H,J=8.0 Hz). [α]D 26=−10.5°(c=1.04,MeOH). Rf :0.52(CHCl3 −MeOH−H2 O 65:15:
1). (c) 化合物25−3の合成 化合物25−1、1.295 gにピリジン20mlを加えて溶か
し、氷冷下撹拌した。ここにジフェニルフォスフォロク
ロリデート714 μlを加え、室温で22時間撹拌した。こ
れを氷冷してベンゾイルクロリド1.04mlを加えて1.5 時
間撹拌した。酢酸エチルを加えて不溶の沈澱を濾去し、
溶媒を減圧下留去した。クロロホルム、蒸留水を加えて
室温で30時間撹拌した。
1 H-NMR (δ, pyridine-d 5 -D 2
O): 0.88 (t, 3H, J = 6.8 Hz), 1.22-1.38
(M, 30H), 1.58-1.64 (m, 2H), 3.45 (t, 2)
H, J = 6.5 Hz), 3.59-3.76 (m, 10H), 3.90-
3.95 (m, 2H), 4.02 (t, 1H, J = 8.3 Hz),
4.18-4.28 (m, 3H), 4.34 (dd, 1H, J = 5.5
Hz, 12.0Hz), 4.53 (dd, 1H, J = 2.5Hz,
12.0 Hz), 4.85 (d, 1H, J = 8.0 Hz). [Α] D 26 = −10.5 ° (c = 1.04, MeOH). R f: 0.52 (CHCl 3 -MeOH -H 2 O 65:15:
1). (c) Synthesis of Compound 25-3 20 ml of pyridine was added to 1.295 g of Compound 25-1 to dissolve it, and the mixture was stirred under ice cooling. 714 μl of diphenylphosphorochloridate was added thereto, and the mixture was stirred at room temperature for 22 hours. This was ice-cooled, benzoyl chloride (1.04 ml) was added, and the mixture was stirred for 1.5 hours. Ethyl acetate was added and the insoluble precipitate was filtered off,
The solvent was distilled off under reduced pressure. Chloroform and distilled water were added, and the mixture was stirred at room temperature for 30 hours.

【0239】有機層を分離し、水層をクロロホルムで抽
出した。合わせた有機層を飽和食塩水で洗い、硫酸マグ
ネシウム上乾燥させた。溶媒を減圧下留去し、残渣をシ
リカゲルカラムクロマトグラフィーで精製し(溶出溶
媒:n−ヘキサン−酢酸エチル2:1)、目的物を無色
粘稠の油状物として1.233 g得た。
The organic layer was separated, and the aqueous layer was extracted with chloroform. The combined organic layers were washed with saturated brine and dried over magnesium sulfate. The solvent was evaporated under reduced pressure, and the residue was purified by silica gel column chromatography (eluting solvent: n-hexane-ethyl acetate 2: 1) to obtain 1.233 g of the desired product as a colorless viscous oily substance.

【0240】1H−NMR(δ,CDCl3 ):0.88
(t,3H,J=7.1 Hz),1.18−1.32(m,30
H),1.52−1.63(m,2H),3.38−3.61(m,12
H),3.72(ddd,1H,J=3.6 Hz,11.1H
z),3.91(ddd,1H,J=3.6 Hz,4.6 Hz,
11.1Hz),4.05−4.08(m,1H),4.40(ddd,
1H,J=6.0 Hz,11.3Hz,8.5 Hz),4.46(d
dd,J=2.5 Hz,11.3Hz,7.0 Hz),4.89
(d,1H,J=7.9 Hz),4.44(dd,1H,J=
7.9 Hz,9.8 Hz),4.45(t,1H,J=9.8 H
z),5.84(t,1H,J=9.8 Hz),7.13−7.54
(m,19H),7.81(dd,J=1.5 Hz,8.5 H
z),7.90(dd,J=1.5 Hz,8.5 Hz),7.95
(dd,J=1.2 Hz,8.3 Hz). [α]D 25=+3.3 °(c=1.04,CHCl3 −MeO
H 1:1) Rf :0.47(n−hexane−AcOEt 1:1). (d) 化合物25−4の合成 化合物25−3、0.498 gに酢酸エチル4ml及びメタノー
ル4mlを加えて溶かし、酸化白金0.05gを加え一晩常圧
下接触還元した。さらに酸化白金0.05gを加え、一晩還
元した。28%ナトリウムメトキシドメタノール溶液で中
和し、触媒を濾去した。溶媒を減圧下留去し、残渣をメ
タノール10mlに溶かし、28%ナトリウムメトキシドメタ
ノール溶液を20滴加え、室温で2日間撹拌した。さらに
28%ナトリウムメトキシドメタノール溶液を10滴追加し
て室温で一晩撹拌した。
1 H-NMR (δ, CDCl 3 ): 0.88
(T, 3H, J = 7.1 Hz), 1.18-1.32 (m, 30
H), 1.52-1.63 (m, 2H), 3.38-3.61 (m, 12
H), 3.72 (ddd, 1H, J = 3.6 Hz, 11.1H
z), 3.91 (ddd, 1H, J = 3.6 Hz, 4.6 Hz,
11.1Hz), 4.05-4.08 (m, 1H), 4.40 (ddd,
1H, J = 6.0 Hz, 11.3 Hz, 8.5 Hz), 4.46 (d
dd, J = 2.5 Hz, 11.3 Hz, 7.0 Hz), 4.89
(D, 1H, J = 7.9 Hz), 4.44 (dd, 1H, J =
7.9 Hz, 9.8 Hz), 4.45 (t, 1H, J = 9.8 H)
z), 5.84 (t, 1H, J = 9.8 Hz), 7.13-7.54
(M, 19H), 7.81 (dd, J = 1.5 Hz, 8.5 H
z), 7.90 (dd, J = 1.5 Hz, 8.5 Hz), 7.95
(Dd, J = 1.2 Hz, 8.3 Hz). [Α] D 25 = + 3.3 ° (c = 1.04, CHCl 3 -MeO
H 1: 1) Rf : 0.47 (n-hexane-AcOEt 1: 1). (d) Synthesis of compound 25-4 To 0.498 g of compound 25-3, 4 ml of ethyl acetate and 4 ml of methanol were added and dissolved, and 0.05 g of platinum oxide was added and subjected to catalytic reduction overnight under normal pressure. Further, 0.05 g of platinum oxide was added and the mixture was reduced overnight. The mixture was neutralized with a 28% sodium methoxide methanol solution, and the catalyst was filtered off. The solvent was evaporated under reduced pressure, the residue was dissolved in 10 ml of methanol, 20 drops of 28% sodium methoxide methanol solution was added, and the mixture was stirred at room temperature for 2 days. further
10 drops of 28% sodium methoxide methanol solution was added, and the mixture was stirred at room temperature overnight.

【0241】1N塩酸で中和し、溶媒を減圧下留去し
た。残渣を三菱化成(株)製「CHP−20」カラム(22
mmφ×400mm )で精製した(溶出溶媒:10%アセトニト
リルから90%アセトニトリルへグラディエント)。アセ
トニトリルを減圧下留去し、残った目的物を含む水溶液
を凍結乾燥して目的化合物を無色非晶質として0.099 g
得た。
It was neutralized with 1N hydrochloric acid, and the solvent was distilled off under reduced pressure. The residue is a "CHP-20" column (22
mmφ × 400 mm) (elution solvent: gradient from 10% acetonitrile to 90% acetonitrile). Acetonitrile was distilled off under reduced pressure, and the remaining aqueous solution containing the target compound was freeze-dried to give the target compound as colorless amorphous 0.099 g.
Obtained.

【0242】1H−NMR(δ,DMSO−d6 −D2
O):0.86(t,3H,J=6.8 Hz),1.16−1.29
(m,30H),1.47(quintet ,2H,J=6.2 H
z),2.97(br t,1H),3.10(t,1H,J=
9.0 Hz),3.16(t,1H,J=9.0 Hz),3.23−
3.26(m,1H),3.36(t,2H,J=6.6 Hz),
3.49−3.61(m,11H),3.83(dt,1H,J=4.0
Hz,11.6Hz),3.86−3.91(m,1H),4.01−4.
04(m,1H),4.18(d,1H,J=7.8 Hz).13 C−NMR(δ,DMSO−d6 ):13.97 ,22.11
,25.67 ,28.71 ,28.90 ,29.02 ,29.23 ,31.31
,64.76 (J=4.8 Hz),67.95 ,69.44 ,69.49
,69.70 ,69.81 ,70.37 ,73.26 ,75.07 (J=7.5
Hz),76.11 ,103.01. [α]D 25=−12.8°(c=1.03,CHCl3 −MeO
H−H2 O 10:10:3). Rf :0.58(CHCl3 −MeOH−H2 O 10:10:
3). FAB−MS[M+H]+ M/Z=645 . 実施例26 本実施例における反応を図18に示す。
1 H-NMR (δ, DMSO-d 6 -D 2
O): 0.86 (t, 3H, J = 6.8 Hz), 1.16-1.29
(M, 30H), 1.47 (quintet, 2H, J = 6.2H
z), 2.97 (br t, 1H), 3.10 (t, 1H, J =
9.0 Hz), 3.16 (t, 1H, J = 9.0 Hz), 3.23−
3.26 (m, 1H), 3.36 (t, 2H, J = 6.6 Hz),
3.49-3.61 (m, 11H), 3.83 (dt, 1H, J = 4.0
Hz, 11.6 Hz), 3.86-3.91 (m, 1H), 4.01-4.
04 (m, 1H), 4.18 (d, 1H, J = 7.8 Hz). 13 C-NMR (δ, DMSO-d 6 ): 13.97, 22.11
, 25.67, 28.71, 28.90, 29.02, 29.23, 31.31
, 64.76 (J = 4.8 Hz), 67.95, 69.44, 69.49
, 69.70, 69.81, 70.37, 73.26, 75.07 (J = 7.5
Hz), 76.11, 103.01. [Α] D 25 = -12.8 ° (c = 1.03, CHCl 3 -MeO
H-H2 O 10: 10: . 3) R f: 0.58 (CHCl 3 -MeOH-H 2 O 10:10:
3). FAB-MS [M + H] + M / Z = 645. Example 26 The reaction in this example is shown in FIG.

【0243】(a) 化合物26−1の合成 ガラクトースパーアセテート(2.733 g)およびヘプタ
エチレングリコールモノセチルエーテル(5.012 g)の
ジクロロメタン( 200ml)溶液にトリフルオロボロンエ
ーテル錯体(4.47g)を加え、室温にて一晩撹拌した。
溶液を氷水に加え、クロロフォルムで抽出した。有機層
を飽和重曹水で2回洗浄し、3回水洗し、無水硫酸ナト
リウムで乾燥した。溶液を濾過し、溶媒を減圧下留去
し、残渣をシリカゲルカラムクロマトグラフィー(シリ
カゲル1000ml、クロロフォルム:メタノール= 100:1
− 100:2)にて分離して目的のグリコシドと原料のア
ルコールのアセテート(アセチルヘプタエチレングリコ
ールモノセチルエーテル)との混合物を3.13g得た。因
みに、NMRスペクトルにて目的物と副生成物とのモル
比は4:1であった。この混合物をメタノール(50ml)
に溶解し、5M/1ナトリウムメトキシドメタノール溶
液(10滴)を加え、室温で一晩撹拌した。溶液にH型酸
性イオン交換樹脂(「Dowex 50W×8」のH型)
を加えて撹拌し、樹脂を濾去し、濾液を濃縮した。残渣
をピリジン(40ml)に溶解し、トリチルクロリド(2.48
7 g)を加え、60℃で10時間撹拌した。溶液を室温まで
冷却し、ベンゾイルクロリド( 2.0g)を加え、室温で
一晩撹拌した。溶液を氷水に加え、クロロフォルムで抽
出した。有機層を水洗し、無水硫酸ナトリウムで乾燥し
た。溶液を濾過し、溶媒を減圧下留去し、残渣をシリカ
ゲルカラムクロマトグラフィー(シリカゲル 500ml、ヘ
キサン:酢酸エチル=1:1−1:2)にて分離して目
的物を得た。2.9066g。
(A) Synthesis of Compound 26-1 A trifluoroboron ether complex (4.47 g) was added to a solution of galactose peracetate (2.733 g) and heptaethylene glycol monocetyl ether (5.012 g) in dichloromethane (200 ml) at room temperature. It was stirred overnight at.
The solution was added to ice water and extracted with chloroform. The organic layer was washed twice with saturated aqueous sodium hydrogen carbonate, washed three times with water, and dried over anhydrous sodium sulfate. The solution was filtered, the solvent was evaporated under reduced pressure, and the residue was subjected to silica gel column chromatography (silica gel 1000 ml, chloroform: methanol = 100: 1).
The mixture was separated by -100: 2) to obtain 3.13 g of a mixture of the target glycoside and the starting alcohol acetate (acetylheptaethylene glycol monocetyl ether). Incidentally, the molar ratio of the target substance to the by-product was 4: 1 in the NMR spectrum. This mixture is methanol (50 ml)
Was added to the solution, and a 5M / 1 sodium methoxide methanol solution (10 drops) was added, followed by stirring at room temperature overnight. H-type acidic ion exchange resin in solution (H-type of "Dowex 50W x 8")
Was added and stirred, the resin was filtered off, and the filtrate was concentrated. The residue was dissolved in pyridine (40 ml) and trityl chloride (2.48) was added.
7 g) was added and the mixture was stirred at 60 ° C. for 10 hours. The solution was cooled to room temperature, benzoyl chloride (2.0 g) was added, and the mixture was stirred at room temperature overnight. The solution was added to ice water and extracted with chloroform. The organic layer was washed with water and dried over anhydrous sodium sulfate. The solution was filtered, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (silica gel 500 ml, hexane: ethyl acetate = 1: 1-1: 2) to obtain the desired product. 2.9066g.

【0244】[α]D 21=+43.8°(c 1.07、CHC
3 ).1 H−NMR(CDCl3 ,δ):0.878 (t,3H,
J=6.9 Hz),1.17−1.35(m,26H),1.53−1.59
(m,2H),3.270 (t,2H,J=8.5 Hz),3.
34−3.69(m,28H),3.76−3.81(m,1H),3.96
−4.01(m,1H),4.06−4.07(br t,1H),
4,837 (d,1H,J=7.6 Hz),5.595 (dd,1
H,J=3.4 Hz),5.646 (dd,1H,J=10.5H
z),6.043 (dd,1H,J=1.0 Hz),7.10−7.
60(m,24H),7.78−7.95(m,6H). (b) 化合物26−2の合成 化合物26−1(2.900 g)クロロフォルム:メタノー
ル:水=65:15:1の混合溶媒(50ml)に溶解し、パラ
トルエンスルホン酸一水和物( 200mg)を加え、50℃で
3時間撹拌した。
[Α] D 21 = + 43.8 ° (c 1.07, CHC
l 3 ). 1 H-NMR (CDCl 3 , δ): 0.878 (t, 3H,
J = 6.9 Hz), 1.17-1.35 (m, 26H), 1.53-1.59
(M, 2H), 3.270 (t, 2H, J = 8.5 Hz), 3.
34-3.69 (m, 28H), 3.76-3.81 (m, 1H), 3.96
-4.01 (m, 1H), 4.06-4.07 (brt, 1H),
4,837 (d, 1H, J = 7.6 Hz), 5.595 (dd, 1
H, J = 3.4 Hz), 5.646 (dd, 1H, J = 10.5H
z), 6.043 (dd, 1H, J = 1.0 Hz), 7.10-7.
60 (m, 24H), 7.78-7.95 (m, 6H). (b) Synthesis of Compound 26-2 Compound 26-1 (2.900 g) was dissolved in a mixed solvent (50 ml) of chloroform: methanol: water = 65: 15: 1, and paratoluenesulfonic acid monohydrate (200 mg) was added. In addition, the mixture was stirred at 50 ° C for 3 hours.

【0245】溶液をトリエチルアミンで中和し、溶媒を
減圧下留去して残渣をトリカゲルカラムクロマトグラフ
ィーにて分離して目的物を得た。1.8236g。
The solution was neutralized with triethylamine, the solvent was distilled off under reduced pressure, and the residue was separated by tricagel column chromatography to obtain the desired product. 1.8236g.

【0246】[α]D 20=+100.9 °(c 1.03、CH
Cl3 ).1 H−NMR(CDCl3 ,δ):0.879 (t,3H,
J=7.0 Hz),1.21−1.31(m,26H),1.54−1.59
(m,2H),2.90(brs,1H),3.42−3.69
(m,29H),3.81−3.90(m,2H),3.98−4.07
(m,2H),4.940(d,1H,J=8.1 Hz),5.5
79 (dd,1H,J=3.4 Hz,10.5Hz),5.805
−5.841 (m,2H),7.23−7.64(m,9H),7.80
−8.12(m,6H). (c) 化合物26−3の合成 化合物26−2(1.8200g)のピリジン(20ml)溶液にジ
フェニル燐酸クロイド( 715mg,1.5eq )を滴下し、室
温で一晩撹拌した。
[Α] D 20 = + 100.9 ° (c 1.03, CH
Cl 3 ). 1 H-NMR (CDCl 3 , δ): 0.879 (t, 3H,
J = 7.0 Hz), 1.21-1.31 (m, 26H), 1.54-1.59
(M, 2H), 2.90 (brs, 1H), 3.42-3.69
(M, 29H), 3.81-3.90 (m, 2H), 3.98-4.07
(M, 2H), 4.940 (d, 1H, J = 8.1 Hz), 5.5
79 (dd, 1H, J = 3.4 Hz, 10.5 Hz), 5.805
-5.841 (m, 2H), 7.23-7.64 (m, 9H), 7.80
-8.12 (m, 6H). (c) Synthesis of Compound 26-3 To a solution of Compound 26-2 (1.8200 g) in pyridine (20 ml) was added dropwise diphenylphosphoric acid cloid (715 mg, 1.5 eq), and the mixture was stirred at room temperature overnight.

【0247】溶液を氷水に加え、クロロフォルムで抽出
した。有機層を水洗し、無水硫酸ナトリウムで乾燥し
た。溶液を濾過し、溶媒を減圧下留去し、残渣をシリカ
ゲルカラムクロマトグラフィー(シリカゲル200ml 、ク
ロロフォルム:メタノール= 100:1)にて分離して目
的物を得た。2.0818g。
The solution was added to ice water and extracted with chloroform. The organic layer was washed with water and dried over anhydrous sodium sulfate. The solution was filtered, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (silica gel 200 ml, chloroform: methanol = 100: 1) to obtain the desired product. 2.0818 g.

【0248】[α]D 25=+60.7°(c 1.16、CHC
3 ).1 H−NMR(CDCl3 ,δ):0.878 (t,3H,
J=6.9 Hz),1.21−1.31(m,26H),1.53−1.59
(m,2H),3.35−3.67(m,28H),3.73−3.77
(m,1H),3.95−3.99(m,1H),4.192 (br
t,1H),4.357 (ddd,1H,J=5.7 Hz,
10.8Hz,8.2 Hz),4.463 (ddd,1H,J=7.
1 Hz,8.8 Hz),4.875 (d,1H,J=8.1 H
z),5.513(dd,1H,J=3.4 Hz),5.739
(dd,J=10.5Hz),5.878 (brd,1H),7.
13−7.62(m,19H),7.77−8.05(m,6H). (d) 化合物26−4の合成 化合物26−3( 501mg)をメタノール(8ml)に溶解
し、酸化白金(50mg)を加えて常温常圧下2日間水素還
元を行った。触媒を濾去し、濾液を1Nナトリウムメチ
ラートメタノール溶液で中和した。溶液を減圧下濃縮
し、残渣をメタノー(10ml)に溶解し、ナトリウムメチ
ラート(5モル/1メタノール溶液,20滴)を加え室温
で2日間撹拌した。
[Α] D 25 = + 60.7 ° (c 1.16, CHC
l 3 ). 1 H-NMR (CDCl 3 , δ): 0.878 (t, 3H,
J = 6.9 Hz), 1.21-1.31 (m, 26H), 1.53-1.59
(M, 2H), 3.35-3.67 (m, 28H), 3.73-3.77
(M, 1H), 3.95-3.99 (m, 1H), 4.192 (br
t, 1H), 4.357 (ddd, 1H, J = 5.7 Hz,
10.8Hz, 8.2Hz), 4.463 (ddd, 1H, J = 7.
1 Hz, 8.8 Hz), 4.875 (d, 1H, J = 8.1 H
z), 5.513 (dd, 1H, J = 3.4 Hz), 5.739
(Dd, J = 10.5 Hz), 5.878 (brd, 1H), 7.
13-7.62 (m, 19H), 7.77-8.05 (m, 6H). (d) Synthesis of Compound 26-4 Compound 26-3 (501 mg) was dissolved in methanol (8 ml), platinum oxide (50 mg) was added, and hydrogen reduction was carried out at room temperature and atmospheric pressure for 2 days. The catalyst was filtered off and the filtrate was neutralized with 1N sodium methylate methanol solution. The solution was concentrated under reduced pressure, the residue was dissolved in methanol (10 ml), sodium methylate (5 mol / 1 methanol solution, 20 drops) was added, and the mixture was stirred at room temperature for 2 days.

【0249】溶液を1N塩酸で中和し、減圧下濃縮し
た。残渣を水(50ml)に溶解し、「CHP−20」カラム
(22mmφ×400mm )にて精製した。水(500ml )、次い
で20−90%アセトニトリル−水 直線グラジエントで溶
出した(総量1000ml,102 フラクション)。フラクショ
ン42−60を濃縮した。残渣に水(40ml)、H型酸性イオ
ン交換樹脂(「Dowex 50W×8」のH型)を加え
て撹拌した。樹脂を濾去し、濾液を凍結乾燥し目的物を
得た。
The solution was neutralized with 1N hydrochloric acid and concentrated under reduced pressure. The residue was dissolved in water (50 ml) and purified with a “CHP-20” column (22 mmφ × 400 mm). Elution was carried out with a linear gradient of water (500 ml) and then 20-90% acetonitrile-water (total volume 1000 ml, 102 fractions). Fractions 42-60 were concentrated. Water (40 ml) and H-type acidic ion exchange resin (H-type of “Dowex 50W × 8”) were added to the residue and stirred. The resin was filtered off, and the filtrate was freeze-dried to obtain the desired product.

【0250】[α]D 21=−3.8 °(c 1.09、ピリジ
ン).13 C−NMR(DMSO−d6 ):13.85 ,22.01 ,2
5.57 ,28.62 −29.14,31.22 ,63.26 (J=4.3 H
z),67.60 ,67.73 ,69.43 ,69.67 −69.85,70.28
,70.38 ,73.03 ,73.26 (J=6.8 Hz),103.4
6.1 H−NMR(DMSO−d6 ):0.858 (t,3H,
J=3.7 Hz),1.18−1.30(m,26H),1.44−1.50
(m,2H),3.26−3.29(m,2H),3.361 (t,
2H,J=6.6 Hz),3.43−3.61(m,28H),3.67
8 (brs,1H),3.73−3.81(m,1H),3.80−
3.85(m,1H),3.86−3.93(m,1H),4.120
(d,1H,J=7.1 Hz). 実施例27 本実施例における反応を図19に示す。
[Α] D 21 = −3.8 ° (c 1.09, pyridine). 13 C-NMR (DMSO-d 6 ): 13.85, 22.01, 2
5.57, 28.62 −29.14, 31.22, 63.26 (J = 4.3 H
z), 67.60, 67.73, 69.43, 69.67 −69.85, 70.28
, 70.38, 73.03, 73.26 (J = 6.8 Hz), 103.4
6. 1 H-NMR (DMSO-d 6 ): 0.858 (t, 3H,
J = 3.7 Hz), 1.18-1.30 (m, 26H), 1.44-1.50
(M, 2H), 3.26-3.29 (m, 2H), 3.361 (t,
2H, J = 6.6 Hz), 3.43-3.61 (m, 28H), 3.67
8 (brs, 1H), 3.73-3.81 (m, 1H), 3.80-
3.85 (m, 1H), 3.86-3.93 (m, 1H), 4.120
(D, 1H, J = 7.1 Hz). Example 27 The reaction in this example is shown in FIG.

【0251】(a) 化合物27−1の合成 β−D−グルコースペンタアセテート6.509 g及び2−
[2−(2−アジドエトキシ)エトキシ]エタノール3.
808 gを塩化メチレン50mlに溶かし、氷冷下撹拌した。
ここに三フッ化硼素ジエチルエーテル錯体9.23mlを塩化
メチレン10mlに溶かして5分間で滴下した。室温で14時
間撹拌した後、氷水にあけ、有機層を分離した。
(A) Synthesis of compound 27-1 β-D-glucose pentaacetate 6.509 g and 2-
[2- (2-azidoethoxy) ethoxy] ethanol 3.
808 g was dissolved in 50 ml of methylene chloride and stirred under ice cooling.
9.23 ml of boron trifluoride diethyl ether complex was dissolved in 10 ml of methylene chloride and added dropwise over 5 minutes. After stirring at room temperature for 14 hours, the mixture was poured into ice water and the organic layer was separated.

【0252】飽和食塩水で5回洗い、硫酸マグネシウム
上乾燥させ、溶媒を減圧下留去した。残渣をシリカゲル
カラムクロマトグラフィーで精製し(溶出溶媒:n−ヘ
キサン−酢酸エチル 1:1)、目的物を無色油状物と
して4.462 g得た。
The extract was washed 5 times with saturated saline and dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (eluting solvent: n-hexane-ethyl acetate 1: 1) to obtain 4.462 g of the desired product as a colorless oil.

【0253】1H−NMR(δ,CDCl3 ):2.01
(s,3H),2.03(s,3H),2.05(s,3H),
2.09(s,3H),3.41(t,2H,J=5.0 Hz),
3.63−3.78(m,10H),3.93−3.97(ddd,1H,
J=3.9 Hz,4.9 Hz,11.2Hz),4.14(dd,1
H,J=2.0 Hz,12.5Hz),4.26(dd,1H,J
=5.0 Hz,12.5Hz),4.62(d,1H,J=7.9 H
z),5.00(dd,1H,J=7.9 Hz,9.8 Hz),
5.09(t,J=9.8 Hz),5.21(t,1H,J=9.8
Hz). [α]D 20=−12.1°(c=1.01,CHCl3 ). Rf :0.20(n−hexane−AcOEt 1:1). (b) 化合物27−2の合成 化合物27−1、4.862 gにメタノール50mlを加えて溶か
した。ここに28%ナトリウムメトキシドメタノール溶液
を8滴加えてpH=10とし、室温で12時間撹拌した。
1 H-NMR (δ, CDCl 3 ): 2.01
(S, 3H), 2.03 (s, 3H), 2.05 (s, 3H),
2.09 (s, 3H), 3.41 (t, 2H, J = 5.0 Hz),
3.63-3.78 (m, 10H), 3.93-3.97 (ddd, 1H,
J = 3.9 Hz, 4.9 Hz, 11.2 Hz), 4.14 (dd, 1
H, J = 2.0 Hz, 12.5 Hz), 4.26 (dd, 1H, J
= 5.0 Hz, 12.5 Hz), 4.62 (d, 1H, J = 7.9 H
z), 5.00 (dd, 1H, J = 7.9 Hz, 9.8 Hz),
5.09 (t, J = 9.8 Hz), 5.21 (t, 1H, J = 9.8)
Hz). [Α] D 20 = -12.1 ° (c = 1.01, CHCl 3 ). Rf : 0.20 (n-hexane-AcOEt 1: 1). (b) Synthesis of compound 27-2 50 ml of methanol was added to and dissolved in 4.862 g of compound 27-1. Eight drops of 28% sodium methoxide methanol solution was added to adjust the pH to 10, and the mixture was stirred at room temperature for 12 hours.

【0254】ここに「ダウエックス50WX−8」イオン
交換樹脂(H型)を加えて中和し、樹脂を濾去した。溶
媒を減圧下留去し、目的物を淡褐色粘稠の油状物として
2.916 g得た。これ以上の精製はせずに以下の反応に用
いた。
[0254] "Dowex 50WX-8" ion exchange resin (H type) was added thereto for neutralization, and the resin was filtered off. The solvent was evaporated under reduced pressure to give the desired product as a pale brown viscous oil.
2.916 g was obtained. It was used in the following reaction without further purification.

【0255】Rf :0.61(CHCl3 −MeOH−H2
O 65:25:4). (e) 化合物27−3の合成 化合物27−2、2.916 gにピリジン40mlを加えて溶か
し、氷冷下撹拌した。ここにジフェニルフォスフォロク
ロリデート2.33mlを加え、室温で9.5 時間撹拌した。再
び氷冷し、ベンゾイルクロリド3.91mlを加え室温で24時
間撹拌した。
R f : 0.61 (CHCl 3 -MeOH-H 2
O 65: 25: 4). (e) Synthesis of compound 27-3 40 ml of pyridine was added to 2.916 g of compound 27-2 to dissolve, and the mixture was stirred under ice cooling. 2.33 ml of diphenylphosphorochloridate was added thereto, and the mixture was stirred at room temperature for 9.5 hours. It was ice-cooled again, 3.91 ml of benzoyl chloride was added, and the mixture was stirred at room temperature for 24 hours.

【0256】酢酸エチルを加えて不溶の沈澱を濾去し、
溶媒を減圧下留去した。残渣をシリカゲルカラムクロマ
トグラフィーで精製し(溶出溶媒:n−ヘキサン−酢酸
エチル 3:2)、目的物を無色油状物として4.315 g
得た。
Ethyl acetate was added to remove insoluble precipitate by filtration,
The solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (eluting solvent: n-hexane-ethyl acetate 3: 2), and the desired product was a colorless oily substance, 4.315 g.
Obtained.

【0257】1H−NMR(δ,CDCl3 ):3.31
(t,2H,J=5.1 Hz),3.38−3.40(m,2
H),3.46−3.48(m,2H),3.53(t,2H,J=
5.1 Hz)3.54−3.62(m,1H),3.73(ddd,1
H,J=3.7 Hz,7.4 Hz,11.3Hz),3.92(dd
d,1GmH=3.5 Hz,4.8 Hz,11.3Hz),4.05
−4.09(m,1H),4.41(ddd,1H,J=6.3 H
z,11.4Hz,8.6 Hz),4.46(ddd,1H,J=
2.6 Hz,11.4Hz,7.2 Hz),4.90(d,1H,J
=8.1 Hz),5.45(dd,1H,J=8.1 Hz,9.8
Hz),5.45(t,J=9.8 Hz),5.85(t,1H,
J=9.8 Hz),7.14−7.54(m,19H),7.81(d
d,2H,J=1.0 Hz,8.3 Hz),7.89(dd,2
H,J=1.1 Hz,8.2 Hz),7.95(dd,2H,J
=1.2 Hz,8.3 Hz). [α]D 22=+2.0 °(c=1.01,CHCl3 ). Rf :0.44(n−hexane−AeOEt 1:1). (d) 化合物27−4の合成 化合物27−3、0.997 gに酢酸エチル50mlを加えて溶か
し、ここにp−トルエンスルホン酸1水和物0.215 g及
びリンドラー触媒0.498 gを加え、50psi で3.5 時間接
触還元した。さらにリンドラー触媒0.498 gを加え、50
psi で4時間接触還元した。
1 H-NMR (δ, CDCl 3 ): 3.31
(T, 2H, J = 5.1 Hz), 3.38-3.40 (m, 2
H), 3.46-3.48 (m, 2H), 3.53 (t, 2H, J =
5.1 Hz) 3.54-3.62 (m, 1H), 3.73 (ddd, 1
H, J = 3.7 Hz, 7.4 Hz, 11.3 Hz), 3.92 (dd
d, 1 GmH = 3.5 Hz, 4.8 Hz, 11.3 Hz), 4.05
-4.09 (m, 1H), 4.41 (ddd, 1H, J = 6.3 H
z, 11.4Hz, 8.6Hz), 4.46 (ddd, 1H, J =
2.6 Hz, 11.4 Hz, 7.2 Hz), 4.90 (d, 1H, J
= 8.1 Hz), 5.45 (dd, 1H, J = 8.1 Hz, 9.8
Hz), 5.45 (t, J = 9.8 Hz), 5.85 (t, 1H,
J = 9.8 Hz), 7.14-7.54 (m, 19H), 7.81 (d
d, 2H, J = 1.0 Hz, 8.3 Hz), 7.89 (dd, 2
H, J = 1.1 Hz, 8.2 Hz), 7.95 (dd, 2H, J
= 1.2 Hz, 8.3 Hz). [Α] D 22 = + 2.0 ° (c = 1.01, CHCl 3 ). Rf : 0.44 (n-hexane-AeOEt 1: 1). (d) Synthesis of Compound 27-4 Compound 27-3 (0.997 g) was dissolved by adding ethyl acetate (50 ml), p-toluenesulfonic acid monohydrate (0.215 g) and Lindlar catalyst (0.498 g) were added thereto, and the mixture was heated at 50 psi for 3.5 hours. Catalytically reduced. Furthermore, 0.498 g of Lindlar catalyst was added,
Catalytic reduction at psi for 4 hours.

【0258】触媒を濾去し、目的物を淡褐色油状物とし
て1.073 g得た。これ以上の精製はせずに、以下の反応
に用いた。
The catalyst was filtered off to obtain 1.073 g of the desired product as a pale brown oily substance. It was used in the following reaction without further purification.

【0259】(e) 化合物27−5の合成 化合物27−4、1.073 gに塩化メチレン10mlを加えて氷
冷下撹拌した。ここにトリエチルアミン146 μlを加
え、氷冷下撹拌した。ここにN−パルミトイルオキシス
クシンイミド0.480 gを加え、室温まで昇温させながら
17時間撹拌した。
(E) Synthesis of compound 27-5 To 1.073 g of compound 27-4, 10 ml of methylene chloride was added and stirred under ice cooling. Triethylamine (146 μl) was added thereto, and the mixture was stirred under ice cooling. 0.480 g of N-palmitoyloxysuccinimide was added to this while heating to room temperature.
It was stirred for 17 hours.

【0260】減圧下溶媒を留去し、残渣をシリカゲルク
ロマトグラフィーで精製し(溶出溶媒:n−ヘキサン−
酢酸エチル 1:4)、目的物を無色非晶質として0.78
6 g得た。
The solvent was distilled off under reduced pressure, and the residue was purified by silica gel chromatography (eluting solvent: n-hexane-
Ethyl acetate 1: 4), 0.78 as the target product as colorless amorphous
6 g were obtained.

【0261】1H−NMR(δ,CDCl3 ):0.88
(t,3H,J=7.0 Hz),1.19−1.31(m,24
H),1.52−1.60(m,2H),2.12(t,2H,J=
7.6 Hz),3.34−3.43(m,6H),3.46−3.48
(m,2H),3.56−3.59(m,2H),3.73(dd
d,1H,J=3.6 Hz,7.2 Hz,11.2Hz),3.92
(ddd,1H,J=3.5 Hz,4.8 Hz,11.2H
z),4.06−4.10(m,1H),4.41(ddd,1H,
J=6.2 Hz,11.4Hz,8.7 Hz),4.47(ddd,
1H,J=2.6 Hz,11.4Hz,7.5 Hz),4.90
(d,1H,J=7.8 Hz),5.44(dd,1H,J=
7.8 Hz,9.7 Hz),5.45(t,J=9.7 Hz),5.
85(t,1H,J=9.7 Hz),6.05(brs,1
H),7.13−7.54(m,19H),7.81(dd,1H,J
=1.2 Hz,8.3 Hz),7.90(dd,2H,J=1.2
Hz,8.3 Hz),7.95(dd,2H,J=1.2 Hz,
8.3 Hz). [α]D 25=+1.0 °(c=1.01,CHCl3 −MeO
H 1:1). Rf :0.18(n−hexane−AcOEt 1:3). (f) 化合物27−6の合成 化合物27−5、0.721 gに酢酸エチル5ml及びメタノー
ル5mlを加えて溶かし、酸化白金0.071 gを加え、常圧
下1週間接触還元した。触媒を濾去し、溶媒を常圧下留
去した。残渣をメタノール10mlに溶かし、28%ナトリウ
ムメトキシドメタノール溶液を20滴加えて室温で3日間
撹拌した。
1 H-NMR (δ, CDCl 3 ): 0.88
(T, 3H, J = 7.0 Hz), 1.19-1.31 (m, 24
H), 1.52-1.60 (m, 2H), 2.12 (t, 2H, J =
7.6 Hz), 3.34-3.43 (m, 6H), 3.46-3.48
(M, 2H), 3.56-3.59 (m, 2H), 3.73 (dd
d, 1H, J = 3.6 Hz, 7.2 Hz, 11.2 Hz), 3.92
(Ddd, 1H, J = 3.5 Hz, 4.8 Hz, 11.2H
z), 4.06-4.10 (m, 1H), 4.41 (ddd, 1H,
J = 6.2 Hz, 11.4 Hz, 8.7 Hz), 4.47 (ddd,
1H, J = 2.6 Hz, 11.4 Hz, 7.5 Hz), 4.90
(D, 1H, J = 7.8 Hz), 5.44 (dd, 1H, J =
7.8 Hz, 9.7 Hz), 5.45 (t, J = 9.7 Hz), 5.
85 (t, 1H, J = 9.7 Hz), 6.05 (brs, 1
H), 7.13-7.54 (m, 19H), 7.81 (dd, 1H, J
= 1.2 Hz, 8.3 Hz), 7.90 (dd, 2H, J = 1.2
Hz, 8.3 Hz), 7.95 (dd, 2H, J = 1.2 Hz,
8.3 Hz). [Α] D 25 = + 1.0 ° (c = 1.01, CHCl 3 -MeO
H 1: 1). Rf : 0.18 (n-hexane-AcOEt 1: 3). (f) Synthesis of Compound 27-6 Compound 27-5 (0.721 g) was dissolved by adding ethyl acetate (5 ml) and methanol (5 ml), and platinum oxide (0.071 g) was added, followed by catalytic reduction for 1 week under normal pressure. The catalyst was filtered off, and the solvent was distilled off under normal pressure. The residue was dissolved in 10 ml of methanol, 20 drops of 28% sodium methoxide methanol solution was added, and the mixture was stirred at room temperature for 3 days.

【0262】1N塩酸で中和し、溶媒を減圧下留去し
た。「CHP−20」カラム(22mmφ×40cm)で精製した
(溶出溶媒:蒸留水からアセトニトリルへのグラディエ
ント)。目的物を含むフラクションを集め、溶媒を減圧
下留去した。残渣に蒸留水50mlを加えて溶かし、「ダウ
エックス50WX−8」イオン交換樹脂(H型)を加えて
中和し、樹脂を濾去した。濾液を凍結乾燥して目的化合
物を無色非晶質として0.067g得た。
It was neutralized with 1N hydrochloric acid, and the solvent was distilled off under reduced pressure. It was purified with a “CHP-20” column (22 mmφ × 40 cm) (elution solvent: gradient from distilled water to acetonitrile). Fractions containing the desired product were collected, and the solvent was evaporated under reduced pressure. 50 ml of distilled water was added to the residue to dissolve it, "Dowex 50WX-8" ion exchange resin (H type) was added to neutralize, and the resin was filtered off. The filtrate was freeze-dried to obtain 0.067 g of the target compound as a colorless amorphous substance.

【0263】1H−NMR(δ,DMSO−d6 & D
2 O):0.86(t,3H,J=7.0Hz),1.16−1.29
(m,24H),1.44−1.50(m,2H),2.05(t,2
H,J=7.4 Hz),2.98(br t,1H),3.05−
3.07(m,1H),3.16(t,1H,J=9.3 Hz),
3.18(quintet ,2H,J=5.9 Hz),3.28(t,1
H,J=9.3 Hz),3.40(t,2H,J=5.9 H
z),3.43−3.60(m,7H),3.71(br t,1
H),3.82(ddd,1H,J=3.1 Hz,7.1 Hz,
13.9Hz),4.00(dt,J=3.1 Hz,11.6Hz),
4.15(d,1H,J=7.8 Hz),7.92(br t,1
H).13 C−NMR(δ,DMSO−d6 ):13.88 ,22.02
,25.21 ,28.62 −31.22 ,35.24 ,38.39 ,63.06
(J=5.1 Hz),67.78 −69.66 ,68.74 ,73.52 ,
75.61 ,76.09 (J=4.0 Hz),103.26,172.20. [α]D 23=−2.7 °(c=0.95,CHCl3 −MeO
H−H2 O 10:10:3) . Rf :0.54(CHCl3 −MeOH−H2 O 10:10:
3) FAB−MS:[M+H]+ ;M/Z=630 ,[M+N
a]+ ;M/Z=652,[M+2Na]+ ;M/Z=674
. 実施例28 本実施例における反応を図20に示す。
1 H-NMR (δ, DMSO-d 6 & D
2 O): 0.86 (t, 3H, J = 7.0Hz), 1.16-1.29
(M, 24H), 1.44-1.50 (m, 2H), 2.05 (t, 2)
H, J = 7.4 Hz), 2.98 (brt, 1H), 3.05-
3.07 (m, 1H), 3.16 (t, 1H, J = 9.3 Hz),
3.18 (quintet, 2H, J = 5.9 Hz), 3.28 (t, 1
H, J = 9.3 Hz), 3.40 (t, 2H, J = 5.9 H)
z), 3.43 to 3.60 (m, 7H), 3.71 (br t, 1)
H), 3.82 (ddd, 1H, J = 3.1 Hz, 7.1 Hz,
13.9 Hz), 4.00 (dt, J = 3.1 Hz, 11.6 Hz),
4.15 (d, 1H, J = 7.8 Hz), 7.92 (br t, 1
H). 13 C-NMR (δ, DMSO-d 6 ): 13.88, 22.02
, 25.21, 28.62 −31.22, 35.24, 38.39, 63.06
(J = 5.1 Hz), 67.78 −69.66, 68.74, 73.52,
75.61, 76.09 (J = 4.0 Hz), 103.26, 172.20. [Α] D 23 = -2.7 ° (c = 0.95, CHCl 3 -MeO
H-H 2 O 10: 10 : 3). R f : 0.54 (CHCl 3 —MeOH—H 2 O 10:10:
3) FAB-MS: [M + H] + ; M / Z = 630, [M + N
a] + ; M / Z = 652, [M + 2Na] + ; M / Z = 674
. Example 28 The reaction in this example is shown in FIG.

【0264】(a) 化合物11−4の合成 化合物11−3、0.745 gに塩化チオニル4mlを加え、5
時間加熱下還流させた。塩化チオニルを減圧下留去し、
残渣にベンゼンを加え、減圧下留去した(2回)。それ
以上の精製はせずに以下の反応に用いた。
(A) Synthesis of Compound 11-4 To 0.745 g of Compound 11-3, 4 ml of thionyl chloride was added, and 5
The mixture was refluxed under heating for an hour. Thionyl chloride was distilled off under reduced pressure,
Benzene was added to the residue and evaporated under reduced pressure (twice). It was used in the following reaction without further purification.

【0265】(b) 化合物28−1の合成 化合物27−4、1.175 gに塩化メチレン10mlを加えて溶
かし、氷冷下撹拌した。ここにトリエチルアミン350 μ
lを加え、さらに(a) で得られた化合物11−4全量を塩
化メチレン5mlに溶かして加え、室温に昇温させつつ14
時間撹拌した。
(B) Synthesis of Compound 28-1 To 1.175 g of Compound 27-4, 10 ml of methylene chloride was added and dissolved, and the mixture was stirred under ice cooling. Triethylamine 350 μ
1 was added, and the whole amount of compound 11-4 obtained in (a) was dissolved in 5 ml of methylene chloride and added, and the temperature was raised to room temperature.
Stir for hours.

【0266】溶媒を減圧下留去し、残渣をシリカゲルク
ロマトグラフィーで精製し(溶出溶媒;n−ヘキサン−
酢酸エチル 1:1)、目的物を無色非晶質として1.23
2 g得た。
The solvent was distilled off under reduced pressure, and the residue was purified by silica gel chromatography (elution solvent; n-hexane-
Ethyl acetate 1: 1), 1.23 as the desired product as colorless amorphous
2 g was obtained.

【0267】1H−NMR(δ,CDCl3 ):0.88
(t,6H,J=7.0 Hz),1.18−1.31(m,56
H),1.33−1.41(m,2H),1.52−1.60(m,2
H),1.93−1.99(m,1H),3.33−3.34(m,2
H),3.37−3.42(m,4H),3.45−3.48(m,2
H),3.56−3.64(m,2H),3.73(ddd,1H,
J=3.6 Hz,7.2 Hz,10.9Hz),3.94(ddd,
1H,J=3.5 Hz,4.7 Hz,11.2Hz),4.06−4.
10(m,1H),4.41(ddd,1H,J=6.3 Hz,
11.5Hz,8.7 Hz),4.47(ddd,1H,J=2.5
Hz,7.3 Hz,11.5Hz),4.89(d,1H,J=8.
0 Hz),5.45(dd,1H,J=8.0 Hz,9.8 H
z),5.45(t,J=9.8 Hz),5.85(t,1H,J
=9.8 Hz),5.96(brs,1H),7.13−7.54
(m,19H),7.81(dd,2H,J=1.2 Hz,8.3
Hz),7.90(dd,2H,J=1.2 Hz,8.3 H
z),7.95(dd,2H,J=1.2 Hz,8.3 Hz). [α]D 25=+1.3 °(c=1.02,CHCl3 −MeO
H 1:1) Rf :0.27(n−hexane−AcOEt 2:3). (c) 化合物28−2の合成 化合物28−1、1.216 gにテトラヒドロフラン30ml及び
メタノール10mlを加えて溶かした。ここに酸化白金0.01
5 gを加え、常圧で6日間接触還元した。触媒を濾去
し、溶媒を減圧下留去した。残渣にベンゼン8ml及びメ
タノール8mlを加えて溶かし、28%ナトリウムメトキシ
ドメタノール溶液を22滴加え(pH=11)、室温で11.5時
間撹拌した。
1 H-NMR (δ, CDCl 3 ): 0.88
(T, 6H, J = 7.0 Hz), 1.18-1.31 (m, 56
H), 1.33-1.41 (m, 2H), 1.52-1.60 (m, 2
H), 1.93-1.99 (m, 1H), 3.33-3.34 (m, 2)
H), 3.37-3.42 (m, 4H), 3.45-3.48 (m, 2)
H), 3.56-3.64 (m, 2H), 3.73 (ddd, 1H,
J = 3.6 Hz, 7.2 Hz, 10.9 Hz), 3.94 (ddd,
1H, J = 3.5 Hz, 4.7 Hz, 11.2 Hz), 4.06-4.
10 (m, 1H), 4.41 (ddd, 1H, J = 6.3 Hz,
11.5Hz, 8.7Hz), 4.47 (ddd, 1H, J = 2.5
Hz, 7.3 Hz, 11.5 Hz), 4.89 (d, 1H, J = 8.
0 Hz), 5.45 (dd, 1H, J = 8.0 Hz, 9.8 H
z), 5.45 (t, J = 9.8 Hz), 5.85 (t, 1H, J
= 9.8 Hz), 5.96 (brs, 1H), 7.13-7.54
(M, 19H), 7.81 (dd, 2H, J = 1.2 Hz, 8.3
Hz), 7.90 (dd, 2H, J = 1.2 Hz, 8.3 H
z), 7.95 (dd, 2H, J = 1.2 Hz, 8.3 Hz). [Α] D 25 = + 1.3 ° (c = 1.02, CHCl 3 -MeO
H 1: 1) Rf : 0.27 (n-hexane-AcOEt 2: 3). (c) Synthesis of Compound 28-2 To 1.216 g of Compound 28-1, 30 ml of tetrahydrofuran and 10 ml of methanol were added and dissolved. Platinum oxide 0.01
5 g was added, and catalytic reduction was carried out under normal pressure for 6 days. The catalyst was filtered off, and the solvent was distilled off under reduced pressure. The residue was dissolved by adding 8 ml of benzene and 8 ml of methanol, 22 drops of 28% sodium methoxide methanol solution (pH = 11) was added, and the mixture was stirred at room temperature for 11.5 hours.

【0268】氷冷して1N塩酸で中和し、溶媒を減圧下
留去した。残渣を「Sepphadex LH−20」カ
ラムで精製した(樹脂:約150ml 、溶出溶媒:クロロホ
ルム−メタノール−水 10:10:3)。目的化合物を無
色粉末として0.640 g得た。
It was ice-cooled and neutralized with 1N hydrochloric acid, and the solvent was evaporated under reduced pressure. The residue was purified by "Sepphadex LH-20" column (resin: about 150 ml, elution solvent: chloroform-methanol-water 10: 10: 3). 0.640 g of the target compound was obtained as a colorless powder.

【0269】1H−NMR(δ,CDCl3 −D2
5:1):0.88(t,6H,J=7.0 Hz),1.16−1.
34(m,56H),1.34−1.44(m,2H),1.46−1.59
(m,2H),2.04−2.11(m,1H),3.26−6.36
(m,19H).13 C−NMR(δ,CDCl3 −CD3 OD−D2
10:10:3):14.25,23.04 ,27.83 ,29.71 ,29.84
,30.02 ,32.30 ,33.07 ,39.23 ,47.78,63.09
(J=2.4 Hz),69.00 −70.50 ,69.28 ,74.12 ,
75.70 ,76.42(J=5.5 Hz),103.55,178.38. [α]D 26=−14.2°(c=1.05,CHCl3 −MeO
H 1:1). Rf :0.44(CHCl3 −MeOH−H2 O 60:35:
7). FAB−MS:[M+H]+ ;M/Z=882 ,[M+N
a]+ ;M/Z=904. 実施例29 本実施例における反応を図21に示す。
1 H-NMR (δ, CDCl 3 -D 2 O
5: 1): 0.88 (t, 6H, J = 7.0 Hz), 1.16-1.
34 (m, 56H), 1.34-1.44 (m, 2H), 1.46-1.59
(M, 2H), 2.04-2.11 (m, 1H), 3.26-6.36
(M, 19H). 13 C-NMR (δ, CDCl 3 -CD 3 OD-D 2 O
10: 10: 3): 14.25, 23.04, 27.83, 29.71, 29.84
, 30.02, 32.30, 33.07, 39.23, 47.78, 63.09
(J = 2.4 Hz), 69.00-70.50, 69.28, 74.12,
75.70, 76.42 (J = 5.5 Hz), 103.55, 178.38. [Α] D 26 = -14.2 ° (c = 1.05, CHCl 3 -MeO
H 1: 1). R f: 0.44 (CHCl 3 -MeOH -H 2 O 60:35:
7). FAB-MS: [M + H] + ; M / Z = 882, [M + N
a] + ; M / Z = 904. Example 29 The reaction in this example is shown in FIG.

【0270】(a) 化合物29−2の合成 化合物29−1、0.422 gをピリジン15mlを加えて溶か
す。三酸化硫黄ピリジン錯体0.307 gを加え、室温で2
日半撹拌した。飽和水酸化バリウム水溶液10mlを加え
(pH=10)、さらにクロロホルム−メタノール(1:
1)90mlを加え、3000rpm で10分間遠心した。上清を硫
酸ナトリウム上乾燥させ、溶媒を減圧下留去した。トル
エンを加え、溶媒を減圧下留去した。メタノール20mlを
加えて懸濁させ(一部溶解)、ここに28%ナトリウムメ
トキシドメタノール溶液を7滴加え(pH=10)、室温で
4.5 時間撹拌した。反応の進行と共に一相溶液となっ
た。
(A) Synthesis of compound 29-2 Compound 29-1, 0.422 g, was dissolved by adding 15 ml of pyridine. Add 0.307 g of sulfur trioxide pyridine complex and add 2 at room temperature.
Stir for half a day. 10 ml of saturated barium hydroxide aqueous solution was added (pH = 10), and then chloroform-methanol (1:
1) 90 ml was added and centrifuged at 3000 rpm for 10 minutes. The supernatant was dried over sodium sulfate, and the solvent was distilled off under reduced pressure. Toluene was added and the solvent was evaporated under reduced pressure. Add 20 ml of methanol to suspend (partially dissolve), add 7 drops of 28% sodium methoxide methanol solution (pH = 10), and at room temperature.
Stir for 4.5 hours. As the reaction proceeded, it became a one-phase solution.

【0271】メタノール100ml を加え、「ダウエックス
50WX−8」イオン交換樹脂(H型)を加えて中和し、
樹脂を濾去した。濾液に重炭酸ソーダの結晶を加え、激
しく撹拌し、残った結晶を濾去した。溶媒を減圧下留去
した。残渣をメタノール−クロロホルムから再沈澱さ
せ、目的化合物を淡黄色粉末として0.199 g得た。
100 ml of methanol was added, and "Dowex
50WX-8 "ion exchange resin (H type) is added to neutralize,
The resin was filtered off. Crystals of sodium bicarbonate were added to the filtrate, the mixture was vigorously stirred, and the remaining crystals were filtered off. The solvent was distilled off under reduced pressure. The residue was reprecipitated from methanol-chloroform to obtain 0.199 g of the objective compound as a pale yellow powder.

【0272】1H−NMR(δ,DMSO−d6 ):0.8
6(t,3H,J=7.0 Hz),1.20−1.29(m,30
H),1.45−1.50(quintet ,2H,J=7.0 Hz),
3.25−3.62(m,17H),3.80(dd,1H,J=6.3
Hz,10.5Hz),3.81−3.85(m,1H),3.86(d
d,1H,J=6.0 Hz,10.5Hz),4.11(d,1
H,J=7.6 Hz).13 C−NMR(δ,DMSO−d6 ):14.00 ,22.14
−31.33 ,65.21 ,67.89 −70.40 ,68.28 ,70.30 ,
72.90 ,73.12 ,103.51. [α]D 25=−3.3 °(c=1.00,CHCl3 −MeO
H−H2 O 10:10:3). Rf :0.32(CHCl3 −MeOH−H2 O 65:25:
4). FAB−MS:[M+H]+ ;M/Z=667 . 実施例30 本実施例における反応を図22に示す。
1 H-NMR (δ, DMSO-d 6 ): 0.8
6 (t, 3H, J = 7.0 Hz), 1.20-1.29 (m, 30
H), 1.45 to 1.50 (quintet, 2H, J = 7.0 Hz),
3.25-3.62 (m, 17H), 3.80 (dd, 1H, J = 6.3
Hz, 10.5 Hz), 3.81-3.85 (m, 1H), 3.86 (d
d, 1H, J = 6.0 Hz, 10.5 Hz), 4.11 (d, 1
H, J = 7.6 Hz). 13 C-NMR (δ, DMSO-d 6 ): 14.00, 22.14
−31.33, 65.21, 67.89 −70.40, 68.28, 70.30,
72.90, 73.12, 103.51. [Α] D 25 = −3.3 ° (c = 1.00, CHCl 3 —MeO
H-H 2 O 10: 10 : 3). R f : 0.32 (CHCl 3 —MeOH—H 2 O 65:25:
4). FAB-MS: [M + H] + ; M / Z = 667. Example 30 The reaction in this example is shown in FIG.

【0273】(a) 化合物30−1の合成 マンノースペンタアセテート(3.90g)と2−[2−
(2−クロロエトキシ)エトキシ]エチルエーテル錯体
(5.68g)を塩化メチレン(200ml )に溶解し、三フッ
化ホウ素ジエチルエーテル錯体(5.68g)を加え、室温
で5日間撹拌した。
(A) Synthesis of compound 30-1 Mannose pentaacetate (3.90 g) and 2- [2-
The (2-chloroethoxy) ethoxy] ethyl ether complex (5.68 g) was dissolved in methylene chloride (200 ml), boron trifluoride diethyl ether complex (5.68 g) was added, and the mixture was stirred at room temperature for 5 days.

【0274】反応液を塩化メチレンで希釈し、水、5%
NaHCO3 水及び水で順次洗浄し、乾燥後溶媒を減圧
下留去した。残渣をシリカゲル(200 g)を用いるカラ
ムクロマトグラフィー(クロロホルム)で精製し、目的
物(4.13g)を無色油状物として得た。
The reaction solution was diluted with methylene chloride, water, 5%
It was washed successively with NaHCO 3 water and water, dried and the solvent was evaporated under reduced pressure. The residue was purified by column chromatography (chloroform) using silica gel (200 g) to obtain the desired product (4.13 g) as a colorless oil.

【0275】[α]D +38.7°(c 1.51,CHC
3 ).1 H−NMR(CDCl3 )δ:0.24(3H,s),2.1
0(3H,s),2.16(3H,s),3.63−3.70(9
H,m),3.75−3.85(3H,m),4.07(1H,dd
d,J=2.4 Hz,5.1 Hz,10.0Hz),4.11(1
H,dd,J=2.4H,12.2Hz),4.29(1H,d
d,J=5.1 Hz,12.2Hz),4.88(1H,d,J=
1.7 Hz),5.27(1H,dd,J=1.7 Hz,3.4 H
z),5.29(1H,t,J=10.0Hz),5.36(1H,
dd,J=3.4 Hz,10.0Hz). (b) 化合物30−2の合成 化合物30−1(3.68g)をDMF(50ml)に溶解し、ア
ジ化ナトリウム(0.72g)を加え、60℃で24時間撹拌し
た。
[Α] D + 38.7 ° (c 1.51, CHC
l 3 ). 1 H-NMR (CDCl 3 ) δ: 0.24 (3H, s), 2.1
0 (3H, s), 2.16 (3H, s), 3.63-3.70 (9
H, m), 3.75-3.85 (3H, m), 4.07 (1H, dd
d, J = 2.4 Hz, 5.1 Hz, 10.0 Hz), 4.11 (1
H, dd, J = 2.4H, 12.2Hz), 4.29 (1H, d
d, J = 5.1 Hz, 12.2 Hz), 4.88 (1H, d, J =
1.7 Hz), 5.27 (1 H, dd, J = 1.7 Hz, 3.4 H
z), 5.29 (1H, t, J = 10.0Hz), 5.36 (1H,
dd, J = 3.4 Hz, 10.0 Hz). (b) Synthesis of Compound 30-2 Compound 30-1 (3.68 g) was dissolved in DMF (50 ml), sodium azide (0.72 g) was added, and the mixture was stirred at 60 ° C. for 24 hours.

【0276】反応液を酢酸エチルで希釈し、水洗し、乾
燥後溶媒を減圧下留去した。残渣をシリカゲル(150
g)を用いるカラムクロマトグラフィー(クロロホルム
−アセトン 10:1) で精製し、アジド体化合物30−2
(3.05g)を無色油状物として得た。
The reaction solution was diluted with ethyl acetate, washed with water, dried and the solvent was distilled off under reduced pressure. The residue is treated with silica gel (150
g) is used for purification by column chromatography (chloroform-acetone 10: 1) to give an azide compound 30-2.
(3.05 g) was obtained as a colorless oil.

【0277】[α]D +35.6°(c 2.54,CHC
3 ).1 H−NMR(CDCl3 )δ:1.99(3H,s),2.0
4(3H,s),2.11(3H,s),2.16(3H,
s),3.40(2H,t,J=5.1 Hz),3.62−3.86
(10H,m),4.06(1H,ddd,J=2.4 Hz,4.
9 Hz,10.0Hz),4.10(1H,dd,J=2.4 H
z,12.2Hz),4.29(1H,dd,J=4.9 Hz,1
2.2Hz),4.88(1H,d,J=1.5 Hz),5.27
(1H,dd,J=1.5 Hz,3.4 Hz),5.29(1
H,t,J=10.0Hz),5.36(1H,dd,J=3.4
Hz,10.0Hz) (c) 化合物30−3の合成 化合物30−2(386mg ,0.76mmol)とp−トルエンスル
ホン酸(145mg ,0.76mmol)をエタノール(20ml)に溶
解し、リンドラー触媒(770mg )を加え、室温50psi で
7.5 時間接触還元を行った。触媒を濾過後、濾液を減圧
下濃縮し、目的物を得た。
[Α] D + 35.6 ° (c 2.54, CHC
l 3 ). 1 H-NMR (CDCl 3 ) δ: 1.99 (3H, s), 2.0
4 (3H, s), 2.11 (3H, s), 2.16 (3H,
s), 3.40 (2H, t, J = 5.1 Hz), 3.62-3.86
(10H, m), 4.06 (1H, ddd, J = 2.4 Hz, 4.
9 Hz, 10.0 Hz), 4.10 (1 H, dd, J = 2.4 H)
z, 12.2Hz), 4.29 (1H, dd, J = 4.9Hz, 1
2.2Hz), 4.88 (1H, d, J = 1.5Hz), 5.27
(1H, dd, J = 1.5 Hz, 3.4 Hz), 5.29 (1
H, t, J = 10.0Hz), 5.36 (1H, dd, J = 3.4)
Hz, 10.0 Hz) (c) Synthesis of compound 30-3 Compound 30-2 (386 mg, 0.76 mmol) and p-toluenesulfonic acid (145 mg, 0.76 mmol) are dissolved in ethanol (20 ml), and Lindlar catalyst (770 mg) is dissolved. At room temperature 50 psi
The catalytic reduction was carried out for 7.5 hours. After filtering the catalyst, the filtrate was concentrated under reduced pressure to obtain the desired product.

【0278】(d) 化合物30−4の合成 化合物30−3(820mg )とN−t−ブトキシカルボニル
−γ−ベンジルグルタミン酸−α−N−ヒドロキシスク
シンイミドエステル(547mg )を塩化メチレン(40ml)
に溶解し、トリエチルアミン(255mg )を加え、室温で
1時間撹拌した。
(D) Synthesis of Compound 30-4 Compound 30-3 (820 mg) and Nt-butoxycarbonyl-γ-benzylglutamic acid-α-N-hydroxysuccinimide ester (547 mg) were added to methylene chloride (40 ml).
, Triethylamine (255 mg) was added, and the mixture was stirred at room temperature for 1 hour.

【0279】反応液を塩化メチレンで希釈し、水、10%
クエン酸水及び水で順次洗浄し、乾燥後溶媒を減圧下留
去した。残渣をシリカゲル(60g)を用いるカラムクロ
マトグラフィー(クロロホルム−メタノール 150 :
1)で精製し、目的物(834mg)を得た。
The reaction solution was diluted with methylene chloride, water, 10%
It was washed successively with citric acid water and water, dried and the solvent was distilled off under reduced pressure. The residue was subjected to column chromatography using silica gel (60 g) (chloroform-methanol 150:
Purification in 1) yielded the desired product (834 mg).

【0280】[α]D +20.9°(c 1.87,CHC
3 ). 1H−NMR(CDCl3 )δ:1.43(9H,s),1.8
8−1.96(1H,m),1.99(3H,s),2.04(3
H,s),2.10(3H,s),2.15(3H,s),2.10
−2.20(1H,m),2.40−2.56(2H,m),3.46
(H,m),3.55(2H,m),3.58−3.71(7H,
m),3.78−3.84(1H,m),4.07(1H,ddd,
J=2.4 Hz,4.9 Hz,10.0Hz),4.12(1H,d
d,J=2.4 Hz,12.2Hz),4.14−4.20(1H,
m),4.28(1H,dd,J=4.9 Hz,12.2Hz),
4.88(1H,d,J=1.7Hz),5.12(2H,
s),5.27(1H,dd,J=1.7 Hz,3.4 Hz),
5.30(1H,t,J=10.0Hz),5.36(1H,dd,
J=3.4 Hz,10.0Hz),6.58(1H,m),7.32−
7.37(5H,m). (e) 化合物30−5の合成 化合物30−4(810mg )をエタノール(30ml)に溶解
し、10%Pd−C(300mg )を加え、室温40psi で4時
間接触還元を行った。触媒を濾去後、濾液を減圧下濃縮
し、目的物を得た。
[Α] D + 20.9 ° (c 1.87, CHC
l 3 ). 1 H-NMR (CDCl 3 ) δ: 1.43 (9H, s), 1.8
8-1.96 (1H, m), 1.99 (3H, s), 2.04 (3
H, s), 2.10 (3H, s), 2.15 (3H, s), 2.10
-2.20 (1H, m), 2.40-2.56 (2H, m), 3.46
(H, m), 3.55 (2H, m), 3.58-3.71 (7H,
m), 3.78-3.84 (1H, m), 4.07 (1H, ddd,
J = 2.4 Hz, 4.9 Hz, 10.0 Hz), 4.12 (1H, d
d, J = 2.4 Hz, 12.2 Hz), 4.14-4.20 (1H,
m), 4.28 (1H, dd, J = 4.9Hz, 12.2Hz),
4.88 (1H, d, J = 1.7Hz), 5.12 (2H,
s), 5.27 (1H, dd, J = 1.7 Hz, 3.4 Hz),
5.30 (1H, t, J = 10.0Hz), 5.36 (1H, dd,
J = 3.4 Hz, 10.0 Hz), 6.58 (1 H, m), 7.32-
7.37 (5H, m). (e) Synthesis of Compound 30-5 Compound 30-4 (810 mg) was dissolved in ethanol (30 ml), 10% Pd-C (300 mg) was added, and catalytic reduction was carried out at room temperature of 40 psi for 4 hours. After removing the catalyst by filtration, the filtrate was concentrated under reduced pressure to obtain the desired product.

【0281】(f) 化合物30−6の合成 化合物30−5(226mg )を塩化メチレン(20ml)に溶解
し、N−ヒドロキシスクシンイミド(37mlg)とN,N′
−ジシクロヘキシルカルボジイミド(66mg)を加え、室
温で20時間撹拌した。反応混合物に化合物7−4(244m
g )とトリエチルアミン(65mg)を加え、室温で4時間
撹拌した。
(F) Synthesis of compound 30-6 Compound 30-5 (226 mg) was dissolved in methylene chloride (20 ml), and N-hydroxysuccinimide (37 mlg) and N, N 'were added.
-Dicyclohexylcarbodiimide (66 mg) was added, and the mixture was stirred at room temperature for 20 hours. Compound 7-4 (244m
g) and triethylamine (65 mg) were added, and the mixture was stirred at room temperature for 4 hours.

【0282】不溶物を濾去し、濾液をクロロホルムで希
釈し、水、5%NaHCO3 水、水、10%クエン酸水及
び水で順次洗浄し、乾燥後溶媒を減圧下留去した。残渣
をシリカゲル(40g)を用いるカラムクロマトグラフィ
ー(クロロホルムーメタノール 25:1)で精製し、目
的化合物(308mg )を得た。
The insoluble matter was filtered off, the filtrate was diluted with chloroform, washed successively with water, 5% aqueous NaHCO 3 solution, water, 10% aqueous citric acid solution and water. After drying, the solvent was evaporated under reduced pressure. The residue was purified by column chromatography (chloroform-methanol 25: 1) using silica gel (40 g) to obtain the target compound (308 mg).

【0283】[α]D +6.8 °(c 1.93,CHC
3 ).1 H−NMR(CDCl3 )δ:1.43(9H,s),1.8
5(3H,s),1.99(3H,s),2.04(3H,
s),2.04(3H,s),2.04(3H,s),2.10(3
H,s),2.14(3H,s),2.16(3H,s),2.18
(3H,s),2.24−2.39(2H,m),2.66(1H,
dd,J=4.6 Hz,12.7Hz),3.37−3.70(22H,
m),3.80(3H,s),3.74−3.90(2H,m),4.
00−4.22(6H,m),4.28(1H,dd,J=4.9 H
z,12.2Hz),4.36(1H,dd,J=2.7 Hz,1
2.5Hz),4.87(1H,d,J=1.7 Hz),4.89−
4.96(1H,m),5.26(1H,dd,J=1.7 Hz,
3.4 Hz),5.29(1H,t,J=10.0Hz),5.32−
5.37(2H,m),5.39(1H,m),5.55(1H,
d). 実施例31 本実施例における反応を図23に示す。
[Α] D + 6.8 ° (c 1.93, CHC
l 3 ). 1 H-NMR (CDCl 3 ) δ: 1.43 (9H, s), 1.8
5 (3H, s), 1.99 (3H, s), 2.04 (3H,
s), 2.04 (3H, s), 2.04 (3H, s), 2.10 (3
H, s), 2.14 (3H, s), 2.16 (3H, s), 2.18
(3H, s), 2.24-2.39 (2H, m), 2.66 (1H,
dd, J = 4.6 Hz, 12.7 Hz), 3.37-3.70 (22H,
m), 3.80 (3H, s), 3.74-3.90 (2H, m), 4.
00-4.22 (6H, m), 4.28 (1H, dd, J = 4.9H
z, 12.2Hz), 4.36 (1H, dd, J = 2.7Hz, 1
2.5Hz), 4.87 (1H, d, J = 1.7Hz), 4.89-
4.96 (1H, m), 5.26 (1H, dd, J = 1.7 Hz,
3.4 Hz), 5.29 (1H, t, J = 10.0 Hz), 5.32-
5.37 (2H, m), 5.39 (1H, m), 5.55 (1H,
d). Example 31 The reaction in this example is shown in FIG.

【0284】(a) 化合物31−2αの合成 L−フコースを無水酢酸とピリジンで処理して得られる
テトラアセテート体化合物31−1(10.16 g)と2−
[2−(2−クロロエトキシ)エトキシ]エタノール
(10.31 g)を塩化メチレン(300ml )に溶解し、三フ
ッ化ホウ素ジエチルエーテル錯体(17.36 g)を加え室
温で25時間撹拌した。反応液を塩化メチレンで希釈し、
水、5%NaHCO3 水及び水で順次洗浄し、乾燥後溶
媒を減圧下留去した。残渣をピリジン(26ml)に溶解
し、無水酢酸(20ml)を加え、室温で15時間撹拌した。
(A) Synthesis of compound 31-2α Tetraacetate compound 31-1 (10.16 g) obtained by treating L-fucose with acetic anhydride and pyridine
[2- (2-Chloroethoxy) ethoxy] ethanol (10.31 g) was dissolved in methylene chloride (300 ml), boron trifluoride diethyl ether complex (17.36 g) was added, and the mixture was stirred at room temperature for 25 hours. Dilute the reaction solution with methylene chloride,
It was washed successively with water, 5% NaHCO 3 water and water, dried and the solvent was distilled off under reduced pressure. The residue was dissolved in pyridine (26 ml), acetic anhydride (20 ml) was added, and the mixture was stirred at room temperature for 15 hr.

【0285】反応混合物を酢酸エチルで希釈し、水、5
%NaHCO3 水、水、10%クエン酸水および水で順次
洗浄し、乾燥後溶媒を減圧下留去した。残渣をシリカゲ
ル(250 g)を用いるカラムクロマトグラフィー(クロ
ロホルム)で精製し、α−グリコシド体化合物31−2α
(4.40g)とβ−グリコシド体化合物31−2β(1.79
g)を無色油状物として得た。
The reaction mixture was diluted with ethyl acetate, washed with water, 5
% NaHCO 3 water, water, 10% citric acid water and water in this order, and after drying, the solvent was distilled off under reduced pressure. The residue was purified by column chromatography (chloroform) using silica gel (250 g) to obtain α-glycoside compound 31-2α.
(4.40 g) and β-glycoside compound 31-2β (1.79)
g) was obtained as a colorless oil.

【0286】α−グリコシド体化合物31−2α: [α]D −112.3 °(c 0.96,CHCl3 ).1 H−NMR(CDCl3 )δ:1.14(3H,d,J=
6.6 Hz),1.99(3H,s),2.08(3H,s),2.
17(3H,s),3.62−3.84(12H,m),4.23(1
H,q,J=6.6 Hz),5.11(1H,d,J=3.7 H
z),5.12(1H,dd,J=3.7 Hz,10.0Hz),
5.30(1H,d,J=3.4 Hz),5.37(1H,dd,
J=3.4 Hz,10.0Hz). (b) 化合物31−3の合成 クロル体化合物31−2α(3.56g)をDMF(50ml)に
溶解し、アジ化ナトリウム(1.05g)を加え、70℃で2
日間撹拌した。
Α-Glycoside compound 31-2α: [α] D -112.3 ° (c 0.96, CHCl 3 ). 1 H-NMR (CDCl 3 ) δ: 1.14 (3H, d, J =
6.6 Hz), 1.99 (3H, s), 2.08 (3H, s), 2.
17 (3H, s), 3.62-3.84 (12H, m), 4.23 (1
H, q, J = 6.6 Hz, 5.11 (1 H, d, J = 3.7 H)
z), 5.12 (1H, dd, J = 3.7 Hz, 10.0 Hz),
5.30 (1H, d, J = 3.4 Hz), 5.37 (1H, dd,
J = 3.4 Hz, 10.0 Hz). (b) Synthesis of compound 31-3 Chloride compound 31-2α (3.56 g) was dissolved in DMF (50 ml), sodium azide (1.05 g) was added, and the mixture was stirred at 70 ° C for 2 hours.
It was stirred for a day.

【0287】反応液を酢酸エチルで希釈し、水洗し、乾
燥後溶媒を減圧下留去した。残渣をシリカゲル(100
g)を用いるカラムクロマトグラフィー(クロロホル
ム)で精製し、目的物(2.98g)を無色油状物として得
た。
The reaction solution was diluted with ethyl acetate, washed with water, dried and the solvent was distilled off under reduced pressure. The residue is treated with silica gel (100
The product was purified by column chromatography (chloroform) using g) to obtain the desired product (2.98 g) as a colorless oil.

【0288】[α]D −113.7 °(c 0.96,CHCl
3 ).1 H−NMR(CDCl3 )δ:1.41(3H,d,J=
6.6 Hz),1.99(3H,s),2.07(3H,s),2.
16(3H,s),3.40(2H,t,J=5.0 Hz),3.
62−3.70(9H,m),3.78−3.84(1H,m),4.23
(1H,dq,J=1.2 Hz,6.6 Hz),5.10(1
H,d,J=3.7 Hz),5.12(1H,dd,J=3.7
Hz),5.30(1H,dd,J=1.2 Hz,3.4 H
z),5.37(1H,dd,J=3.4 Hz,10.3Hz). (c) 化合物31−4の合成 アジド体化合物31−3(2.21g)とp−トルエンスルホ
ン酸(0.94g)をエタノール(100ml )に溶解し、リン
ドラー触媒(4.40g)を加え、室温50psi で7時間接触
還元を行った。
[Α] D −113.7 ° (c 0.96, CHCl
3 ). 1 H-NMR (CDCl 3 ) δ: 1.41 (3H, d, J =
6.6 Hz), 1.99 (3H, s), 2.07 (3H, s), 2.
16 (3H, s), 3.40 (2H, t, J = 5.0 Hz), 3.
62-3.70 (9H, m), 3.78-3.84 (1H, m), 4.23
(1H, dq, J = 1.2 Hz, 6.6 Hz), 5.10 (1
H, d, J = 3.7 Hz), 5.12 (1H, dd, J = 3.7)
Hz), 5.30 (1 H, dd, J = 1.2 Hz, 3.4 H
z), 5.37 (1H, dd, J = 3.4 Hz, 10.3 Hz). (c) Synthesis of compound 31-4 Azide compound 31-3 (2.21 g) and p-toluenesulfonic acid (0.94 g) were dissolved in ethanol (100 ml), Lindlar catalyst (4.40 g) was added, and room temperature was 50 psi. The catalytic reduction was performed for 7 hours.

【0289】触媒を濾去後、濾液を減圧下濃縮し、目的
物(2.84g)を無色油状物質として得た。
After removing the catalyst by filtration, the filtrate was concentrated under reduced pressure to obtain the desired product (2.84 g) as a colorless oily substance.

【0290】(d) 化合物31−5の合成 アミン体化合物31−4(637mg )とN−t−ブトキシカ
ルボニル−γ−ベンジルグルタミン酸−α−N−ヒドロ
キシスクシンイミドエステル(466mg )を塩化メチレン
(30ml)に溶解し、トリエチルアミン(217mg )を加
え、室温で3.5 時間撹拌した。
(D) Synthesis of Compound 31-5 Amine compound 31-4 (637 mg) and Nt-butoxycarbonyl-γ-benzylglutamic acid-α-N-hydroxysuccinimide ester (466 mg) were added to methylene chloride (30 ml). , Ethyl acetate (217 mg) was added, and the mixture was stirred at room temperature for 3.5 hours.

【0291】反応液を塩化メチレンで希釈し、水、10%
クエン酸水及び水で順次洗浄し、乾燥後溶媒を減圧下留
去した。残渣をシリカゲル(50g)を用いるカラムクロ
マトグラフィー(クロロホルム−メタノール 100:1)
で精製し、目的化合物(689mg )を無色油状物として得
た。
The reaction solution was diluted with methylene chloride, and water, 10%
It was washed successively with citric acid water and water, dried and the solvent was distilled off under reduced pressure. Column chromatography of the residue using silica gel (50 g) (chloroform-methanol 100: 1)
And the target compound (689 mg) was obtained as a colorless oil.

【0292】[α]D −52.1°(c 1.80,CHC
3 ).1 H−NMR(CDCl3 )δ:1.13(3H,d,J=
6.6 Hz),1.43(9H,s),1.88−1.96(1H,
m),1.99(3H,s),2.07(3H,s),2.16(3
H,s),2.10−2.20(1H,m),2.40−2.56(2
H,m),3.42−3.48(2H,m),3.54(2H,
m),3.56−3.68(7H,m),3.76−3.83(1H,
m),4.14−4.22(1H,m),4.23(1H,dq,J
=1.0 Hz,6.6 Hz),5.09−5.14(4H,m),5.
29(1H,dd,J=1.0 Hz,3.4 Hz),5.37(1
H,dd,J=3.4 Hz,10.3Hz),6.60(1H,
m). (e) 化合物31−6の合成 ベンジルエステル体化合物31−5(546mg )をエタノー
ル(20ml)に溶解し、10%Pd−C(200mg )を加え、
室温40psi で4時間接触還元を行った。触媒を濾去後、
濾液を減圧下濃縮し、目的物(546mg )を得た。
[Α] D −52.1 ° (c 1.80, CHC
l 3 ). 1 H-NMR (CDCl 3 ) δ: 1.13 (3H, d, J =
6.6 Hz), 1.43 (9H, s), 1.88-1.96 (1H,
m), 1.99 (3H, s), 2.07 (3H, s), 2.16 (3
H, s), 2.10-2.20 (1H, m), 2.40-2.56 (2
H, m), 3.42-3.48 (2H, m), 3.54 (2H,
m), 3.56-3.68 (7H, m), 3.76-3.83 (1H,
m), 4.14-4.22 (1H, m), 4.23 (1H, dq, J
= 1.0 Hz, 6.6 Hz), 5.09-5.14 (4H, m), 5.
29 (1H, dd, J = 1.0 Hz, 3.4 Hz), 5.37 (1
H, dd, J = 3.4 Hz, 10.3 Hz), 6.60 (1 H,
m). (e) Synthesis of compound 31-6 Benzyl ester compound 31-5 (546 mg) was dissolved in ethanol (20 ml), 10% Pd-C (200 mg) was added,
Catalytic reduction was carried out at room temperature of 40 psi for 4 hours. After filtering off the catalyst,
The filtrate was concentrated under reduced pressure to obtain the desired product (546 mg).

【0293】(f) 化合物31−7の合成 カルボン酸31−6(232mg )を塩化メチレン(20ml)に
溶解し、N−ヒドロキシスクシンイミド(41mg)とN,
N′−ジシクロヘキシルカルボジイミド(74mg)を加
え、室温で4.5 時間撹拌した。反応混合物に塩化メチレ
ン(15ml)に溶解したアミン体化合物7−4(273mg )
とトリエチルアミン(72mg)を加え、室温で4時間撹拌
した。
(F) Synthesis of compound 31-7 Carboxylic acid 31-6 (232 mg) was dissolved in methylene chloride (20 ml), and N-hydroxysuccinimide (41 mg) and N,
N'-Dicyclohexylcarbodiimide (74 mg) was added, and the mixture was stirred at room temperature for 4.5 hours. Amine compound 7-4 (273 mg) dissolved in methylene chloride (15 ml) in the reaction mixture
And triethylamine (72 mg) were added, and the mixture was stirred at room temperature for 4 hours.

【0294】不溶物を濾去し、濾液をクロロホルムで希
釈し、水、5%NaHCO3 水、水、10%クエン酸水及
び水で順次洗浄し、乾燥後溶媒を減圧下留去した。残渣
をシリカゲル(50g)を用いるカラムクロマトグラフィ
ー(クロロホルム−メタノール 25:1)で精製し、目
的化合物(295mg )を得た。
The insoluble matter was filtered off, the filtrate was diluted with chloroform, washed successively with water, 5% NaHCO 3 water, water, 10% citric acid water and water, dried and the solvent was distilled off under reduced pressure. The residue was purified by column chromatography (chloroform-methanol 25: 1) using silica gel (50 g) to obtain the target compound (295 mg).

【0295】[α]D −36.7°(c 1.00,CHC
3 ).1 H−NMR(CDCl3 )δ:1.14(3H,d,J=
6.6 Hz),1.43(9H,s),1.85(3H,s),1.
99(3H,s),2.03(3H,s),2.04(3H,
s),2.07(3H,s),2.13(3H,s),2.14(3
H,s),2.17(3H,s),2.24−2.39(2H,
m),2.67(1H,dd,J=4.6 Hz,12. 7H
z),3.37−3.70(22H,m),3.80(3H,s),3.
76−3.89(2H,m),4.00−4.12(3H,m),4.14
−4.22(1H,m),4.22(1H,dq,J=1.0 H
z,6.6 Hz),4.37(1H,dd,J=2.7 Hz,1
2.5Hz),4.92(1H,m),5.11(1H,d,J=
3.7 Hz),5.11(1H,dd,J=3.7 Hz,10.0H
z),5.29(1H,dd,J=1.0 Hz,3.4 Hz),
5.34(1H,m),5.36−5.42(2H,m),5.59(1
H,d),5.66(1H,d). (g) 化合物31−8の合成 化合物31−7(146mg )をメタノール(2ml)に溶解
し、28%ナトリウムメトキシドメタノール溶液(20μ
l)を加え、室温で1.5 時間撹拌した。反応液を減圧下
濃縮乾固し、残渣に0.1 N NaOH水(4ml)を加
え、室温で2時間撹拌した。
[Α] D −36.7 ° (c 1.00, CHC
l 3 ). 1 H-NMR (CDCl 3 ) δ: 1.14 (3H, d, J =
6.6 Hz), 1.43 (9H, s), 1.85 (3H, s), 1.
99 (3H, s), 2.03 (3H, s), 2.04 (3H,
s), 2.07 (3H, s), 2.13 (3H, s), 2.14 (3
H, s), 2.17 (3H, s), 2.24-2.39 (2H,
m), 2.67 (1H, dd, J = 4.6 Hz, 12.7H
z), 3.37-3.70 (22H, m), 3.80 (3H, s), 3.
76-3.89 (2H, m), 4.00-4.12 (3H, m), 4.14
-4.22 (1H, m), 4.22 (1H, dq, J = 1.0 H
z, 6.6 Hz), 4.37 (1H, dd, J = 2.7 Hz, 1
2.5Hz), 4.92 (1H, m), 5.11 (1H, d, J =
3.7 Hz, 5.11 (1H, dd, J = 3.7 Hz, 10.0H
z), 5.29 (1H, dd, J = 1.0 Hz, 3.4 Hz),
5.34 (1H, m), 5.36-5.42 (2H, m), 5.59 (1
H, d), 5.66 (1H, d). (g) Synthesis of compound 31-8 Compound 31-7 (146 mg) was dissolved in methanol (2 ml) and 28% sodium methoxide methanol solution (20 μm) was added.
1) was added, and the mixture was stirred at room temperature for 1.5 hours. The reaction solution was concentrated to dryness under reduced pressure, 0.1 N NaOH aqueous solution (4 ml) was added to the residue, and the mixture was stirred at room temperature for 2 hours.

【0296】反応液に「アンバーライトIRC−50」を
加え、不溶物を濾去後濾液を減圧下濃縮乾固した。残渣
にクロロホルム−メタノール 1:1の混合溶媒を加
え、不溶物を濾去後濾液を減圧下濃縮乾固し、残渣をエ
ーテルで洗浄して目的化合物(88mg)を無色粉末として
得た。
"Amberlite IRC-50" was added to the reaction solution, the insoluble matter was filtered off, and the filtrate was concentrated to dryness under reduced pressure. A mixed solvent of chloroform-methanol 1: 1 was added to the residue, the insoluble material was filtered off, the filtrate was concentrated to dryness under reduced pressure, and the residue was washed with ether to obtain the target compound (88 mg) as a colorless powder.

【0297】[α]D −34.7°(C 0.78,MeO
H).1 H−NMR(CD3 OD)δ:1.21(3H,d,J=
6.6 Hz),1.44(9H,s),1.85−1.94(1H,
m),2.01(3H,s),1.97−2.06(1H,m),2.
31(2H,m),2.85(1H,dd,J=4.2 Hz,1
2.2Hz). 実施例32 本実施例における反応を図24に示す。
[Α] D −34.7 ° (C 0.78, MeO
H). 1 H-NMR (CD 3 OD) δ: 1.21 (3 H, d, J =
6.6 Hz), 1.44 (9H, s), 1.85-1.94 (1H,
m), 2.01 (3H, s), 1.97-2.06 (1H, m), 2.
31 (2H, m), 2.85 (1H, dd, J = 4.2 Hz, 1
2.2 Hz). Example 32 The reaction in this example is shown in FIG.

【0298】(a) 化合物32−1の合成 化合物31−7(150mg )に氷冷下トリフルオロ酢酸(2
ml)を加え、同温で1時間撹拌した。反応液を減圧下濃
縮乾固し、目的化合物を得た。このものは精製すること
なく次の反応に用いた。
(A) Synthesis of Compound 32-1 Compound 31-7 (150 mg) was added to trifluoroacetic acid (2
ml) was added and the mixture was stirred at the same temperature for 1 hour. The reaction solution was concentrated to dryness under reduced pressure to obtain the target compound. This product was used in the next reaction without purification.

【0299】(b) 化合物32−2の合成 カルボン酸31−6(78mg)を塩化メチレン(10ml)に溶
解し、N−ヒドロキシスクシンイミド(14mg)とN,N
−ジシクロヘキシルカルボジイミド(25mg)を加え室温
で5時間撹拌した。反応混合物に塩化メチレン(15ml)
に溶解したアミン体化合物32−1とトリエチルアミンを
加え、室温で24時間撹拌した。
(B) Synthesis of Compound 32-2 Carboxylic acid 31-6 (78 mg) was dissolved in methylene chloride (10 ml) to prepare N-hydroxysuccinimide (14 mg) and N, N.
-Dicyclohexylcarbodiimide (25 mg) was added, and the mixture was stirred at room temperature for 5 hours. Methylene chloride (15 ml) in the reaction mixture
The amine compound 32-1 dissolved in and triethylamine were added, and the mixture was stirred at room temperature for 24 hours.

【0300】不溶物を濾去し、濾液をクロロホルムで希
釈し、水、5%NaHCO3 水、水、10%クエン酸水、
及び水で順次洗浄し、乾燥後溶媒を減圧下留去した。残
渣をシリカゲル(30g)を用いるカラムクロマトグラフ
ィー(クロロホルム−メタノール 25:1)で精製し、
目的化合物(130mg )を無色油状物として得た。
The insoluble matter was removed by filtration, the filtrate was diluted with chloroform, and water, 5% NaHCO 3 water, water, 10% citric acid water,
And successively washed with water and dried, and the solvent was distilled off under reduced pressure. The residue was purified by column chromatography (chloroform-methanol 25: 1) using silica gel (30 g),
The target compound (130 mg) was obtained as a colorless oil.

【0301】[α]D −38.5°(c 0.88,CHC
3 ).1 H−NMR(CDCl3 )δ:1.14(6H,d,J=
6.5 Hz),1.42(9H,s),1.85(3H,s),1.
99(6H,s,CH3 CO×2),2.04(3H,s,C
3 CO),2.04(3H,s,CH3 CO),2.07(3
H,s,CH3CO),2.08(3H,s),2.14(3
H,s),2.14(3H,s),2.17(3H,s),2.17
(3H,s),2.24−2.44(4H,m),2.66(1H,
dd,J=4.6 Hz,12.7Hz),3.32−3.70(33H,
m),3.81(3H,s),3.76−3.89(3H,m),4.
03−4.15(4H,m),4.18−4.25(2H,m),4.39
(1H,dd,J=2.0 Hz,11.5Hz9,4.43−4.50
(1H,m),4.92(1H,m),5.09−5.14(4H,
m),5.28−5.32(2H,m),5.33−5.40(4H,
m). (c) 化合物32−3の合成 化合物32−2(116mg )をメタノール(2ml)に溶解
し、28%ナトリウムメトキシドメタノール溶液(20μ
l)を加え、室温で2時間撹拌した。反応液を減圧下濃
縮乾固し、残渣に0.1 N NaOH水(4ml)を加え、
室温で4時間撹拌した。
[Α] D −38.5 ° (c 0.88, CHC
l 3 ). 1 H-NMR (CDCl 3 ) δ: 1.14 (6H, d, J =
6.5 Hz), 1.42 (9H, s), 1.85 (3H, s), 1.
99 (6H, s, CH 3 CO × 2), 2.04 (3H, s, C
H 3 CO), 2.04 (3H, s, CH 3 CO), 2.07 (3
H, s, CH 3 CO), 2.08 (3H, s), 2.14 (3
H, s), 2.14 (3H, s), 2.17 (3H, s), 2.17
(3H, s), 2.24-2.44 (4H, m), 2.66 (1H,
dd, J = 4.6 Hz, 12.7 Hz), 3.32-3.70 (33 H,
m), 3.81 (3H, s), 3.76-3.89 (3H, m), 4.
03-4.15 (4H, m), 4.18-4.25 (2H, m), 4.39
(1H, dd, J = 2.0 Hz, 11.5 Hz 9, 4.43-4.50
(1H, m), 4.92 (1H, m), 5.09-5.14 (4H,
m), 5.28-5.32 (2H, m), 5.33-5.40 (4H,
m). (c) Synthesis of Compound 32-3 Compound 32-2 (116 mg) was dissolved in methanol (2 ml), and 28% sodium methoxide methanol solution (20 μm was added.
1) was added, and the mixture was stirred at room temperature for 2 hours. The reaction mixture was concentrated to dryness under reduced pressure, 0.1 N NaOH aqueous solution (4 ml) was added to the residue,
Stir at room temperature for 4 hours.

【0302】反応液に「アンバーライトIRC−50」を
加え、不溶物を濾去後濾液を減圧下濃縮乾固した。残渣
にクロロホルム−メタノール 1:1の混合溶媒を加
え、不溶物を濾去後濾液を減圧下濃縮乾固し、残渣をエ
ーテルで洗浄して目的化合物(80mg)を無色粉末として
得た。
"Amberlite IRC-50" was added to the reaction solution, the insoluble material was filtered off, and the filtrate was concentrated to dryness under reduced pressure. A mixed solvent of chloroform-methanol 1: 1 was added to the residue, the insoluble material was filtered off, the filtrate was concentrated to dryness under reduced pressure, and the residue was washed with ether to obtain the target compound (80 mg) as a colorless powder.

【0303】[α]D −30.4°(C 1.05,MeO
H).1 H−NMR(CDCl3 )δ:1.22(6H,d,J=
6.5 Hz),1.44(9H,s),2.02(3H,s),2.
85(1H,dd,J=4.4 Hz,12.2Hz). 実施例33 本実施例における反応を図25に示す。
[Α] D −30.4 ° (C 1.05, MeO
H). 1 H-NMR (CDCl 3 ) δ: 1.22 (6H, d, J =
6.5 Hz), 1.44 (9H, s), 2.02 (3H, s), 2.
85 (1H, dd, J = 4.4 Hz, 12.2 Hz). Example 33 The reaction in this example is shown in FIG.

【0304】(a) 2−(Trimethylsilyl)ethyl O −
(methyl 5−Acetamido −4,7,8,9−tetra −
O −acetyl−3.5 −dideoxy −D −glycero −α−D −
galacto −2−nonulopyranosylonate)(2→3)−
2,4−di−O −acetyl−6−O−benzoyl −β−D −g
alactopyranoside (化合物33−1)の合成 J.Carbohydrate Chemistry, 8(2),265−283 (198
9)の記載に従って合成した。
(A) 2- (Trimethylsilyl) ethyl O −
(Methyl 5-Acetamido-4,7,8,9-tetra-
O −acetyl−3.5 −dideoxy −D −glycero −α−D −
galacto-2-nonulopyranosylonate) (2 → 3)-
2,4-di-O-acetyl-6-O-benzoyl-β-D-g
Synthesis of alactopyranoside (Compound 33-1) J. Carbohydrate Chemistry, 8 (2), 265-283 (198
It was synthesized as described in 9).

【0305】(b) 化合物33−2の合成 化合物33−1(2.00g)を塩化メチレン(30ml)に溶解
し、三フッ化ホウ素ジエチルエーテル錯体(1.30ml)を
加え、0℃で5時間撹拌した。反応液を塩化メチレンに
希釈し、飽和炭酸水素ナトリウム水溶液で洗浄し、乾燥
後溶媒を減圧下留去した。次いで、得られた残渣を塩化
メチレン(15ml)に溶解し、トリクロロアセトニトリル
(5ml)及び1,8−ジアザビシクロ[5.4.0]−
7−ウンデンセン(160 μl)を順次加えて、0℃で30
分撹拌した。
(B) Synthesis of Compound 33-2 Compound 33-1 (2.00 g) was dissolved in methylene chloride (30 ml), boron trifluoride diethyl ether complex (1.30 ml) was added, and the mixture was stirred at 0 ° C. for 5 hours. did. The reaction mixture was diluted with methylene chloride, washed with saturated aqueous sodium hydrogen carbonate solution, dried and the solvent was evaporated under reduced pressure. Then, the obtained residue was dissolved in methylene chloride (15 ml), trichloroacetonitrile (5 ml) and 1,8-diazabicyclo [5.4.0]-
Add 7-undensen (160 μl) sequentially and add 30 ° C at 0 ° C.
Stir for minutes.

【0306】反応液は減圧下濃縮した後、シリカゲル
(90g)を用いるカラムクロマトグラフィー(塩化メチ
レン−メタノール 50:1)で精製し、目的化合物(1.
83g)をα及びβが1:1の混合物として得た。なお、
1H−NMRは、α及びβ各々の1H分を1Hと表示す
る。
The reaction solution was concentrated under reduced pressure and then purified by column chromatography using silica gel (90 g) (methylene chloride-methanol 50: 1) to obtain the desired compound (1.
83 g) was obtained as a mixture of α and β of 1: 1. In addition,
1 H-NMR displays 1 H for each of α and β as 1 H.

【0307】1H−NMR(CDCl3 )δ:8.67,8.6
2(each s),8.03−7.99(4H,m),7.57−7.52
(2H,m),7.44−7.38(4H,m),6.56(1H,
d,J=3.9 Hz),5.99(1H,d,J=8.3 H
z),5.57(1H,ddd,J=8.8 ,6.1 ,2.4 H
z),5.47(1H,ddd,J=9.5 ,4.2 ,3.2 H
z),5.38−5.29(5H,m),5.14(1H,d,J=
3.4 Hz),5.11(1H,d,J=10.0),5.07(1
H,dd,J=10.3,3.4 Hz),5.06(1H,d,J
=10.5Hz),4.93(1H,ddd,J=12.3,10.5,
4.7 Hz),4.89(1H,ddd,12.3,10.5,4.6 H
z),4.79(1H,dd,J=10.3,3.4 Hz),4.58
(1H,dd,J=6.8 ,6.4 Hz),4.45−4.36(3
H,m),4.28−4.17(4H,m),4.12(1H,d
d,J=12.5,4.2 Hz),4.05(1H,m),4.02−
3.94(2H,m),3.75(1H,dd,J=10.7,2.2
Hz),3.65(1H,dd,J=10.7,2.7 Hz),2.
61(1H,dd,J=12.9,4.6 Hz),2.51(1H,
dd,J=12.7,4.6 Hz),1.73(1H,dd,J=
12.7,12.3Hz),1.71(1H,dd,J=12.9,12.3
Hz),3.79,3.78,2.18,2.15,2.13,2.13,2.11,
2.04,2.03,2.01,2.00,1.87,1.85,(each 3H,
s). (c) 化合物33−3の合成 「モレキュラーシーブズ4A」(4g)を含む塩化メチ
レン(10ml)に化合物33−2(300mg )及び2−[2−
(2−アジドエトキシ)エトキシ]エタノール(160mg
)を溶解し、室温で2時間撹拌した後、0℃で三フッ
化ホウ素ジエチルエーテル錯体(112 μl)を加え、同
温度で1時間撹拌した。
1 H-NMR (CDCl 3 ) δ: 8.67, 8.6
2 (each s), 8.03-7.99 (4H, m), 7.57-7.52
(2H, m), 7.44-7.38 (4H, m), 6.56 (1H,
d, J = 3.9 Hz), 5.99 (1H, d, J = 8.3 H)
z), 5.57 (1H, ddd, J = 8.8, 6.1, 2.4H
z), 5.47 (1H, ddd, J = 9.5, 4.2, 3.2H
z), 5.38-5.29 (5H, m), 5.14 (1H, d, J =
3.4 Hz), 5.11 (1H, d, J = 10.0), 5.07 (1
H, dd, J = 10.3, 3.4 Hz), 5.06 (1H, d, J
= 10.5Hz), 4.93 (1H, ddd, J = 12.3, 10.5,
4.7 Hz), 4.89 (1H, ddd, 12.3, 10.5, 4.6 H
z), 4.79 (1H, dd, J = 10.3, 3.4 Hz), 4.58
(1H, dd, J = 6.8, 6.4 Hz), 4.45-4.36 (3
H, m), 4.28-4.17 (4H, m), 4.12 (1H, d
d, J = 12.5, 4.2 Hz), 4.05 (1H, m), 4.02-
3.94 (2H, m), 3.75 (1H, dd, J = 10.7,2.2
Hz), 3.65 (1H, dd, J = 10.7, 2.7 Hz), 2.
61 (1H, dd, J = 12.9, 4.6 Hz), 2.51 (1H,
dd, J = 12.7, 4.6 Hz), 1.73 (1H, dd, J =
12.7, 12.3Hz), 1.71 (1H, dd, J = 12.9, 12.3
Hz), 3.79, 3.78, 2.18, 2.15, 2.13, 2.13, 2.11,
2.04, 2.03, 2.01, 2.00, 1.87, 1.85, (each 3H,
s). (c) Synthesis of Compound 33-3 Compound 33-2 (300 mg) and 2- [2-] in methylene chloride (10 ml) containing "Molecular Sieves 4A" (4 g).
(2-azidoethoxy) ethoxy] ethanol (160mg
) Was dissolved and the mixture was stirred at room temperature for 2 hours, then boron trifluoride diethyl ether complex (112 μl) was added at 0 ° C., and the mixture was stirred at the same temperature for 1 hour.

【0308】反応液はセライト濾過した後、濾液を飽和
炭酸水素ナトリウム水溶液で洗浄し、乾燥後溶媒を減圧
下留去した。残渣をシリカゲル(20g)を用いるカラム
クロマトグラフィー(トルエンーアセトン 3:1)で
精製し、目的化合物(219mg)を無色油状物として得
た。
The reaction solution was filtered through Celite, the filtrate was washed with a saturated aqueous solution of sodium hydrogen carbonate, dried and the solvent was distilled off under reduced pressure. The residue was purified by column chromatography using silica gel (20 g) (toluene-acetone 3: 1) to obtain the target compound (219 mg) as a colorless oil.

【0309】[α]D 27−17.0°(c 1.03,CHCl
3 ). IR(CHCl3 ):1744,1690cm-11 H−NMR(CDCl3 )δ:8.03(2H,d,J=
7.0 Hz),7.57(1H,m),7.44(1H,m),5.
56(1H,ddd,9.3 ,5.4 ,2.7 Hz),5.38(1
H,dd,9.3 ,2.7 ),5.09(1H,br.d,J=
11.5Hz),5.07(1H,dd,J=10.3,8.1 H
z),5.06(1H,br.d),4.89(1H,m),4.
69(1H,d,J=8.1 Hz),4.61(1H,dd,J
=10.3,3.4Hz),4.43(1H,dd,J=11.2,6.6
Hz),4.35(1H,dd,J=12.7,2.7 Hz),
4.22(1H,dd,11.2,6.8 Hz),4.08−3.98(4
H,m),3.77(1H,m),3.77(3H,s),3.71
−3.61(9H,m),3.39(2H,t,J=5.0 H
z),2.59(1H,dd,J=12.7,4.6 Hz),1.72
(1H,dd,J=12.7,12.3Hz),2.22,2.13,2.
12,2.09,2.06,2.01,1.86(each 3H,s). (d) 化合物33−4の合成 化合物33−3(90mg)とパラトルエンスルホン酸(17.5
mg)を溶解したメタノール(5ml)溶液に、リンドラー
触媒(70mg)を加え、中圧水素気流下(50psi)室温
で、2時間撹拌した。続いて、同触媒(70mg)を更に加
え、同条件で1時間撹拌した。
[Α] D 27 -17.0 ° (c 1.03, CHCl
3 ). IR (CHCl 3 ): 1744, 1690 cm −1 . 1 H-NMR (CDCl 3 ) δ: 8.03 (2H, d, J =
7.0 Hz), 7.57 (1H, m), 7.44 (1H, m), 5.
56 (1H, ddd, 9.3, 5.4, 2.7 Hz), 5.38 (1
H, dd, 9.3, 2.7), 5.09 (1H, br.d, J =
11.5Hz), 5.07 (1H, dd, J = 10.3, 8.1H
z), 5.06 (1H, br.d), 4.89 (1H, m), 4.
69 (1H, d, J = 8.1 Hz), 4.61 (1H, dd, J
= 10.3, 3.4Hz), 4.43 (1H, dd, J = 11.2, 6.6)
Hz), 4.35 (1H, dd, J = 12.7, 2.7 Hz),
4.22 (1H, dd, 11.2, 6.8 Hz), 4.08-3.98 (4
H, m), 3.77 (1H, m), 3.77 (3H, s), 3.71
-3.61 (9H, m), 3.39 (2H, t, J = 5.0H
z), 2.59 (1H, dd, J = 12.7, 4.6 Hz), 1.72
(1H, dd, J = 12.7, 12.3Hz), 2.22, 2.13, 2.
12, 2.09, 2.06, 2.01, 1.86 (each 3H, s). (d) Synthesis of Compound 33-4 Compound 33-3 (90 mg) and paratoluenesulfonic acid (17.5
Lindlar catalyst (70 mg) was added to a solution of methanol (5 ml) in which (mg) was dissolved, and the mixture was stirred at room temperature under a medium-pressure hydrogen stream (50 psi) for 2 hours. Subsequently, the same catalyst (70 mg) was further added, and the mixture was stirred under the same conditions for 1 hour.

【0310】反応液より触媒を濾去した後、濾液を減圧
下濃縮して、目的化合物(103mg )を粗生成物として得
た。
After removing the catalyst from the reaction solution by filtration, the filtrate was concentrated under reduced pressure to obtain the desired compound (103 mg) as a crude product.

【0311】(e) 化合物33−5の合成 化合物31−6(71mg)を塩化メチレン(1.5ml )に溶解
し、N−ヒドロキシスシンイミド(12.5mg)とN,N′
−ジシクロヘキシルカルボジイミド(22.5mg)を加え、
0℃で3時間撹拌した。反応混合物に化合物33−4(10
3mg )とトリエチルアミン(13μl)を溶解した塩化メ
チレン(1.5ml )溶液を加え、室温で4時間撹拌した。
(E) Synthesis of compound 33-5 Compound 31-6 (71 mg) was dissolved in methylene chloride (1.5 ml), and N-hydroxysuccinimide (12.5 mg) and N, N 'were added.
-Dicyclohexylcarbodiimide (22.5 mg) was added,
Stirred at 0 ° C. for 3 hours. Compound 33-4 (10
A methylene chloride (1.5 ml) solution in which 3 mg) and triethylamine (13 μl) were dissolved was added, and the mixture was stirred at room temperature for 4 hours.

【0312】不溶物を濾去し、濾液を塩化メチレンで希
釈し、飽和食塩水で洗浄し、乾燥後溶媒を減圧下留去し
た。残渣をシリカゲル(20g)を用いるカラムクロマト
グラフィー(塩化メチレン−メタノール 25:1)で精
製し、目的化合物(96mg)を無色油状物として得た。
The insoluble material was filtered off, the filtrate was diluted with methylene chloride, washed with saturated brine, dried and the solvent was evaporated under reduced pressure. The residue was purified by column chromatography using silica gel (20 g) (methylene chloride-methanol 25: 1) to obtain the target compound (96 mg) as a colorless oil.

【0313】[α]D 27−38.6°(c 1.05,CHCl
3 ). IR(CHCl3 ):1744,1690cm-11 H−NMR(CDCl3 )δ:8.03(2H,d,J=
8.0 Hz),7.57(1H,m),6.77(1H,br.
s),5.71(1H,br.d,J=7.3 Hz),5.56
(1H,ddd,J=9.3 ,5.6 ,2.7 Hz),5.37
(1H,dd,J=9.3 ,2.7 Hz),5.35(1H,d
d,J=10.5,3.4 Hz),5.29(1H,dd,J=3.
4 ,1.2 Hz),5.16(1H,d,10.3Hz),5.13−
5.10(2H,m),5.06(1H,d,J=3.2 Hz),
5.05(1H,dd,J=10.3,8.0 Hz),4.90(1
H,ddd,J=12.3,10.5,4.6 Hz),4.67(1
H,d,J=8.1 Hz),4.61(1H,dd,J=10.
3,3.4 Hz),4.44(1H,dd,J=11.0,6.6 H
z),4.36(1H,dd,J=12.2,2.7 Hz),4.21
(1H,dd,J=11.0,6.9 Hz),4.21(1H,
m),4.12(1H,m),4.07−3.97(4H,m),3.
80(2H,m),3.69−3.54(18H,m),3.51−3.40
(4H,m),2.69(1H,dd,J=12.7,4.6 H
z),2.35(1H,m),2.27(1H,m),1.71(1
H,dd,J=12.7,12.3Hz),1.13(3H,d,J
=6.6 Hz),3.77,2.22,2.16,2.13,2.12,2.09,
2.07,2.05,2.01,1.99,1.85(each 3H,s),1.
43(9H,s). (f) 化合物33−6の合成 化合物33−5(60mg)が溶解したメタノール(1ml)溶
液に、3%ナトリウムメトキシド−メタノール溶液(20
0 μl)を加え、室温で2時間撹拌した。反応液に「ア
ンバーライトIRC−50」を加え、不溶物を濾去後濾液
を減圧下濃縮した。次いで得られた残渣に0.1 N水酸化
ナトリウム水溶液(1ml)を加え、室温で3時間撹拌し
た。
[Α] D 27 -38.6 ° (c 1.05, CHCl
3 ). IR (CHCl 3 ): 1744, 1690 cm −1 . 1 H-NMR (CDCl 3 ) δ: 8.03 (2H, d, J =
8.0 Hz), 7.57 (1H, m), 6.77 (1H, br.
s), 5.71 (1H, br.d, J = 7.3 Hz), 5.56
(1H, ddd, J = 9.3, 5.6, 2.7 Hz), 5.37
(1H, dd, J = 9.3, 2.7 Hz), 5.35 (1H, d
d, J = 10.5, 3.4 Hz), 5.29 (1H, dd, J = 3.
4, 1.2 Hz), 5.16 (1H, d, 10.3 Hz), 5.13-
5.10 (2H, m), 5.06 (1H, d, J = 3.2 Hz),
5.05 (1H, dd, J = 10.3, 8.0 Hz), 4.90 (1
H, ddd, J = 12.3, 10.5, 4.6 Hz), 4.67 (1
H, d, J = 8.1 Hz), 4.61 (1H, dd, J = 10.
3,3.4 Hz), 4.44 (1H, dd, J = 11.0,6.6H
z), 4.36 (1H, dd, J = 12.2, 2.7 Hz), 4.21
(1H, dd, J = 11.0, 6.9 Hz), 4.21 (1H,
m), 4.12 (1H, m), 4.07-3.97 (4H, m), 3.
80 (2H, m), 3.69-3.54 (18H, m), 3.51-3.40
(4H, m), 2.69 (1H, dd, J = 12.7, 4.6 H
z), 2.35 (1H, m), 2.27 (1H, m), 1.71 (1
H, dd, J = 12.7, 12.3 Hz), 1.13 (3H, d, J
= 6.6 Hz), 3.77, 2.22, 2.16, 2.13, 2.12, 2.09,
2.07, 2.05, 2.01, 1.99, 1.85 (each 3H, s), 1.
43 (9H, s). (f) Synthesis of compound 33-6 A solution of compound 33-5 (60 mg) in methanol (1 ml) dissolved in 3% sodium methoxide-methanol solution (20
0 μl) was added, and the mixture was stirred at room temperature for 2 hours. "Amberlite IRC-50" was added to the reaction solution, the insoluble material was filtered off, and the filtrate was concentrated under reduced pressure. Then, a 0.1 N sodium hydroxide aqueous solution (1 ml) was added to the obtained residue and the mixture was stirred at room temperature for 3 hours.

【0314】その後、「アンバーライトIRC−50」に
よる中和、不溶物の濾去、濾液の減圧下濃縮、および
「セファデックスLH−20」(45g)を用いたカラムク
ロマトグラフィー(メタノール)による精製により目的
化合物(37mg)を白色粉末として得た。
Then, neutralization with "Amberlite IRC-50", filtration of insoluble matter, concentration of the filtrate under reduced pressure, and purification by column chromatography (methanol) using "Sephadex LH-20" (45 g). Thus, the target compound (37 mg) was obtained as a white powder.

【0315】[α]D 27−18.2°(c 0.53,MeO
H).1 H−NMR(D2 O)δ:4.87(1H,d,J=3.7
Hz),4.47(1H,d,J=7.8 Hz),4.10−4.03
(2H,m),3.98−3.52(37H,m),3.43−3.35
(3H,m),2.73(1H,dd,J=12.3,4.6 H
z),2.34(2H,m),2.02(1H,m),2.01(3
H,s),1.88(1H,m),1.79(1H,dd,J=
12.3,12.0Hz),1.41(9H,s),1.19(3H,
d,J=6.6 Hz). 検査例1(水溶性の検査) 下記構造式Aで示される化合物はクロロホルム−メタノ
ール系溶媒には全く溶解しなかったが、下記構造式Bで
示される本発明の化合物は、脂肪鎖部分がより大きくな
っているにも拘わらず、同じ溶媒に10mg/mlの濃度で容
易に溶解した。このようにポリエチレングリコール部を
化合物中に導入することにより溶解性の改善を図ること
ができた。
[Α] D 27 -18.2 ° (c 0.53, MeO
H). 1 H-NMR (D 2 O) δ: 4.87 (1 H, d, J = 3.7
Hz), 4.47 (1H, d, J = 7.8 Hz), 4.10-4.03
(2H, m), 3.98-3.52 (37H, m), 3.43-3.35
(3H, m), 2.73 (1H, dd, J = 12.3, 4.6 H
z), 2.34 (2H, m), 2.02 (1H, m), 2.01 (3
H, s), 1.88 (1H, m), 1.79 (1H, dd, J =
12.3, 12.0Hz), 1.41 (9H, s), 1.19 (3H,
d, J = 6.6 Hz). Test Example 1 (Water Solubility Test) The compound represented by the following structural formula A was not dissolved at all in a chloroform-methanol solvent, but the compound of the present invention represented by the following structural formula B was Despite being large, it easily dissolved in the same solvent at a concentration of 10 mg / ml. Thus, by introducing the polyethylene glycol part into the compound, the solubility could be improved.

【0316】[0316]

【化5】 実施例34(微粒子キャリヤーの調製) L−α−ジパルミトイルフォスファチジルコリン80μmo
l 、コレステロール80μmol 、及び化合物3−8、4−
3、7−6または8−2、16μmol をクロロホルムおよ
びメタノールの混液(容積比1:1)に溶かした。次
に、窒素ガス気流中で有機溶媒を除去して遠沈管のガラ
ス壁にリピッドフィルムを生成させた。
[Chemical 5] Example 34 (Preparation of fine particle carrier) L-α-dipalmitoylphosphatidylcholine 80 μmo
l, cholesterol 80 μmol, and compounds 3-8, 4-
3, 7-6 or 8-2, 16 µmol was dissolved in a mixed solution of chloroform and methanol (volume ratio 1: 1). Next, the organic solvent was removed in a nitrogen gas stream to form a lipid film on the glass wall of the centrifuge tube.

【0317】ここに予め45℃に加温した 3H−イヌリン
5.29MBq(160 μCi)を含有する1mMイヌリンの
リン酸緩衝化生理食塩水(pH7.4 。以下、PBSと略す
ることがある)8mlを加えて約50℃に保温しながら振盪
し、更に軽く超音波処理してリポソームの懸濁液を調製
した。これを60℃に加温し、0.2 μm、0.1 μm及び0.
08μmの孔径を有するポリカーボネート製メンブランフ
ィルターを順に通過させ、粒径約0.08μmのリポソーム
の懸濁液を調製した。
Here, 3 H-inulin preheated to 45 ° C.
Add 8 ml of 1 mM inulin phosphate-buffered saline (pH 7.4; sometimes abbreviated as PBS hereinafter) containing 5.29 MBq (160 μCi), shake at a temperature of about 50 ° C, and shake lightly. A liposome suspension was prepared by sonication. This is heated to 60 ℃, 0.2 μm, 0.1 μm and 0.
It was passed through a polycarbonate membrane filter having a pore size of 08 μm in order to prepare a liposome suspension having a particle size of about 0.08 μm.

【0318】次にこれを3回超遠心分離し(1回目は10
5 ×gで14時間、2および3回目は105 ×gで2時
間)、上澄液を除去することによりリポソームに保持さ
れなかったイヌリンを除去し、PBSを加えて全量6ml
のリポソーム懸濁液を4種得た。
Then, this was subjected to ultracentrifugation three times (10 times for the first time).
14 hours 5 × g, 2 h 2 and the third time 10 5 × g), to remove the inulin was not retained in the liposomes by removing the supernatant, the total amount added to PBS 6 ml
4 types of liposome suspensions were obtained.

【0319】また、化合物を配合しないで、上記と同様
にして全量6mlのリポソーム懸濁液を得た。これをコン
トロールリポソームとした。
Further, a liposome suspension having a total amount of 6 ml was obtained in the same manner as described above without compounding. This was used as a control liposome.

【0320】検査例2(微粒子キャリヤーの薬物送達
能) イ.試験方法 実施例34で調製した5種の試料をそれぞれSD系雄性ラ
ット(体重200 〜250g)の後肢静脈より体重100 g当
たりL−α−ジパルミトイルフォスファチジルコリンお
よびコレステロールの合計として5μmol を注入した。
Test Example 2 (Drug Delivery Ability of Microparticle Carrier) a. Test method The 5 samples prepared in Example 34 were each injected from the hindlimb vein of SD male rats (body weight: 200 to 250 g) in an amount of 5 μmol as a total of L-α-dipalmitoylphosphatidylcholine and cholesterol per 100 g of body weight. did.

【0321】投与後15分、30分、1時間、2時間、4時
間及び6時間目に頸静脈より血液を約0.2ml 採血し、遠
心後血漿0.1ml を濾紙に取り、乾燥後燃焼装置にて燃焼
し、液体シンチレーション法によりその放射活性を求め
た。また、投与後6時間目にラットを屠殺し、各種組織
を各約200mg 採り、乾燥後燃焼装置にて燃焼し、液体シ
ンチレーション法によりその放射活性を求め、各臓器1
g当たりのイヌリン濃度を求めた。
Approximately 0.2 ml of blood was collected from the jugular vein at 15 minutes, 30 minutes, 1 hour, 2 hours, 4 hours and 6 hours after administration, and 0.1 ml of plasma was collected on a filter paper after centrifugation and dried on a combustion device. Then, the radioactivity was determined by liquid scintillation method. Rats were sacrificed 6 hours after the administration, various tissues (about 200 mg each) were dried, burned in a burning device, and the radioactivity was determined by liquid scintillation method.
The inulin concentration per gram was determined.

【0322】ロ.結果と考察 図26に示すように、脾蔵中の濃度がコントロールに対し
化合物3−8、4−3、7−6及び8−2を使用したも
のはいずれも低下したことより、これらの化合物を有す
るリポソームはいずれも細網内皮系組織を回避している
ことが明らかになった。
B. Results and Discussion As shown in FIG. 26, the concentration in the spleen was decreased in all of the compounds 3-8, 4-3, 7-6 and 8-2 compared with the control, and therefore these compounds were It was clarified that all liposomes having circadian circumscription avoid the reticuloendothelial system tissue.

【0323】[0323]

【発明の効果】従来の微粒子キャリヤーは細網内皮系組
織に捕捉され、血液中の滞留時間が短かかった。本発明
の酸性官能基を有する脂質誘導体により被覆された微粒
子キャリヤーは細網内皮系組織に捕捉されがたく、薬剤
キャリヤーとして有益である。
EFFECTS OF THE INVENTION The conventional fine particle carrier has been trapped in the reticuloendothelial tissue and has a short residence time in blood. The fine particle carrier coated with the lipid derivative having an acidic functional group of the present invention is not easily trapped by the reticuloendothelial system tissue and is useful as a drug carrier.

【図面の簡単な説明】[Brief description of drawings]

【図1】実施例1および2における反応を示す。FIG. 1 shows the reactions in Examples 1 and 2.

【図2】実施例3および4における反応を示す。FIG. 2 shows the reactions in Examples 3 and 4.

【図3】実施例5における反応を示す。FIG. 3 shows the reaction in Example 5.

【図4】実施例6における反応を示す。FIG. 4 shows the reaction in Example 6.

【図5】実施例7および8における反応を示す。FIG. 5 shows the reactions in Examples 7 and 8.

【図6】実施例9および10における反応を示す。FIG. 6 shows the reactions in Examples 9 and 10.

【図7】実施例11における反応を示す。FIG. 7 shows the reaction in Example 11.

【図8】実施例12における反応を示す。FIG. 8 shows the reaction in Example 12.

【図9】実施例13における反応を示す。FIG. 9 shows the reaction in Example 13.

【図10】実施例14および15における反応を示す。FIG. 10 shows the reaction in Examples 14 and 15.

【図11】実施例16おける反応を示す。FIG. 11 shows the reaction in Example 16.

【図12】実施例17および18における反応を示す。FIG. 12 shows the reactions in Examples 17 and 18.

【図13】実施例19および20における反応を示す。FIG. 13 shows the reactions in Examples 19 and 20.

【図14】実施例21における反応を示す。FIG. 14 shows the reaction in Example 21.

【図15】実施例22および23における反応を示す。FIG. 15 shows the reaction in Examples 22 and 23.

【図16】実施例24における反応を示す。16 shows the reaction in Example 24. FIG.

【図17】実施例25における反応を示す。FIG. 17 shows the reaction in Example 25.

【図18】実施例26における反応を示す。FIG. 18 shows the reaction in Example 26.

【図19】実施例27における反応を示す。FIG. 19 shows the reaction in Example 27.

【図20】実施例28における反応を示す。FIG. 20 shows the reaction in Example 28.

【図21】実施例29における反応を示す。FIG. 21 shows the reaction in Example 29.

【図22】実施例30における反応を示す。22 shows the reaction in Example 30. FIG.

【図23】実施例31における反応を示す。23 shows the reaction in Example 31. FIG.

【図24】実施例32における反応を示す。FIG. 24 shows the reaction in Example 32.

【図25】実施例33における反応を示す。FIG. 25 shows the reaction in Example 33.

【図26】検査例2における結果を示す。FIG. 26 shows the results of inspection example 2.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 佐々木 淳 茨城県つくば市春日4−19−13 エーザイ 紫山寮 (72)発明者 村橋 直一 茨城県北相馬郡守谷町松前台7−2−4 (72)発明者 阪上 昌浩 千葉県柏市明原4−4−4 インペリアル レジデンス102 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Jun Sasaki 4-19-13 Kasuga, Tsukuba, Ibaraki Prefecture Eisai Shiyama Dormitory (72) Inventor Naoichi Murahashi 7-2-4 Matsumaedai, Moriya-cho, Kitasoma-gun, Ibaraki ( 72) Inventor Masahiro Sakagami 4-4-4 Meihara, Kashiwa City, Chiba Imperial Residence 102

Claims (10)

【特許請求の範囲】[Claims] 【請求項1】 エチレングリコールの重合度が3以上の
ポリエチレングリコール鎖の一端に1個または複数個の
酸性官能基を有する化合物が付加されかつ他端に1個ま
たは複数個の炭素原子数5以上のアルキル基および/ま
たはアルケニル基を有する化合物が付加されてなる酸性
官能基を有する脂質誘導体。
1. A polyethylene glycol chain having a degree of polymerization of ethylene glycol of 3 or more is added with one or more compounds having an acidic functional group at one end and one or more carbon atoms having 5 or more carbon atoms at the other end. A lipid derivative having an acidic functional group, which is formed by adding a compound having an alkyl group and / or an alkenyl group.
【請求項2】 該酸性官能基を有する化合物が、酸性官
能基を有する糖である請求項1記載の酸性官能基を有す
る脂質誘導体。
2. The lipid derivative having an acidic functional group according to claim 1, wherein the compound having an acidic functional group is a sugar having an acidic functional group.
【請求項3】 該酸性官能基を有する糖が、ガラクトー
ス、フコース、マンノース及びグルコースならびにこれ
らの誘導体から選ばれる1個または複数個の糖である請
求項2記載の酸性官能基を有する脂質誘導体。
3. The lipid derivative having an acidic functional group according to claim 2, wherein the sugar having an acidic functional group is one or more sugars selected from galactose, fucose, mannose, glucose and derivatives thereof.
【請求項4】 該酸性官能基を有する化合物が、分子内
にシアル酸およびウロン酸の1個もしくは複数個を有す
る化合物であるかまたはシアル酸もしくはウロン酸であ
る請求項1記載の酸性官能基を有する脂質誘導体。
4. The acidic functional group according to claim 1, wherein the compound having the acidic functional group is a compound having one or more of sialic acid and uronic acid in the molecule, or sialic acid or uronic acid. A lipid derivative having
【請求項5】 該酸性官能基を有する化合物が、燐酸、
燐酸残基を有する化合物、硫酸、硫酸残基を有する化合
物、フォスフェン酸、フォスフォン酸、スルフォン酸、
スルフィン酸、スルフェン酸またはカルボン酸である請
求項1〜3のいずれかに記載の酸性官能基を有する脂質
誘導体、
5. The compound having an acidic functional group is phosphoric acid,
Compounds having a phosphoric acid residue, sulfuric acid, compounds having a sulfuric acid residue, phosphenic acid, phosphonic acid, sulfonic acid,
A lipid derivative having an acidic functional group according to any one of claims 1 to 3, which is sulfinic acid, sulfenic acid, or a carboxylic acid.
【請求項6】 該酸性官能基が、燐酸残基、硫酸残基、
フォスフェニル基、フォスフォニル基、スルフォニル
基、スルフィニル基、スルフェニル基またはカルボキシ
ル基である請求項1〜3のいずれかに記載の酸性官能基
を有する脂質誘導体。
6. The acidic functional group is a phosphoric acid residue, a sulfuric acid residue,
The lipid derivative having an acidic functional group according to claim 1, which is a phosphonyl group, a phosphonyl group, a sulfonyl group, a sulfinyl group, a sulfenyl group or a carboxyl group.
【請求項7】 該ポリエチレングリコールの重合度が3
〜10である請求項1〜6のいずれかに記載の酸性官能基
を有する脂質誘導体。
7. The degree of polymerization of the polyethylene glycol is 3.
The lipid derivative having an acidic functional group according to any one of claims 1 to 6, which is -10.
【請求項8】 該他端に付加されるアルキル基および/
またはアルケニル基が2個である請求項1〜7のいずれ
かに記載の酸性官能基を有する脂質誘導体。
8. An alkyl group added to the other end and /
Alternatively, the lipid derivative having an acidic functional group according to claim 1, which has two alkenyl groups.
【請求項9】 請求項1〜8のいずれかに記載の酸性官
能基を有する脂質誘導体により被覆された微粒子キャリ
ヤー。
9. A fine particle carrier coated with the lipid derivative having an acidic functional group according to claim 1.
【請求項10】 微粒子キャリヤーがリポソームである
請求項9記載の微粒子キャリヤー。
10. The fine particle carrier according to claim 9, wherein the fine particle carrier is a liposome.
JP4259090A 1992-09-02 1992-09-02 Lipid derivatives having acidic functional groups and fine particle carriers coated with the same Expired - Lifetime JP2710900B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4259090A JP2710900B2 (en) 1992-09-02 1992-09-02 Lipid derivatives having acidic functional groups and fine particle carriers coated with the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4259090A JP2710900B2 (en) 1992-09-02 1992-09-02 Lipid derivatives having acidic functional groups and fine particle carriers coated with the same

Publications (2)

Publication Number Publication Date
JPH0680686A true JPH0680686A (en) 1994-03-22
JP2710900B2 JP2710900B2 (en) 1998-02-10

Family

ID=17329180

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4259090A Expired - Lifetime JP2710900B2 (en) 1992-09-02 1992-09-02 Lipid derivatives having acidic functional groups and fine particle carriers coated with the same

Country Status (1)

Country Link
JP (1) JP2710900B2 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846951A (en) * 1991-06-06 1998-12-08 The School Of Pharmacy, University Of London Pharmaceutical compositions
EP0912587A1 (en) * 1996-05-20 1999-05-06 Texas Biotechnology Corporation High yield stereospecific mannosylation
JP2004505898A (en) * 2000-08-03 2004-02-26 ディ − ファーム リミテッド Derivatives of branched lipophilic molecules and their use
US7357321B2 (en) 1999-12-03 2008-04-15 Sega Corporation Card stack reader, card thereof, card case, method for manufacturing card, game machine using the same, computer-readable storage medium on which game program is recorded
JP2008184412A (en) * 2007-01-29 2008-08-14 Naoto Oku [18f]-labeling compound and its manufacturing method, and manufacturing method of [18f]-labeled liposome and [18f]-labeled liposome preparation
US8802654B2 (en) 2009-07-07 2014-08-12 Adenovir Pharma Ab Antiviral compounds

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846951A (en) * 1991-06-06 1998-12-08 The School Of Pharmacy, University Of London Pharmaceutical compositions
EP0912587A1 (en) * 1996-05-20 1999-05-06 Texas Biotechnology Corporation High yield stereospecific mannosylation
EP0912587A4 (en) * 1996-05-20 2001-12-19 Texas Biotechnology Corp High yield stereospecific mannosylation
US7357321B2 (en) 1999-12-03 2008-04-15 Sega Corporation Card stack reader, card thereof, card case, method for manufacturing card, game machine using the same, computer-readable storage medium on which game program is recorded
US7556197B2 (en) 1999-12-03 2009-07-07 Sega Corporation Card stack reader, card thereof, card case, method for manufacturing card, game machine using the same, computer-readable storage medium on which game program is recorded
US8382579B2 (en) 1999-12-03 2013-02-26 Sega Corporation Card for use with a game apparatus
JP2004505898A (en) * 2000-08-03 2004-02-26 ディ − ファーム リミテッド Derivatives of branched lipophilic molecules and their use
JP2008184412A (en) * 2007-01-29 2008-08-14 Naoto Oku [18f]-labeling compound and its manufacturing method, and manufacturing method of [18f]-labeled liposome and [18f]-labeled liposome preparation
US8802654B2 (en) 2009-07-07 2014-08-12 Adenovir Pharma Ab Antiviral compounds

Also Published As

Publication number Publication date
JP2710900B2 (en) 1998-02-10

Similar Documents

Publication Publication Date Title
US5763413A (en) Lewis-associated compound, process for producing the same, and anti-inflammatory
JP2854203B2 (en) Method for producing liposomes
JPH0826057B2 (en) Sialic acid oligosaccharide derivative and fine particle carrier
CN103788141A (en) Sulfated oligosaccharide derivatives
JP2774417B2 (en) Branched-chain saccharide complex having peptide skeleton and fine particle carrier
EP0489162A1 (en) Derivative of glycolipid containing sialic acid
JP2710900B2 (en) Lipid derivatives having acidic functional groups and fine particle carriers coated with the same
JP2774430B2 (en) Phospholipids and liposomes
JP2766141B2 (en) Acid sugar derivatives
AU595987B2 (en) Disaccharide derivatives
CN100365007C (en) New type trisaccharide and penta saccharid oligo saccharide antigen, their synthesis method and application in preparation of medicine for inhibiting exclusion reaction
CN106432371A (en) Beta-1,2-D-oligomeric mannoprotein conjugates and preparation method and application thereof
JP2004217630A (en) Dextrorotatory glucose lipid a analog
Ogawa et al. Synthesis and immunoadjuvant activity of the conjugates of 1-thio-N-acetyl-muramoyl dipeptide with lipid A subunit analogs
JPH07110872B2 (en) Acid glycolipid and fine particle carrier
JP2001348396A (en) Analogue of lipid carboxymethylated at a1 position
WO1997022615A1 (en) Fluorinated ganglioside gm3 analogues and intermediates therefor
WO2004058788A1 (en) Lipid a analogues having glucose as the right sugar
JP2774429B2 (en) Branched-chain derivatives having a sugar skeleton
WO2001077133A1 (en) 1-carboxymethyl analogues of lipid a
CN106608893A (en) Phosphoryl mannopentaose and derivatives thereof, and preparation methods and application thereof
HU217114B (en) Process for producing new monosaccharide derivatives and pharmaceutical compositions containing them
WO2000047595A1 (en) Ether type lipid a1-carboxylic acid analogues
CN1930180B (en) L-saccharide glucose lipid A analogue
JPH05202082A (en) 1-substituted lipid a analog